Virus name	Accession ID	Collection date	Location	Host	Passage	Specimen	Additional host information	Sequencing technology	Assembly method	Comment	Comment type	Lineage	Clade
hCoV-19/Switzerland/BE-ETHZ-481127/2021	EPI_ISL_1004032	2021-02-02	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177	GV
hCoV-19/Switzerland/BE-ETHZ-480533/2021	EPI_ISL_1004033	2021-02-02	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177	GV
hCoV-19/England/CAMC-120A9AC/2021	EPI_ISL_1012625	2021-02-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				V.1	GV
hCoV-19/Belgium/121020969/2021	EPI_ISL_1013771	2021-02-03	Europe / Belgium / Antwerp	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.177.77	GV
hCoV-19/Scotland/QEUH-109B131/2021	EPI_ISL_1019938	2021-01-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.77	GV
hCoV-19/Denmark/DCGC-42886/2021	EPI_ISL_1023164	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-42892/2021	EPI_ISL_1023170	2021-02-08	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44023/2021	EPI_ISL_1024401	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44029/2021	EPI_ISL_1024407	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44059/2021	EPI_ISL_1024437	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44095/2021	EPI_ISL_1024473	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44117/2021	EPI_ISL_1024495	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44232/2021	EPI_ISL_1024610	2021-02-01	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-45448/2020	EPI_ISL_1025826	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-45460/2020	EPI_ISL_1025838	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/England/ALDP-12A0BB1/2021	EPI_ISL_1043722	2021-02-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-1294B92/2021	EPI_ISL_1044943	2021-02-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/CAMC-12991AA/2021	EPI_ISL_1061449	2021-02-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 8 nucleotide(s) found at refpos 27571 (frameshift confirmed by the submitter). NS7a without BLAST coverage.	info	B.1.177.4	GV
hCoV-19/Denmark/DCGC-46782/2021	EPI_ISL_1066292	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-46900/2021	EPI_ISL_1066411	2021-02-15	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-46913/2020	EPI_ISL_1066424	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-46938/2021	EPI_ISL_1066449	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-46949/2021	EPI_ISL_1066460	2021-02-15	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Scotland/QEUH-96A96A/2020	EPI_ISL_534665	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.60	GV
hCoV-19/Scotland/QEUH-96B204/2020	EPI_ISL_534686	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-99234D/2020	EPI_ISL_540673	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/MILK-99236B/2020	EPI_ISL_540674	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NORW-EF9FD/2020	EPI_ISL_540698	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Spain/MD-IBV-99007146/2020	EPI_ISL_541918	2020-08-07	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/England/MILK-9A6ABA/2020	EPI_ISL_550065	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A91A3/2020	EPI_ISL_551213	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A9792/2020	EPI_ISL_551223	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-975C63/2020	EPI_ISL_552601	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-975911/2020	EPI_ISL_552624	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9751EC/2020	EPI_ISL_552634	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-974C55/2020	EPI_ISL_552688	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-975C36/2020	EPI_ISL_552695	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/SHEF-C6AF9/2020	EPI_ISL_559913	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-C9C96/2020	EPI_ISL_559927	2020-09-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-CD746/2020	EPI_ISL_559933	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-D1A64/2020	EPI_ISL_559941	2020-09-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-D1EFF/2020	EPI_ISL_559943	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/Scotland/CVR4297/2020	EPI_ISL_559968	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-997BE6/2020	EPI_ISL_559994	2020-08-28	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Scotland/QEUH-99B4C9/2020	EPI_ISL_559995	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Scotland/QEUH-99B4D8/2020	EPI_ISL_559996	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-9BEA91/2020	EPI_ISL_568006	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9BE985/2020	EPI_ISL_568010	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9BDDF3/2020	EPI_ISL_568118	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9BDBBD/2020	EPI_ISL_568123	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9BECB9/2020	EPI_ISL_568124	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-9BDE2D/2020	EPI_ISL_568129	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9BDB44/2020	EPI_ISL_568131	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9BE90D/2020	EPI_ISL_568133	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9BE17E/2020	EPI_ISL_568166	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9BEC40/2020	EPI_ISL_568181	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9BE509/2020	EPI_ISL_568197	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/SHEF-C33A6/2020	EPI_ISL_572961	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/ALDP-9B5F13/2020	EPI_ISL_572976	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16C14A/2020	EPI_ISL_574015	2020-09-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16C1B3/2020	EPI_ISL_574021	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16C1FF/2020	EPI_ISL_574024	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16C362/2020	EPI_ISL_574045	2020-09-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Scotland/QEUH-9DA5DA/2020	EPI_ISL_575348	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9DC1E3/2020	EPI_ISL_575376	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9D7DD5/2020	EPI_ISL_576630	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9D8C22/2020	EPI_ISL_576656	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9D8DB6/2020	EPI_ISL_576671	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9D8E0E/2020	EPI_ISL_576675	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.2	GV
hCoV-19/England/ALDP-9D90CB/2020	EPI_ISL_576696	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-9DE4AC/2020	EPI_ISL_581133	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9E3125/2020	EPI_ISL_581158	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9E318F/2020	EPI_ISL_581180	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9E229C/2020	EPI_ISL_581187	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A0C26E/2020	EPI_ISL_584968	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-A2F0F2/2020	EPI_ISL_587118	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2FC85/2020	EPI_ISL_587120	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2EFBA/2020	EPI_ISL_587123	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A2F669/2020	EPI_ISL_587135	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2F6A5/2020	EPI_ISL_587144	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-A2FAD6/2020	EPI_ISL_587151	2020-10-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2EE44/2020	EPI_ISL_587156	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A2F836/2020	EPI_ISL_587157	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2FCEF/2020	EPI_ISL_587160	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2F177/2020	EPI_ISL_587175	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2ECA4/2020	EPI_ISL_587188	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A2FE43/2020	EPI_ISL_587189	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2EC86/2020	EPI_ISL_587195	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 1 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-A2F70C/2020	EPI_ISL_587197	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2F274/2020	EPI_ISL_587245	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A2FD73/2020	EPI_ISL_587258	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F818/2020	EPI_ISL_587268	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2F49C/2020	EPI_ISL_587272	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A2F784/2020	EPI_ISL_587282	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2F9BB/2020	EPI_ISL_587286	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2ED83/2020	EPI_ISL_587289	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A2F4E7/2020	EPI_ISL_587292	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2EB2F/2020	EPI_ISL_587294	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2EEAE/2020	EPI_ISL_587295	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A1EBAA/2020	EPI_ISL_587320	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-A1DADB/2020	EPI_ISL_587321	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177.2	GV
hCoV-19/England/QEUH-A1F4EA/2020	EPI_ISL_587330	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A1E560/2020	EPI_ISL_587344	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A1E82B/2020	EPI_ISL_587349	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A1F471/2020	EPI_ISL_587351	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F5937/2020	EPI_ISL_588448	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F58EF/2020	EPI_ISL_588449	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F58B2/2020	EPI_ISL_588451	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F5005/2020	EPI_ISL_588456	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Northern Ireland/QEUH-9F32D4/2020	EPI_ISL_588484	2020-09-23	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9F322F/2020	EPI_ISL_588502	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F36AB/2020	EPI_ISL_588516	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F54EB/2020	EPI_ISL_588519	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F421F/2020	EPI_ISL_588592	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F3210/2020	EPI_ISL_588603	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F418B/2020	EPI_ISL_588609	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F3465/2020	EPI_ISL_588616	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F3C4F/2020	EPI_ISL_588629	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F381E/2020	EPI_ISL_588634	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F4349/2020	EPI_ISL_588652	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F417C/2020	EPI_ISL_588656	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F34ED/2020	EPI_ISL_588664	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-9EA0D6/2020	EPI_ISL_589781	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/ALDP-9EB002/2020	EPI_ISL_589784	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9D0905/2020	EPI_ISL_589961	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9D01B2/2020	EPI_ISL_589973	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Wales/PHWC-47EF57/2020	EPI_ISL_595616	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-9F6DD0/2020	EPI_ISL_595633	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-9F812D/2020	EPI_ISL_595732	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-9F8415/2020	EPI_ISL_595738	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-9F9C49/2020	EPI_ISL_595755	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Ireland/D-NVRL-73IRL76165/2020	EPI_ISL_596900	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL76166/2020	EPI_ISL_596901	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL76171/2020	EPI_ISL_596902	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL76167/2020	EPI_ISL_596904	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL76207/2020	EPI_ISL_596909	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KY-NVRL-73IRL83928/2020	EPI_ISL_596910	2020-09-15	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-73IRL76194/2020	EPI_ISL_596911	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL76233/2020	EPI_ISL_596913	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL85097/2020	EPI_ISL_596914	2020-09-16	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL76182/2020	EPI_ISL_596917	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KE-NVRL-73IRL78912/2020	EPI_ISL_596918	2020-09-15	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL84977/2020	EPI_ISL_596920	2020-09-16	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-73IRL76184/2020	EPI_ISL_596921	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL92397/2020	EPI_ISL_596923	2020-09-16	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-73IRL76176/2020	EPI_ISL_596924	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL76188/2020	EPI_ISL_596925	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/OY-NVRL-73IRL87287/2020	EPI_ISL_596927	2020-09-16	Europe / Ireland / Offaly	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/England/CAMC-A5948A/2020	EPI_ISL_596954	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A58B3B/2020	EPI_ISL_596966	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A5962A/2020	EPI_ISL_596968	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A58E32/2020	EPI_ISL_596978	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A515E9/2020	EPI_ISL_598000	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A0B9D3/2020	EPI_ISL_599167	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0B9E2/2020	EPI_ISL_599178	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0B092/2020	EPI_ISL_599184	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0B1EA/2020	EPI_ISL_599192	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A0B95B/2020	EPI_ISL_599198	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0BFD1/2020	EPI_ISL_599199	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0B44B/2020	EPI_ISL_599217	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0AE99/2020	EPI_ISL_599234	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-A0AF87/2020	EPI_ISL_599263	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A0B0CF/2020	EPI_ISL_599285	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A0AF96/2020	EPI_ISL_599289	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0BE4D/2020	EPI_ISL_599297	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A0B733/2020	EPI_ISL_599309	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A0AB56/2020	EPI_ISL_599327	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0BA85/2020	EPI_ISL_599328	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-9FA950/2020	EPI_ISL_600612	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Scotland/QEUH-9F4A62/2020	EPI_ISL_600711	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7A69C/2020	EPI_ISL_606804	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7A007/2020	EPI_ISL_606812	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	G
hCoV-19/England/MILK-A7A5AE/2020	EPI_ISL_606820	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A79E0E/2020	EPI_ISL_606823	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A79A19/2020	EPI_ISL_606825	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A79590/2020	EPI_ISL_606840	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7CEB0/2020	EPI_ISL_606849	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A799C1/2020	EPI_ISL_606864	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A79DF2/2020	EPI_ISL_606870	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A796AC/2020	EPI_ISL_606876	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A79A91/2020	EPI_ISL_606882	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A79E3B/2020	EPI_ISL_606885	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7CE83/2020	EPI_ISL_606920	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6CA0A/2020	EPI_ISL_606930	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6CA55/2020	EPI_ISL_606953	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6EEFD/2020	EPI_ISL_606954	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A6DD5B/2020	EPI_ISL_606963	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6EA9F/2020	EPI_ISL_606966	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6C9C1/2020	EPI_ISL_606980	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6BE4B/2020	EPI_ISL_609059	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A64905/2020	EPI_ISL_609077	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A69302/2020	EPI_ISL_609085	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-A6C0AE/2020	EPI_ISL_609128	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A68057/2020	EPI_ISL_609132	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A680FD/2020	EPI_ISL_609146	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67FC4/2020	EPI_ISL_609150	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-A6461D/2020	EPI_ISL_609156	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/CAMC-A58A6B/2020	EPI_ISL_609161	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/CAMC-A59657/2020	EPI_ISL_609174	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/CAMC-A57501/2020	EPI_ISL_609180	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/QEUH-A5E77D/2020	EPI_ISL_609190	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-A5E3B5/2020	EPI_ISL_609191	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AA03E1/2020	EPI_ISL_611374	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AA0211/2020	EPI_ISL_611379	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A9EED6/2020	EPI_ISL_611384	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A9FDC9/2020	EPI_ISL_611389	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-AA03B4/2020	EPI_ISL_611410	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A9EF4C/2020	EPI_ISL_611418	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A9FDE7/2020	EPI_ISL_611421	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AA028A/2020	EPI_ISL_611427	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A9F5FE/2020	EPI_ISL_611437	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A9FE02/2020	EPI_ISL_611442	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A9B668/2020	EPI_ISL_611451	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A9FE11/2020	EPI_ISL_611452	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-AA01C9/2020	EPI_ISL_611462	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AA02A8/2020	EPI_ISL_611473	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A9F655/2020	EPI_ISL_611478	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/NOTT-1183FC/2020	EPI_ISL_612601	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-118408/2020	EPI_ISL_612602	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-47F8F1/2020	EPI_ISL_612742	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-47FABF/2020	EPI_ISL_612768	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-47FBDA/2020	EPI_ISL_612784	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Denmark/DCGC-4204/2020	EPI_ISL_622097	2020-09-14	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.177.57	GV
hCoV-19/England/MILK-AB7A4C/2020	EPI_ISL_623354	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ABB468/2020	EPI_ISL_623358	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AAFD4E/2020	EPI_ISL_623360	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AB80B2/2020	EPI_ISL_623372	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ABB7C9/2020	EPI_ISL_623376	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ABB79C/2020	EPI_ISL_623378	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AB748A/2020	EPI_ISL_623382	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-AB8216/2020	EPI_ISL_623403	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.77	GV
hCoV-19/England/CAMC-AAFD3F/2020	EPI_ISL_623411	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AB8692/2020	EPI_ISL_623412	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ABB741/2020	EPI_ISL_623416	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-AB7790/2020	EPI_ISL_623429	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AB77AF/2020	EPI_ISL_623452	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-AB801C/2020	EPI_ISL_623461	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AB7806/2020	EPI_ISL_623469	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AAFE78/2020	EPI_ISL_623494	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AAFB44/2020	EPI_ISL_623495	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A94CC7/2020	EPI_ISL_624713	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-A9614E/2020	EPI_ISL_624719	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A95DF0/2020	EPI_ISL_624720	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A96472/2020	EPI_ISL_624730	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A94C7C/2020	EPI_ISL_624731	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A94B51/2020	EPI_ISL_624734	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A958FF/2020	EPI_ISL_624749	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A961B7/2020	EPI_ISL_624774	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A95D2D/2020	EPI_ISL_624787	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A95EEE/2020	EPI_ISL_624792	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-485306/2020	EPI_ISL_628167	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-485360/2020	EPI_ISL_628172	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-485728/2020	EPI_ISL_628211	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-485755/2020	EPI_ISL_628214	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-485AB6/2020	EPI_ISL_628248	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-485AE3/2020	EPI_ISL_628251	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-485C65/2020	EPI_ISL_628270	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-485DAE/2020	EPI_ISL_628279	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-485DBD/2020	EPI_ISL_628280	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-48604A/2020	EPI_ISL_628303	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/England/PORT-2D7282/2020	EPI_ISL_628329	2020-10-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A3228D/2020	EPI_ISL_628338	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A323F3/2020	EPI_ISL_628351	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/MILK-AC8082/2020	EPI_ISL_629496	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACE7A5/2020	EPI_ISL_629501	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACF1E2/2020	EPI_ISL_629505	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/MILK-ACEABB/2020	EPI_ISL_629506	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ACE7D2/2020	EPI_ISL_629510	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACFA50/2020	EPI_ISL_629530	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AC8DF4/2020	EPI_ISL_629561	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AC81BC/2020	EPI_ISL_629577	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC7EE3/2020	EPI_ISL_629578	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACF1B5/2020	EPI_ISL_629584	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC8F0D/2020	EPI_ISL_629586	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACF0F4/2020	EPI_ISL_629615	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC8055/2020	EPI_ISL_629639	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC931F/2020	EPI_ISL_629646	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC9081/2020	EPI_ISL_629655	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-AC7F0E/2020	EPI_ISL_629667	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC9124/2020	EPI_ISL_629670	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AC8231/2020	EPI_ISL_629674	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A6703A/2020	EPI_ISL_630481	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A68DE7/2020	EPI_ISL_630487	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A66E22/2020	EPI_ISL_630498	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67270/2020	EPI_ISL_630510	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67207/2020	EPI_ISL_630517	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A686CE/2020	EPI_ISL_630523	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A66FA7/2020	EPI_ISL_630525	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A676ED/2020	EPI_ISL_630534	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A66BA3/2020	EPI_ISL_630539	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A679D5/2020	EPI_ISL_630542	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A68DC9/2020	EPI_ISL_630551	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A671EC/2020	EPI_ISL_630552	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A668AC/2020	EPI_ISL_630561	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67683/2020	EPI_ISL_630588	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6702B/2020	EPI_ISL_630589	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A679E4/2020	EPI_ISL_630594	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67049/2020	EPI_ISL_630595	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67586/2020	EPI_ISL_630599	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A678C9/2020	EPI_ISL_630602	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A675B3/2020	EPI_ISL_630606	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A686BF/2020	EPI_ISL_630617	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A67920/2020	EPI_ISL_630637	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A670EF/2020	EPI_ISL_630638	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A66C82/2020	EPI_ISL_630653	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A68DAB/2020	EPI_ISL_630654	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A66A2E/2020	EPI_ISL_630660	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A670FE/2020	EPI_ISL_630661	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AD526E/2020	EPI_ISL_634001	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD3770/2020	EPI_ISL_634006	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD298A/2020	EPI_ISL_634023	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD053D/2020	EPI_ISL_634037	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD50BF/2020	EPI_ISL_634048	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD0CCF/2020	EPI_ISL_634049	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD50A0/2020	EPI_ISL_634081	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD4108/2020	EPI_ISL_634084	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD3804/2020	EPI_ISL_634086	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD6643/2020	EPI_ISL_634100	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD4988/2020	EPI_ISL_634105	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD246B/2020	EPI_ISL_634112	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD4A0D/2020	EPI_ISL_634115	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD294E/2020	EPI_ISL_634130	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD2C63/2020	EPI_ISL_634136	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD5116/2020	EPI_ISL_634157	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD30EE/2020	EPI_ISL_634166	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD2261/2020	EPI_ISL_634180	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD51BC/2020	EPI_ISL_634192	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD3B92/2020	EPI_ISL_634199	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/CAMC-9DF256/2020	EPI_ISL_639003	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.177.3	GV
hCoV-19/England/QEUH-B11E52/2020	EPI_ISL_642468	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B10F23/2020	EPI_ISL_642482	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B10C0E/2020	EPI_ISL_642491	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B144D5/2020	EPI_ISL_642496	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B12B1E/2020	EPI_ISL_642497	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B12AE4/2020	EPI_ISL_642503	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B1012D/2020	EPI_ISL_642513	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B100F3/2020	EPI_ISL_642519	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0F1B8/2020	EPI_ISL_642523	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B1201F/2020	EPI_ISL_642531	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B10B98/2020	EPI_ISL_642571	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B10B2F/2020	EPI_ISL_642585	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B108FB/2020	EPI_ISL_642614	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B1003F/2020	EPI_ISL_642622	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-B11371/2020	EPI_ISL_642648	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B07077/2020	EPI_ISL_643801	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B082E9/2020	EPI_ISL_643827	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B09260/2020	EPI_ISL_643843	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B085C2/2020	EPI_ISL_643857	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B071DE/2020	EPI_ISL_643866	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B074A8/2020	EPI_ISL_643868	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B08270/2020	EPI_ISL_643872	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B07FD4/2020	EPI_ISL_643922	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B07253/2020	EPI_ISL_643932	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/CAMC-B088E7/2020	EPI_ISL_643934	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B07129/2020	EPI_ISL_643944	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-B0828F/2020	EPI_ISL_643952	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B08CBE/2020	EPI_ISL_643955	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B0927F/2020	EPI_ISL_643958	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B07684/2020	EPI_ISL_643959	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B08BDF/2020	EPI_ISL_643965	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACD1B7/2020	EPI_ISL_643984	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1AC22/2020	EPI_ISL_646002	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1B82D/2020	EPI_ISL_646005	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1AC40/2020	EPI_ISL_646010	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B1ACAA/2020	EPI_ISL_646011	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B1F874/2020	EPI_ISL_646019	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1A369/2020	EPI_ISL_646021	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1A30F/2020	EPI_ISL_646024	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B1AD7A/2020	EPI_ISL_646026	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B1FA7E/2020	EPI_ISL_646029	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1C060/2020	EPI_ISL_646043	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1AE4A/2020	EPI_ISL_646044	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B1AE68/2020	EPI_ISL_646048	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B1A2E4/2020	EPI_ISL_646059	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B1FA14/2020	EPI_ISL_646069	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1B869/2020	EPI_ISL_646074	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1BD79/2020	EPI_ISL_646079	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1AEB3/2020	EPI_ISL_646081	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B22586/2020	EPI_ISL_646105	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B1F7B3/2020	EPI_ISL_646109	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1A35A/2020	EPI_ISL_646111	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1A40C/2020	EPI_ISL_646114	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B1A387/2020	EPI_ISL_646119	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1D5BB/2020	EPI_ISL_646121	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2E1C2/2020	EPI_ISL_646142	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B240DE/2020	EPI_ISL_646148	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B23C80/2020	EPI_ISL_646157	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-B23ED5/2020	EPI_ISL_646170	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B21CFB/2020	EPI_ISL_647332	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B213AB/2020	EPI_ISL_647333	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B227DB/2020	EPI_ISL_647337	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B21930/2020	EPI_ISL_647361	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B22A3C/2020	EPI_ISL_647364	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B22841/2020	EPI_ISL_647372	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B217CD/2020	EPI_ISL_647386	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B22647/2020	EPI_ISL_647403	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B219E5/2020	EPI_ISL_647414	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B2160C/2020	EPI_ISL_647426	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B22F3D/2020	EPI_ISL_647434	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B2148A/2020	EPI_ISL_647442	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B21499/2020	EPI_ISL_647444	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B22A2D/2020	EPI_ISL_647447	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B224F2/2020	EPI_ISL_647448	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B22BDF/2020	EPI_ISL_647456	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B219F4/2020	EPI_ISL_647459	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B1AA37/2020	EPI_ISL_647468	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B1FCC3/2020	EPI_ISL_647470	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1AA91/2020	EPI_ISL_647473	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1A466/2020	EPI_ISL_647477	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B206FE/2020	EPI_ISL_647481	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B20E7E/2020	EPI_ISL_647482	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.60	GV
hCoV-19/Spain/PV-IBV-98008335/2020	EPI_ISL_654568	2020-10-09	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/England/QEUH-B6600D/2020	EPI_ISL_655769	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5C3D4/2020	EPI_ISL_655774	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6C7C6/2020	EPI_ISL_655780	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5C538/2020	EPI_ISL_655787	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B65EC8/2020	EPI_ISL_655788	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5BF59/2020	EPI_ISL_655791	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5C50B/2020	EPI_ISL_655801	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B5CCBB/2020	EPI_ISL_655803	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5CAB1/2020	EPI_ISL_655820	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5BF2C/2020	EPI_ISL_655823	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5C820/2020	EPI_ISL_655824	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B5C714/2020	EPI_ISL_655829	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B5BED4/2020	EPI_ISL_655837	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5CB27/2020	EPI_ISL_655844	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5CA84/2020	EPI_ISL_655851	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-B5BFD1/2020	EPI_ISL_655852	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B5CE2E/2020	EPI_ISL_655853	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B660B2/2020	EPI_ISL_655854	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5CF0D/2020	EPI_ISL_655855	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B65EE6/2020	EPI_ISL_655861	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5BF68/2020	EPI_ISL_655872	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5CEF1/2020	EPI_ISL_655890	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B65EAA/2020	EPI_ISL_655891	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B5CE79/2020	EPI_ISL_655894	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B5CC7F/2020	EPI_ISL_655902	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5C7D8/2020	EPI_ISL_655919	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5C6BD/2020	EPI_ISL_655930	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B5C6AE/2020	EPI_ISL_655946	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B5CA57/2020	EPI_ISL_655955	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B5BF86/2020	EPI_ISL_655963	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B54F50/2020	EPI_ISL_658017	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B5167C/2020	EPI_ISL_658020	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B54AAA/2020	EPI_ISL_658021	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B54A31/2020	EPI_ISL_658026	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B514DC/2020	EPI_ISL_658034	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B511F3/2020	EPI_ISL_658036	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B54C86/2020	EPI_ISL_658038	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B51102/2020	EPI_ISL_658046	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B55353/2020	EPI_ISL_658047	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B54AD7/2020	EPI_ISL_658058	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B5A44C/2020	EPI_ISL_658067	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-B55BD3/2020	EPI_ISL_658070	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B5A576/2020	EPI_ISL_658103	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B55D91/2020	EPI_ISL_658108	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B55DBF/2020	EPI_ISL_658130	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B55DA0/2020	EPI_ISL_658132	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B5A85F/2020	EPI_ISL_658139	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B5A3C7/2020	EPI_ISL_658140	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B55DFB/2020	EPI_ISL_658141	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B5A27F/2020	EPI_ISL_658169	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B545E5/2020	EPI_ISL_658181	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B55DDD/2020	EPI_ISL_658184	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B5A488/2020	EPI_ISL_658185	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B545D6/2020	EPI_ISL_658191	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/CAMC-B54767/2020	EPI_ISL_658198	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B3341C/2020	EPI_ISL_659301	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B33C6F/2020	EPI_ISL_659319	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B32C15/2020	EPI_ISL_659328	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B3326D/2020	EPI_ISL_659334	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B334EF/2020	EPI_ISL_659339	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B33018/2020	EPI_ISL_659357	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B32BDC/2020	EPI_ISL_659370	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B33F57/2020	EPI_ISL_659376	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B32204/2020	EPI_ISL_659382	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B322D7/2020	EPI_ISL_659383	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B323C5/2020	EPI_ISL_659385	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B33C7E/2020	EPI_ISL_659388	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177.56	GV
hCoV-19/England/CAMC-B33B62/2020	EPI_ISL_659413	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B32C24/2020	EPI_ISL_659423	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-B3424E/2020	EPI_ISL_659425	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B3566F/2020	EPI_ISL_659444	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B32969/2020	EPI_ISL_659455	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B3483D/2020	EPI_ISL_659479	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B3476D/2020	EPI_ISL_659495	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6C571/2020	EPI_ISL_661602	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B66665/2020	EPI_ISL_661612	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B67DF6/2020	EPI_ISL_661628	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B7FE70/2020	EPI_ISL_661642	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B779C2/2020	EPI_ISL_661647	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B8052C/2020	EPI_ISL_661648	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B7793B/2020	EPI_ISL_661664	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B779FF/2020	EPI_ISL_661684	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B78387/2020	EPI_ISL_661697	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B7ED0B/2020	EPI_ISL_661701	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B81039/2020	EPI_ISL_661703	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B8101B/2020	EPI_ISL_661719	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B80559/2020	EPI_ISL_661722	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B8229C/2020	EPI_ISL_661725	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B80A96/2020	EPI_ISL_661748	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B78396/2020	EPI_ISL_661775	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B77B53/2020	EPI_ISL_661783	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B7FF6E/2020	EPI_ISL_661787	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF5884/2020	EPI_ISL_662938	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AF5E55/2020	EPI_ISL_662947	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF514D/2020	EPI_ISL_662963	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AF56E4/2020	EPI_ISL_662967	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AF4BF5/2020	EPI_ISL_662973	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF55AB/2020	EPI_ISL_662978	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF4894/2020	EPI_ISL_662981	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF674A/2020	EPI_ISL_662999	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/LOND-12506BF/2020	EPI_ISL_665226	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-48CB70/2020	EPI_ISL_666513	2020-10-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-48CBDA/2020	EPI_ISL_666518	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-48D140/2020	EPI_ISL_666585	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Australia/NSW1186/2020	EPI_ISL_667787	2020-10-21	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B78ADD/2020	EPI_ISL_667815	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B79D5B/2020	EPI_ISL_667823	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B79DB5/2020	EPI_ISL_667862	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B78DC5/2020	EPI_ISL_667869	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B79DF1/2020	EPI_ISL_667871	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B7E530/2020	EPI_ISL_667889	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B7EDED/2020	EPI_ISL_667893	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-B79DE2/2020	EPI_ISL_667896	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B7E9AD/2020	EPI_ISL_667927	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B9AE7F/2020	EPI_ISL_673613	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B9A352/2020	EPI_ISL_673615	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B98D74/2020	EPI_ISL_673647	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B98E71/2020	EPI_ISL_673648	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B99E9E/2020	EPI_ISL_673671	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B98A6E/2020	EPI_ISL_673682	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B99F40/2020	EPI_ISL_673693	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B94B7E/2020	EPI_ISL_673702	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B9AE8E/2020	EPI_ISL_673707	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B99E61/2020	EPI_ISL_673710	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B98D38/2020	EPI_ISL_673711	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B9A219/2020	EPI_ISL_673718	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B998EB/2020	EPI_ISL_673734	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B98891/2020	EPI_ISL_673755	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-B983EB/2020	EPI_ISL_673756	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B98512/2020	EPI_ISL_673757	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B9AE33/2020	EPI_ISL_673758	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B94FEB/2020	EPI_ISL_673765	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B95102/2020	EPI_ISL_673787	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B949DE/2020	EPI_ISL_673790	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B95524/2020	EPI_ISL_673798	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B98187/2020	EPI_ISL_674917	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B9807B/2020	EPI_ISL_674923	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B980F3/2020	EPI_ISL_674962	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B96DC1/2020	EPI_ISL_674966	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B9765C/2020	EPI_ISL_674970	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B96C2E/2020	EPI_ISL_674971	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B961E3/2020	EPI_ISL_674979	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B95ACB/2020	EPI_ISL_674994	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Belgium/ULG-10874/2020	EPI_ISL_678417	2020-11-13	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/Belgium/ULG-10883/2020	EPI_ISL_678426	2020-11-13	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/Belgium/ULG-10893/2020	EPI_ISL_678435	2020-11-14	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/England/MILK-B3ADFC/2020	EPI_ISL_679732	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3B0F2/2020	EPI_ISL_679743	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3B2B0/2020	EPI_ISL_679747	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3BDDD/2020	EPI_ISL_679811	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3CCDF/2020	EPI_ISL_679829	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3D2FA/2020	EPI_ISL_679834	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3E2DB/2020	EPI_ISL_679851	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B599D5/2020	EPI_ISL_679895	2020-11-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/MILK-B59AF0/2020	EPI_ISL_679907	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/Wales/PHWC-48E482/2020	EPI_ISL_680863	2020-11-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-48E640/2020	EPI_ISL_680889	2020-11-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/England/ALDP-BBAFA3/2020	EPI_ISL_701678	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB8E3F/2020	EPI_ISL_702807	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB99E2/2020	EPI_ISL_702811	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB9BFB/2020	EPI_ISL_702912	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-BB599B/2020	EPI_ISL_702914	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-BB9CBC/2020	EPI_ISL_702924	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BB28CE/2020	EPI_ISL_702929	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB27EF/2020	EPI_ISL_702938	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BB8E20/2020	EPI_ISL_702943	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BB995B/2020	EPI_ISL_702958	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-BB3256/2020	EPI_ISL_702995	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BC0A6D/2020	EPI_ISL_705016	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BC0405/2020	EPI_ISL_705073	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BC08DC/2020	EPI_ISL_705085	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BC0EE9/2020	EPI_ISL_705131	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BBFF08/2020	EPI_ISL_705177	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/NORT-1B71FA5/2020	EPI_ISL_706329	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NORT-28D582/2020	EPI_ISL_706349	2020-11-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NORT-2A75A0/2020	EPI_ISL_706354	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NORW-EED6B/2020	EPI_ISL_706357	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-EEEB3/2020	EPI_ISL_706360	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F62AD/2020	EPI_ISL_706362	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F62F8/2020	EPI_ISL_706363	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F639B/2020	EPI_ISL_706364	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F646B/2020	EPI_ISL_706366	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1	G
hCoV-19/England/NORW-F653B/2020	EPI_ISL_706367	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F6568/2020	EPI_ISL_706368	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/NORW-F6726/2020	EPI_ISL_706375	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F6744/2020	EPI_ISL_706376	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F6771/2020	EPI_ISL_706377	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F700C/2020	EPI_ISL_706388	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F7057/2020	EPI_ISL_706389	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F7172/2020	EPI_ISL_706390	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F734F/2020	EPI_ISL_706392	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F76FB/2020	EPI_ISL_706400	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NOTT-11D2DC/2020	EPI_ISL_706420	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D7BF/2020	EPI_ISL_706421	2020-11-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11DAF2/2020	EPI_ISL_706422	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11DB0E/2020	EPI_ISL_706423	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11DB3B/2020	EPI_ISL_706424	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11DF7B/2020	EPI_ISL_706426	2020-11-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11E2AE/2020	EPI_ISL_706427	2020-11-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11E6A2/2020	EPI_ISL_706428	2020-11-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11ECCE/2020	EPI_ISL_706429	2020-12-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11ECEC/2020	EPI_ISL_706430	2020-12-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11F3F5/2020	EPI_ISL_706431	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1201BB/2020	EPI_ISL_706435	2020-12-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1202F4/2020	EPI_ISL_706437	2020-12-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-49047E/2020	EPI_ISL_706481	2020-10-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-4904BA/2020	EPI_ISL_706483	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-490687/2020	EPI_ISL_706499	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-BE9354/2020	EPI_ISL_708960	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BE8F9D/2020	EPI_ISL_708967	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BE8E36/2020	EPI_ISL_708973	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BE905D/2020	EPI_ISL_708974	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BE9697/2020	EPI_ISL_708977	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Denmark/DCGC-16535/2020	EPI_ISL_714822	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-16554/2020	EPI_ISL_714834	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/England/CAMC-C466F1/2020	EPI_ISL_718357	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C46381/2020	EPI_ISL_718385	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-C45F9D/2020	EPI_ISL_718424	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C46B5C/2020	EPI_ISL_718450	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-C4698F/2020	EPI_ISL_718477	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BA1974/2020	EPI_ISL_719705	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BA0ADC/2020	EPI_ISL_719712	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BA191A/2020	EPI_ISL_719715	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-BA03A4/2020	EPI_ISL_719720	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BA0A72/2020	EPI_ISL_719724	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-BA08C3/2020	EPI_ISL_719726	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B9ECAE/2020	EPI_ISL_719727	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B9FF59/2020	EPI_ISL_719729	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BA04FC/2020	EPI_ISL_719750	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B9EED5/2020	EPI_ISL_719766	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-BA078A/2020	EPI_ISL_719770	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BA0720/2020	EPI_ISL_719789	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B9FFE0/2020	EPI_ISL_719790	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BA074E/2020	EPI_ISL_719792	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-BA0562/2020	EPI_ISL_719798	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BAC85E/2020	EPI_ISL_720632	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB1B11/2020	EPI_ISL_720642	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAC5C0/2020	EPI_ISL_720643	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BAC5B1/2020	EPI_ISL_720653	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BAC803/2020	EPI_ISL_720655	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BB0C1F/2020	EPI_ISL_720661	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAC311/2020	EPI_ISL_720662	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C049D8/2020	EPI_ISL_720694	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C006D5/2020	EPI_ISL_720698	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BFCC17/2020	EPI_ISL_720706	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BFCB47/2020	EPI_ISL_720724	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C008C0/2020	EPI_ISL_720725	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C01337/2020	EPI_ISL_720728	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C04A4E/2020	EPI_ISL_720741	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C049BA/2020	EPI_ISL_720745	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BFF5FB/2020	EPI_ISL_720747	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C00884/2020	EPI_ISL_720753	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C04A6C/2020	EPI_ISL_720770	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C0068A/2020	EPI_ISL_720772	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C01391/2020	EPI_ISL_720776	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C04B0F/2020	EPI_ISL_720779	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-C01355/2020	EPI_ISL_720792	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-BFF5EC/2020	EPI_ISL_720797	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/EXET-1393F5/2020	EPI_ISL_724253	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NORW-FA3D3/2020	EPI_ISL_725501	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-FA3E2/2020	EPI_ISL_725502	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NOTT-11E305/2020	EPI_ISL_725525	2020-11-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11E745/2020	EPI_ISL_725534	2020-11-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11E754/2020	EPI_ISL_725535	2020-11-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11E763/2020	EPI_ISL_725536	2020-11-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11E772/2020	EPI_ISL_725537	2020-11-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11EF7A/2020	EPI_ISL_725538	2020-12-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11F629/2020	EPI_ISL_725548	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11F638/2020	EPI_ISL_725549	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11F6CF/2020	EPI_ISL_725555	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11F726/2020	EPI_ISL_725560	2020-11-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11F762/2020	EPI_ISL_725563	2020-11-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11F771/2020	EPI_ISL_725564	2020-11-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11F7BD/2020	EPI_ISL_725568	2020-11-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11F7CC/2020	EPI_ISL_725569	2020-11-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11F920/2020	EPI_ISL_725586	2020-11-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11F93F/2020	EPI_ISL_725587	2020-11-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-12040D/2020	EPI_ISL_725613	2020-12-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-120555/2020	EPI_ISL_725626	2020-12-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1205DD/2020	EPI_ISL_725631	2020-12-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-49743B/2020	EPI_ISL_726830	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4976CC/2020	EPI_ISL_726867	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-497A93/2020	EPI_ISL_726927	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-C39AB9/2020	EPI_ISL_731313	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3912D/2020	EPI_ISL_731323	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C31091/2020	EPI_ISL_731345	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C3132F/2020	EPI_ISL_731349	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C391C3/2020	EPI_ISL_731351	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C39390/2020	EPI_ISL_731363	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C312E6/2020	EPI_ISL_731378	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3ACFE/2020	EPI_ISL_731388	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.54	GV
hCoV-19/England/ALDP-C3AD46/2020	EPI_ISL_731391	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C30A2B/2020	EPI_ISL_731393	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C312F5/2020	EPI_ISL_731400	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C310DD/2020	EPI_ISL_731417	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3AB2E/2020	EPI_ISL_731434	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3A46F/2020	EPI_ISL_731448	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-C31240/2020	EPI_ISL_731466	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-C30A49/2020	EPI_ISL_731479	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C39239/2020	EPI_ISL_731483	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C30AC1/2020	EPI_ISL_731485	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Spain/RI-IBV-99010953/2020	EPI_ISL_732783	2020-09-13	Europe / Spain / La_Rioja / Logrono	Human	Original			Illumina_MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/England/MILK-C2F6C1/2020	EPI_ISL_733902	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C2FAA7/2020	EPI_ISL_733904	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C33F29/2020	EPI_ISL_733916	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C34535/2020	EPI_ISL_733918	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-C3427A/2020	EPI_ISL_733924	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C346BA/2020	EPI_ISL_733927	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-C343B3/2020	EPI_ISL_733928	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C33ED1/2020	EPI_ISL_733940	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C33B07/2020	EPI_ISL_733970	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-C33FED/2020	EPI_ISL_733979	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C34526/2020	EPI_ISL_733983	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C57F4D/2020	EPI_ISL_736189	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/SHEF-10D374A/2020	EPI_ISL_742059	2020-12-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10D5C94/2020	EPI_ISL_742081	2020-12-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Northern Ireland/NIRE-23562C/2020	EPI_ISL_742122	2020-11-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/Northern Ireland/NIRE-23564A/2020	EPI_ISL_742123	2020-10-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235677/2020	EPI_ISL_742124	2020-10-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.2	GV
hCoV-19/Northern Ireland/NIRE-235686/2020	EPI_ISL_742125	2020-10-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.2	GV
hCoV-19/Northern Ireland/NIRE-235695/2020	EPI_ISL_742126	2020-11-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2356C2/2020	EPI_ISL_742129	2020-11-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.2	GV
hCoV-19/Northern Ireland/NIRE-2356D1/2020	EPI_ISL_742130	2020-11-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.2	GV
hCoV-19/Northern Ireland/NIRE-2356FF/2020	EPI_ISL_742131	2020-11-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23570B/2020	EPI_ISL_742132	2020-11-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235729/2020	EPI_ISL_742134	2020-11-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.2	GV
hCoV-19/Northern Ireland/NIRE-2357B0/2020	EPI_ISL_742143	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2357CF/2020	EPI_ISL_742144	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2357DE/2020	EPI_ISL_742145	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2357ED/2020	EPI_ISL_742146	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235808/2020	EPI_ISL_742148	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235817/2020	EPI_ISL_742149	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235826/2020	EPI_ISL_742150	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235835/2020	EPI_ISL_742151	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235844/2020	EPI_ISL_742152	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235853/2020	EPI_ISL_742153	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235862/2020	EPI_ISL_742154	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235871/2020	EPI_ISL_742155	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235880/2020	EPI_ISL_742156	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23589F/2020	EPI_ISL_742157	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2358AE/2020	EPI_ISL_742158	2020-11-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2358EA/2020	EPI_ISL_742161	2020-11-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.2	GV
hCoV-19/Northern Ireland/NIRE-2358F9/2020	EPI_ISL_742162	2020-11-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.2	GV
hCoV-19/Wales/PHWC-49F9BC/2020	EPI_ISL_743300	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-49F9CB/2020	EPI_ISL_743301	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-49FA13/2020	EPI_ISL_743306	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-49FA31/2020	EPI_ISL_743308	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-49FA6E/2020	EPI_ISL_743311	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-49FA7D/2020	EPI_ISL_743312	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-49FC68/2020	EPI_ISL_743338	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-49FF41/2020	EPI_ISL_743372	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49FF50/2020	EPI_ISL_743373	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49FF7E/2020	EPI_ISL_743375	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49FF8D/2020	EPI_ISL_743376	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Luxembourg/LNS7741644/2020	EPI_ISL_744624	2020-11-03	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS7760954/2020	EPI_ISL_744628	2020-10-26	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS7844782/2020	EPI_ISL_744642	2020-10-26	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS7937572/2020	EPI_ISL_744658	2020-10-27	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS8070453/2020	EPI_ISL_744676	2020-12-18	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS8419054/2020	EPI_ISL_744734	2020-12-16	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS8483681/2020	EPI_ISL_744744	2020-10-27	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Denmark/DCGC-18640/2020	EPI_ISL_749522	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.177.77	GV
hCoV-19/Denmark/DCGC-17794/2020	EPI_ISL_749572	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-16749/2020	EPI_ISL_750537	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-16847/2020	EPI_ISL_750599	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-16868/2020	EPI_ISL_750611	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/ALDP-C8B5A8/2020	EPI_ISL_756612	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-C8AC68/2020	EPI_ISL_756620	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-C84EE0/2020	EPI_ISL_756675	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C7B611/2020	EPI_ISL_756778	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB5E31/2020	EPI_ISL_761119	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/ALDP-CB59B8/2020	EPI_ISL_761129	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB4685/2020	EPI_ISL_761164	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB3C48/2020	EPI_ISL_761174	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-CB4AD4/2020	EPI_ISL_761192	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB3853/2020	EPI_ISL_761201	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB3DEB/2020	EPI_ISL_761248	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB4694/2020	EPI_ISL_761253	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB4069/2020	EPI_ISL_761261	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB4B59/2020	EPI_ISL_761265	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB498C/2020	EPI_ISL_761279	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-CB3FE5/2020	EPI_ISL_761282	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB399C/2020	EPI_ISL_761295	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-CA9D06/2020	EPI_ISL_762507	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-CA458B/2020	EPI_ISL_762542	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-BC7644/2020	EPI_ISL_767321	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/ALDP-BC7653/2020	EPI_ISL_767330	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-AIIDV1085v1/2020	EPI_ISL_768765	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-AIIDM0161v1/2020	EPI_ISL_768766	2020-09-21	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-AIIDV1088v1/2020	EPI_ISL_768767	2020-09-10	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-AIIDM0156v1/2020	EPI_ISL_768768	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-AIIDVNA883v1/2020	EPI_ISL_768769	2020-09-20	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/WW-NVRL-AIIDV1098v1/2020	EPI_ISL_768771	2020-09-18	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-AIIDV1190v1/2020	EPI_ISL_768774	2020-10-06	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-AIIDV1213v1/2020	EPI_ISL_768777	2020-10-08	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-AIIDV1252v1/2020	EPI_ISL_768781	2020-10-21	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/WW-NVRL-AIIDV1257v1/2020	EPI_ISL_768782	2020-10-21	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-AIIDM0179v1/2020	EPI_ISL_768787	2020-11-03	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Luxembourg/LNS5755279/2020	EPI_ISL_770915	2020-11-29	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS9974678/2020	EPI_ISL_770924	2020-11-29	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS5453199/2020	EPI_ISL_770934	2020-12-01	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2609501/2020	EPI_ISL_770936	2020-12-01	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS7935054/2020	EPI_ISL_770938	2020-11-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS5239699/2020	EPI_ISL_770940	2020-11-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0490955/2020	EPI_ISL_770954	2020-12-01	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS8056927/2020	EPI_ISL_770955	2020-12-01	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS7574226/2020	EPI_ISL_770962	2020-11-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2332603/2020	EPI_ISL_770965	2020-11-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS9749716/2020	EPI_ISL_770980	2020-12-03	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0276550/2020	EPI_ISL_770981	2020-12-03	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2320968/2020	EPI_ISL_770983	2020-12-03	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS4511488/2020	EPI_ISL_770993	2020-12-02	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177	GV
hCoV-19/Luxembourg/LNS8199676/2020	EPI_ISL_770996	2020-12-01	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/England/QEUH-CC2D43/2020	EPI_ISL_778042	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CC07B0/2020	EPI_ISL_778048	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-CC25D2/2020	EPI_ISL_778098	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CC2DBC/2020	EPI_ISL_778156	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Australia/NT92/2021	EPI_ISL_779410	2021-01-03	Oceania / Australia / Northern Territory	Human	Original			Illumina iSeq	ARTIC v3, minimap2 v2.17, ivar v1.3, samtools v1.11			B.1.177.60	GV
hCoV-19/England/CAMC-CF5309/2020	EPI_ISL_781620	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-CFDA2A/2020	EPI_ISL_781641	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-CF4944/2020	EPI_ISL_781678	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-CF52FD/2020	EPI_ISL_781713	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-C30496/2020	EPI_ISL_782900	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C30997/2020	EPI_ISL_782940	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C2FED8/2020	EPI_ISL_782950	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C30223/2020	EPI_ISL_782951	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-C25C9C/2020	EPI_ISL_782964	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C308B8/2020	EPI_ISL_782975	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C3001A/2020	EPI_ISL_782995	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-23195/2020	EPI_ISL_793604	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-23243/2020	EPI_ISL_793642	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-23269/2020	EPI_ISL_793660	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-25255/2020	EPI_ISL_794915	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/England/MILK-DAA821/2020	EPI_ISL_797208	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-D74204/2020	EPI_ISL_798478	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-D74E88/2020	EPI_ISL_798481	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-D6B859/2020	EPI_ISL_798509	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-D6B8FF/2020	EPI_ISL_798529	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-D6925D/2020	EPI_ISL_798573	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-D67D7C/2020	EPI_ISL_798589	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-D278A4/2020	EPI_ISL_799715	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-D1ACB7/2020	EPI_ISL_799766	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-D1BE0B/2020	EPI_ISL_799789	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-D1ACD5/2020	EPI_ISL_799795	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-CE2053/2020	EPI_ISL_799840	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BC2676/2020	EPI_ISL_801025	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-BC2AC5/2020	EPI_ISL_801029	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-E0728D/2020	EPI_ISL_811990	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Denmark/DCGC-27424/2020	EPI_ISL_815662	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27427/2020	EPI_ISL_815664	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/TFCI-26FAA87/2020	EPI_ISL_816852	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/TFCI-26FACBE/2020	EPI_ISL_816880	2020-12-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/TFCI-26FAD51/2020	EPI_ISL_816890	2020-12-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/TFCI-26FB181/2020	EPI_ISL_816936	2020-12-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Denmark/DCGC-26117/2021	EPI_ISL_819005	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-26159/2021	EPI_ISL_819009	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-26300/2021	EPI_ISL_819022	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-26331/2021	EPI_ISL_819027	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/LOND-12F2691/2020	EPI_ISL_820000	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NORW-222701/2020	EPI_ISL_820002	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/LOND-12F2804/2020	EPI_ISL_820040	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NORW-222798/2020	EPI_ISL_820042	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/NORW-223023/2020	EPI_ISL_820044	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-220A19/2020	EPI_ISL_820102	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-222983/2020	EPI_ISL_820103	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-222B7E/2020	EPI_ISL_820106	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/NORW-22315D/2020	EPI_ISL_820108	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-C6B614/2020	EPI_ISL_820163	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-E5C9DF/2020	EPI_ISL_821454	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-E2DF6C/2021	EPI_ISL_821469	2021-01-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-E2DFA8/2021	EPI_ISL_821483	2021-01-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Iceland/3725/2021	EPI_ISL_827416	2021-01-05	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.177.60	GV
hCoV-19/England/QEUH-EF842F/2021	EPI_ISL_834606	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-EF3688/2021	EPI_ISL_834656	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/CVR6238/2020	EPI_ISL_838119	2020-12-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Scotland/CVR6351/2020	EPI_ISL_838141	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/MILK-B5A093/2020	EPI_ISL_839405	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B5A0FD/2020	EPI_ISL_839410	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B5A1BE/2020	EPI_ISL_839420	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4B1046/2020	EPI_ISL_840525	2020-12-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Denmark/DCGC-29973/2020	EPI_ISL_844020	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-29982/2020	EPI_ISL_844029	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-29030/2021	EPI_ISL_845341	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-28782/2021	EPI_ISL_845360	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-28845/2021	EPI_ISL_845363	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-28943/2021	EPI_ISL_845367	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-28972/2021	EPI_ISL_845369	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-29045/2021	EPI_ISL_845370	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-29131/2021	EPI_ISL_845376	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-28477/2021	EPI_ISL_845409	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-28498/2021	EPI_ISL_845413	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-31646/2021	EPI_ISL_856062	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-31723/2021	EPI_ISL_856139	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-31748/2021	EPI_ISL_856164	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Wales/ALDP-DCB81B/2020	EPI_ISL_858653	2020-12-31	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/France/PDL-IPP00338/2021	EPI_ISL_860926	2021-01-07	Europe / France / Pays De La Loire / Nantes Cedex	Human	Original	Nasopharyngeal		Illumina NextSeq 500	CLC Genomics Suite			B.1.177.77	GV
hCoV-19/England/ALDP-FB6A84/2021	EPI_ISL_863116	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-FB6459/2021	EPI_ISL_863128	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-FB6B27/2021	EPI_ISL_863172	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-FB600A/2021	EPI_ISL_863180	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-FB64D1/2021	EPI_ISL_863194	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-100433D/2021	EPI_ISL_863299	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/LOND-12E8ED2/2020	EPI_ISL_865795	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Denmark/DCGC-32266/2021	EPI_ISL_869270	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-32270/2021	EPI_ISL_869274	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-32280/2021	EPI_ISL_869284	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-32309/2021	EPI_ISL_869313	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-32342/2021	EPI_ISL_869346	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 5 nucleotide(s) found at refpos 28028 (frameshift confirmed by the submitter). NS8 without BLAST coverage.	info	B.1.177.77	GV
hCoV-19/Denmark/DCGC-32347/2021	EPI_ISL_869351	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-32354/2021	EPI_ISL_869358	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-32406/2021	EPI_ISL_869410	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-32454/2021	EPI_ISL_869458	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33252/2021	EPI_ISL_870257	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-33277/2021	EPI_ISL_870282	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-33340/2021	EPI_ISL_870350	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-33345/2021	EPI_ISL_870355	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-33349/2021	EPI_ISL_870359	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-33350/2021	EPI_ISL_870360	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-33356/2021	EPI_ISL_870366	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33424/2021	EPI_ISL_870434	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-33428/2021	EPI_ISL_870438	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33435/2021	EPI_ISL_870445	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-33452/2021	EPI_ISL_870462	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33459/2021	EPI_ISL_870469	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-34650/2020	EPI_ISL_871661	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/ALDP-FB58D6/2021	EPI_ISL_882246	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-FB57E8/2021	EPI_ISL_882265	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-F74554/2020	EPI_ISL_882372	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-F7530E/2021	EPI_ISL_882412	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Belgium/rega-1792/2021	EPI_ISL_894216	2021-01-07	Europe / Belgium / Kortenaken	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Switzerland/AG-ETHZ-430847/2020	EPI_ISL_899182	2020-12-25	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Switzerland/AG-ETHZ-430849/2020	EPI_ISL_899183	2020-12-25	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Switzerland/AG-ETHZ-430850/2020	EPI_ISL_899184	2020-12-25	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Switzerland/BE-ETHZ-430976/2020	EPI_ISL_899289	2020-12-27	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Italy/CAM-TIGEM-1497/2020	EPI_ISL_900663	2020-12-12	Europe / Italy / Campania	Human	Original	Oropharyngeal swab		MGI DNBSEQ-G400	SARS-CoV-2_Multi-PCR_v1.0			B.1.177.55	GV
hCoV-19/Netherlands/NB-RIVM-21401/2020	EPI_ISL_905428	2020-12-28	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/England/MILK-10AECFE/2021	EPI_ISL_909031	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-1087A79/2021	EPI_ISL_909143	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Belgium/AZDelta2103-25488/2021	EPI_ISL_911275	2021-01	Europe / Belgium / Torhout	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.177.77	GV
hCoV-19/France/un-21012050016/2021	EPI_ISL_912724	2021-01-04	Europe / France	Human	Original	Nasopharyngeal swab		Illumina NextSeq500	Illumina DRAGEN COVIDSeq Test Pipeline v.1.2.2			B.1.177.57	GV
hCoV-19/France/un-21012100103/2021	EPI_ISL_912745	2021-01-10	Europe / France	Human	Original	Nasopharyngeal swab		Illumina NextSeq500	Illumina DRAGEN COVIDSeq Test Pipeline v.1.2.2			B.1.177.77	GV
hCoV-19/France/un-21012200393/2021	EPI_ISL_912767	2021-01-20	Europe / France	Human	Original	Nasopharyngeal swab		Illumina NextSeq500	Illumina DRAGEN COVIDSeq Test Pipeline v.1.2.2			B.1.177.77	GV
hCoV-19/England/NOTT-24A123/2021	EPI_ISL_922008	2021-01-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-24BB8E/2021	EPI_ISL_922115	2021-01-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-24BBBB/2021	EPI_ISL_922118	2021-01-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Denmark/DCGC-36970/2021	EPI_ISL_928111	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-36977/2020	EPI_ISL_928118	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/Denmark/DCGC-36980/2021	EPI_ISL_928121	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-36987/2021	EPI_ISL_928128	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-37148/2021	EPI_ISL_928289	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-38296/2021	EPI_ISL_929437	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-38348/2021	EPI_ISL_929489	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-38356/2020	EPI_ISL_929497	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-38402/2021	EPI_ISL_929543	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-39408/2021	EPI_ISL_930550	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Lithuania/ID3771/2020	EPI_ISL_934101	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3772/2020	EPI_ISL_934102	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3777/2020	EPI_ISL_934106	2020-12-14	Europe / Lithuania / Alytaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3797/2020	EPI_ISL_934111	2020-12-12	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3809/2020	EPI_ISL_934121	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3816/2020	EPI_ISL_934125	2020-12-11	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3820/2020	EPI_ISL_934127	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3822/2020	EPI_ISL_934128	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.79	GV
hCoV-19/Belgium/rega-2179/2021	EPI_ISL_935274	2021-01-11	Europe / Belgium / Heist-op-den-Berg	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2215/2021	EPI_ISL_935307	2021-01-21	Europe / Belgium / Serskamp	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2217/2021	EPI_ISL_935309	2021-01-21	Europe / Belgium / Wichelen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2218/2021	EPI_ISL_935310	2021-01-21	Europe / Belgium / Wichelen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/England/MILK-1152979/2021	EPI_ISL_937909	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11457D9/2021	EPI_ISL_948534	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-11454C3/2021	EPI_ISL_948719	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/OXON-F46BFF/2020	EPI_ISL_950922	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/TFCI-2704139/2021	EPI_ISL_953232	2021-01-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/Denmark/DCGC-39613/2021	EPI_ISL_971019	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-40642/2021	EPI_ISL_972319	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-41898/2021	EPI_ISL_973674	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/CAMC-12085AA/2021	EPI_ISL_985578	2021-02-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-121E18F/2021	EPI_ISL_985650	2021-02-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-121E240/2021	EPI_ISL_985694	2021-02-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-121F4A3/2021	EPI_ISL_986969	2021-02-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-11CEE00/2021	EPI_ISL_989298	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-1197CBB/2021	EPI_ISL_990199	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-11971F8/2021	EPI_ISL_990256	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10EEC01/2021	EPI_ISL_992840	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10E8548/2021	EPI_ISL_992845	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/NOTT-24DB8C/2021	EPI_ISL_998898	2021-02-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-24EA06/2020	EPI_ISL_998926	2020-12-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-24EA8E/2020	EPI_ISL_998931	2020-12-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/ALDP-121DE7A/2021	EPI_ISL_1006543	2021-02-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-1253643/2021	EPI_ISL_1012263	2021-02-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.60	GV
hCoV-19/Norway/3173/2021	EPI_ISL_1013509	2021-02-05	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			U.3	GV
hCoV-19/Norway/3175/2021	EPI_ISL_1013511	2021-02-05	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			U.3	GV
hCoV-19/Norway/3176/2021	EPI_ISL_1013512	2021-02-05	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			U.3	GV
hCoV-19/Belgium/121020954/2021	EPI_ISL_1013594	2021-02-03	Europe / Belgium / Antwerp	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.177.77	GV
hCoV-19/Scotland/QEUH-114D768/2021	EPI_ISL_1019706	2021-01-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-114D73B/2021	EPI_ISL_1019744	2021-01-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-114BECF/2021	EPI_ISL_1019746	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.77	GV
hCoV-19/Scotland/QEUH-109B73F/2021	EPI_ISL_1019881	2021-01-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-42987/2021	EPI_ISL_1023265	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-43845/2021	EPI_ISL_1024223	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44177/2021	EPI_ISL_1024555	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-45141/2020	EPI_ISL_1025519	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-45157/2020	EPI_ISL_1025535	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-45164/2020	EPI_ISL_1025542	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Netherlands/UT-RIVM-13224/2021	EPI_ISL_1035083	2021-02-10	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION		NS8_G50stop results in 59.5% truncation of the protein sequence.	info	B.1.177.77	GV
hCoV-19/Netherlands/UT-RIVM-13078/2021	EPI_ISL_1035084	2021-02-10	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION		NS8_G50stop results in 59.5% truncation of the protein sequence.	info	B.1.177.77	GV
hCoV-19/Netherlands/NB-RIVM-12992/2021	EPI_ISL_1035085	2021-02-06	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION		NS8_G50stop results in 59.5% truncation of the protein sequence.	info	B.1.177.77	GV
hCoV-19/Netherlands/NB-RIVM-12391/2021	EPI_ISL_1035086	2021-01-26	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION		NS8_G50stop results in 59.5% truncation of the protein sequence.	info	B.1.177.77	GV
hCoV-19/Netherlands/GE-RIVM-12692/2021	EPI_ISL_1035087	2021-02-03	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION		NS8_G50stop results in 59.5% truncation of the protein sequence.	info	B.1.177.77	GV
hCoV-19/Netherlands/GE-RIVM-12556/2021	EPI_ISL_1035088	2021-01-31	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION		NS8_G50stop results in 59.5% truncation of the protein sequence.	info	B.1.177.77	GV
hCoV-19/Netherlands/ZH-RIVM-21755/2020	EPI_ISL_1035248	2020-11-02	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/England/OXON-F655B0/2021	EPI_ISL_1051840	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-4C9B0E/2021	EPI_ISL_1053080	2021-02-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/CAMC-1298D10/2021	EPI_ISL_1061584	2021-02-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/Denmark/DCGC-46537/2020	EPI_ISL_1066047	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-47999/2021	EPI_ISL_1067534	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-48028/2021	EPI_ISL_1067563	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/England/CAMC-12A51C9/2021	EPI_ISL_1069993	2021-02-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 8 nucleotide(s) found at refpos 27571 (frameshift confirmed by the submitter). NS7a without BLAST coverage.	info	B.1.177.4	GV
hCoV-19/Belgium/IPG-23/2021	EPI_ISL_1079696	2021-02-19	Europe / Belgium / Wallonie	Human	Original	Nasopharyngeal swab		Nanopore Gridion	Artic pipeline			B.1.177.77	GV
hCoV-19/Scotland/QEUH-96E66F/2020	EPI_ISL_534471	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.79	GV
hCoV-19/Scotland/QEUH-96D4DF/2020	EPI_ISL_534572	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-96D3D2/2020	EPI_ISL_534574	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-96DDB6/2020	EPI_ISL_534592	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-998EA0/2020	EPI_ISL_541795	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-998EBF/2020	EPI_ISL_541812	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A9756/2020	EPI_ISL_551067	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9AB402/2020	EPI_ISL_551071	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A9E9D/2020	EPI_ISL_551081	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A93DA/2020	EPI_ISL_551089	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9A9149/2020	EPI_ISL_551118	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9A9598/2020	EPI_ISL_551126	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A9ED9/2020	EPI_ISL_551128	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A8F31/2020	EPI_ISL_551147	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A8FB9/2020	EPI_ISL_551148	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9A9783/2020	EPI_ISL_551172	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A9404/2020	EPI_ISL_551247	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9A9774/2020	EPI_ISL_551262	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A9D09/2020	EPI_ISL_551280	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/MILK-9947E5/2020	EPI_ISL_552285	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-994D01/2020	EPI_ISL_552287	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-991DF5/2020	EPI_ISL_552409	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-974D43/2020	EPI_ISL_552460	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-974C73/2020	EPI_ISL_552542	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-997CC5/2020	EPI_ISL_559760	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9BEA82/2020	EPI_ISL_568053	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9BE9A3/2020	EPI_ISL_568056	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9BE132/2020	EPI_ISL_568071	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9BE0DB/2020	EPI_ISL_568076	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9BE4FD/2020	EPI_ISL_568080	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9BEDC5/2020	EPI_ISL_568083	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9BDEC3/2020	EPI_ISL_568095	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9D7616/2020	EPI_ISL_576572	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9D7670/2020	EPI_ISL_576576	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9D768F/2020	EPI_ISL_576577	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9D76AD/2020	EPI_ISL_576578	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9D77C8/2020	EPI_ISL_576585	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-9DC8DF/2020	EPI_ISL_581016	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9DC769/2020	EPI_ISL_581024	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/MILK-9E1215/2020	EPI_ISL_581054	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/QEUH-9DAC4E/2020	EPI_ISL_581055	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9DCE0A/2020	EPI_ISL_581060	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9DB0C9/2020	EPI_ISL_581063	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/MILK-9E127F/2020	EPI_ISL_581067	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9DCE37/2020	EPI_ISL_581072	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/MILK-9E1251/2020	EPI_ISL_581084	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/NOTT-11479A/2020	EPI_ISL_584750	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-1147A9/2020	EPI_ISL_584751	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1148C4/2020	EPI_ISL_584754	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1148D3/2020	EPI_ISL_584755	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11493A/2020	EPI_ISL_584756	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114976/2020	EPI_ISL_584757	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114A73/2020	EPI_ISL_584760	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11533B/2020	EPI_ISL_584804	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-115359/2020	EPI_ISL_584805	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-115386/2020	EPI_ISL_584808	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/QEUH-9E34A4/2020	EPI_ISL_584848	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-A00507/2020	EPI_ISL_584884	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-A2F4F6/2020	EPI_ISL_587016	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A2F951/2020	EPI_ISL_587034	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2FA03/2020	EPI_ISL_587035	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2F5B7/2020	EPI_ISL_587044	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2F854/2020	EPI_ISL_587056	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2FCC1/2020	EPI_ISL_587057	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2EF7E/2020	EPI_ISL_587066	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2F9D9/2020	EPI_ISL_587074	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2FB2E/2020	EPI_ISL_587075	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2F10E/2020	EPI_ISL_587076	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2FDDD/2020	EPI_ISL_587093	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A2FA6D/2020	EPI_ISL_587099	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2ED65/2020	EPI_ISL_587101	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A2F97F/2020	EPI_ISL_587103	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A2F933/2020	EPI_ISL_587104	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2FA12/2020	EPI_ISL_587105	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2EEEA/2020	EPI_ISL_587106	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A2F9E8/2020	EPI_ISL_587107	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A2FAB8/2020	EPI_ISL_587112	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2F6E1/2020	EPI_ISL_587206	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2F960/2020	EPI_ISL_587212	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2E943/2020	EPI_ISL_587213	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2EC4A/2020	EPI_ISL_587217	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2F3EA/2020	EPI_ISL_587229	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9FAEAC/2020	EPI_ISL_588215	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9FA60E/2020	EPI_ISL_588233	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9FA45F/2020	EPI_ISL_588247	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F4956/2020	EPI_ISL_588290	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9F4CF3/2020	EPI_ISL_588291	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F5D4A/2020	EPI_ISL_588335	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F6918/2020	EPI_ISL_588340	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F6909/2020	EPI_ISL_588351	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F49DE/2020	EPI_ISL_588384	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-9F64AE/2020	EPI_ISL_588440	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9F380F/2020	EPI_ISL_588529	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F408E/2020	EPI_ISL_588537	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F359F/2020	EPI_ISL_588544	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9E581F/2020	EPI_ISL_589571	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-9F1977/2020	EPI_ISL_589675	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-9F1045/2020	EPI_ISL_589688	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-9F1C7E/2020	EPI_ISL_589694	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9F1CBA/2020	EPI_ISL_589702	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9F0AB1/2020	EPI_ISL_589708	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9F1CF6/2020	EPI_ISL_589714	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9F14FE/2020	EPI_ISL_589718	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9F09E1/2020	EPI_ISL_589725	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9D0DBE/2020	EPI_ISL_589810	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9B749A/2020	EPI_ISL_590541	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B8068/2020	EPI_ISL_590547	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B6F8B/2020	EPI_ISL_590655	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B7DBD/2020	EPI_ISL_590673	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B7DDB/2020	EPI_ISL_590674	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B810B/2020	EPI_ISL_590677	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B6FB8/2020	EPI_ISL_590684	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B7E41/2020	EPI_ISL_590685	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-47E8A7/2020	EPI_ISL_595515	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-47E959/2020	EPI_ISL_595526	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-47EB17/2020	EPI_ISL_595554	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-47EE4B/2020	EPI_ISL_595599	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-9F75AA/2020	EPI_ISL_595688	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Scotland/QEUH-9F771D/2020	EPI_ISL_595697	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Australia/WA299/2020	EPI_ISL_596842	2020-10-06	Oceania / Australia / Western Australia	Human	Original			Illumina MiSeq				B.1.177	GV
hCoV-19/Ireland/KE-NVRL-73IRL55350/2020	EPI_ISL_596890	2020-09-11	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL62905/2020	EPI_ISL_596893	2020-09-12	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL38401/2020	EPI_ISL_596894	2020-09-08	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KE-NVRL-73IRL48809/2020	EPI_ISL_596895	2020-09-10	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL76160/2020	EPI_ISL_596897	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/WX-NVRL-73IRL52567/2020	EPI_ISL_596898	2020-09-10	Europe / Ireland / Wexford	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL76164/2020	EPI_ISL_596899	2020-09-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/England/CAMC-A598F7/2020	EPI_ISL_596986	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A58C65/2020	EPI_ISL_596989	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-A20CFD/2020	EPI_ISL_599093	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-A0B4C3/2020	EPI_ISL_599206	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9FF126/2020	EPI_ISL_600490	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-9FDCCD/2020	EPI_ISL_600526	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/ALDP-9FDC72/2020	EPI_ISL_600531	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/ALDP-9FDC36/2020	EPI_ISL_600534	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Scotland/QEUH-9F4455/2020	EPI_ISL_600691	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9D0CEE/2020	EPI_ISL_601853	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9CE67C/2020	EPI_ISL_601885	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9CF30B/2020	EPI_ISL_601910	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7CB5F/2020	EPI_ISL_606601	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A795BE/2020	EPI_ISL_606605	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A79D3E/2020	EPI_ISL_606607	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7CE65/2020	EPI_ISL_606670	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7A3A4/2020	EPI_ISL_606673	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A7AC9A/2020	EPI_ISL_606678	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A799B2/2020	EPI_ISL_606686	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7D07D/2020	EPI_ISL_606687	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A79A0A/2020	EPI_ISL_606703	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7ABCA/2020	EPI_ISL_606706	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/MILK-A79B43/2020	EPI_ISL_606709	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A79BBC/2020	EPI_ISL_606714	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7CE47/2020	EPI_ISL_606723	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7ACA9/2020	EPI_ISL_606741	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7D031/2020	EPI_ISL_606743	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A79BF8/2020	EPI_ISL_606748	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A7A5CC/2020	EPI_ISL_606755	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7A2C5/2020	EPI_ISL_606757	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7CE74/2020	EPI_ISL_606758	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A79FDE/2020	EPI_ISL_606766	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6DFEC/2020	EPI_ISL_607900	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6D939/2020	EPI_ISL_607909	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6DF55/2020	EPI_ISL_607923	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F3A2/2020	EPI_ISL_607927	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6E16D/2020	EPI_ISL_607935	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F533/2020	EPI_ISL_607948	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6BCE7/2020	EPI_ISL_609001	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A67FD3/2020	EPI_ISL_609002	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A692E7/2020	EPI_ISL_609012	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A69214/2020	EPI_ISL_609022	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/MILK-A6BE1E/2020	EPI_ISL_609029	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A69469/2020	EPI_ISL_609040	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6BD4E/2020	EPI_ISL_609046	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A92AED/2020	EPI_ISL_611129	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A93976/2020	EPI_ISL_611131	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A938D3/2020	EPI_ISL_611134	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A93FFC/2020	EPI_ISL_611142	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A938F1/2020	EPI_ISL_611143	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A92D4E/2020	EPI_ISL_611149	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A96E92/2020	EPI_ISL_611155	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A924FE/2020	EPI_ISL_611157	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A92DA8/2020	EPI_ISL_611167	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A92C05/2020	EPI_ISL_611176	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A92D3F/2020	EPI_ISL_611178	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A93CE6/2020	EPI_ISL_611184	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A9232E/2020	EPI_ISL_611221	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A93615/2020	EPI_ISL_611235	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A92EE1/2020	EPI_ISL_611243	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A92A29/2020	EPI_ISL_611258	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A939B2/2020	EPI_ISL_611267	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A92D99/2020	EPI_ISL_611268	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A93AFB/2020	EPI_ISL_611269	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A943A4/2020	EPI_ISL_611283	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A9F594/2020	EPI_ISL_611287	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AA0299/2020	EPI_ISL_611294	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A9F6EC/2020	EPI_ISL_611297	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A9F51C/2020	EPI_ISL_611300	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A9FB74/2020	EPI_ISL_611328	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A9EF00/2020	EPI_ISL_611329	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A9F43D/2020	EPI_ISL_611330	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AA040C/2020	EPI_ISL_611331	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A9FDD8/2020	EPI_ISL_611333	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A9FB1A/2020	EPI_ISL_611349	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A18DF5/2020	EPI_ISL_612463	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-A18E10/2020	EPI_ISL_612464	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36	G
hCoV-19/England/MILK-A18ED4/2020	EPI_ISL_612472	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-A19529/2020	EPI_ISL_612515	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-A229D6/2020	EPI_ISL_612535	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-108EA3/2020	EPI_ISL_612546	2020-09-18	Europe / United Kingdom / Northern Ireland	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108EC1/2020	EPI_ISL_612547	2020-09-18	Europe / United Kingdom / Northern Ireland	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/NORT-1B6BF9F/2020	EPI_ISL_612556	2020-09-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.55	GV
hCoV-19/England/NORT-1B6C110/2020	EPI_ISL_612565	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NORT-2A80AE/2020	EPI_ISL_612570	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-116BE7/2020	EPI_ISL_612573	2020-10-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-116F63/2020	EPI_ISL_612575	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-116F72/2020	EPI_ISL_612576	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-117630/2020	EPI_ISL_612577	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11767C/2020	EPI_ISL_612578	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11768B/2020	EPI_ISL_612579	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1176F4/2020	EPI_ISL_612581	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11771F/2020	EPI_ISL_612583	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-117779/2020	EPI_ISL_612586	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-117C4D/2020	EPI_ISL_612588	2020-10-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-117C6B/2020	EPI_ISL_612589	2020-10-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-117D95/2020	EPI_ISL_612590	2020-10-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-117FAE/2020	EPI_ISL_612594	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-118426/2020	EPI_ISL_612603	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/Denmark/DCGC-7054/2020	EPI_ISL_619903	2020-10-12	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.177.4	GV
hCoV-19/England/MILK-AB7675/2020	EPI_ISL_623228	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AB8252/2020	EPI_ISL_623236	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-AAFD20/2020	EPI_ISL_623256	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AB7A97/2020	EPI_ISL_623261	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ABB529/2020	EPI_ISL_623265	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AB0393/2020	EPI_ISL_623281	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-AB7666/2020	EPI_ISL_623309	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AB86DE/2020	EPI_ISL_623329	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AB7736/2020	EPI_ISL_623331	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AB7727/2020	EPI_ISL_623338	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AB0384/2020	EPI_ISL_623347	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA3D4A/2020	EPI_ISL_624451	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA47D2/2020	EPI_ISL_624453	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA2358/2020	EPI_ISL_624455	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA4BF4/2020	EPI_ISL_624471	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2464/2020	EPI_ISL_624480	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA42FF/2020	EPI_ISL_624483	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA4286/2020	EPI_ISL_624497	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA4611/2020	EPI_ISL_624501	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA1D97/2020	EPI_ISL_624508	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA3A16/2020	EPI_ISL_624510	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA1AAF/2020	EPI_ISL_624527	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA3A25/2020	EPI_ISL_624533	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA48EE/2020	EPI_ISL_624547	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA2033/2020	EPI_ISL_624553	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA0F74/2020	EPI_ISL_624555	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA4945/2020	EPI_ISL_624559	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A94C21/2020	EPI_ISL_624568	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-A945AE/2020	EPI_ISL_624574	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A9473F/2020	EPI_ISL_624576	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A95279/2020	EPI_ISL_624579	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A952E2/2020	EPI_ISL_624582	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A9426B/2020	EPI_ISL_624586	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A95886/2020	EPI_ISL_624589	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A9468D/2020	EPI_ISL_624591	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A96375/2020	EPI_ISL_624592	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A9522E/2020	EPI_ISL_624594	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A952D3/2020	EPI_ISL_624607	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A963B1/2020	EPI_ISL_624609	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A9425C/2020	EPI_ISL_624614	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A96490/2020	EPI_ISL_624623	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A958E0/2020	EPI_ISL_624624	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A963C0/2020	EPI_ISL_624631	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A963DF/2020	EPI_ISL_624633	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A95A80/2020	EPI_ISL_624637	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A95A26/2020	EPI_ISL_624643	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A95DB4/2020	EPI_ISL_624648	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A947D5/2020	EPI_ISL_624650	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-48554C/2020	EPI_ISL_628189	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-ACBE1C/2020	EPI_ISL_629302	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC9670/2020	EPI_ISL_629303	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACEC1F/2020	EPI_ISL_629343	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACE444/2020	EPI_ISL_629348	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACC77A/2020	EPI_ISL_629353	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACE8DF/2020	EPI_ISL_629359	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AC8495/2020	EPI_ISL_629367	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-AC8398/2020	EPI_ISL_629394	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC7CE9/2020	EPI_ISL_629427	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AC83F2/2020	EPI_ISL_629429	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ACEFCB/2020	EPI_ISL_629441	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC744B/2020	EPI_ISL_630307	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACDFBD/2020	EPI_ISL_630313	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AC734E/2020	EPI_ISL_630346	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A66C91/2020	EPI_ISL_630348	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A686EC/2020	EPI_ISL_630352	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A67173/2020	EPI_ISL_630365	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A67AD2/2020	EPI_ISL_630384	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A672E9/2020	EPI_ISL_630388	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A67577/2020	EPI_ISL_630391	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67568/2020	EPI_ISL_630399	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6746B/2020	EPI_ISL_630400	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A668BB/2020	EPI_ISL_630401	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67164/2020	EPI_ISL_630403	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A68655/2020	EPI_ISL_630409	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67AB4/2020	EPI_ISL_630410	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A671FB/2020	EPI_ISL_630413	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6753B/2020	EPI_ISL_630417	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6743E/2020	EPI_ISL_630423	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A689F2/2020	EPI_ISL_630425	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6752C/2020	EPI_ISL_630441	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A66A88/2020	EPI_ISL_630442	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A66851/2020	EPI_ISL_630445	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6747A/2020	EPI_ISL_630446	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A66833/2020	EPI_ISL_630453	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A66CBF/2020	EPI_ISL_630456	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A66E8C/2020	EPI_ISL_630457	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A679C6/2020	EPI_ISL_630464	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A67261/2020	EPI_ISL_630466	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A670D0/2020	EPI_ISL_630472	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A66DE9/2020	EPI_ISL_630475	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Norway/4098/2020	EPI_ISL_635137	2020-10-01	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/4590/2020	EPI_ISL_635165	2020-10-18	Europe / Norway / Trndelag	Human	Original			Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Belgium/ULG-10636/2020	EPI_ISL_636614	2020-10-26	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/ULG-10651/2020	EPI_ISL_636629	2020-10-26	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/England/QEUH-A783F1/2020	EPI_ISL_637855	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina		NS8_Q23stop results in 81.8% truncation of the protein sequence.	info	B.1.177.57	GV
hCoV-19/England/MILK-A7DF61/2020	EPI_ISL_637867	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177.57	GV
hCoV-19/England/QEUH-B116C3/2020	EPI_ISL_642314	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B1310C/2020	EPI_ISL_642316	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B12880/2020	EPI_ISL_642337	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B11CEF/2020	EPI_ISL_642351	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B11775/2020	EPI_ISL_642352	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.55	GV
hCoV-19/England/QEUH-B13087/2020	EPI_ISL_642354	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B11678/2020	EPI_ISL_642355	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B119D9/2020	EPI_ISL_642395	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B11924/2020	EPI_ISL_642409	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B11599/2020	EPI_ISL_642424	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B13157/2020	EPI_ISL_642428	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B12932/2020	EPI_ISL_642448	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B08243/2020	EPI_ISL_643601	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0C90E/2020	EPI_ISL_643604	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B0CDC6/2020	EPI_ISL_643608	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B0AE3E/2020	EPI_ISL_643611	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0846B/2020	EPI_ISL_643617	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B0ADB9/2020	EPI_ISL_643619	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0CC05/2020	EPI_ISL_643627	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-B0BAC0/2020	EPI_ISL_643629	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B07903/2020	EPI_ISL_643659	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B08656/2020	EPI_ISL_643681	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B08C63/2020	EPI_ISL_643700	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B087BD/2020	EPI_ISL_643702	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B08B75/2020	EPI_ISL_643704	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B0798B/2020	EPI_ISL_643709	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0751E/2020	EPI_ISL_643717	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B079C7/2020	EPI_ISL_643723	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B07A1F/2020	EPI_ISL_643765	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B2443C/2020	EPI_ISL_647108	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B23A2C/2020	EPI_ISL_647118	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B22F6A/2020	EPI_ISL_647141	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B22F2E/2020	EPI_ISL_647206	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B21AB5/2020	EPI_ISL_647216	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B22A5A/2020	EPI_ISL_647225	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B216C0/2020	EPI_ISL_647234	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B22D15/2020	EPI_ISL_647236	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/CAMC-B22692/2020	EPI_ISL_647246	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B21B58/2020	EPI_ISL_647247	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B228AB/2020	EPI_ISL_647254	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B21B76/2020	EPI_ISL_647259	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B21824/2020	EPI_ISL_647278	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B21B85/2020	EPI_ISL_647282	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B2296C/2020	EPI_ISL_647285	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B22683/2020	EPI_ISL_647286	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B2146C/2020	EPI_ISL_647288	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/CAMC-B22999/2020	EPI_ISL_647293	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-AD01DF/2020	EPI_ISL_649737	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Scotland/QEUH-AD6670/2020	EPI_ISL_649739	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Scotland/QEUH-AD0227/2020	EPI_ISL_649755	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Scotland/QEUH-AD01FD/2020	EPI_ISL_649761	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/C200041985/2020	EPI_ISL_649791	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/C200042043/2020	EPI_ISL_649801	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/C200042062/2020	EPI_ISL_649802	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/C200042066/2020	EPI_ISL_649804	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/C200042086/2020	EPI_ISL_649807	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/204341433/2020	EPI_ISL_649831	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204380853/2020	EPI_ISL_649847	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204380856/2020	EPI_ISL_649848	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204380861/2020	EPI_ISL_649849	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204381353/2020	EPI_ISL_649856	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204381371/2020	EPI_ISL_649860	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/204390683/2020	EPI_ISL_649869	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204391000/2020	EPI_ISL_649877	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/204393818/2020	EPI_ISL_649886	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204742224/2020	EPI_ISL_649927	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/QEUH-AAEFD0/2020	EPI_ISL_653010	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-AAF43A/2020	EPI_ISL_653023	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-AF5F52/2020	EPI_ISL_653035	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/QEUH-AF5FBC/2020	EPI_ISL_653040	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/SHEF-C0E4E/2020	EPI_ISL_653060	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-C7BE6/2020	EPI_ISL_653072	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-C8356/2020	EPI_ISL_653073	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-CB942/2020	EPI_ISL_653077	2020-10-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-CC352/2020	EPI_ISL_653081	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-CE53C/2020	EPI_ISL_653087	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-CE824/2020	EPI_ISL_653088	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-CEEC8/2020	EPI_ISL_653090	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Spain/MD-IBV-99008787/2020	EPI_ISL_654327	2020-10-20	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/MD-IBV-99009608/2020	EPI_ISL_654357	2020-09-18	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/MD-IBV-99009615/2020	EPI_ISL_654361	2020-10-16	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/MD-IBV-99009662/2020	EPI_ISL_654390	2020-10-23	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/England/ALDP-B5B0DE/2020	EPI_ISL_655601	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5E6F7/2020	EPI_ISL_655614	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5BD31/2020	EPI_ISL_655619	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5B52A/2020	EPI_ISL_655625	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B62E9E/2020	EPI_ISL_655628	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B62D82/2020	EPI_ISL_655637	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B5C26E/2020	EPI_ISL_655646	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B5BF0E/2020	EPI_ISL_655652	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5C5DE/2020	EPI_ISL_655671	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B5CF94/2020	EPI_ISL_655675	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5CE4C/2020	EPI_ISL_655680	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B65F6B/2020	EPI_ISL_655699	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5BE2F/2020	EPI_ISL_655710	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5BF3B/2020	EPI_ISL_655721	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5C86C/2020	EPI_ISL_655724	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B65F7A/2020	EPI_ISL_655727	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B5BCF8/2020	EPI_ISL_655731	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6C7D5/2020	EPI_ISL_655735	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B66049/2020	EPI_ISL_655737	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B67840/2020	EPI_ISL_655739	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6C77B/2020	EPI_ISL_655744	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B5C5B0/2020	EPI_ISL_655749	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5C653/2020	EPI_ISL_655786	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B54503/2020	EPI_ISL_656914	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B53F60/2020	EPI_ISL_656925	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.54	GV
hCoV-19/England/CAMC-B53391/2020	EPI_ISL_656934	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B5410F/2020	EPI_ISL_656943	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B533DD/2020	EPI_ISL_656954	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B568EA/2020	EPI_ISL_656961	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B53847/2020	EPI_ISL_656975	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B5449D/2020	EPI_ISL_656993	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B3375F/2020	EPI_ISL_659109	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-B324A4/2020	EPI_ISL_659113	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B3227D/2020	EPI_ISL_659119	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B33388/2020	EPI_ISL_659195	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B33B53/2020	EPI_ISL_659198	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B33DF3/2020	EPI_ISL_659200	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B33212/2020	EPI_ISL_659208	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B338C5/2020	EPI_ISL_659214	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B32240/2020	EPI_ISL_659217	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B3226E/2020	EPI_ISL_659218	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B32EF1/2020	EPI_ISL_659220	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B323E3/2020	EPI_ISL_659223	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B33F75/2020	EPI_ISL_659226	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B321E9/2020	EPI_ISL_659227	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B32565/2020	EPI_ISL_659234	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-B33DB7/2020	EPI_ISL_659264	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B33E2D/2020	EPI_ISL_659268	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B32FD0/2020	EPI_ISL_659272	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B33397/2020	EPI_ISL_659284	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B6829C/2020	EPI_ISL_661401	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B68A2B/2020	EPI_ISL_661410	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B66674/2020	EPI_ISL_661500	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B67B38/2020	EPI_ISL_661506	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B682F6/2020	EPI_ISL_661508	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B67A0E/2020	EPI_ISL_661519	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B6935C/2020	EPI_ISL_661545	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6C67E/2020	EPI_ISL_661554	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B689E2/2020	EPI_ISL_661578	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B66225/2020	EPI_ISL_661584	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B689C4/2020	EPI_ISL_661591	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B665A4/2020	EPI_ISL_661592	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AF0BF9/2020	EPI_ISL_662705	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF00EB/2020	EPI_ISL_662724	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AEFAC3/2020	EPI_ISL_662747	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AF28F0/2020	EPI_ISL_662753	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF068F/2020	EPI_ISL_662767	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AF23A4/2020	EPI_ISL_662769	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AEFF88/2020	EPI_ISL_662808	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-AF0072/2020	EPI_ISL_662809	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AF0C7E/2020	EPI_ISL_662818	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF4849/2020	EPI_ISL_662851	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AF0054/2020	EPI_ISL_662856	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AF0A0B/2020	EPI_ISL_662857	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AF06DA/2020	EPI_ISL_662867	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF0CAB/2020	EPI_ISL_662872	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AF0133/2020	EPI_ISL_662876	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF1062/2020	EPI_ISL_662888	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF0F93/2020	EPI_ISL_662889	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AF5417/2020	EPI_ISL_662910	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AF4DE0/2020	EPI_ISL_662913	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AF5787/2020	EPI_ISL_662922	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AF5189/2020	EPI_ISL_662925	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMB-1BB11F/2020	EPI_ISL_665001	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMC-B234A6/2020	EPI_ISL_665040	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMC-B235A3/2020	EPI_ISL_665045	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/EXET-138DF8/2020	EPI_ISL_665046	2020-10-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/EXET-1390A3/2020	EPI_ISL_665052	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/EXET-1390C1/2020	EPI_ISL_665053	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/EXET-1392DA/2020	EPI_ISL_665060	2020-10-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/LIVE-DBD30C/2020	EPI_ISL_665131	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DBD3A2/2020	EPI_ISL_665133	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/LIVE-DBE8DF/2020	EPI_ISL_665136	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/LIVE-DBEABB/2020	EPI_ISL_665139	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NSP11 without BLAST coverage.	warn	B.1.177.4	GV
hCoV-19/England/LOND-124F48C/2020	EPI_ISL_665155	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-48BD02/2020	EPI_ISL_666347	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-48C75E/2020	EPI_ISL_666464	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Japan/IC-0299/2020	EPI_ISL_667728	2020-11-07	Asia / Japan	Human	Original		COVID-19 positive case who entered from United Kingdom.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.177.57	GV
hCoV-19/Denmark/DCGC-9334/2020	EPI_ISL_668913	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-9364/2020	EPI_ISL_668930	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-9459/2020	EPI_ISL_668982	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/CAMC-B9A45F/2020	EPI_ISL_673400	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B994F6/2020	EPI_ISL_673411	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B9A52F/2020	EPI_ISL_673483	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B9A02E/2020	EPI_ISL_673488	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B997A2/2020	EPI_ISL_673497	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B99BD3/2020	EPI_ISL_673502	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B9C50F/2020	EPI_ISL_673508	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B99AE5/2020	EPI_ISL_673515	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B9A149/2020	EPI_ISL_673538	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B99353/2020	EPI_ISL_673544	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.60	GV
hCoV-19/England/CAMC-B99B79/2020	EPI_ISL_673547	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B9AC1B/2020	EPI_ISL_673552	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B99FB9/2020	EPI_ISL_673555	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B99C58/2020	EPI_ISL_673557	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B992B0/2020	EPI_ISL_673563	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B99BF1/2020	EPI_ISL_673564	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B99EDA/2020	EPI_ISL_673569	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B99E8F/2020	EPI_ISL_673579	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B9A5D4/2020	EPI_ISL_673580	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B98E17/2020	EPI_ISL_673581	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B9A1EF/2020	EPI_ISL_673596	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8DDEB/2020	EPI_ISL_674721	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8E7EC/2020	EPI_ISL_674733	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8DD72/2020	EPI_ISL_674734	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B808D8/2020	EPI_ISL_674745	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B97197/2020	EPI_ISL_674820	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B971D3/2020	EPI_ISL_674839	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B97346/2020	EPI_ISL_674844	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B980A8/2020	EPI_ISL_674849	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B95946/2020	EPI_ISL_674869	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B97522/2020	EPI_ISL_674875	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B96CA6/2020	EPI_ISL_674878	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B970A9/2020	EPI_ISL_674894	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B9814B/2020	EPI_ISL_674908	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Belgium/ULG-10924/2020	EPI_ISL_678464	2020-11-24	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/Belgium/ULG-10930/2020	EPI_ISL_678469	2020-11-24	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/Belgium/ULG-10933/2020	EPI_ISL_678472	2020-11-24	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/Belgium/ULG-10934/2020	EPI_ISL_678473	2020-11-24	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/England/MILK-B3963E/2020	EPI_ISL_679631	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.2	GV
hCoV-19/England/MILK-B39C3C/2020	EPI_ISL_679663	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B39DB1/2020	EPI_ISL_679666	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B39DEE/2020	EPI_ISL_679668	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B39E36/2020	EPI_ISL_679671	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B39E45/2020	EPI_ISL_679672	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3A0C6/2020	EPI_ISL_679679	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3A0F3/2020	EPI_ISL_679681	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3A907/2020	EPI_ISL_679689	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3AA04/2020	EPI_ISL_679701	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3AB2F/2020	EPI_ISL_679705	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-B3ABC5/2020	EPI_ISL_679713	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3B010/2020	EPI_ISL_679735	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3BC0D/2020	EPI_ISL_679795	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3BC1C/2020	EPI_ISL_679796	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-48D81E/2020	EPI_ISL_680684	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-48DE76/2020	EPI_ISL_680768	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Wales/PHWC-48DF28/2020	EPI_ISL_680779	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/England/ALDP-BB3924/2020	EPI_ISL_701684	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BBB151/2020	EPI_ISL_701691	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BB544F/2020	EPI_ISL_701699	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BBB2E5/2020	EPI_ISL_701712	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BBA064/2020	EPI_ISL_701718	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB5193/2020	EPI_ISL_701731	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB510C/2020	EPI_ISL_701734	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB54C7/2020	EPI_ISL_701745	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB3836/2020	EPI_ISL_701749	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BBA42C/2020	EPI_ISL_701760	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BBB34C/2020	EPI_ISL_701779	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BBB4C1/2020	EPI_ISL_701787	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-BBB43A/2020	EPI_ISL_701790	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB38CD/2020	EPI_ISL_701793	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177.56	GV
hCoV-19/England/ALDP-BB9E01/2020	EPI_ISL_701804	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BBB29A/2020	EPI_ISL_701813	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCC74C/2020	EPI_ISL_704031	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BC4A87/2020	EPI_ISL_704093	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-4906C3/2020	EPI_ISL_706500	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4906F0/2020	EPI_ISL_706502	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-490CEF/2020	EPI_ISL_706561	2020-11-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-490D0A/2020	EPI_ISL_706562	2020-11-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-490D46/2020	EPI_ISL_706566	2020-11-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-490E07/2020	EPI_ISL_706574	2020-11-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-490F22/2020	EPI_ISL_706587	2020-11-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-491176/2020	EPI_ISL_706619	2020-11-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-491273/2020	EPI_ISL_706633	2020-11-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/USA/MI-UM-10036778541/2020	EPI_ISL_707844	2020-11-04	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.177.54	GV
hCoV-19/Wales/QEUH-B2B365/2020	EPI_ISL_711007	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/CAMC-B20BD1/2020	EPI_ISL_711038	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/Denmark/DCGC-15150/2020	EPI_ISL_713661	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/England/CAMC-C46AE6/2020	EPI_ISL_718517	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-C46AD7/2020	EPI_ISL_718547	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-C404A2/2020	EPI_ISL_718619	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C4762D/2020	EPI_ISL_718630	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C480B5/2020	EPI_ISL_718637	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C498BC/2020	EPI_ISL_718662	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C49861/2020	EPI_ISL_718676	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C48167/2020	EPI_ISL_718678	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-C477FD/2020	EPI_ISL_718688	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C47F8C/2020	EPI_ISL_718691	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-BA2120/2020	EPI_ISL_719810	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-B9F0ED/2020	EPI_ISL_719881	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-BA22C3/2020	EPI_ISL_719889	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B9E716/2020	EPI_ISL_719914	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BA18A4/2020	EPI_ISL_719918	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BA1BC9/2020	EPI_ISL_719922	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B9E6EC/2020	EPI_ISL_719925	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_G50stop results in 59.5% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-B9ED9C/2020	EPI_ISL_719934	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BA27E2/2020	EPI_ISL_719944	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/QEUH-BA273D/2020	EPI_ISL_719965	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-BB0FCB/2020	EPI_ISL_719998	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/ALDP-C04A99/2020	EPI_ISL_720810	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C013BF/2020	EPI_ISL_720811	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C008B1/2020	EPI_ISL_720820	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C01407/2020	EPI_ISL_720834	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BFCC08/2020	EPI_ISL_720835	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C0130A/2020	EPI_ISL_720850	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BFF6CB/2020	EPI_ISL_720854	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-BFCF69/2020	EPI_ISL_720860	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C05D53/2020	EPI_ISL_720864	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C006F3/2020	EPI_ISL_720878	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-BFF704/2020	EPI_ISL_720879	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C05C74/2020	EPI_ISL_720880	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-BFF740/2020	EPI_ISL_720884	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BFD205/2020	EPI_ISL_720896	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-C048EA/2020	EPI_ISL_720907	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B9E215/2020	EPI_ISL_720927	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B9FB19/2020	EPI_ISL_720995	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BA35AB/2020	EPI_ISL_720996	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/204880322/2020	EPI_ISL_723017	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/205020748/2020	EPI_ISL_723039	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/205020752/2020	EPI_ISL_723040	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/205020756/2020	EPI_ISL_723041	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/Wales/LIVE-DCA4FA/2020	EPI_ISL_724365	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DCA5F7/2020	EPI_ISL_724369	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DCA67C/2020	EPI_ISL_724372	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DCA6F4/2020	EPI_ISL_724378	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DCA74C/2020	EPI_ISL_724380	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DCB7B4/2020	EPI_ISL_724427	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DCB866/2020	EPI_ISL_724434	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/LIVE-DCBA24/2020	EPI_ISL_724446	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/LIVE-DCBA7F/2020	EPI_ISL_724449	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DCBDB2/2020	EPI_ISL_724464	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DCBFDA/2020	EPI_ISL_724479	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/NOTT-120379/2020	EPI_ISL_725607	2020-12-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-12076E/2020	EPI_ISL_725643	2020-12-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1207AA/2020	EPI_ISL_725646	2020-12-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-492773/2020	EPI_ISL_725696	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-492CCF/2020	EPI_ISL_725775	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-492D35/2020	EPI_ISL_725781	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-C30EC5/2020	EPI_ISL_731536	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C39354/2020	EPI_ISL_731539	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-C39381/2020	EPI_ISL_731545	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3BB0F/2020	EPI_ISL_731552	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3BF7C/2020	EPI_ISL_731574	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3CE14/2020	EPI_ISL_731577	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3BFB8/2020	EPI_ISL_731583	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3CA89/2020	EPI_ISL_731607	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3BE8E/2020	EPI_ISL_731654	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/ALDP-C3B8EA/2020	EPI_ISL_731659	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-C3C6EF/2020	EPI_ISL_731662	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3C870/2020	EPI_ISL_731669	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-C3DA79/2020	EPI_ISL_731695	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Belgium/rega-09211061/2020	EPI_ISL_735006	2020-09-21	Europe / Belgium / Kessel-Lo	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-09231004/2020	EPI_ISL_735027	2020-09-23	Europe / Belgium / Bekkevoort	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.57	GV
hCoV-19/Belgium/rega-10031031/2020	EPI_ISL_735048	2020-10-03	Europe / Belgium / Rotselaar	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10061034/2020	EPI_ISL_735055	2020-10-06	Europe / Belgium / Rotselaar	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10061039/2020	EPI_ISL_735059	2020-10-06	Europe / Belgium / Leuven	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10061045/2020	EPI_ISL_735065	2020-10-06	Europe / Belgium / Leuven	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10071237/2020	EPI_ISL_735077	2020-10-07	Europe / Belgium / Nossegem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10081220/2020	EPI_ISL_735082	2020-10-08	Europe / Belgium / Kasterlee	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10081226/2020	EPI_ISL_735084	2020-10-08	Europe / Belgium / Diegem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10081233/2020	EPI_ISL_735086	2020-10-08	Europe / Belgium / Overijse	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10151115/2020	EPI_ISL_735096	2020-10-15	Europe / Belgium / Hoeilaart	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10181073/2020	EPI_ISL_735113	2020-10-18	Europe / Belgium / Anderlecht	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10181087/2020	EPI_ISL_735127	2020-10-18	Europe / Belgium / Kessel-Lo	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10191097/2020	EPI_ISL_735144	2020-10-19	Europe / Belgium / Bierbeek	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10191099/2020	EPI_ISL_735146	2020-10-19	Europe / Belgium / Bost	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10191100/2020	EPI_ISL_735147	2020-10-19	Europe / Belgium / Bunsbeek	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10191107/2020	EPI_ISL_735151	2020-10-19	Europe / Belgium / Tervuren	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10191123/2020	EPI_ISL_735154	2020-10-19	Europe / Belgium / Rijkevorsel	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10191126/2020	EPI_ISL_735157	2020-10-19	Europe / Belgium / Maaseik	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10191128/2020	EPI_ISL_735159	2020-10-19	Europe / Belgium / Ans	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10191234/2020	EPI_ISL_735165	2020-10-19	Europe / Belgium / Tervuren	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10191270/2020	EPI_ISL_735180	2020-10-19	Europe / Belgium / Wezembeek-Oppem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10191272/2020	EPI_ISL_735182	2020-10-19	Europe / Belgium / Overijse	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10191286/2020	EPI_ISL_735193	2020-10-19	Europe / Belgium / Tervuren	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10191293/2020	EPI_ISL_735198	2020-10-19	Europe / Belgium / Nossegem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/England/QEUH-C5456C/2020	EPI_ISL_736304	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C52E54/2020	EPI_ISL_736314	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C57A88/2020	EPI_ISL_736371	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS6_E55stop results in 11.5% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-C53E08/2020	EPI_ISL_736390	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C52610/2020	EPI_ISL_736403	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C5462D/2020	EPI_ISL_736426	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-C541E0/2020	EPI_ISL_736438	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C53EEA/2020	EPI_ISL_736455	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-C48D81/2020	EPI_ISL_736482	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C484D7/2020	EPI_ISL_736485	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-49B0AC/2020	EPI_ISL_742291	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49B0BB/2020	EPI_ISL_742292	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49B0CA/2020	EPI_ISL_742293	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49B561/2020	EPI_ISL_742352	2020-12-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-49B5BC/2020	EPI_ISL_742356	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4A0F2F/2020	EPI_ISL_743596	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A0F6B/2020	EPI_ISL_743599	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Luxembourg/LNS8875749/2020	EPI_ISL_744818	2020-10-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS9101888/2020	EPI_ISL_744854	2020-11-13	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS9305404/2020	EPI_ISL_744882	2020-10-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177	GV
hCoV-19/Luxembourg/LNS9434917/2020	EPI_ISL_744914	2020-11-11	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Denmark/DCGC-18090/2020	EPI_ISL_749750	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-17073/2020	EPI_ISL_750743	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-17139/2020	EPI_ISL_750781	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/England/204980166/2020	EPI_ISL_754349	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204980285/2020	EPI_ISL_754353	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204990003/2020	EPI_ISL_754356	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204991113/2020	EPI_ISL_754357	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/205260868/2020	EPI_ISL_754371	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/205260874/2020	EPI_ISL_754373	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/205260875/2020	EPI_ISL_754374	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/MILK-C7B778/2020	EPI_ISL_756860	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C7B75A/2020	EPI_ISL_756865	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C796C8/2020	EPI_ISL_756872	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C7D8CE/2020	EPI_ISL_756895	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-CB4A3E/2020	EPI_ISL_761306	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB4913/2020	EPI_ISL_761349	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-CA6DAF/2020	EPI_ISL_761417	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-CA68BD/2020	EPI_ISL_761446	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-CA6880/2020	EPI_ISL_761447	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-CA9F97/2020	EPI_ISL_761452	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-CA639E/2020	EPI_ISL_761464	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-CA6862/2020	EPI_ISL_761495	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-C7FE51/2020	EPI_ISL_762648	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C8870F/2020	EPI_ISL_762655	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-C8874B/2020	EPI_ISL_762706	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C8B56C/2020	EPI_ISL_762733	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-C80B1A/2020	EPI_ISL_762784	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-4A62E4/2020	EPI_ISL_765023	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/204881987/2020	EPI_ISL_766278	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/205020757/2020	EPI_ISL_766281	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/205022338/2020	EPI_ISL_766282	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/205041400/2020	EPI_ISL_766286	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/205081143/2020	EPI_ISL_766290	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/205090680/2020	EPI_ISL_766296	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/Ireland/D-NVRL-AIIDM0184v1/2020	EPI_ISL_768791	2020-11-05	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/England/MILK-CAA1DC/2020	EPI_ISL_768871	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C7569F/2020	EPI_ISL_768909	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C71E31/2020	EPI_ISL_768915	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C6F6A7/2020	EPI_ISL_778319	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C643C9/2020	EPI_ISL_778322	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-D042DC/2020	EPI_ISL_781824	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-D0BF83/2020	EPI_ISL_781880	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CC990C/2020	EPI_ISL_781956	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Ireland/un-NVRL-AIIDB0132v1/2020	EPI_ISL_791307	2020-12-11	Europe / Ireland	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/un-NVRL-AIIDB0134v1-2/2020	EPI_ISL_791308	2020-12-11	Europe / Ireland	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/un-NVRL-AIIDB0138v1/2020	EPI_ISL_791309	2020-12-17	Europe / Ireland	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Denmark/DCGC-23453/2020	EPI_ISL_793762	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-23462/2020	EPI_ISL_793768	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-25231/2020	EPI_ISL_796005	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/MILK-DAA7CA/2020	EPI_ISL_797374	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-DED1EB/2020	EPI_ISL_797455	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-D74222/2020	EPI_ISL_798648	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-D14D14/2020	EPI_ISL_799906	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-D0E6A9/2020	EPI_ISL_799936	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CE150A/2020	EPI_ISL_799956	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-D0E2C3/2020	EPI_ISL_799959	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BC2870/2020	EPI_ISL_801040	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BC2A98/2020	EPI_ISL_801043	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.60	GV
hCoV-19/England/CAMC-BC2184/2020	EPI_ISL_801058	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BC3244/2020	EPI_ISL_801120	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-BC3208/2020	EPI_ISL_801133	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BAFF38/2020	EPI_ISL_801194	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BAFB8F/2020	EPI_ISL_801198	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/BIRM-684OA/2020	EPI_ISL_813029	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-69D3B/2020	EPI_ISL_813048	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-69ECF/2020	EPI_ISL_813058	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-6C4F7/2020	EPI_ISL_813060	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.55	GV
hCoV-19/England/BIRM-6C55E/2020	EPI_ISL_813063	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.55	GV
hCoV-19/England/BIRM-6C5E5/2020	EPI_ISL_813069	2020-12-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-6C62E/2020	EPI_ISL_813072	2020-12-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/BIRM-6C688/2020	EPI_ISL_813076	2020-12-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-6C6C4/2020	EPI_ISL_813079	2020-12-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.55	GV
hCoV-19/Denmark/DCGC-27439/2020	EPI_ISL_815673	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27450/2020	EPI_ISL_815681	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27453/2020	EPI_ISL_815683	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27462/2020	EPI_ISL_815687	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27472/2020	EPI_ISL_815694	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27474/2020	EPI_ISL_815695	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27486/2020	EPI_ISL_815703	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27493/2020	EPI_ISL_815707	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-27496/2020	EPI_ISL_815710	2020-12-28	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27601/2020	EPI_ISL_815772	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-27676/2020	EPI_ISL_815826	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27703/2020	EPI_ISL_815840	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-27245/2020	EPI_ISL_818023	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27372/2020	EPI_ISL_818096	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27377/2020	EPI_ISL_818098	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/NORW-2209EF/2020	EPI_ISL_820238	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-C6991D/2020	EPI_ISL_820298	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/NORW-2234EB/2020	EPI_ISL_820388	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-4AF4A9/2020	EPI_ISL_822736	2020-12-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Iceland/4032/2020	EPI_ISL_827728	2020-10-31	Europe / Iceland / Reykjavik	Human	Original			Illumina Miseq	MPileup			B.1.177.60	GV
hCoV-19/Switzerland/SO-42487067/2020	EPI_ISL_831010	2020-09-19	Europe / Switzerland / Solothurn / Breitenbach	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.177.77	GV
hCoV-19/England/ALDP-EE4909/2021	EPI_ISL_834890	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/205261496/2020	EPI_ISL_837035	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/205261510/2020	EPI_ISL_837036	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/205341113/2020	EPI_ISL_837048	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/205341149/2020	EPI_ISL_837049	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/NORT-1B73152/2020	EPI_ISL_839557	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Insertion of 2 nucleotide(s) found at refpos 28251 (Frameshift confirmed by the submitter). NSP11 without BLAST coverage.	info	B.1.177.54	GV
hCoV-19/England/LOND-1287C9F/2020	EPI_ISL_843005	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Denmark/DCGC-29041/2021	EPI_ISL_845528	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-31784/2021	EPI_ISL_856200	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-31790/2021	EPI_ISL_856206	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-31902/2021	EPI_ISL_856318	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-31931/2021	EPI_ISL_856347	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-31963/2021	EPI_ISL_856379	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/CAMC-FB1C92/2021	EPI_ISL_857551	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-CE1D11/2020	EPI_ISL_858857	2020-12-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/ALDP-CE1CC9/2020	EPI_ISL_858866	2020-12-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/ALDP-CE2493/2020	EPI_ISL_858889	2020-12-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/ALDP-CEFD8C/2020	EPI_ISL_858978	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/ALDP-C8C413/2020	EPI_ISL_858998	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-100369F/2021	EPI_ISL_863279	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-10042C7/2021	EPI_ISL_863360	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-FAFCA6/2021	EPI_ISL_864516	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Switzerland/GE-32923005/2021	EPI_ISL_864678	2021-01-10	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/LOND-12F61D8/2021	EPI_ISL_865954	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NOTT-24A457/2020	EPI_ISL_867000	2020-12-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-24A4A2/2020	EPI_ISL_867004	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-10C66A7/2021	EPI_ISL_868379	2021-01-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Denmark/DCGC-32534/2021	EPI_ISL_869538	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-32607/2021	EPI_ISL_869611	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-32629/2021	EPI_ISL_869633	2021-01-18	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-33503/2021	EPI_ISL_870513	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-33524/2021	EPI_ISL_870534	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33569/2021	EPI_ISL_870579	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-33591/2021	EPI_ISL_870601	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-33593/2021	EPI_ISL_870603	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33619/2021	EPI_ISL_870629	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33650/2021	EPI_ISL_870660	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Ireland/D-NVRL-AIIDM0209/2020	EPI_ISL_871808	2020-12-31	Europe / Ireland / Dublin	Human	Original	Oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 protocol			V.2	GV
hCoV-19/Ireland/D-NVRL-AIIDV1497/2020	EPI_ISL_871809	2020-12-22	Europe / Ireland / Dublin	Human	Original	Oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-AIIDB0152/2020	EPI_ISL_871813	2020-12-22	Europe / Ireland / Dublin	Human	Original	Oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 protocol			B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-AIIDB0149/2020	EPI_ISL_871814	2020-12-22	Europe / Ireland / Dublin	Human	Original	Oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 protocol			B.1.177.56	GV
hCoV-19/Belgium/55-2101-276/2021	EPI_ISL_871831	2021-01-05	Europe / Belgium / Zonhoven	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/55-2153-117/2021	EPI_ISL_871832	2021-01-03	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Spain/MD-ISCIII-2014666/2020	EPI_ISL_871987	2020-08-18	Europe / Spain / Madrid	Human	Original			Illumina MiSeq				B.1.177	GV
hCoV-19/Spain/MD-ISCIII-2014758/2020	EPI_ISL_871990	2020-08-21	Europe / Spain / Madrid	Human	Original			Illumina MiSeq				B.1.177	GV
hCoV-19/England/ALDP-FC12F7/2021	EPI_ISL_874005	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-FEC44B/2021	EPI_ISL_874041	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-FC1233/2021	EPI_ISL_874053	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-FEC399/2021	EPI_ISL_874193	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Ireland/D-NVRL-21IRL11624/2021	EPI_ISL_875368	2021-01-12	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.60	GV
hCoV-19/Ireland/LH-NVRL-21IRL09345/2021	EPI_ISL_875371	2021-01-12	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/England/ALDP-1092246/2021	EPI_ISL_877905	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-10923AD/2021	EPI_ISL_877957	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1016A24/2021	EPI_ISL_881158	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-10169DC/2021	EPI_ISL_881171	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-F74BCB/2021	EPI_ISL_882514	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-F74396/2021	EPI_ISL_882543	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-F75605/2021	EPI_ISL_882553	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-109DAAD/2021	EPI_ISL_886099	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Netherlands/LI-RIVM-10209/2021	EPI_ISL_905641	2021-01-04	Europe / Netherlands / Limburg	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/LI-RIVM-10217/2021	EPI_ISL_905664	2021-01-07	Europe / Netherlands / Limburg	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/GE-RIVM-21492/2020	EPI_ISL_905674	2020-12-29	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/England/MILK-10AED55/2021	EPI_ISL_909231	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-10B7EB0/2021	EPI_ISL_909270	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/MILK-10D4B6B/2021	EPI_ISL_909384	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Luxembourg/LNS3350846/2020	EPI_ISL_910362	2020-12-04	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS9551518/2020	EPI_ISL_910367	2020-12-04	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS1934850/2020	EPI_ISL_910387	2020-11-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Belgium/AZDelta2103-12780/2021	EPI_ISL_911399	2021-01-20	Europe / Belgium / Tielt	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/France/un-21012170125/2021	EPI_ISL_912960	2021-01-17	Europe / France	Human	Original	Nasopharyngeal swab		Illumina NextSeq500	Illumina DRAGEN COVIDSeq Test Pipeline v.1.2.2			B.1.177.77	GV
hCoV-19/England/ALDP-10ECB42/2021	EPI_ISL_916324	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-10EC4A1/2021	EPI_ISL_916359	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10EC66F/2021	EPI_ISL_916361	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-11219FB/2021	EPI_ISL_917639	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/BIRM-6EBD2/2020	EPI_ISL_918828	2020-12-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-6ECEE/2020	EPI_ISL_918838	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-6EF8B/2021	EPI_ISL_918860	2021-01-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/BIRM-6F6C1/2021	EPI_ISL_918901	2021-01-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.55	GV
hCoV-19/England/BIRM-7143B/2021	EPI_ISL_918976	2021-01-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-236737/2021	EPI_ISL_921016	2021-01-13	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/Northern Ireland/NIRE-245A78/2020	EPI_ISL_921032	2020-12-30	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-245B0C/2020	EPI_ISL_921036	2020-12-31	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.2	GV
hCoV-19/Northern Ireland/NIRE-245B2A/2020	EPI_ISL_921037	2020-12-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-245B57/2021	EPI_ISL_921038	2021-01-01	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-245B66/2021	EPI_ISL_921039	2021-01-01	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-245B93/2020	EPI_ISL_921042	2020-12-30	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/Northern Ireland/NIRE-245C09/2021	EPI_ISL_921048	2021-01-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-245C18/2021	EPI_ISL_921049	2021-01-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-245C27/2021	EPI_ISL_921050	2021-01-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-245C45/2021	EPI_ISL_921051	2021-01-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NOTT-24B6AB/2021	EPI_ISL_922045	2021-01-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-24B6C9/2021	EPI_ISL_922046	2021-01-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-24B799/2021	EPI_ISL_922059	2021-01-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-24BA27/2021	EPI_ISL_922095	2021-01-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-24C6C8/2021	EPI_ISL_922157	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-24C859/2021	EPI_ISL_922167	2021-01-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/OXON-F4DC6E/2021	EPI_ISL_922188	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/OXON-F4F14F/2021	EPI_ISL_922194	2021-01-07	Europe / United Kingdom / England	Human	Original			Illumina				U.1	GV
hCoV-19/England/OXON-F5172A/2020	EPI_ISL_922253	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4BAAD6/2021	EPI_ISL_922371	2021-01-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Denmark/DCGC-35872/2021	EPI_ISL_927013	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-35898/2020	EPI_ISL_927039	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-37059/2021	EPI_ISL_928200	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-38371/2021	EPI_ISL_929512	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-38381/2021	EPI_ISL_929522	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-38496/2021	EPI_ISL_929637	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-38529/2021	EPI_ISL_929670	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-39369/2021	EPI_ISL_930511	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-39370/2021	EPI_ISL_930512	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/QEUH-114B269/2021	EPI_ISL_933002	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Lithuania/ID3767/2020	EPI_ISL_934097	2020-12-14	Europe / Lithuania / Alytaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3836/2020	EPI_ISL_934134	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3837/2020	EPI_ISL_934135	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3838/2020	EPI_ISL_934136	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3840/2020	EPI_ISL_934137	2020-12-11	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3841/2020	EPI_ISL_934138	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3847/2020	EPI_ISL_934139	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.177.60	GV
hCoV-19/Lithuania/ID3861/2020	EPI_ISL_934142	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3864/2020	EPI_ISL_934143	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3865/2020	EPI_ISL_934144	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3897/2020	EPI_ISL_934162	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3899/2020	EPI_ISL_934164	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID3926/2020	EPI_ISL_934169	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID6924/2021	EPI_ISL_934232	2021-01-06	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/England/QEUH-1189092/2021	EPI_ISL_946199	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-118C32D/2021	EPI_ISL_946306	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-114D9BD/2021	EPI_ISL_947494	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-114E58B/2021	EPI_ISL_947622	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-112A400/2021	EPI_ISL_948966	2021-01-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.77	GV
hCoV-19/Belgium/Jessa_55-2103-000103/2021	EPI_ISL_948997	2021-01-18	Europe / Belgium / Diepenbeek	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/England/OXON-F47666/2020	EPI_ISL_950977	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-11A477E/2021	EPI_ISL_958157	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Latvia/257/2021	EPI_ISL_961809	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/264/2021	EPI_ISL_961815	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/266/2021	EPI_ISL_961817	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/279/2021	EPI_ISL_961823	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/280/2021	EPI_ISL_961824	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/281/2021	EPI_ISL_961825	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/282/2021	EPI_ISL_961826	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			U.3	GV
hCoV-19/Latvia/283/2021	EPI_ISL_961827	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/286/2021	EPI_ISL_961830	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/293/2021	EPI_ISL_961832	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/299/2021	EPI_ISL_961836	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/300/2021	EPI_ISL_961837	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/303/2021	EPI_ISL_961840	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/305/2021	EPI_ISL_961842	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.79	GV
hCoV-19/Latvia/307/2021	EPI_ISL_961844	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			U.3	GV
hCoV-19/Latvia/311/2021	EPI_ISL_961848	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			U.3	GV
hCoV-19/Latvia/313/2021	EPI_ISL_961850	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			U.3	GV
hCoV-19/Latvia/315/2021	EPI_ISL_961851	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/England/ALDP-11BA274/2021	EPI_ISL_964151	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Belgium/ULG-11760/2021	EPI_ISL_965482	2021-01-26	Europe / Belgium / Hainaut	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Denmark/DCGC-39685/2021	EPI_ISL_971203	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-40738/2021	EPI_ISL_972415	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-40935/2021	EPI_ISL_972612	2021-02-01	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Belgium/AZDelta20613-2105R/2021	EPI_ISL_978792	2021-02-06	Europe / Belgium / Koekelare	Human	Original	Nasopharyngeal swab	unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/England/MILK-11EFCA5/2021	EPI_ISL_980739	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-121E231/2021	EPI_ISL_985798	2021-02-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-1197E88/2021	EPI_ISL_990453	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10E91BC/2021	EPI_ISL_992744	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10E9DD6/2021	EPI_ISL_992753	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/BIRM-70751/2021	EPI_ISL_996427	2021-01-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/BIRM-70D9B/2021	EPI_ISL_996467	2021-01-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BRIS-25EB2E/2021	EPI_ISL_996528	2021-01-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.55	GV
hCoV-19/Belgium/ULG-12024/2021	EPI_ISL_1000058	2021-02-01	Europe / Belgium / Namur	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/ULG-12025/2021	EPI_ISL_1000059	2021-01-01	Europe / Belgium / Namur	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Switzerland/BE-ETHZ-480312/2021	EPI_ISL_1003944	2021-02-01	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Switzerland/SO-ETHZ-480375/2021	EPI_ISL_1003989	2021-02-01	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/England/ALDP-119744A/2021	EPI_ISL_1007553	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Netherlands/NB-RIVM-11900/2021	EPI_ISL_1013690	2021-01-30	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION		NS8_G50stop results in 59.5% truncation of the protein sequence.	info	B.1.177.77	GV
hCoV-19/Netherlands/UT-RIVM-12023/2021	EPI_ISL_1013691	2021-02-02	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION		NS8_G50stop results in 59.5% truncation of the protein sequence.	info	B.1.177.77	GV
hCoV-19/Scotland/QEUH-120C03C/2021	EPI_ISL_1019572	2021-02-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.77	GV
hCoV-19/Denmark/DCGC-42759/2021	EPI_ISL_1023037	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-43992/2021	EPI_ISL_1024370	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-43995/2021	EPI_ISL_1024373	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/CAMC-126241A/2021	EPI_ISL_1033823	2021-02-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-1292E40/2021	EPI_ISL_1042174	2021-02-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 2 nucleotide(s) found at refpos 28251 (frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/England/BIRM-BCY19B/2021	EPI_ISL_1047003	2021-01-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-BCY1SU/2021	EPI_ISL_1047005	2021-01-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-BCY1ZT/2021	EPI_ISL_1047008	2021-01-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Germany/SH-RKI-N-0225/2021	EPI_ISL_1048326	2021-01-14	Europe / Germany / Schleswig-Holstein	Human	Original			Illumina iSeq	Covpipe			B.1.177.77	GV
hCoV-19/Ireland/KY-NVRL-21IRL35823/2020	EPI_ISL_1055114	2020-11-02	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KY-NVRL-21IRL35855/2020	EPI_ISL_1055117	2020-12-21	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177	GV
hCoV-19/Ireland/KY-NVRL-21IRL35861/2020	EPI_ISL_1055119	2020-11-10	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KY-NVRL-21IRL35857/2020	EPI_ISL_1055124	2020-12-17	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KY-NVRL-21IRL35812/2020	EPI_ISL_1055126	2020-11-05	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KY-NVRL-21IRL35858/2020	EPI_ISL_1055127	2020-10-28	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KY-NVRL-21IRL35822/2020	EPI_ISL_1055133	2020-10-31	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KY-NVRL-21IRL35808/2020	EPI_ISL_1055135	2020-11-05	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KY-NVRL-21IRL35862/2020	EPI_ISL_1055136	2020-11-02	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KY-NVRL-21IRL35866/2020	EPI_ISL_1055137	2020-10-28	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KY-NVRL-21IRL35863/2020	EPI_ISL_1055140	2020-10-28	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KY-NVRL-21IRL35809/2020	EPI_ISL_1055142	2020-11-02	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KY-NVRL-21IRL35865/2020	EPI_ISL_1055145	2020-11-03	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KY-NVRL-21IRL35867/2020	EPI_ISL_1055146	2020-10-28	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-21IRL35072/2021	EPI_ISL_1055162	2021-01-03	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-21IRL34988/2020	EPI_ISL_1055163	2020-12-17	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-21IRL34989/2020	EPI_ISL_1055167	2020-12-05	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Scotland/QEUH-12A9D1C/2021	EPI_ISL_1062304	2021-02-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.77	GV
hCoV-19/England/QEUH-12A8779/2021	EPI_ISL_1062334	2021-02-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Denmark/DCGC-46620/2021	EPI_ISL_1066130	2021-02-15	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GR
hCoV-19/Denmark/DCGC-47935/2021	EPI_ISL_1067470	2021-02-15	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-47949/2021	EPI_ISL_1067484	2021-02-15	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/MILK-12B481D/2021	EPI_ISL_1069869	2021-02-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-1292CBF/2021	EPI_ISL_1070763	2021-02-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-96AA3A/2020	EPI_ISL_531316	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Northern Ireland/QEUH-96AF86/2020	EPI_ISL_531324	2020-08-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-96FBD8/2020	EPI_ISL_540301	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-96F82C/2020	EPI_ISL_540306	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-96F65F/2020	EPI_ISL_540341	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-98EE9E/2020	EPI_ISL_540398	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-9B1EFC/2020	EPI_ISL_549401	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-9B22D1/2020	EPI_ISL_549406	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/MILK-9A8845/2020	EPI_ISL_549428	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/MILK-9A8854/2020	EPI_ISL_549429	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/MILK-9A91EF/2020	EPI_ISL_551000	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A97DE/2020	EPI_ISL_551002	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A97B0/2020	EPI_ISL_551030	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A946E/2020	EPI_ISL_551036	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-995201/2020	EPI_ISL_552340	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/MILK-994633/2020	EPI_ISL_552357	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-993BEA/2020	EPI_ISL_552361	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-995492/2020	EPI_ISL_552372	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-991E01/2020	EPI_ISL_552375	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-994985/2020	EPI_ISL_552384	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9C39C9/2020	EPI_ISL_566903	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/MILK-9C3D36/2020	EPI_ISL_566909	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/MILK-9C3B3C/2020	EPI_ISL_566931	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9C3E06/2020	EPI_ISL_566958	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C3DCD/2020	EPI_ISL_566995	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9C845A/2020	EPI_ISL_567208	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9C86EB/2020	EPI_ISL_567223	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9C8BFB/2020	EPI_ISL_567233	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9CA652/2020	EPI_ISL_567276	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9C940E/2020	EPI_ISL_567279	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9CC16E/2020	EPI_ISL_573088	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9CC2B6/2020	EPI_ISL_573095	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9CC32C/2020	EPI_ISL_573099	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/ALDP-9CC553/2020	EPI_ISL_573113	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9CC5F9/2020	EPI_ISL_573118	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-9CC975/2020	EPI_ISL_573122	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-9CC9EE/2020	EPI_ISL_573123	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9CCA63/2020	EPI_ISL_573125	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-9C062F/2020	EPI_ISL_573192	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9CB1BA/2020	EPI_ISL_575723	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9748E8/2020	EPI_ISL_575797	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9EA1D3/2020	EPI_ISL_580208	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EA0A9/2020	EPI_ISL_580214	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EB07B/2020	EPI_ISL_580215	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EB06C/2020	EPI_ISL_580216	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EA4AD/2020	EPI_ISL_580217	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EAC87/2020	EPI_ISL_580219	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9EB099/2020	EPI_ISL_580228	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9EACD2/2020	EPI_ISL_580238	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-9EA8DE/2020	EPI_ISL_580239	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EA8A1/2020	EPI_ISL_580245	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9EB0A8/2020	EPI_ISL_580249	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E79FC/2020	EPI_ISL_580255	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9EA4BC/2020	EPI_ISL_580258	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-9EABC6/2020	EPI_ISL_580260	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9EA601/2020	EPI_ISL_580273	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-9E69FD/2020	EPI_ISL_580277	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E634A/2020	EPI_ISL_580280	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E7288/2020	EPI_ISL_580291	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E6614/2020	EPI_ISL_580295	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/NOTT-114B61/2020	EPI_ISL_584764	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114C22/2020	EPI_ISL_584765	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114CF5/2020	EPI_ISL_584767	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-114DA7/2020	EPI_ISL_584771	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-114DB6/2020	EPI_ISL_584772	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-114DD4/2020	EPI_ISL_584773	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-114E0E/2020	EPI_ISL_584774	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-114EFF/2020	EPI_ISL_584779	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-114F47/2020	EPI_ISL_584780	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-114F56/2020	EPI_ISL_584781	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-114F65/2020	EPI_ISL_584782	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114FA1/2020	EPI_ISL_584784	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114FCF/2020	EPI_ISL_584785	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114FDE/2020	EPI_ISL_584786	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114FED/2020	EPI_ISL_584787	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-115104/2020	EPI_ISL_584790	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-115113/2020	EPI_ISL_584791	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-115131/2020	EPI_ISL_584792	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1151AA/2020	EPI_ISL_584795	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1151C8/2020	EPI_ISL_584797	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1151E6/2020	EPI_ISL_584799	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-CD62B/2020	EPI_ISL_585060	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-CE01D/2020	EPI_ISL_585064	2020-09-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-CE0B3/2020	EPI_ISL_585065	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-CF0B2/2020	EPI_ISL_585072	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/SHEF-D0E1E/2020	EPI_ISL_585077	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-D233B/2020	EPI_ISL_585084	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-D318B/2020	EPI_ISL_585089	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-D33FE/2020	EPI_ISL_585091	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-A210E1/2020	EPI_ISL_587700	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9FD322/2020	EPI_ISL_587733	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FDAC3/2020	EPI_ISL_587758	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FE00C/2020	EPI_ISL_587760	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD735/2020	EPI_ISL_587764	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9FCC28/2020	EPI_ISL_587765	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FCBB2/2020	EPI_ISL_587768	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD88D/2020	EPI_ISL_587771	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-9FCF5C/2020	EPI_ISL_587779	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9FD6DE/2020	EPI_ISL_587781	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9FA7A1/2020	EPI_ISL_588220	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9FABE1/2020	EPI_ISL_588225	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9FAF7C/2020	EPI_ISL_588256	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9FA404/2020	EPI_ISL_588262	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9FA46E/2020	EPI_ISL_588272	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F4B14/2020	EPI_ISL_588277	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F4947/2020	EPI_ISL_588287	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9F4EEE/2020	EPI_ISL_588302	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-9F48A4/2020	EPI_ISL_588307	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9E5AA0/2020	EPI_ISL_589547	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9E5C5F/2020	EPI_ISL_589556	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/MILK-9F0D5E/2020	EPI_ISL_589580	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/MILK-9F09B4/2020	EPI_ISL_589596	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9F1986/2020	EPI_ISL_589621	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9F0969/2020	EPI_ISL_589635	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9F1616/2020	EPI_ISL_589647	2020-09-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/QEUH-9B8165/2020	EPI_ISL_590539	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B7E32/2020	EPI_ISL_590587	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9B7D35/2020	EPI_ISL_590612	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B7360/2020	EPI_ISL_590613	2020-09-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B72DC/2020	EPI_ISL_590620	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CVR5080/2020	EPI_ISL_594813	2020-10-11	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/LOND-12625AE/2020	EPI_ISL_594863	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/LOND-126292A/2020	EPI_ISL_594882	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/Wales/MILK-9EEFA8/2020	EPI_ISL_594891	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/MILK-9EF0D1/2020	EPI_ISL_594899	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-47E36A/2020	EPI_ISL_595443	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-47E5DD/2020	EPI_ISL_595475	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/England/CAMC-A57F7C/2020	EPI_ISL_597039	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A589C8/2020	EPI_ISL_597040	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A58667/2020	EPI_ISL_597046	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A58C29/2020	EPI_ISL_597047	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A5904A/2020	EPI_ISL_597053	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A58D17/2020	EPI_ISL_597059	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A589E6/2020	EPI_ISL_597069	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A59639/2020	EPI_ISL_597073	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A5954B/2020	EPI_ISL_597091	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A58CED/2020	EPI_ISL_597095	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-A59280/2020	EPI_ISL_597101	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-A58C0B/2020	EPI_ISL_597107	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A58FA8/2020	EPI_ISL_597117	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A5838E/2020	EPI_ISL_597131	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-A5800F/2020	EPI_ISL_597137	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A595C3/2020	EPI_ISL_597141	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A58333/2020	EPI_ISL_597147	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/MILK-A46DEF/2020	EPI_ISL_598393	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A46D1C/2020	EPI_ISL_598405	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A46981/2020	EPI_ISL_598423	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-A46F25/2020	EPI_ISL_598425	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A47A23/2020	EPI_ISL_598465	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A47197/2020	EPI_ISL_598474	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9DE284/2020	EPI_ISL_599764	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A00859/2020	EPI_ISL_600410	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9FF89A/2020	EPI_ISL_600424	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9FFEB6/2020	EPI_ISL_600462	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-9D4B74/2020	EPI_ISL_601717	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-9D401B/2020	EPI_ISL_601767	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-9D1EC9/2020	EPI_ISL_601785	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9B711B/2020	EPI_ISL_602108	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-A7A896/2020	EPI_ISL_606581	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7A9DF/2020	EPI_ISL_606587	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7A6BA/2020	EPI_ISL_606589	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A79EA4/2020	EPI_ISL_606625	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A7D09B/2020	EPI_ISL_606636	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/MILK-A79A28/2020	EPI_ISL_606637	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A79DD4/2020	EPI_ISL_606642	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7A2D4/2020	EPI_ISL_606650	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6E73E/2020	EPI_ISL_607953	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6DFFB/2020	EPI_ISL_607959	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6E710/2020	EPI_ISL_607965	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F032/2020	EPI_ISL_607967	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A7072A/2020	EPI_ISL_607981	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6C32D/2020	EPI_ISL_607983	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6D483/2020	EPI_ISL_607985	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6D2E3/2020	EPI_ISL_608200	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A6D3D1/2020	EPI_ISL_608201	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A708CD/2020	EPI_ISL_608205	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6D878/2020	EPI_ISL_608206	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6C4A2/2020	EPI_ISL_608207	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6D517/2020	EPI_ISL_608208	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A6C378/2020	EPI_ISL_608209	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6D7D5/2020	EPI_ISL_608230	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6D4B0/2020	EPI_ISL_608238	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6D526/2020	EPI_ISL_608241	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6CBAD/2020	EPI_ISL_608285	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A40D03/2020	EPI_ISL_609504	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A40EA6/2020	EPI_ISL_609509	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A41EB4/2020	EPI_ISL_609513	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A419E0/2020	EPI_ISL_609526	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F578/2020	EPI_ISL_609539	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177.4	GV
hCoV-19/England/CAMC-A3EBE0/2020	EPI_ISL_609541	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A3F332/2020	EPI_ISL_609555	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	G
hCoV-19/England/CAMC-A3F772/2020	EPI_ISL_609558	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A3E746/2020	EPI_ISL_609562	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F587/2020	EPI_ISL_609569	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A3F5B4/2020	EPI_ISL_609570	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A3F9D6/2020	EPI_ISL_609571	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3EC38/2020	EPI_ISL_609607	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-A856BC/2020	EPI_ISL_610501	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A84E6A/2020	EPI_ISL_610505	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A8542B/2020	EPI_ISL_610507	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A85CF6/2020	EPI_ISL_610513	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A850BE/2020	EPI_ISL_610521	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A8527C/2020	EPI_ISL_610528	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A85704/2020	EPI_ISL_610532	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A851CA/2020	EPI_ISL_610544	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A85B44/2020	EPI_ISL_610546	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A84F67/2020	EPI_ISL_610551	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A85A38/2020	EPI_ISL_610560	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A85E69/2020	EPI_ISL_610567	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A92E3C/2020	EPI_ISL_611106	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A939C1/2020	EPI_ISL_611113	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A93ACE/2020	EPI_ISL_611114	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A92D7B/2020	EPI_ISL_611119	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A93C9B/2020	EPI_ISL_611122	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A926DA/2020	EPI_ISL_611125	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-AB754B/2020	EPI_ISL_623807	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AB88BA/2020	EPI_ISL_623813	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AB7A00/2020	EPI_ISL_623837	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AB1D58/2020	EPI_ISL_623856	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AB21C4/2020	EPI_ISL_623857	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA3102/2020	EPI_ISL_623881	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA523A/2020	EPI_ISL_623885	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA474B/2020	EPI_ISL_624407	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA46D5/2020	EPI_ISL_624410	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA3C3E/2020	EPI_ISL_624413	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA22E2/2020	EPI_ISL_624433	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Denmark/DCGC-8915/2020	EPI_ISL_626127	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Scotland/CVR5214/2020	EPI_ISL_627391	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5226/2020	EPI_ISL_627398	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5242/2020	EPI_ISL_627408	2020-10-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/Scotland/CVR5245/2020	EPI_ISL_627409	2020-10-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5251/2020	EPI_ISL_627413	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5252/2020	EPI_ISL_627414	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5263/2020	EPI_ISL_627422	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/EXET-138736/2020	EPI_ISL_627426	2020-10-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/EXET-138BA3/2020	EPI_ISL_627436	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/MILK-A18A94/2020	EPI_ISL_627477	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/MILK-A6A301/2020	EPI_ISL_627498	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A6446E/2020	EPI_ISL_628700	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-AC84A4/2020	EPI_ISL_629212	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ACBB9D/2020	EPI_ISL_629222	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACBDA6/2020	EPI_ISL_629225	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACBFFB/2020	EPI_ISL_629230	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ACEBE5/2020	EPI_ISL_629243	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AC835C/2020	EPI_ISL_629250	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-AC92C7/2020	EPI_ISL_629256	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ACE23B/2020	EPI_ISL_629261	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACECC4/2020	EPI_ISL_629266	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACE8EE/2020	EPI_ISL_629291	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACE8C0/2020	EPI_ISL_629293	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACE480/2020	EPI_ISL_629295	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ACCFCD/2020	EPI_ISL_630202	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC740F/2020	EPI_ISL_630208	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACD17B/2020	EPI_ISL_630231	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AC72F6/2020	EPI_ISL_630253	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC77F7/2020	EPI_ISL_630258	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ACE17A/2020	EPI_ISL_630280	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACDB40/2020	EPI_ISL_630297	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AEA73A/2020	EPI_ISL_633239	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE4C40/2020	EPI_ISL_633240	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-AEAD0B/2020	EPI_ISL_633242	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE5210/2020	EPI_ISL_633243	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AEA98F/2020	EPI_ISL_633248	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-AEA9E9/2020	EPI_ISL_633254	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AEB0D4/2020	EPI_ISL_633257	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE4BF8/2020	EPI_ISL_633268	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AEA62E/2020	EPI_ISL_633292	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACC525/2020	EPI_ISL_634507	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD445A/2020	EPI_ISL_634530	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD5EA6/2020	EPI_ISL_634570	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD5A39/2020	EPI_ISL_634573	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD18E8/2020	EPI_ISL_634578	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Norway/4688/2020	EPI_ISL_635178	2020-10-22	Europe / Norway / Oslo	Human	Original			Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/4696/2020	EPI_ISL_635179	2020-10-14	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/4699/2020	EPI_ISL_635180	2020-10-16	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/4700/2020	EPI_ISL_635181	2020-10-19	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/4747/2020	EPI_ISL_635198	2020-10-19	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Wales/PHWC-486A6A/2020	EPI_ISL_638042	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Wales/PHWC-486BD0/2020	EPI_ISL_638043	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Wales/PHWC-4872E9/2020	EPI_ISL_638045	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Wales/PHWC-489681/2020	EPI_ISL_638048	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Wales/PHWC-4896FA/2020	EPI_ISL_638049	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Wales/PHWC-48838B/2020	EPI_ISL_639385	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-488497/2020	EPI_ISL_639396	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B13E8D/2020	EPI_ISL_641692	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B106F1/2020	EPI_ISL_641694	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B1388F/2020	EPI_ISL_641706	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B13773/2020	EPI_ISL_641731	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B13746/2020	EPI_ISL_641769	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0F83B/2020	EPI_ISL_641776	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B13B0E/2020	EPI_ISL_641782	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B1397D/2020	EPI_ISL_641795	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B0E6AB/2020	EPI_ISL_642203	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B10E17/2020	EPI_ISL_642215	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B10D65/2020	EPI_ISL_642235	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B10C95/2020	EPI_ISL_642240	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B12923/2020	EPI_ISL_642245	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B10E53/2020	EPI_ISL_642262	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B1149C/2020	EPI_ISL_642283	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B12835/2020	EPI_ISL_642290	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0AE2F/2020	EPI_ISL_643521	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B07DCB/2020	EPI_ISL_643526	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B084F2/2020	EPI_ISL_643530	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B084B6/2020	EPI_ISL_643537	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B07E6E/2020	EPI_ISL_643539	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B089B7/2020	EPI_ISL_643549	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0C92C/2020	EPI_ISL_643550	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B0C8E3/2020	EPI_ISL_643558	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B0CD5D/2020	EPI_ISL_643571	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B0C87A/2020	EPI_ISL_643589	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B35EFE/2020	EPI_ISL_645220	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B36446/2020	EPI_ISL_645222	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B36983/2020	EPI_ISL_645247	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B3674D/2020	EPI_ISL_645257	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B370BA/2020	EPI_ISL_645262	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/CAMC-B3676B/2020	EPI_ISL_645276	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B35FA0/2020	EPI_ISL_645283	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B369DE/2020	EPI_ISL_645298	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2C892/2020	EPI_ISL_646517	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B25107/2020	EPI_ISL_646541	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B25037/2020	EPI_ISL_646549	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B260AF/2020	EPI_ISL_646557	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B26467/2020	EPI_ISL_646571	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B264C1/2020	EPI_ISL_646576	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B2B8A2/2020	EPI_ISL_646582	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B24D8C/2020	EPI_ISL_646594	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-B251E9/2020	EPI_ISL_646599	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B20FC6/2020	EPI_ISL_647154	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B21833/2020	EPI_ISL_647158	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B224B6/2020	EPI_ISL_647171	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B21DBC/2020	EPI_ISL_647172	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B22CEB/2020	EPI_ISL_647176	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/QEUH-B13F02/2020	EPI_ISL_647800	2020-10-31	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/QEUH-B0DE86/2020	EPI_ISL_647803	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/MILK-B02504/2020	EPI_ISL_647810	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AABD42/2020	EPI_ISL_651086	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/NOTT-11C6D1/2020	EPI_ISL_651107	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-1095CB/2020	EPI_ISL_652336	2020-10-13	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/NORT-286EBB/2020	EPI_ISL_652341	2020-10-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NORW-F2DEC/2020	EPI_ISL_652349	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F610A/2020	EPI_ISL_652350	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F6A96/2020	EPI_ISL_652354	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/NORW-F7A0E/2020	EPI_ISL_652361	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NOTT-11B432/2020	EPI_ISL_652365	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11B47E/2020	EPI_ISL_652367	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11B5B7/2020	EPI_ISL_652369	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11B6C3/2020	EPI_ISL_652370	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11B6D2/2020	EPI_ISL_652371	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11B6E1/2020	EPI_ISL_652372	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11B72A/2020	EPI_ISL_652373	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11B739/2020	EPI_ISL_652374	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11B757/2020	EPI_ISL_652375	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11B766/2020	EPI_ISL_652376	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11B7A2/2020	EPI_ISL_652377	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11B7B1/2020	EPI_ISL_652378	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11BBC4/2020	EPI_ISL_652382	2020-11-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11BC49/2020	EPI_ISL_652383	2020-11-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11BD28/2020	EPI_ISL_652384	2020-11-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11BD46/2020	EPI_ISL_652385	2020-11-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11BD73/2020	EPI_ISL_652386	2020-11-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11BEAD/2020	EPI_ISL_652389	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11BEBC/2020	EPI_ISL_652390	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11BEE9/2020	EPI_ISL_652393	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11BFD7/2020	EPI_ISL_652394	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C079/2020	EPI_ISL_652396	2020-11-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C1B2/2020	EPI_ISL_652400	2020-11-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C334/2020	EPI_ISL_652402	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C361/2020	EPI_ISL_652403	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C370/2020	EPI_ISL_652404	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C38F/2020	EPI_ISL_652405	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C5A7/2020	EPI_ISL_652406	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C6C2/2020	EPI_ISL_652407	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11C71A/2020	EPI_ISL_652408	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C747/2020	EPI_ISL_652409	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C7B0/2020	EPI_ISL_652410	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C7ED/2020	EPI_ISL_652411	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11C826/2020	EPI_ISL_652412	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C844/2020	EPI_ISL_652413	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Spain/MD-IBV-99008644/2020	EPI_ISL_654212	2020-09-29	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/MD-IBV-99008663/2020	EPI_ISL_654224	2020-09-30	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/England/ALDP-B5B496/2020	EPI_ISL_655501	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B5BB19/2020	EPI_ISL_655536	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5AEA8/2020	EPI_ISL_655556	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B5366B/2020	EPI_ISL_656812	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B534BC/2020	EPI_ISL_656816	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B53838/2020	EPI_ISL_656821	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B522D1/2020	EPI_ISL_656825	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B544F7/2020	EPI_ISL_656852	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B536B6/2020	EPI_ISL_656856	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B56747/2020	EPI_ISL_656862	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B534F8/2020	EPI_ISL_656898	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B40555/2020	EPI_ISL_657207	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B425AE/2020	EPI_ISL_657222	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B4377A/2020	EPI_ISL_657256	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B4277B/2020	EPI_ISL_657265	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B40661/2020	EPI_ISL_657266	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-B424FC/2020	EPI_ISL_657274	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B401AC/2020	EPI_ISL_657278	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B436F5/2020	EPI_ISL_657288	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B3F3D7/2020	EPI_ISL_658525	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B41387/2020	EPI_ISL_658541	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B3F36E/2020	EPI_ISL_658543	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B41888/2020	EPI_ISL_658544	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B3F42F/2020	EPI_ISL_658558	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B41053/2020	EPI_ISL_658565	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B3FB93/2020	EPI_ISL_658573	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B41AEC/2020	EPI_ISL_658582	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B41879/2020	EPI_ISL_658597	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B336BC/2020	EPI_ISL_659144	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B3383E/2020	EPI_ISL_659159	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B334D0/2020	EPI_ISL_659163	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B32662/2020	EPI_ISL_659183	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2F63B/2020	EPI_ISL_659801	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.54	GV
hCoV-19/England/QEUH-B2E951/2020	EPI_ISL_659831	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-B2E872/2020	EPI_ISL_659859	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B2D3BE/2020	EPI_ISL_659867	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B2CD84/2020	EPI_ISL_659873	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2D390/2020	EPI_ISL_659880	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2D6D3/2020	EPI_ISL_659883	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B67682/2020	EPI_ISL_661468	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B67646/2020	EPI_ISL_661475	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B6701B/2020	EPI_ISL_661486	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B6838A/2020	EPI_ISL_661492	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AF24FC/2020	EPI_ISL_662782	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AF0018/2020	EPI_ISL_662783	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AEF9B7/2020	EPI_ISL_662791	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AF00DC/2020	EPI_ISL_662792	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF48FE/2020	EPI_ISL_663002	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF6980/2020	EPI_ISL_663010	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF5B6D/2020	EPI_ISL_663011	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AF69BD/2020	EPI_ISL_663027	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF5778/2020	EPI_ISL_663029	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AF52B3/2020	EPI_ISL_663034	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AF4928/2020	EPI_ISL_663049	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF505F/2020	EPI_ISL_663066	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF3DB4/2020	EPI_ISL_663069	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/PHWC-48AD03/2020	EPI_ISL_665750	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Wales/PHWC-48B0CD/2020	EPI_ISL_665751	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Wales/PHWC-48B2F4/2020	EPI_ISL_665752	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Wales/PHWC-48B3B5/2020	EPI_ISL_665753	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Wales/PHWC-48BDF3/2020	EPI_ISL_665754	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Wales/PHWC-48C2A8/2020	EPI_ISL_665756	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Wales/PHWC-48B1BB/2020	EPI_ISL_666203	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-48B5CE/2020	EPI_ISL_666257	2020-11-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-BA3444/2020	EPI_ISL_672807	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BA2E1A/2020	EPI_ISL_672854	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-BA30F5/2020	EPI_ISL_672863	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-BA2F53/2020	EPI_ISL_672868	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-BA11C7/2020	EPI_ISL_672872	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BA3031/2020	EPI_ISL_672879	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BA1EEE/2020	EPI_ISL_672886	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BA10F7/2020	EPI_ISL_672899	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B9A2BF/2020	EPI_ISL_673394	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B99098/2020	EPI_ISL_673395	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B98F14/2020	EPI_ISL_673422	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B98B3E/2020	EPI_ISL_673454	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B8EC83/2020	EPI_ISL_674755	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B7F757/2020	EPI_ISL_674779	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8E98C/2020	EPI_ISL_674797	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B8E39D/2020	EPI_ISL_674799	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B97285/2020	EPI_ISL_675032	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B96C4C/2020	EPI_ISL_675034	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B96523/2020	EPI_ISL_675035	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B9714C/2020	EPI_ISL_675086	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B968B1/2020	EPI_ISL_676300	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B95DB3/2020	EPI_ISL_676306	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B969AF/2020	EPI_ISL_676310	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Scotland/QEUH-B694E0/2020	EPI_ISL_676322	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-B6C887/2020	EPI_ISL_676360	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B74A4A/2020	EPI_ISL_678961	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/ALDP-B74A86/2020	EPI_ISL_678965	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/ALDP-B74AD1/2020	EPI_ISL_678970	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/ALDP-B74B0B/2020	EPI_ISL_678972	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/ALDP-B74E11/2020	EPI_ISL_678994	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/LOND-1263FDC/2020	EPI_ISL_679511	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/LOND-12D4C0C/2020	EPI_ISL_679557	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Scotland/EDB9082/2020	EPI_ISL_680511	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Scotland/QEUH-B2D020/2020	EPI_ISL_680576	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/204762042/2020	EPI_ISL_683562	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.56	GV
hCoV-19/England/204781667/2020	EPI_ISL_683570	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/ALDP-BB4F9A/2020	EPI_ISL_701807	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BB3DBF/2020	EPI_ISL_701809	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BBAF58/2020	EPI_ISL_701836	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BBA3B6/2020	EPI_ISL_701852	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB5430/2020	EPI_ISL_701872	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB51A2/2020	EPI_ISL_701889	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB9FE0/2020	EPI_ISL_701890	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BBA0CE/2020	EPI_ISL_701893	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB4A11/2020	EPI_ISL_702400	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB9690/2020	EPI_ISL_702402	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB9C8F/2020	EPI_ISL_702417	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BBADC7/2020	EPI_ISL_702424	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-BBB564/2020	EPI_ISL_702437	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BBB591/2020	EPI_ISL_702443	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BBA6BD/2020	EPI_ISL_702444	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BB4D63/2020	EPI_ISL_702448	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BBB3C4/2020	EPI_ISL_702449	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BBB3D3/2020	EPI_ISL_702456	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB4A3F/2020	EPI_ISL_702467	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB4A20/2020	EPI_ISL_702468	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BBB573/2020	EPI_ISL_702479	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-BC3763/2020	EPI_ISL_704109	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/PHWC-491079/2020	EPI_ISL_705418	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/England/SHEF-10C7600/2020	EPI_ISL_705421	2020-12-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/Wales/PHWC-49199C/2020	EPI_ISL_706719	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-BE037B/2020	EPI_ISL_709843	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BE0302/2020	EPI_ISL_709870	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B88E74/2020	EPI_ISL_709891	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Northern Ireland/MILK-B947A7/2020	EPI_ISL_709898	2020-11-13	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/ALDP-B5CF67/2020	EPI_ISL_710865	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-B5CF1C/2020	EPI_ISL_710869	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-B630F1/2020	EPI_ISL_710875	2020-11-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-B47D47/2020	EPI_ISL_710893	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-B49291/2020	EPI_ISL_710899	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-13026/2020	EPI_ISL_712537	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/England/CAMC-C478BE/2020	EPI_ISL_718703	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C49A4D/2020	EPI_ISL_718715	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-C47177/2020	EPI_ISL_718727	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C47D19/2020	EPI_ISL_718738	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C47ECB/2020	EPI_ISL_718744	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C40C31/2020	EPI_ISL_719236	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C44F07/2020	EPI_ISL_719240	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C40E3B/2020	EPI_ISL_719253	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB1FBB/2020	EPI_ISL_720208	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB0189/2020	EPI_ISL_720215	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB1F51/2020	EPI_ISL_720230	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB204E/2020	EPI_ISL_720234	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB04AE/2020	EPI_ISL_720238	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB14DA/2020	EPI_ISL_720248	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB17B3/2020	EPI_ISL_720258	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-BB1513/2020	EPI_ISL_720277	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BC7B63/2020	EPI_ISL_721502	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-BC876E/2020	EPI_ISL_721510	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-A8B80B/2020	EPI_ISL_721538	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AAE213/2020	EPI_ISL_721551	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A9EAD2/2020	EPI_ISL_721564	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Netherlands/UT-RIVM-20066/2020	EPI_ISL_723249	2020-11-24	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/NH-RIVM-20076/2020	EPI_ISL_723255	2020-11-08	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/England/LIVE-DCC4CB/2020	EPI_ISL_724510	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21F707/2020	EPI_ISL_725042	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21F743/2020	EPI_ISL_725045	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21F752/2020	EPI_ISL_725046	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21F79E/2020	EPI_ISL_725049	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21F7E9/2020	EPI_ISL_725051	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21F85F/2020	EPI_ISL_725057	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21F87D/2020	EPI_ISL_725058	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21F88C/2020	EPI_ISL_725059	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21F8AA/2020	EPI_ISL_725060	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21FE20/2020	EPI_ISL_725069	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21FE7B/2020	EPI_ISL_725073	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-220DB6/2020	EPI_ISL_725093	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-220F47/2020	EPI_ISL_725103	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-EFBD9/2020	EPI_ISL_725108	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-EFC4F/2020	EPI_ISL_725110	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F1846/2020	EPI_ISL_725113	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NORW-F3817/2020	EPI_ISL_725140	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F3826/2020	EPI_ISL_725141	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F3844/2020	EPI_ISL_725143	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F39F6/2020	EPI_ISL_725148	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-492EBA/2020	EPI_ISL_725803	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-492ED8/2020	EPI_ISL_725804	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4955EF/2020	EPI_ISL_726370	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-495682/2020	EPI_ISL_726378	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-495B56/2020	EPI_ISL_726445	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/ALDP-C3D2DB/2020	EPI_ISL_731706	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Hong Kong/CM20000221/2020	EPI_ISL_733574	2020-11-05	Asia / Hong Kong	Human	Original	Throat saliva		Illumina MiSeq				B.1.177.57	GV
hCoV-19/England/C200026732/2020	EPI_ISL_733582	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.56	GV
hCoV-19/England/C200026740/2020	EPI_ISL_733583	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.56	GV
hCoV-19/England/C200028755/2020	EPI_ISL_733586	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.56	GV
hCoV-19/England/C200028758/2020	EPI_ISL_733587	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.56	GV
hCoV-19/England/C200030587/2020	EPI_ISL_733588	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.56	GV
hCoV-19/Belgium/rega-0801925/2020	EPI_ISL_734867	2020-08-01	Europe / Belgium / Winksele	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10201104/2020	EPI_ISL_735210	2020-10-20	Europe / Belgium / Keerbergen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10201108/2020	EPI_ISL_735213	2020-10-20	Europe / Belgium / Nossegem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-11031208/2020	EPI_ISL_735219	2020-11-03	Europe / Belgium / Ieper	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/England/ALDP-C48853/2020	EPI_ISL_736513	2020-12-13	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C48862/2020	EPI_ISL_736518	2020-12-13	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-C50366/2020	EPI_ISL_736523	2020-12-11	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C48677/2020	EPI_ISL_736541	2020-12-13	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C48A4E/2020	EPI_ISL_736559	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C48440/2020	EPI_ISL_736562	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.4	GV
hCoV-19/Belgium/rega-10141366/2020	EPI_ISL_738419	2020-10-14	Europe / Belgium / Leuven	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0061167/2020	EPI_ISL_739704	2020-10-26	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0128091/2020	EPI_ISL_739719	2020-11-16	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/England/CAMC-B79F19/2020	EPI_ISL_741063	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-B79F46/2020	EPI_ISL_741066	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-B79F91/2020	EPI_ISL_741070	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-B7A1F4/2020	EPI_ISL_741087	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-B7A200/2020	EPI_ISL_741088	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-B7A2E2/2020	EPI_ISL_741096	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Luxembourg/LNS5364228/2020	EPI_ISL_744223	2020-11-13	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS5578604/2020	EPI_ISL_744254	2020-11-16	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS5621871/2020	EPI_ISL_744261	2020-10-31	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS5638426/2020	EPI_ISL_744267	2020-11-24	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Denmark/DCGC-18801/2020	EPI_ISL_748563	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-19578/2020	EPI_ISL_749039	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-19690/2020	EPI_ISL_749112	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-18196/2020	EPI_ISL_749808	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-18289/2020	EPI_ISL_749866	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-18541/2020	EPI_ISL_750031	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-17212/2020	EPI_ISL_750830	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-17285/2020	EPI_ISL_750879	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-17313/2020	EPI_ISL_750898	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/204990734/2020	EPI_ISL_754308	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/205260476/2020	EPI_ISL_754325	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/205260860/2020	EPI_ISL_754326	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/205260872/2020	EPI_ISL_754329	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/205260878/2020	EPI_ISL_754331	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204881383/2020	EPI_ISL_754333	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.2	GV
hCoV-19/England/204890402/2020	EPI_ISL_754335	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204890403/2020	EPI_ISL_754336	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204890704/2020	EPI_ISL_754338	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204900001/2020	EPI_ISL_754339	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204900563/2020	EPI_ISL_754340	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204941327/2020	EPI_ISL_754342	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.56	GV
hCoV-19/England/204941525/2020	EPI_ISL_754344	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204941587/2020	EPI_ISL_754345	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204960393/2020	EPI_ISL_754346	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204960397/2020	EPI_ISL_754347	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/205260864/2020	EPI_ISL_754386	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/205260867/2020	EPI_ISL_754387	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/Denmark/DCGC-20619/2020	EPI_ISL_759258	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/South Korea/KDCA0430/2020	EPI_ISL_760214	2020-11-07	Asia / South Korea	Human	Original		Imported case from UK	Illumina MiSeq				B.1.177.57	GV
hCoV-19/South Korea/KDCA0441/2020	EPI_ISL_760225	2020-10-04	Asia / South Korea	Human	Original		Imported case from UK	Illumina MiSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CC2BD0/2020	EPI_ISL_760252	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-CC2323/2020	EPI_ISL_760257	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C9961D/2020	EPI_ISL_762026	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-C98B88/2020	EPI_ISL_762091	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C804D3/2020	EPI_ISL_762806	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C7AE83/2020	EPI_ISL_762864	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C8B283/2020	EPI_ISL_762883	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Netherlands/ZH-EMC-1240/2020	EPI_ISL_763309	2020-12-25	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.54	GV
hCoV-19/Netherlands/ZH-EMC-1246/2020	EPI_ISL_763315	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/Wales/PHWC-4A44E0/2020	EPI_ISL_764701	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A641B/2020	EPI_ISL_765035	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A6AA0/2020	EPI_ISL_765099	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/205100233/2020	EPI_ISL_766302	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/205140694/2020	EPI_ISL_766398	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/CAMC-C70B59/2020	EPI_ISL_768948	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-C7488B/2020	EPI_ISL_768950	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C70CA1/2020	EPI_ISL_768952	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-C70C74/2020	EPI_ISL_768959	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/CAMC-C755CF/2020	EPI_ISL_768971	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C71C0A/2020	EPI_ISL_768977	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-C74636/2020	EPI_ISL_768984	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-C5CA0B/2020	EPI_ISL_769519	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-C5CA74/2020	EPI_ISL_769524	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-C60C77/2020	EPI_ISL_769536	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C5CA29/2020	EPI_ISL_769540	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-C51936/2020	EPI_ISL_769561	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C51884/2020	EPI_ISL_769563	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C51990/2020	EPI_ISL_769584	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C4FE5A/2020	EPI_ISL_769596	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr234964/2020	EPI_ISL_770500	2020-12-17	Europe / Lithuania / Marijampoles apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr235011/2020	EPI_ISL_770501	2020-12-17	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr235793/2020	EPI_ISL_770503	2020-12-18	Europe / Lithuania / Marijampoles apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr236244/2020	EPI_ISL_770505	2020-12-19	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr236247/2020	EPI_ISL_770506	2020-12-19	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr236309/2020	EPI_ISL_770507	2020-12-19	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr236563/2020	EPI_ISL_770508	2020-12-20	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr236583/2020	EPI_ISL_770509	2020-12-20	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr236584/2020	EPI_ISL_770510	2020-12-20	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr236600/2020	EPI_ISL_770511	2020-12-20	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr236601/2020	EPI_ISL_770512	2020-12-20	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr236606/2020	EPI_ISL_770513	2020-12-20	Europe / Lithuania / Alytaus apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr237105/2020	EPI_ISL_770514	2020-12-21	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr237251/2020	EPI_ISL_770515	2020-12-21	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr237513/2020	EPI_ISL_770516	2020-12-22	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr237525/2020	EPI_ISL_770517	2020-12-22	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr237556/2020	EPI_ISL_770518	2020-12-22	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr237653/2020	EPI_ISL_770519	2020-12-22	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr237654/2020	EPI_ISL_770520	2020-12-22	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr238011/2020	EPI_ISL_770521	2020-12-22	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr238179/2020	EPI_ISL_770522	2020-12-22	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr238180/2020	EPI_ISL_770523	2020-12-22	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr238208/2020	EPI_ISL_770524	2020-12-22	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr238273/2020	EPI_ISL_770526	2020-12-22	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr238277/2020	EPI_ISL_770527	2020-12-22	Europe / Lithuania / Marijampoles apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr238309/2020	EPI_ISL_770528	2020-12-22	Europe / Lithuania / Marijampoles apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr238362/2020	EPI_ISL_770530	2020-12-22	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr238395/2020	EPI_ISL_770531	2020-12-22	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr238418/2020	EPI_ISL_770532	2020-12-22	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj1/2020	EPI_ISL_770533	2020-11	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj12/2020	EPI_ISL_770534	2020-11	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj14/2020	EPI_ISL_770535	2020-11	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj15/2020	EPI_ISL_770536	2020-11	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj17/2020	EPI_ISL_770537	2020-11	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.79	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj18/2020	EPI_ISL_770538	2020-11	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj20/2020	EPI_ISL_770539	2020-11	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj21/2020	EPI_ISL_770540	2020-11	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj22/2020	EPI_ISL_770541	2020-11	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj23/2020	EPI_ISL_770542	2020-12	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj24/2020	EPI_ISL_770543	2020-12	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.79	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj5/2020	EPI_ISL_770544	2020-12	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj6/2020	EPI_ISL_770545	2020-12	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj8/2020	EPI_ISL_770546	2020-12	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnrj9/2020	EPI_ISL_770547	2020-12	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr569/2020	EPI_ISL_770548	2020-12	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr507/2020	EPI_ISL_770549	2020-12	Europe / Lithuania / Jonavos apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Norway/4634/2020	EPI_ISL_775315	2020-10-18	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/5411/2020	EPI_ISL_775327	2020-10-30	Europe / Norway / Rogaland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/5413/2020	EPI_ISL_775329	2020-11-03	Europe / Norway / Rogaland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/5951/2020	EPI_ISL_775349	2020-11-16	Europe / Norway / Vestfold og Telemark	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/England/ALDP-C8C1A3/2020	EPI_ISL_777036	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C8C3F8/2020	EPI_ISL_777048	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-C8C3E9/2020	EPI_ISL_777051	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-CB7C35/2020	EPI_ISL_777942	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C6C622/2020	EPI_ISL_778350	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C65489/2020	EPI_ISL_778356	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C6CC8A/2020	EPI_ISL_778383	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C6F65C/2020	EPI_ISL_778393	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C6B8F0/2020	EPI_ISL_778396	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-D0BF74/2020	EPI_ISL_781916	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CC99B1/2020	EPI_ISL_781928	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-D0BF65/2020	EPI_ISL_781947	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CED46B/2020	EPI_ISL_781970	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C32898/2020	EPI_ISL_782500	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-C32CE7/2020	EPI_ISL_782532	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C32AB0/2020	EPI_ISL_782552	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GV
hCoV-19/England/QEUH-C33624/2020	EPI_ISL_782555	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C31FB2/2020	EPI_ISL_782575	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C323D3/2020	EPI_ISL_782579	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Ireland/D-NVRL-20IRL11497/2020	EPI_ISL_789088	2020-12-22	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Netherlands/FR-RIVM-20777/2020	EPI_ISL_790918	2020-12-12	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/FR-RIVM-20895/2020	EPI_ISL_790932	2020-12-12	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/OV-RIVM-20922/2020	EPI_ISL_790950	2020-12-23	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/FR-RIVM-20927/2020	EPI_ISL_790954	2020-12-16	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/FR-RIVM-20928/2020	EPI_ISL_790955	2020-12-14	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/FR-RIVM-20929/2020	EPI_ISL_790956	2020-12-12	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/FR-RIVM-20930/2020	EPI_ISL_790957	2020-12-12	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/FR-RIVM-20931/2020	EPI_ISL_790958	2020-12-12	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Ireland/un-NVRL-AIIDB0139v1/2020	EPI_ISL_791310	2020-12-17	Europe / Ireland	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/un-NVRL-AIIDB0141v1/2020	EPI_ISL_791311	2020-12-17	Europe / Ireland	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/un-NVRL-AIIDB0142v1-2/2020	EPI_ISL_791312	2020-12-17	Europe / Ireland	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/un-NVRL-AIIDB0143v1-2/2020	EPI_ISL_791313	2020-12-17	Europe / Ireland	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/un-NVRL-AIIDV1098day8/2020	EPI_ISL_791316	2020-09-25	Europe / Ireland	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/WX-NVRL-AIIDW002v1/2020	EPI_ISL_791324	2020-12-11	Europe / Ireland / Wexford	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Denmark/DCGC-22783/2020	EPI_ISL_794507	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177	GV
hCoV-19/Denmark/DCGC-24932/2020	EPI_ISL_795820	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/QEUH-D52D29/2020	EPI_ISL_798022	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-D42C01/2020	EPI_ISL_798029	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/QEUH-D51364/2020	EPI_ISL_798030	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-D3480E/2020	EPI_ISL_798828	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-D3711F/2020	EPI_ISL_798843	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-D64DCA/2020	EPI_ISL_798844	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-D14BCF/2020	EPI_ISL_799309	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-D14CAE/2020	EPI_ISL_799336	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C1A948/2020	EPI_ISL_800821	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C22C80/2020	EPI_ISL_800830	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C1832E/2020	EPI_ISL_800841	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BC2421/2020	EPI_ISL_801151	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BC1589/2020	EPI_ISL_801159	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BC204B/2020	EPI_ISL_801178	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C3268F/2020	EPI_ISL_801179	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAFB61/2020	EPI_ISL_801201	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAFB70/2020	EPI_ISL_801207	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB11B5/2020	EPI_ISL_801210	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAFEFF/2020	EPI_ISL_801212	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAFD7A/2020	EPI_ISL_801218	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/MILK-BAFB9E/2020	EPI_ISL_801220	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAFBAD/2020	EPI_ISL_801227	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B81F69/2020	EPI_ISL_801232	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B7FBF1/2020	EPI_ISL_801242	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B80146/2020	EPI_ISL_801249	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B82083/2020	EPI_ISL_801268	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/BIRM-6E255/2020	EPI_ISL_813133	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-6E264/2020	EPI_ISL_813134	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-6E413/2020	EPI_ISL_813152	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMB-A99390/2020	EPI_ISL_813239	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-4A8385/2020	EPI_ISL_815001	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A8ADB/2020	EPI_ISL_815075	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A8AEA/2020	EPI_ISL_815076	2020-12-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Denmark/DCGC-27737/2020	EPI_ISL_815861	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27772/2020	EPI_ISL_815882	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27776/2020	EPI_ISL_815885	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/SHEF-10C970B/2020	EPI_ISL_816314	2020-12-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-10CA0E1/2020	EPI_ISL_816335	2020-12-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10CBF98/2021	EPI_ISL_816387	2021-01-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Denmark/DCGC-26537/2021	EPI_ISL_817612	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-26623/2020	EPI_ISL_817668	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-26675/2020	EPI_ISL_817700	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-26694/2020	EPI_ISL_817708	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-25703/2021	EPI_ISL_818964	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-25808/2021	EPI_ISL_818979	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/England/QEUH-C63E50/2020	EPI_ISL_820320	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-DD2D6D/2021	EPI_ISL_822242	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/PHWC-4AC2A2/2020	EPI_ISL_823535	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4AC62E/2020	EPI_ISL_823577	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4AC6B5/2020	EPI_ISL_823583	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-A95F45/2020	EPI_ISL_826483	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A95F81/2020	EPI_ISL_826485	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177.56	GV
hCoV-19/England/ALDP-AA548F/2020	EPI_ISL_826489	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2E0C/2020	EPI_ISL_826499	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA0FED/2020	EPI_ISL_826513	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Iceland/3349/2021	EPI_ISL_827041	2021-01-03	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.60	GV
hCoV-19/Iceland/3350/2021	EPI_ISL_827044	2021-01-03	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.60	GV
hCoV-19/England/QEUH-E8F126/2021	EPI_ISL_835515	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-E8F0ED/2021	EPI_ISL_835564	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-E882FD/2021	EPI_ISL_836836	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-E87470/2021	EPI_ISL_836843	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-E92BD7/2021	EPI_ISL_836846	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-E948DE/2021	EPI_ISL_836853	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/205140116/2020	EPI_ISL_837202	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/205190570/2020	EPI_ISL_837203	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/NOTT-24679E/2021	EPI_ISL_840012	2021-01-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-247E3E/2020	EPI_ISL_840072	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-247F59/2020	EPI_ISL_840090	2020-12-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-247FE0/2020	EPI_ISL_840099	2020-12-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-4B283E/2020	EPI_ISL_840789	2020	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Denmark/DCGC-29883/2020	EPI_ISL_843930	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-29923/2020	EPI_ISL_843970	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/England/ALDP-F83112/2021	EPI_ISL_846212	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-31132/2021	EPI_ISL_847494	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-31539/2021	EPI_ISL_855939	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Belgium/UGent-395/2021	EPI_ISL_855949	2021-01-04	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/UGent-396/2021	EPI_ISL_855951	2021-01-04	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/UGent-397/2021	EPI_ISL_855953	2021-01-04	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/UGent-398/2021	EPI_ISL_855955	2021-01-04	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/UGent-399/2021	EPI_ISL_855957	2021-01-04	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/UGent-400/2021	EPI_ISL_855959	2021-01-04	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/UGent-401/2021	EPI_ISL_855960	2021-01-04	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/UGent-402/2021	EPI_ISL_855962	2021-01-04	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/UGent-403/2021	EPI_ISL_855964	2021-01-04	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Denmark/DCGC-31551/2021	EPI_ISL_855965	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Belgium/UGent-404/2021	EPI_ISL_855966	2021-01-04	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/UGent-405/2021	EPI_ISL_855968	2021-01-04	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Scotland/QEUH-EFDC9B/2021	EPI_ISL_858166	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.77	GV
hCoV-19/Scotland/QEUH-EF736F/2021	EPI_ISL_858244	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Scotland/QEUH-EF84D4/2021	EPI_ISL_858258	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-C31B27/2020	EPI_ISL_859523	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Norway/Trondheim202-S2/2020	EPI_ISL_860548	2020-09-30	Europe / Norway / Trondelag / Trondheim	Human	Original			Illumina NextSeq 500/550 Mid				B.1.177.77	GV
hCoV-19/Spain/MD-IBV-99014221/2020	EPI_ISL_861830	2020-12-09	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/MD-IBV-99014276/2020	EPI_ISL_861846	2020-12-05	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Germany/NW-ChVir22091/2021	EPI_ISL_862175	2021-01-08	Europe / Germany / North Rhine-Westphalia	Human	Original			Illumina MiSeq	bowtie2			B.1.177.4	GV
hCoV-19/England/ALDP-1003F2B/2021	EPI_ISL_864001	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-1006650/2021	EPI_ISL_864002	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-1005B8F/2021	EPI_ISL_864021	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1005BAD/2021	EPI_ISL_864055	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/NOTT-24A7E5/2021	EPI_ISL_867027	2021-01-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Denmark/DCGC-34133/2021	EPI_ISL_871143	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Wales/ALDP-FFFDE0/2021	EPI_ISL_874119	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-1000146/2021	EPI_ISL_874161	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-FEC91F/2021	EPI_ISL_874165	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Ireland/D-NVRL-21IRL10781/2021	EPI_ISL_875406	2021-01-11	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/MH-NVRL-21IRL09031/2021	EPI_ISL_875409	2021-01-11	Europe / Ireland / Meath	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CN-NVRL-83IRL31265/2021	EPI_ISL_875433	2021-01-10	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-83IRL08462/2021	EPI_ISL_875436	2021-01-10	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-83IRL08530/2021	EPI_ISL_875437	2021-01-10	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.60	GV
hCoV-19/Ireland/KE-NVRL-83IRL01007/2021	EPI_ISL_875438	2021-01-10	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.60	GV
hCoV-19/Ireland/KE-NVRL-83IRL01017/2021	EPI_ISL_875439	2021-01-10	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LK-NVRL-83IRL13134/2021	EPI_ISL_875443	2021-01-10	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.60	GV
hCoV-19/Ireland/LS-NVRL-83IRL08236/2021	EPI_ISL_875444	2021-01-10	Europe / Ireland / Laois	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.60	GV
hCoV-19/Ireland/WH-NVRL-83IRL31330/2021	EPI_ISL_875447	2021-01-10	Europe / Ireland / Westmeath	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/SO-NVRL-82IRL93277/2021	EPI_ISL_875459	2021-01-08	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-82IRL72237/2021	EPI_ISL_875483	2021-01-07	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-82IRL73948/2021	EPI_ISL_875485	2021-01-07	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-82IRL75859/2021	EPI_ISL_875486	2021-01-07	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/KE-NVRL-82IRL76168/2021	EPI_ISL_875491	2021-01-07	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/England/ALDP-101B078/2021	EPI_ISL_880990	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-101481D/2021	EPI_ISL_881350	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-109E3B0/2021	EPI_ISL_885835	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-10B5535/2021	EPI_ISL_886100	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Belgium/rega-1458/2020	EPI_ISL_888709	2020-10-08	Europe / Belgium / Nossegem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1480/2020	EPI_ISL_888730	2020-10-07	Europe / Belgium / Genval	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1488/2020	EPI_ISL_888738	2020-10-08	Europe / Belgium / Hoeilaart	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1536/2020	EPI_ISL_888779	2020-12-13	Europe / Belgium / Kessel-Lo	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1710/2021	EPI_ISL_890326	2021-01-06	Europe / Belgium / Brussel	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.79	GV
hCoV-19/Wales/ALDP-1031416/2021	EPI_ISL_892000	2021-01-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Belgium/rega-1929/2021	EPI_ISL_896476	2021-01-15	Europe / Belgium / Leopoldsburg	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1930/2021	EPI_ISL_896477	2021-01-15	Europe / Belgium / Zolder	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1931/2021	EPI_ISL_896478	2021-01-15	Europe / Belgium / Heusden	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1932/2021	EPI_ISL_896479	2021-01-15	Europe / Belgium / Zolder	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1934/2021	EPI_ISL_896480	2021-01-15	Europe / Belgium / Zolder	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1935/2021	EPI_ISL_896481	2021-01-15	Europe / Belgium / Zolder	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1936/2021	EPI_ISL_896482	2021-01-15	Europe / Belgium / Zolder	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1938/2021	EPI_ISL_896483	2021-01-15	Europe / Belgium / Zolder	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1939/2021	EPI_ISL_896484	2021-01-15	Europe / Belgium / Zolder	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1940/2021	EPI_ISL_896485	2021-01-15	Europe / Belgium / Zolder	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1927/2021	EPI_ISL_896489	2021-01-15	Europe / Belgium / Zolder	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1928/2021	EPI_ISL_896490	2021-01-15	Europe / Belgium / Zolder	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1933/2021	EPI_ISL_896491	2021-01-15	Europe / Belgium / Houthalen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1937/2021	EPI_ISL_896492	2021-01-15	Europe / Belgium / Lummen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1965/2021	EPI_ISL_896493	2021-01-11	Europe / Belgium / Zichem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Finland/7T5DB11_S171/2021	EPI_ISL_902892	2021-01-07	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.177	GV
hCoV-19/Finland/8T10DE7_S174/2021	EPI_ISL_902894	2021-01-08	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.177	GV
hCoV-19/Netherlands/LI-EMC-231/2020	EPI_ISL_904450	2020-10-24	Europe / Netherlands / Limburg	Human	Original			Illumina				B.1.177.77	G
hCoV-19/Netherlands/ZH-EMC-1332/2020	EPI_ISL_904469	2020-11-26	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/Netherlands/ZH-EMC-1330/2020	EPI_ISL_904471	2020-11-27	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/Netherlands/ZH-EMC-1331/2020	EPI_ISL_904472	2020-11-27	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/Netherlands/ZH-EMC-1333/2020	EPI_ISL_904473	2020-11-28	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/Netherlands/GE-RIVM-21506/2020	EPI_ISL_905712	2020-12-29	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/OV-RIVM-10257/2021	EPI_ISL_905723	2021-01-08	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/England/ALDP-10EB008/2021	EPI_ISL_907605	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/Belgium/AZDelta-2103-2178_S4/2021	EPI_ISL_913501	2021-01-18	Europe / Belgium / Dentergem	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZDelta-2103-2342_S11/2021	EPI_ISL_913503	2021-01-18	Europe / Belgium / Diksmuide	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZDelta-2103-2704_S7/2021	EPI_ISL_913506	2021-01-18	Europe / Belgium / Ardooie	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.177.77	GV
hCoV-19/England/ALDP-100E52E/2021	EPI_ISL_917008	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-10100A0/2021	EPI_ISL_917089	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.60	GV
hCoV-19/England/ALDP-110AE53/2021	EPI_ISL_917715	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-110BC94/2021	EPI_ISL_917763	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/LOND-132629F/2020	EPI_ISL_920647	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NORW-226FBA/2021	EPI_ISL_921910	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.60	GV
hCoV-19/England/NORW-2277A2/2021	EPI_ISL_921953	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.60	GV
hCoV-19/England/NOTT-2495FB/2021	EPI_ISL_921988	2021-01-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-249E0F/2021	EPI_ISL_921997	2021-01-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/OXON-F52097/2021	EPI_ISL_922294	2021-01-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/OXON-F520B5/2021	EPI_ISL_922295	2021-01-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/SHEF-10C89BB/2020	EPI_ISL_924141	2020-11-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10C90D3/2021	EPI_ISL_924151	2021-01-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/SHEF-10CA245/2020	EPI_ISL_924168	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/Belgium/ULG-11530/2020	EPI_ISL_925474	2020-10-12	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/ULG-11538/2020	EPI_ISL_925482	2020-10-20	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Denmark/DCGC-35712/2021	EPI_ISL_926853	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-36031/2021	EPI_ISL_927172	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-37331/2021	EPI_ISL_928472	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-37944/2021	EPI_ISL_929085	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-38945/2021	EPI_ISL_930087	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/MILK-1134EF6/2021	EPI_ISL_932654	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/Lithuania/ID2724/2020	EPI_ISL_933945	2020-12-03	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.60	GV
hCoV-19/Lithuania/ID2737/2020	EPI_ISL_933947	2020-12-02	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177.79	GV
hCoV-19/England/QEUH-116E95C/2021	EPI_ISL_948144	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/PHWC-4BFD8D/2021	EPI_ISL_951787	2021-01-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Belgium/Jessa_11-2105-000694/2021	EPI_ISL_953440	2021-02-01	Europe / Belgium / Heusden-Zolder	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZDelta02057-2105R/2021	EPI_ISL_954767	2021-02-01	Europe / Belgium / Wevelgem	Human	Original	Nasopharyngeal swab	unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZDelta05850-2105R/2021	EPI_ISL_954773	2021-02-01	Europe / Belgium / Wingene	Human	Original	Nasopharyngeal swab	unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZDelta23807-2104R/2021	EPI_ISL_954775	2021-01-30	Europe / Belgium / Kortemark	Human	Original	Nasopharyngeal swab	unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZDelta02577-2105R/2021	EPI_ISL_961181	2021-02-04	Europe / Belgium / Roeselare	Human	Original	Nasopharyngeal swab	Unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZDelta02740-2105R/2021	EPI_ISL_961182	2021-02-04	Europe / Belgium / Koekelare	Human	Original	Nasopharyngeal swab	Unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZDelta05412-2105R/2021	EPI_ISL_961188	2021-02-04	Europe / Belgium / Tielt	Human	Original	Nasopharyngeal swab	Unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/Latvia/241/2021	EPI_ISL_961853	2021-01-19	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.60	GV
hCoV-19/Latvia/250/2021	EPI_ISL_961856	2021-01-19	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/252/2021	EPI_ISL_961857	2021-01-19	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2	Stretches of NNNs (1.53% of overall sequence).	warn	B.1.177.79	GV
hCoV-19/Latvia/272/2021	EPI_ISL_961860	2021-01-19	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			U.3	GV
hCoV-19/Latvia/294/2021	EPI_ISL_961861	2021-01-19	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/239/2021	EPI_ISL_961862	2021-01-18	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/240/2021	EPI_ISL_961863	2021-01-18	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2	Gap of 2 nucleotide(s) found at refpos 27986 (FRAMESHIFT not confirmed by the submitter). NS8 without BLAST coverage.	warn	B.1.177.79	GV
hCoV-19/Latvia/249/2021	EPI_ISL_961865	2021-01-18	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/270/2021	EPI_ISL_961866	2021-01-18	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/274/2021	EPI_ISL_961868	2021-01-18	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177	GV
hCoV-19/Latvia/290/2021	EPI_ISL_961869	2021-01-18	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/291/2021	EPI_ISL_961870	2021-01-18	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			U.3	GV
hCoV-19/Latvia/314/2021	EPI_ISL_961872	2021-01-18	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/244/2021	EPI_ISL_961873	2021-01-17	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/275/2021	EPI_ISL_961874	2021-01-17	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/287/2021	EPI_ISL_961876	2021-01-12	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/247/2021	EPI_ISL_961878	2021-01-11	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.60	GV
hCoV-19/Latvia/255/2021	EPI_ISL_961879	2021-01-11	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/295/2021	EPI_ISL_961880	2021-01-11	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/England/ALDP-11B276E/2021	EPI_ISL_963787	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-41538/2021	EPI_ISL_973215	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/ALDP-11CDB55/2021	EPI_ISL_989336	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				V.1	GV
hCoV-19/England/ALDP-119890E/2021	EPI_ISL_990369	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-115C3EA/2021	EPI_ISL_991680	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-10ED938/2021	EPI_ISL_992355	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10E844B/2021	EPI_ISL_992923	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-10EEB5F/2021	EPI_ISL_992948	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/BIRM-70CAD/2021	EPI_ISL_996457	2021-01-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-70E10/2021	EPI_ISL_996472	2021-01-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-BCYYEN/2021	EPI_ISL_996476	2021-02-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Switzerland/ZH-ETHZ-470434/2021	EPI_ISL_1003806	2021-01-27	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Switzerland/ZH-ETHZ-471120/2021	EPI_ISL_1003807	2021-01-27	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Spain/CL-IBV-98012124/2020	EPI_ISL_1007693	2020-12-30	Europe / Spain / Castilla y Leon / Valladolid	Human	Original			Illumina_NextSeq	BWA/IVAR			B.1.177	GV
hCoV-19/England/CAMC-1252FB2/2021	EPI_ISL_1012188	2021-02-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/Norway/2990/2021	EPI_ISL_1013498	2021-01-30	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			U.3	GV
hCoV-19/Norway/3001/2021	EPI_ISL_1013499	2021-02-04	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			U.3	GV
hCoV-19/Spain/MD-IBV-99018519/2020	EPI_ISL_1014720	2020-09-15	Europe / Spain / Madrid / Madrid	Human	Original			Illumina_MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/MD-IBV-99018526/2020	EPI_ISL_1014727	2020-10-08	Europe / Spain / Madrid / Madrid	Human	Original			Illumina_MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/MD-IBV-99018547/2020	EPI_ISL_1014748	2020-11-08	Europe / Spain / Madrid / Madrid	Human	Original			Illumina_MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Hong Kong/HKPU-05090/2020	EPI_ISL_1018315	2020-10-01	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.177.4	GV
hCoV-19/Denmark/DCGC-43723/2021	EPI_ISL_1024101	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-43768/2021	EPI_ISL_1024146	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/MILK-1260CBA/2021	EPI_ISL_1033984	2021-02-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-127F26B/2021	EPI_ISL_1044263	2021-02-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-128994B/2021	EPI_ISL_1044644	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-12783D8/2021	EPI_ISL_1045970	2021-02-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ARCH-REACT0000798/2020	EPI_ISL_1046903	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ARCH-REACT0001331/2020	EPI_ISL_1046911	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ARCH-REACT0002282/2020	EPI_ISL_1046924	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ARCH-REACT0002809/2020	EPI_ISL_1046932	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ARCH-REACT0003416/2020	EPI_ISL_1046938	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ARCH-REACT0003511/2020	EPI_ISL_1046939	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/BIRM-70A2B/2021	EPI_ISL_1046987	2021-01-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-70A85/2021	EPI_ISL_1046990	2021-01-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-70AD0/2021	EPI_ISL_1046991	2021-01-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-70B46/2021	EPI_ISL_1046995	2021-01-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Belgium/rega-2403/2020	EPI_ISL_1049127	2020-10-12	Europe / Belgium / Hofstade	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods	Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.177.77	GV
hCoV-19/Belgium/rega-2661/2021	EPI_ISL_1049132	2021-01-22	Europe / Belgium / Nijlen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2372/2020	EPI_ISL_1049141	2020-10-09	Europe / Belgium / Zaventem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2401/2020	EPI_ISL_1049161	2020-10-12	Europe / Belgium / Diegem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2428/2021	EPI_ISL_1049167	2021-01-22	Europe / Belgium / Ham	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2603/2021	EPI_ISL_1049189	2021-01-25	Europe / Belgium / Turnhout	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2604/2021	EPI_ISL_1049190	2021-01-25	Europe / Belgium / Lille	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Italy/CAM-TIGEM-1690/2021	EPI_ISL_1049432	2021	Europe / Italy / Campania	Human	Original	Oropharyngeal swab		MGI DNBSEQ-G400	SARS-CoV-2_Multi-PCR_v1.0			B.1.177.55	GV
hCoV-19/Italy/CAM-TIGEM-1692/2021	EPI_ISL_1049433	2021	Europe / Italy / Campania	Human	Original	Oropharyngeal swab		MGI DNBSEQ-G400	SARS-CoV-2_Multi-PCR_v1.0			B.1.177.55	GV
hCoV-19/Scotland/CVR6883/2021	EPI_ISL_1050174	2021-01-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.77	GV
hCoV-19/Scotland/CVR6931/2021	EPI_ISL_1050183	2021-02-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.77	GV
hCoV-19/Scotland/CVR6943/2021	EPI_ISL_1050195	2021-02-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.77	GV
hCoV-19/Belgium/rega-2936/2021	EPI_ISL_1050401	2021-02-04	Europe / Belgium / Turnhout	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2921/2021	EPI_ISL_1050410	2021-02-02	Europe / Belgium / Herentals	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Spain/IB-IBV-99019880/2021	EPI_ISL_1056650	2021-02-02	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-964C85/2020	EPI_ISL_531061	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CVR4150/2020	EPI_ISL_540835	2020-08-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-16A55F/2020	EPI_ISL_540904	2020-09-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16A5D7/2020	EPI_ISL_540912	2020-09-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16A65C/2020	EPI_ISL_540920	2020-09-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/MILK-9C4A6B/2020	EPI_ISL_549475	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11329A/2020	EPI_ISL_549491	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/MILK-9A8B1F/2020	EPI_ISL_550252	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99A1D2/2020	EPI_ISL_550310	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-999EBE/2020	EPI_ISL_550351	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-999EEB/2020	EPI_ISL_550352	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-999F06/2020	EPI_ISL_550361	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-999EAF/2020	EPI_ISL_550366	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99A99E/2020	EPI_ISL_550372	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99A5C7/2020	EPI_ISL_550381	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-99A9AD/2020	EPI_ISL_550386	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99424E/2020	EPI_ISL_551616	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-99426C/2020	EPI_ISL_551618	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-99425D/2020	EPI_ISL_551625	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-99568D/2020	EPI_ISL_551626	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-995C9A/2020	EPI_ISL_551661	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Northern Ireland/QEUH-9C85A2/2020	EPI_ISL_567016	2020-09-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9C91F8/2020	EPI_ISL_567051	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9C887C/2020	EPI_ISL_567065	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9C7E5D/2020	EPI_ISL_567069	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9C8FE0/2020	EPI_ISL_567118	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9C7AFF/2020	EPI_ISL_567160	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-990215/2020	EPI_ISL_568333	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Scotland/QEUH-998D85/2020	EPI_ISL_568350	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-997EFC/2020	EPI_ISL_568388	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-96FEC0/2020	EPI_ISL_568414	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Scotland/QEUH-98F53E/2020	EPI_ISL_568437	2020-08-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-98EFD7/2020	EPI_ISL_568444	2020-08-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9B661D/2020	EPI_ISL_573020	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/ALDP-9B663B/2020	EPI_ISL_573021	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-9B6659/2020	EPI_ISL_573023	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9B6668/2020	EPI_ISL_573024	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9B6677/2020	EPI_ISL_573025	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9B6792/2020	EPI_ISL_573036	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-9CC438/2020	EPI_ISL_573106	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-16CDDD/2020	EPI_ISL_574169	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16CE16/2020	EPI_ISL_574173	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/England/ALDP-9CB105/2020	EPI_ISL_575602	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9CBDB6/2020	EPI_ISL_575614	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-9CBF83/2020	EPI_ISL_575663	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9CBE59/2020	EPI_ISL_575664	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9CB5DC/2020	EPI_ISL_575676	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9CAAED/2020	EPI_ISL_575756	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9CB967/2020	EPI_ISL_575757	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-9766DD/2020	EPI_ISL_575774	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMB-1B6369/2020	EPI_ISL_576901	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMC-9DFB1F/2020	EPI_ISL_576923	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/CAMC-9DFBB5/2020	EPI_ISL_576924	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/CAMC-9DFCD0/2020	EPI_ISL_576932	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/CAMC-9DFD64/2020	EPI_ISL_576936	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/CAMC-9DFF6E/2020	EPI_ISL_576946	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-9DFFAA/2020	EPI_ISL_576948	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-9DFFE6/2020	EPI_ISL_576950	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/CAMC-9E000D/2020	EPI_ISL_576951	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-9E001C/2020	EPI_ISL_576952	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/CAMC-9E0191/2020	EPI_ISL_576960	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/New Zealand/20CV0387/2020	EPI_ISL_579116	2020-10-04	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.177.57	GV
hCoV-19/England/ALDP-9EAD2A/2020	EPI_ISL_580000	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EA57D/2020	EPI_ISL_580004	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EAFCA/2020	EPI_ISL_580016	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-9EA971/2020	EPI_ISL_580017	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EA425/2020	EPI_ISL_580019	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EABA8/2020	EPI_ISL_580023	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E9D67/2020	EPI_ISL_580035	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EABB7/2020	EPI_ISL_580039	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9E9B7C/2020	EPI_ISL_580104	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EAFF7/2020	EPI_ISL_580111	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E9DD0/2020	EPI_ISL_580112	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-9EA319/2020	EPI_ISL_580115	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EA0E5/2020	EPI_ISL_580123	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EB0B7/2020	EPI_ISL_580125	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-9EAF9D/2020	EPI_ISL_580127	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9EA908/2020	EPI_ISL_580131	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EAD75/2020	EPI_ISL_580136	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E9CE2/2020	EPI_ISL_580143	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E9AE8/2020	EPI_ISL_580157	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EAABA/2020	EPI_ISL_580158	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9EAB7B/2020	EPI_ISL_580181	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9E9BE5/2020	EPI_ISL_580189	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EA179/2020	EPI_ISL_580190	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9E21CC/2020	EPI_ISL_581322	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9DE7FE/2020	EPI_ISL_581337	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-9E31DA/2020	EPI_ISL_581338	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9E2BA0/2020	EPI_ISL_581362	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/SHEF-C6385/2020	EPI_ISL_585025	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-C79BF/2020	EPI_ISL_585031	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-47D583/2020	EPI_ISL_586161	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-47D5ED/2020	EPI_ISL_586167	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-A21694/2020	EPI_ISL_587487	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A1DC11/2020	EPI_ISL_587491	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A1E2E1/2020	EPI_ISL_587536	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A1EBB9/2020	EPI_ISL_587553	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9FC8D9/2020	EPI_ISL_587712	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD5FF/2020	EPI_ISL_587714	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD8F6/2020	EPI_ISL_587723	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FCF7A/2020	EPI_ISL_587731	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9FDC54/2020	EPI_ISL_587743	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9FD28F/2020	EPI_ISL_587747	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FDB39/2020	EPI_ISL_587748	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F8891/2020	EPI_ISL_588873	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F863D/2020	EPI_ISL_588877	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F5964/2020	EPI_ISL_588917	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F814B/2020	EPI_ISL_588920	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F9308/2020	EPI_ISL_588921	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F9089/2020	EPI_ISL_588922	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9F8D29/2020	EPI_ISL_588953	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F8D47/2020	EPI_ISL_588957	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/BIRM-65F39/2020	EPI_ISL_594609	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMC-9ECB5B/2020	EPI_ISL_594641	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Scotland/CVR4901/2020	EPI_ISL_594668	2020-10-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4910/2020	EPI_ISL_594676	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/Scotland/CVR4917/2020	EPI_ISL_594683	2020-10-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4955/2020	EPI_ISL_594719	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4965/2020	EPI_ISL_594729	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5027/2020	EPI_ISL_594761	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5033/2020	EPI_ISL_594767	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5037/2020	EPI_ISL_594771	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5043/2020	EPI_ISL_594777	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5046/2020	EPI_ISL_594780	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5049/2020	EPI_ISL_594783	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5051/2020	EPI_ISL_594785	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A48CD1/2020	EPI_ISL_595918	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/CAMC-A58F5D/2020	EPI_ISL_597005	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A5951E/2020	EPI_ISL_597021	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A583D9/2020	EPI_ISL_597024	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A58658/2020	EPI_ISL_597025	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-A596FD/2020	EPI_ISL_597037	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A51455/2020	EPI_ISL_598147	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A52393/2020	EPI_ISL_598151	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A512E2/2020	EPI_ISL_598164	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A5169B/2020	EPI_ISL_598175	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A51279/2020	EPI_ISL_598180	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A528A3/2020	EPI_ISL_598181	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A51FEB/2020	EPI_ISL_598201	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-A47F15/2020	EPI_ISL_598255	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A4764D/2020	EPI_ISL_598266	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A47953/2020	EPI_ISL_598267	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A473BF/2020	EPI_ISL_598286	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A474F8/2020	EPI_ISL_598300	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A476B6/2020	EPI_ISL_598307	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A47B20/2020	EPI_ISL_598337	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A4799F/2020	EPI_ISL_598344	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A47FCA/2020	EPI_ISL_598348	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A47021/2020	EPI_ISL_598353	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A0BB64/2020	EPI_ISL_599458	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A0B34E/2020	EPI_ISL_599460	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A0B9A6/2020	EPI_ISL_599462	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0BE10/2020	EPI_ISL_599464	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-A0B751/2020	EPI_ISL_599467	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0BA1C/2020	EPI_ISL_599471	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A0B654/2020	EPI_ISL_599476	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A0B19F/2020	EPI_ISL_599479	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9DE4CA/2020	EPI_ISL_599605	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9DD434/2020	EPI_ISL_599620	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9DDBB7/2020	EPI_ISL_599621	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9DE3CD/2020	EPI_ISL_599643	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9DDC1E/2020	EPI_ISL_599656	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9DDD93/2020	EPI_ISL_599672	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9DDD75/2020	EPI_ISL_599696	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9DDB3F/2020	EPI_ISL_599703	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/Scotland/QEUH-9CF769/2020	EPI_ISL_602018	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Scotland/QEUH-9CEE0B/2020	EPI_ISL_602023	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C2441/2020	EPI_ISL_602027	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9C7F0F/2020	EPI_ISL_602031	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-9B461F/2020	EPI_ISL_602059	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9B45D6/2020	EPI_ISL_602060	2020-09-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Switzerland/VD-ETHZ-300256/2020	EPI_ISL_603288	2020-09-30	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.177	GV
hCoV-19/England/ALDP-A864DF/2020	EPI_ISL_605956	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A864B1/2020	EPI_ISL_605962	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A87465/2020	EPI_ISL_605966	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A87ABE/2020	EPI_ISL_605969	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A87492/2020	EPI_ISL_605987	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A86114/2020	EPI_ISL_605989	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A6D289/2020	EPI_ISL_608093	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A700D4/2020	EPI_ISL_608094	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6D474/2020	EPI_ISL_608107	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6FF71/2020	EPI_ISL_608113	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A6FF35/2020	EPI_ISL_608114	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6D3B3/2020	EPI_ISL_608115	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6D368/2020	EPI_ISL_608122	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A6CF83/2020	EPI_ISL_608125	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A6D113/2020	EPI_ISL_608132	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6D27A/2020	EPI_ISL_608133	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A6CB25/2020	EPI_ISL_608151	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A6C3C3/2020	EPI_ISL_608155	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A6D3E0/2020	EPI_ISL_608160	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A70283/2020	EPI_ISL_608162	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6D061/2020	EPI_ISL_608184	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A6D711/2020	EPI_ISL_608187	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6D40B/2020	EPI_ISL_608197	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6C879/2020	EPI_ISL_608264	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A70951/2020	EPI_ISL_608265	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6D73F/2020	EPI_ISL_608268	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A416CB/2020	EPI_ISL_609408	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A42080/2020	EPI_ISL_609415	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A41D20/2020	EPI_ISL_609422	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A41203/2020	EPI_ISL_609423	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A41898/2020	EPI_ISL_609441	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A40D7C/2020	EPI_ISL_609443	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A41986/2020	EPI_ISL_609452	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A41D99/2020	EPI_ISL_609458	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A41133/2020	EPI_ISL_609460	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-A4177D/2020	EPI_ISL_609462	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A420EA/2020	EPI_ISL_609465	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A4183E/2020	EPI_ISL_609469	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A41968/2020	EPI_ISL_609473	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A40F58/2020	EPI_ISL_609474	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A42035/2020	EPI_ISL_609478	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A4186B/2020	EPI_ISL_609480	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/CAMC-A40DB8/2020	EPI_ISL_609487	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A417B9/2020	EPI_ISL_609490	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A41300/2020	EPI_ISL_609496	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F52D/2020	EPI_ISL_609576	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A3F7CD/2020	EPI_ISL_609577	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F4A8/2020	EPI_ISL_609579	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F36F/2020	EPI_ISL_609588	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F1CF/2020	EPI_ISL_609590	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A3F4B7/2020	EPI_ISL_609593	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F3C9/2020	EPI_ISL_609597	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A84996/2020	EPI_ISL_610406	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A85397/2020	EPI_ISL_610408	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A8533D/2020	EPI_ISL_610417	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.2	GV
hCoV-19/England/ALDP-A8541C/2020	EPI_ISL_610423	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A84A2A/2020	EPI_ISL_610440	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A85546/2020	EPI_ISL_610443	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A85713/2020	EPI_ISL_610445	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A85555/2020	EPI_ISL_610447	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A856E9/2020	EPI_ISL_610452	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A85E87/2020	EPI_ISL_610459	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A84BBE/2020	EPI_ISL_610461	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A8591D/2020	EPI_ISL_610465	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A85DE4/2020	EPI_ISL_610469	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A85C9C/2020	EPI_ISL_610473	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A84EA6/2020	EPI_ISL_610479	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A84AEE/2020	EPI_ISL_610481	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A84ED3/2020	EPI_ISL_610482	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A856F8/2020	EPI_ISL_610483	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A85731/2020	EPI_ISL_610486	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A84EC4/2020	EPI_ISL_610491	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A85F0C/2020	EPI_ISL_610558	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A85F57/2020	EPI_ISL_610588	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A84D4F/2020	EPI_ISL_610594	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A85E1E/2020	EPI_ISL_610596	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/PHWC-48080C/2020	EPI_ISL_612935	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-480936/2020	EPI_ISL_612952	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/CAMC-AB23FB/2020	EPI_ISL_623702	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AB8E7C/2020	EPI_ISL_623714	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AB1E0A/2020	EPI_ISL_623725	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-AB7C91/2020	EPI_ISL_623737	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AB1347/2020	EPI_ISL_623758	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/CAMC-AB1B7C/2020	EPI_ISL_623759	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AB8DAC/2020	EPI_ISL_623768	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AB8A2D/2020	EPI_ISL_623777	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AB1DEF/2020	EPI_ISL_623785	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AB1356/2020	EPI_ISL_623788	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/CAMC-AB21D3/2020	EPI_ISL_623793	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/MILK-AB7903/2020	EPI_ISL_623795	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA14A1/2020	EPI_ISL_623875	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA34DC/2020	EPI_ISL_623880	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2288/2020	EPI_ISL_624912	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA5294/2020	EPI_ISL_624923	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA44EA/2020	EPI_ISL_624930	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/PHWC-485F3F/2020	EPI_ISL_627206	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/England/NOTT-1186D5/2020	EPI_ISL_627309	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/NOTT-1196D4/2020	EPI_ISL_627310	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/CAMC-A665A5/2020	EPI_ISL_627320	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Wales/CVR4747/2020	EPI_ISL_627338	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.177.3	GV
hCoV-19/Wales/CVR4760/2020	EPI_ISL_627341	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.177.3	GV
hCoV-19/Scotland/CVR4780/2020	EPI_ISL_627349	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Scotland/CVR5129/2020	EPI_ISL_627378	2020-10-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A4BAE3/2020	EPI_ISL_628508	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A4BB0E/2020	EPI_ISL_628509	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A4BCA1/2020	EPI_ISL_628521	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-A4BD71/2020	EPI_ISL_628527	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A4BF7B/2020	EPI_ISL_628534	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A4C0B3/2020	EPI_ISL_628542	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A4C2F9/2020	EPI_ISL_628560	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-A4C61B/2020	EPI_ISL_628571	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A4C772/2020	EPI_ISL_628572	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A4C781/2020	EPI_ISL_628573	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A4D313/2020	EPI_ISL_628594	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A4D4E3/2020	EPI_ISL_628602	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A4D54A/2020	EPI_ISL_628603	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A4D832/2020	EPI_ISL_628613	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-A614BC/2020	EPI_ISL_628619	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A61601/2020	EPI_ISL_628622	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/QEUH-A6164D/2020	EPI_ISL_628625	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A61892/2020	EPI_ISL_628637	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A618A1/2020	EPI_ISL_628638	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A61908/2020	EPI_ISL_628643	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A61962/2020	EPI_ISL_628645	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A61D2A/2020	EPI_ISL_628648	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-A640A6/2020	EPI_ISL_628686	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/QEUH-A640D3/2020	EPI_ISL_628687	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-A64307/2020	EPI_ISL_628688	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A643E9/2020	EPI_ISL_628695	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A64431/2020	EPI_ISL_628698	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A64440/2020	EPI_ISL_628699	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-AD0931/2020	EPI_ISL_629809	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AD06FE/2020	EPI_ISL_629821	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD39E3/2020	EPI_ISL_629827	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD2692/2020	EPI_ISL_629837	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD1824/2020	EPI_ISL_629845	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD22DA/2020	EPI_ISL_629856	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD2577/2020	EPI_ISL_629864	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AD39F2/2020	EPI_ISL_629872	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD1CFB/2020	EPI_ISL_629875	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD2683/2020	EPI_ISL_629879	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD0F20/2020	EPI_ISL_629900	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD2DCA/2020	EPI_ISL_629915	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD2243/2020	EPI_ISL_629938	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD26CF/2020	EPI_ISL_629945	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD235F/2020	EPI_ISL_629954	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD1C73/2020	EPI_ISL_629959	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD1DCB/2020	EPI_ISL_629964	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD2629/2020	EPI_ISL_629981	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AD044F/2020	EPI_ISL_629984	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD17DC/2020	EPI_ISL_629997	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA31B7/2020	EPI_ISL_630801	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA25CB/2020	EPI_ISL_630802	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-AA1BF7/2020	EPI_ISL_630805	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA3FEA/2020	EPI_ISL_630809	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA0994/2020	EPI_ISL_630811	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AAE231/2020	EPI_ISL_630813	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA26D7/2020	EPI_ISL_630817	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA1BAC/2020	EPI_ISL_630819	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-AA26E6/2020	EPI_ISL_630842	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2929/2020	EPI_ISL_630843	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA4D94/2020	EPI_ISL_630844	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-AA4E19/2020	EPI_ISL_630847	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA25F8/2020	EPI_ISL_630852	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA1C4F/2020	EPI_ISL_630860	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA1C03/2020	EPI_ISL_630874	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA4E91/2020	EPI_ISL_630877	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA4E64/2020	EPI_ISL_630880	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AAF2A9/2020	EPI_ISL_630883	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA2992/2020	EPI_ISL_630884	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA30D8/2020	EPI_ISL_630886	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA3919/2020	EPI_ISL_630908	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA4FBC/2020	EPI_ISL_630913	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA1B33/2020	EPI_ISL_630924	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA4DEF/2020	EPI_ISL_630934	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA390A/2020	EPI_ISL_630954	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA5249/2020	EPI_ISL_630960	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA317B/2020	EPI_ISL_630961	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA4B30/2020	EPI_ISL_630963	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-AC11FF/2020	EPI_ISL_630982	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-ABD32D/2020	EPI_ISL_630994	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ABC27C/2020	EPI_ISL_630995	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AEACC2/2020	EPI_ISL_633106	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AEA855/2020	EPI_ISL_633109	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AEAF8D/2020	EPI_ISL_633117	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE4B34/2020	EPI_ISL_633152	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE4F1A/2020	EPI_ISL_633154	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AEAE62/2020	EPI_ISL_633156	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE4B61/2020	EPI_ISL_633171	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE50AD/2020	EPI_ISL_633174	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AEA63D/2020	EPI_ISL_633177	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AEA837/2020	EPI_ISL_633199	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-AEABF2/2020	EPI_ISL_633219	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE4B70/2020	EPI_ISL_633226	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACCF18/2020	EPI_ISL_634368	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ACD5F7/2020	EPI_ISL_634388	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-AC80EC/2020	EPI_ISL_634390	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AC79F1/2020	EPI_ISL_634419	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC7A76/2020	EPI_ISL_634444	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACD82B/2020	EPI_ISL_634466	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACC974/2020	EPI_ISL_634488	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD4CAD/2020	EPI_ISL_634545	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD4C70/2020	EPI_ISL_634548	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD5F0D/2020	EPI_ISL_634550	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AD3576/2020	EPI_ISL_634551	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AD4180/2020	EPI_ISL_634555	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr470/2020	EPI_ISL_636900	2020-09-12	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr471/2020	EPI_ISL_636901	2020-09-12	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr475/2020	EPI_ISL_636903	2020-09-12	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr476/2020	EPI_ISL_636904	2020-09-12	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.79	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr477/2020	EPI_ISL_636905	2020-09-12	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr479/2020	EPI_ISL_636906	2020-09-12	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Wales/PHWC-4872CB/2020	EPI_ISL_639180	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-487D24/2020	EPI_ISL_639300	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B10882/2020	EPI_ISL_641616	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B10864/2020	EPI_ISL_641630	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B1370A/2020	EPI_ISL_641633	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B137FB/2020	EPI_ISL_641634	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B107D0/2020	EPI_ISL_641641	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B14280/2020	EPI_ISL_641645	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B1353D/2020	EPI_ISL_641646	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0F0BB/2020	EPI_ISL_641651	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B12D27/2020	EPI_ISL_641656	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B107C1/2020	EPI_ISL_641678	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0EFCE/2020	EPI_ISL_641679	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B0EFEC/2020	EPI_ISL_641683	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B02364/2020	EPI_ISL_642808	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B02A05/2020	EPI_ISL_642821	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B020F4/2020	EPI_ISL_642825	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B02D2A/2020	EPI_ISL_642830	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B02E09/2020	EPI_ISL_642840	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B060A5/2020	EPI_ISL_642862	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B028FC/2020	EPI_ISL_642863	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B02434/2020	EPI_ISL_642877	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B02425/2020	EPI_ISL_642878	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B0270E/2020	EPI_ISL_642884	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B0306C/2020	EPI_ISL_642915	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B01E28/2020	EPI_ISL_642920	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B0267A/2020	EPI_ISL_642960	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-B05EF7/2020	EPI_ISL_642962	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-B02391/2020	EPI_ISL_642983	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B02935/2020	EPI_ISL_642985	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B0307B/2020	EPI_ISL_642987	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B024AD/2020	EPI_ISL_642994	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B23FD2/2020	EPI_ISL_646347	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B23FB4/2020	EPI_ISL_646354	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2DDFC/2020	EPI_ISL_646359	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B31AEF/2020	EPI_ISL_646361	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2DE9F/2020	EPI_ISL_646365	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2ECEF/2020	EPI_ISL_646371	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2E4BA/2020	EPI_ISL_646372	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B23D6F/2020	EPI_ISL_646376	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-B2E4E7/2020	EPI_ISL_646380	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B240CF/2020	EPI_ISL_646382	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B2DE53/2020	EPI_ISL_646386	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-B2F844/2020	EPI_ISL_646409	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B23E8A/2020	EPI_ISL_646412	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B240A1/2020	EPI_ISL_646420	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2DDB0/2020	EPI_ISL_646427	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B23E11/2020	EPI_ISL_646431	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B23F87/2020	EPI_ISL_646442	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2B64E/2020	EPI_ISL_646464	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B24EE3/2020	EPI_ISL_646468	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B26018/2020	EPI_ISL_646478	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B24D6E/2020	EPI_ISL_646487	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B262A9/2020	EPI_ISL_646494	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B2525F/2020	EPI_ISL_646497	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B25152/2020	EPI_ISL_646514	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B25028/2020	EPI_ISL_646515	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B261BB/2020	EPI_ISL_646520	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B2643A/2020	EPI_ISL_646533	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B1FD1B/2020	EPI_ISL_647690	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B20852/2020	EPI_ISL_647694	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1A475/2020	EPI_ISL_647695	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B1A888/2020	EPI_ISL_647698	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B20C47/2020	EPI_ISL_647724	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B20E8D/2020	EPI_ISL_647736	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B1FCF0/2020	EPI_ISL_647743	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B1A9D0/2020	EPI_ISL_647750	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B20931/2020	EPI_ISL_647753	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B1A527/2020	EPI_ISL_647762	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/CAMC-B1FBB7/2020	EPI_ISL_647777	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B1FCE1/2020	EPI_ISL_647783	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/MILK-B02B4E/2020	EPI_ISL_647838	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/Wales/MILK-B02BC6/2020	EPI_ISL_647850	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/QEUH-A8BAE7/2020	EPI_ISL_647856	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/QEUH-A8BAD8/2020	EPI_ISL_647857	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/QEUH-A8B59B/2020	EPI_ISL_647859	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/QEUH-A8B777/2020	EPI_ISL_647860	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B04748/2020	EPI_ISL_652169	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/MILK-B04DFB/2020	EPI_ISL_652177	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.55	GV
hCoV-19/England/MILK-B05862/2020	EPI_ISL_652200	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/MILK-B059D8/2020	EPI_ISL_652212	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/MILK-B059E7/2020	EPI_ISL_652213	2020-10-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/MILK-B05CEE/2020	EPI_ISL_652223	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B05D09/2020	EPI_ISL_652224	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B05D36/2020	EPI_ISL_652225	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B05D45/2020	EPI_ISL_652226	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/MILK-B063CA/2020	EPI_ISL_652228	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B0670A/2020	EPI_ISL_652244	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B06764/2020	EPI_ISL_652245	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-B067CE/2020	EPI_ISL_652248	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B06843/2020	EPI_ISL_652250	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B068CB/2020	EPI_ISL_652252	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B06C83/2020	EPI_ISL_652270	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B06D80/2020	EPI_ISL_652275	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B06EAB/2020	EPI_ISL_652280	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B06EF6/2020	EPI_ISL_652283	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B06F8A/2020	EPI_ISL_652286	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/MILK-B3923A/2020	EPI_ISL_652298	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Northern Ireland/NIRE-108FA0/2020	EPI_ISL_652304	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108FCE/2020	EPI_ISL_652306	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-1090D9/2020	EPI_ISL_652313	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-109103/2020	EPI_ISL_652315	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-109130/2020	EPI_ISL_652316	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-10915E/2020	EPI_ISL_652317	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-10917C/2020	EPI_ISL_652318	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-109200/2020	EPI_ISL_652321	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-10922E/2020	EPI_ISL_652322	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-10923D/2020	EPI_ISL_652323	2020-10-21	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-10924C/2020	EPI_ISL_652324	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-109288/2020	EPI_ISL_652325	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-109297/2020	EPI_ISL_652326	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-10933A/2020	EPI_ISL_652329	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-109394/2020	EPI_ISL_652330	2020-10-13	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-B68A76/2020	EPI_ISL_654964	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B684D2/2020	EPI_ISL_654979	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B56CEE/2020	EPI_ISL_657003	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B5406C/2020	EPI_ISL_657009	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B56CDF/2020	EPI_ISL_657011	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B5223B/2020	EPI_ISL_657015	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/QEUH-B43473/2020	EPI_ISL_657032	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B405FB/2020	EPI_ISL_657045	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B4090E/2020	EPI_ISL_657061	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B3FEE5/2020	EPI_ISL_657083	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B436D7/2020	EPI_ISL_657086	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B3FE03/2020	EPI_ISL_657088	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B426AB/2020	EPI_ISL_657090	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B42201/2020	EPI_ISL_657102	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B437E3/2020	EPI_ISL_657109	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B3FED6/2020	EPI_ISL_657130	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B40889/2020	EPI_ISL_657145	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B3FDE8/2020	EPI_ISL_657151	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B437A7/2020	EPI_ISL_657159	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B436E6/2020	EPI_ISL_657166	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B423A4/2020	EPI_ISL_657169	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B407F5/2020	EPI_ISL_657171	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B407AA/2020	EPI_ISL_657175	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B40652/2020	EPI_ISL_657176	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B4091D/2020	EPI_ISL_657177	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B425DB/2020	EPI_ISL_657186	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B518A3/2020	EPI_ISL_658320	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B55DCE/2020	EPI_ISL_658324	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B5A7AD/2020	EPI_ISL_658325	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B5604C/2020	EPI_ISL_658328	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B56079/2020	EPI_ISL_658329	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B55D19/2020	EPI_ISL_658346	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B5466A/2020	EPI_ISL_658348	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B5A558/2020	EPI_ISL_658357	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B55F9B/2020	EPI_ISL_658369	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B5A6EC/2020	EPI_ISL_658384	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B5A479/2020	EPI_ISL_658385	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B5A6BF/2020	EPI_ISL_658393	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B516B8/2020	EPI_ISL_658402	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B3F44D/2020	EPI_ISL_658408	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B413C3/2020	EPI_ISL_658427	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B3F3F5/2020	EPI_ISL_658449	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B3FAB4/2020	EPI_ISL_658508	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B3F52C/2020	EPI_ISL_658516	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B3474F/2020	EPI_ISL_659682	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B3475E/2020	EPI_ISL_659688	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B34044/2020	EPI_ISL_659693	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B32B72/2020	EPI_ISL_659694	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B32B54/2020	EPI_ISL_659714	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B34994/2020	EPI_ISL_659735	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B2CE63/2020	EPI_ISL_659744	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2D275/2020	EPI_ISL_659753	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2CE45/2020	EPI_ISL_659759	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/England/QEUH-B2DF23/2020	EPI_ISL_659763	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B2D257/2020	EPI_ISL_659771	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B2F668/2020	EPI_ISL_659784	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2F60E/2020	EPI_ISL_659794	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2EFAA/2020	EPI_ISL_659799	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/204490923/2020	EPI_ISL_660759	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/204490931/2020	EPI_ISL_660761	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204490933/2020	EPI_ISL_660762	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204491176/2020	EPI_ISL_660770	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204491198/2020	EPI_ISL_660771	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204500127/2020	EPI_ISL_660775	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204500132/2020	EPI_ISL_660776	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204500136/2020	EPI_ISL_660778	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204500453/2020	EPI_ISL_660784	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/204501192/2020	EPI_ISL_660787	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204501194/2020	EPI_ISL_660788	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204521640/2020	EPI_ISL_660793	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/ALDP-B7438B/2020	EPI_ISL_661961	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B75083/2020	EPI_ISL_661977	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6928C/2020	EPI_ISL_661979	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B755A2/2020	EPI_ISL_661991	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B67F3C/2020	EPI_ISL_661997	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF50D7/2020	EPI_ISL_663075	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF5329/2020	EPI_ISL_663079	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF5B4F/2020	EPI_ISL_663082	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF3DE1/2020	EPI_ISL_663088	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Denmark/DCGC-9539/2020	EPI_ISL_669028	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-9616/2020	EPI_ISL_669069	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-10576/2020	EPI_ISL_670063	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-10766/2020	EPI_ISL_670194	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/QEUH-BA2EDE/2020	EPI_ISL_672765	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-BA2EA1/2020	EPI_ISL_672780	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-BA122E/2020	EPI_ISL_672789	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8D5D4/2020	EPI_ISL_673946	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B8E6B2/2020	EPI_ISL_673964	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B85DE3/2020	EPI_ISL_673970	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8609E/2020	EPI_ISL_673974	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B8D677/2020	EPI_ISL_673986	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8E6D0/2020	EPI_ISL_673994	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B974E9/2020	EPI_ISL_675052	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B95937/2020	EPI_ISL_675067	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B973BF/2020	EPI_ISL_675074	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B93D79/2020	EPI_ISL_676119	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B93D5B/2020	EPI_ISL_676232	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B96839/2020	EPI_ISL_676234	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B9608C/2020	EPI_ISL_676235	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B944CE/2020	EPI_ISL_676255	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/204841810/2020	EPI_ISL_678780	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/ALDP-B5CD7C/2020	EPI_ISL_678837	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-B5CFD0/2020	EPI_ISL_678841	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/ALDP-B5D018/2020	EPI_ISL_678844	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/ALDP-B5D115/2020	EPI_ISL_678858	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/ALDP-B5D124/2020	EPI_ISL_678859	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-B5D19D/2020	EPI_ISL_678865	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/ALDP-B5D25E/2020	EPI_ISL_678877	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.2	GV
hCoV-19/England/ALDP-B5D42B/2020	EPI_ISL_678898	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/ALDP-B745D0/2020	EPI_ISL_678933	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-B7460A/2020	EPI_ISL_678936	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/C200046950/2020	EPI_ISL_683487	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/ALDP-BBB3A6/2020	EPI_ISL_702490	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB4DDC/2020	EPI_ISL_702493	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB92E7/2020	EPI_ISL_702501	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB4E15/2020	EPI_ISL_702503	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BB9C70/2020	EPI_ISL_702526	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BBA9A5/2020	EPI_ISL_702527	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BBAA1B/2020	EPI_ISL_702532	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB96CD/2020	EPI_ISL_702534	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB92BA/2020	EPI_ISL_702542	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB9311/2020	EPI_ISL_702548	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BB4D90/2020	EPI_ISL_702557	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB3432/2020	EPI_ISL_702629	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BCA8B4/2020	EPI_ISL_703814	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCA4FC/2020	EPI_ISL_703817	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BC3693/2020	EPI_ISL_703878	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BC4B57/2020	EPI_ISL_703882	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BCBCD5/2020	EPI_ISL_703883	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCB482/2020	EPI_ISL_703959	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A919C3/2020	EPI_ISL_706000	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-A91A2A/2020	EPI_ISL_706004	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-A91A75/2020	EPI_ISL_706006	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-B39FAC/2020	EPI_ISL_706013	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3A327/2020	EPI_ISL_706017	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3A372/2020	EPI_ISL_706021	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3A6C4/2020	EPI_ISL_706027	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3A72B/2020	EPI_ISL_706030	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3A794/2020	EPI_ISL_706035	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3A7C1/2020	EPI_ISL_706037	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3AB10/2020	EPI_ISL_706048	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3B380/2020	EPI_ISL_706059	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3B599/2020	EPI_ISL_706065	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3B70C/2020	EPI_ISL_706080	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3BEBC/2020	EPI_ISL_706105	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3C02E/2020	EPI_ISL_706114	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3C167/2020	EPI_ISL_706123	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3C4AA/2020	EPI_ISL_706148	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-B3C792/2020	EPI_ISL_706157	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3C8AE/2020	EPI_ISL_706165	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3C8CC/2020	EPI_ISL_706166	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3C8DB/2020	EPI_ISL_706167	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3C941/2020	EPI_ISL_706170	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3C9BA/2020	EPI_ISL_706174	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3C9F6/2020	EPI_ISL_706177	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3CD90/2020	EPI_ISL_706198	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-B55256/2020	EPI_ISL_709901	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/QEUH-B30B0B/2020	EPI_ISL_710906	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Wales/ALDP-B1D58E/2020	EPI_ISL_710982	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-B1D621/2020	EPI_ISL_710986	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-B1D57F/2020	EPI_ISL_710988	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-B1D524/2020	EPI_ISL_710993	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Belgium/UGent-261/2020	EPI_ISL_718000	2020-11-10	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/UGent-267/2020	EPI_ISL_718005	2020-11-10	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Germany/NW-HHU-392/2020	EPI_ISL_718073	2020-11-01	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177.77	GV
hCoV-19/England/MILK-BB04F9/2020	EPI_ISL_720322	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB1F33/2020	EPI_ISL_720324	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAC2E7/2020	EPI_ISL_720334	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB03B0/2020	EPI_ISL_720337	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB0EA0/2020	EPI_ISL_720342	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB005F/2020	EPI_ISL_720365	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAFADD/2020	EPI_ISL_720373	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/MILK-BAC821/2020	EPI_ISL_720393	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB2336/2020	EPI_ISL_720399	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BABA59/2020	EPI_ISL_720410	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BAFC04/2020	EPI_ISL_720421	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BABAA4/2020	EPI_ISL_720426	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAC5DF/2020	EPI_ISL_720428	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BB0F52/2020	EPI_ISL_720434	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB1CE1/2020	EPI_ISL_720436	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAC5A2/2020	EPI_ISL_720438	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB1D1B/2020	EPI_ISL_720442	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB03A1/2020	EPI_ISL_720448	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAC5EE/2020	EPI_ISL_720449	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB1ABA/2020	EPI_ISL_720455	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB113D/2020	EPI_ISL_720460	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB21A5/2020	EPI_ISL_720465	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB210F/2020	EPI_ISL_720479	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB0C4C/2020	EPI_ISL_720498	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Belgium/ULG-11033/2020	EPI_ISL_722950	2020-11-30	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/Belgium/ULG-11040/2020	EPI_ISL_722954	2020-11-30	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/England/NORW-F37FC/2020	EPI_ISL_725139	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F3A3F/2020	EPI_ISL_725151	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F3AC6/2020	EPI_ISL_725156	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F3E60/2020	EPI_ISL_725161	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F3EE8/2020	EPI_ISL_725167	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NORW-F3F9A/2020	EPI_ISL_725174	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NORW-F651D/2020	EPI_ISL_725298	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-495BCF/2020	EPI_ISL_726452	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-495EF3/2020	EPI_ISL_726503	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-495F0F/2020	EPI_ISL_726504	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-496153/2020	EPI_ISL_726538	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-49619F/2020	EPI_ISL_726542	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-496223/2020	EPI_ISL_726549	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49629C/2020	EPI_ISL_726555	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4962AB/2020	EPI_ISL_726556	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-B7C67B/2020	EPI_ISL_727809	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B7C68A/2020	EPI_ISL_727810	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B7D56E/2020	EPI_ISL_727827	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-B7D908/2020	EPI_ISL_727831	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.2	GV
hCoV-19/England/QEUH-B7DA32/2020	EPI_ISL_727841	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B7DCC3/2020	EPI_ISL_727845	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B7E2C0/2020	EPI_ISL_727851	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/SHEF-10C802F/2020	EPI_ISL_727878	2020-12-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10CD761/2020	EPI_ISL_727916	2020-12-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10CF7BA/2020	EPI_ISL_727934	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-C3C7DD/2020	EPI_ISL_731036	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3CCCF/2020	EPI_ISL_731039	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3B932/2020	EPI_ISL_731049	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-C3BD54/2020	EPI_ISL_731069	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3C7FB/2020	EPI_ISL_731071	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3B7B0/2020	EPI_ISL_731073	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3CF99/2020	EPI_ISL_731077	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3DB1C/2020	EPI_ISL_731092	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3B729/2020	EPI_ISL_731112	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3D96D/2020	EPI_ISL_731121	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3A292/2020	EPI_ISL_731188	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3B747/2020	EPI_ISL_731190	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-76IRL26419/2020	EPI_ISL_732458	2020-10-17	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/SO-NVRL-76IRL31587/2020	EPI_ISL_732461	2020-10-18	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/WX-NVRL-76IRL29790/2020	EPI_ISL_732462	2020-10-18	Europe / Ireland / Wexford	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/CN-NVRL-76IRL32242/2020	EPI_ISL_732463	2020-10-18	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CO-NVRL-76IRL32468/2020	EPI_ISL_732465	2020-10-18	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/CO-NVRL-76IRL32562/2020	EPI_ISL_732466	2020-10-18	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/G-NVRL-76IRL33539/2020	EPI_ISL_732469	2020-10-18	Europe / Ireland / Galway	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KE-NVRL-76IRL26522/2020	EPI_ISL_732470	2020-10-18	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/SO-NVRL-76IRL31614/2020	EPI_ISL_732477	2020-10-18	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CO-NVRL-76IRL32367/2020	EPI_ISL_732478	2020-10-18	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-76IRL32023/2020	EPI_ISL_732479	2020-10-18	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KE-NVRL-76IRL26703/2020	EPI_ISL_732481	2020-10-18	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/LH-NVRL-20ILR08017/2020	EPI_ISL_732482	2020-11-09	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-76IRL32009/2020	EPI_ISL_732483	2020-10-18	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/LH-NVRL-76IRL28215/2020	EPI_ISL_732485	2020-10-18	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/MH-NVRL-76IRL26873/2020	EPI_ISL_732487	2020-10-18	Europe / Ireland / Meath	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/England/ALDP-C23056/2020	EPI_ISL_733613	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C305B1/2020	EPI_ISL_733644	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C305A2/2020	EPI_ISL_733664	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C2328D/2020	EPI_ISL_733699	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C2CFBA/2020	EPI_ISL_733716	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C23241/2020	EPI_ISL_733737	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C2FB86/2020	EPI_ISL_733739	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-C2F95F/2020	EPI_ISL_733746	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C2FC38/2020	EPI_ISL_733749	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C305C0/2020	EPI_ISL_733757	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C23047/2020	EPI_ISL_733759	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C30575/2020	EPI_ISL_733760	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C23C52/2020	EPI_ISL_733766	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C22EB7/2020	EPI_ISL_733797	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Belgium/rega-0916975/2020	EPI_ISL_734965	2020-09-16	Europe / Belgium / Steenokkerzeel	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-0916978/2020	EPI_ISL_734968	2020-09-16	Europe / Belgium / Winksele	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-0916980/2020	EPI_ISL_734970	2020-09-16	Europe / Belgium / Winksele	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-0917988/2020	EPI_ISL_734980	2020-09-17	Europe / Belgium / Koekelberg	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-09181055/2020	EPI_ISL_734997	2020-09-18	Europe / Belgium / Steenokkerzeel	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10141395/2020	EPI_ISL_738447	2020-10-14	Europe / Belgium / Tervuren	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10141396/2020	EPI_ISL_738448	2020-10-14	Europe / Belgium / Putte	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10131418/2020	EPI_ISL_738470	2020-10-13	Europe / Belgium / Kraainem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-12141420/2020	EPI_ISL_738472	2020-12-14	Europe / Belgium / Beerse	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10141428/2020	EPI_ISL_738480	2020-10-14	Europe / Belgium / Diegem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-10131434/2020	EPI_ISL_738486	2020-10-13	Europe / Belgium / Leuven	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-12141436/2020	EPI_ISL_738488	2020-12-14	Europe / Belgium / Rijkevorsel	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Belgium/rega-12141437/2020	EPI_ISL_738489	2020-12-14	Europe / Belgium / Merksplas	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0406231/2020	EPI_ISL_739769	2020-10-22	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0418639/2020	EPI_ISL_739771	2020-11-23	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0469996/2020	EPI_ISL_739781	2020-10-19	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0554561/2020	EPI_ISL_739798	2020-11-12	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0694152/2020	EPI_ISL_739817	2020-11-02	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0901454/2020	EPI_ISL_739849	2020-11-25	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS6346257/2020	EPI_ISL_744400	2020-12-16	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS6722271/2020	EPI_ISL_744457	2020-11-12	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS6734577/2020	EPI_ISL_744459	2020-10-29	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS6741137/2020	EPI_ISL_744460	2020-11-03	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/France/OCC-178/2020	EPI_ISL_751496	2020-10-09	Europe / France / Occitanie	Human	Original	Nasopharyngeal swab		Pacific Biosciences Sequel I	Minimap2, bcftools			B.1.177.57	GV
hCoV-19/England/ALDP-C8B54E/2020	EPI_ISL_756407	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C8B414/2020	EPI_ISL_756439	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-C85456/2020	EPI_ISL_756444	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C860CA/2020	EPI_ISL_756499	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-22508/2020	EPI_ISL_757602	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-22553/2020	EPI_ISL_757632	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-22572/2020	EPI_ISL_757646	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-22579/2020	EPI_ISL_757652	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/QEUH-C93507/2020	EPI_ISL_762110	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C98BF1/2020	EPI_ISL_762135	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-C98B79/2020	EPI_ISL_762163	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C994B9/2020	EPI_ISL_762183	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-CA4CA4/2020	EPI_ISL_762241	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-CA95A4/2020	EPI_ISL_762265	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-CA372C/2020	EPI_ISL_762281	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-4A49D2/2020	EPI_ISL_764754	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A49E1/2020	EPI_ISL_764755	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A4AA2/2020	EPI_ISL_764765	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A4DE5/2020	EPI_ISL_764793	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A5494/2020	EPI_ISL_764871	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/ALDP-C499D7/2020	EPI_ISL_767148	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-C3B3F8/2020	EPI_ISL_767151	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-C51620/2020	EPI_ISL_769645	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/MILK-C53A04/2020	EPI_ISL_769682	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-C53460/2020	EPI_ISL_769728	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C51611/2020	EPI_ISL_769732	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C4FDC6/2020	EPI_ISL_769748	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C4B683/2020	EPI_ISL_769758	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Germany/NW-HHU-471/2020	EPI_ISL_770705	2020-12-11	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177.77	GV
hCoV-19/Norway/7102/2020	EPI_ISL_775425	2020-12-18	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Spain/MD-IBV-99012355/2020	EPI_ISL_780001	2020-11-22	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/England/ALDP-CEB500/2020	EPI_ISL_781330	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-CF8EBA/2020	EPI_ISL_781371	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C3292C/2020	EPI_ISL_782564	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C31F58/2020	EPI_ISL_782567	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C32731/2020	EPI_ISL_782588	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C32FB1/2020	EPI_ISL_782592	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C335DC/2020	EPI_ISL_782629	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-C32722/2020	EPI_ISL_782649	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C32537/2020	EPI_ISL_782670	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C33536/2020	EPI_ISL_782676	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C33642/2020	EPI_ISL_782682	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C32591/2020	EPI_ISL_782690	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C32379/2020	EPI_ISL_782697	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C33017/2020	EPI_ISL_782705	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C3283E/2020	EPI_ISL_782711	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C302E7/2020	EPI_ISL_782766	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C25DD5/2020	EPI_ISL_782774	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/France/NA-IPP11369/2020	EPI_ISL_792053	2020-12-26	Europe / France / Aquitaine / PAU	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500	CLC Genomics Suite			B.1.177.4	GV
hCoV-19/Canada/ON-S2041/2021	EPI_ISL_792090	2021-01-05	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.177.54	GV
hCoV-19/New Zealand/21CV0020/2020	EPI_ISL_794622	2020-12-29	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.77	GV
hCoV-19/Denmark/DCGC-25027/2020	EPI_ISL_795882	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/QEUH-D54DFA/2020	EPI_ISL_798136	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-D14CDB/2020	EPI_ISL_799455	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-D1E6E2/2020	EPI_ISL_799473	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-D19DA6/2020	EPI_ISL_799510	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-D1239C/2020	EPI_ISL_799553	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-C1842B/2020	EPI_ISL_800858	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C18300/2020	EPI_ISL_800861	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C21B84/2020	EPI_ISL_800867	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C1B9CF/2020	EPI_ISL_800870	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C18661/2020	EPI_ISL_800884	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BC2782/2020	EPI_ISL_800913	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BC2D08/2020	EPI_ISL_800914	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-BC24D6/2020	EPI_ISL_800926	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BC2BE0/2020	EPI_ISL_800932	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BC2C83/2020	EPI_ISL_800960	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BC0FE6/2020	EPI_ISL_800969	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BC29E6/2020	EPI_ISL_800977	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/France/PAC-IHUCOVID-2548/2020	EPI_ISL_804513	2020-10-18	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4A8F81/2020	EPI_ISL_815124	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A9409/2020	EPI_ISL_815173	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-4A9454/2020	EPI_ISL_815176	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/SHEF-10CDB29/2020	EPI_ISL_816426	2020-12-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10D0EA2/2021	EPI_ISL_816493	2021-01-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10D65A7/2020	EPI_ISL_816610	2020-12-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/Denmark/DCGC-26952/2020	EPI_ISL_817865	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-27115/2020	EPI_ISL_817956	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/ALDP-E308F2/2021	EPI_ISL_821031	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-E2BD46/2021	EPI_ISL_821050	2021-01-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-E371B4/2021	EPI_ISL_821170	2021-01-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-D4075D/2020	EPI_ISL_822300	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Northern Ireland/CAMC-A41A83/2020	EPI_ISL_822310	2020-10-06	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Northern Ireland/CAMC-A41A92/2020	EPI_ISL_822311	2020-10-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				V.1	GV
hCoV-19/Northern Ireland/CAMC-A41A1A/2020	EPI_ISL_822312	2020-10-06	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Northern Ireland/CAMC-A4182F/2020	EPI_ISL_822314	2020-10-06	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Northern Ireland/CAMC-A41AB0/2020	EPI_ISL_822315	2020-10-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Northern Ireland/CAMC-A419A4/2020	EPI_ISL_822316	2020-10-06	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	B.1.177.54	GV
hCoV-19/Northern Ireland/ALDP-A2D4DA/2020	EPI_ISL_822317	2020-10-06	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Northern Ireland/QEUH-9F4B05/2020	EPI_ISL_822321	2020-09-25	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Northern Ireland/QEUH-96CC14/2020	EPI_ISL_822328	2020-08-21	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/PHWC-4AE54D/2020	EPI_ISL_822494	2020-12-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4ACFF6/2020	EPI_ISL_823675	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4AD0F2/2020	EPI_ISL_823687	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4AD9AC/2020	EPI_ISL_823764	2020-12-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Belgium/ULG-11168/2020	EPI_ISL_824804	2020-12-28	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/Belgium/ULG-11177/2020	EPI_ISL_824813	2020-12-29	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/Iceland/3459/2020	EPI_ISL_827152	2020-11-30	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.177.60	GV
hCoV-19/Iceland/3477/2020	EPI_ISL_827170	2020-11-30	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.177.60	GV
hCoV-19/Iceland/4713/2020	EPI_ISL_828404	2020-11-11	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.177.4	GV
hCoV-19/Iceland/4806/2021	EPI_ISL_828497	2021-01-05	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.177.60	GV
hCoV-19/Iceland/6127/2020	EPI_ISL_829805	2020-12-27	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.177.60	GV
hCoV-19/Iceland/6149/2020	EPI_ISL_829827	2020-10-30	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.177.60	GV
hCoV-19/Belgium/ULG-11167/2020	EPI_ISL_833186	2020-12-28	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/England/ALDP-E8657E/2021	EPI_ISL_835608	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-E94962/2021	EPI_ISL_836916	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/LOND-12F426E/2021	EPI_ISL_839145	2021-01-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/LOND-12F4811/2021	EPI_ISL_839190	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NOTT-246D23/2020	EPI_ISL_840047	2020-12-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-2480A0/2020	EPI_ISL_840110	2020-12-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-2480BF/2020	EPI_ISL_840111	2020-12-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-248213/2021	EPI_ISL_840130	2021-01-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/ALDP-F82B33/2021	EPI_ISL_846350	2021-01-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-F81D3E/2021	EPI_ISL_846436	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/ALDP-E87407/2021	EPI_ISL_858403	2021-01-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-E482CC/2021	EPI_ISL_858438	2021-01-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/205341153/2020	EPI_ISL_860643	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/Germany/NW-ChVir22090/2021	EPI_ISL_860787	2021-01-08	Europe / Germany / North Rhine-Westphalia	Human	Original			GridION				B.1.177.4	GV
hCoV-19/England/MILK-FAFC5B/2021	EPI_ISL_864297	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/NORW-225A8D/2021	EPI_ISL_866706	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-225E45/2021	EPI_ISL_866751	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.60	GV
hCoV-19/England/TFCI-26FFA73/2020	EPI_ISL_869010	2020-11-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/Denmark/DCGC-33111/2021	EPI_ISL_870116	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33122/2021	EPI_ISL_870127	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-34226/2021	EPI_ISL_871236	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/England/ALDP-FC0FE2/2021	EPI_ISL_873962	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-FFFCB6/2021	EPI_ISL_873964	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-1064D6A/2021	EPI_ISL_878703	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-1064F64/2021	EPI_ISL_878708	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-FB4B83/2021	EPI_ISL_882030	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-FAF857/2021	EPI_ISL_882110	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-FAF611/2021	EPI_ISL_882112	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-1091F40/2021	EPI_ISL_891899	2021-01-15	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Netherlands/UT-RIVM-10391/2021	EPI_ISL_905116	2021-01-10	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/NB-RIVM-10402/2021	EPI_ISL_905268	2021-01-04	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Luxembourg/LNS0503519/2020	EPI_ISL_911013	2020-12-14	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177	GV
hCoV-19/Luxembourg/LNS6700595/2021	EPI_ISL_911131	2021-01-11	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Spain/MD-IBV-99015908/2021	EPI_ISL_912286	2021-01-13	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA / IVAR			B.1.177	GV
hCoV-19/Spain/MD-IBV-99015955/2020	EPI_ISL_912331	2020-12-18	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA / IVAR			B.1.177	GV
hCoV-19/Belgium/rega-1847/2021	EPI_ISL_912454	2021-01-03	Europe / Belgium / Werchter	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1851/2021	EPI_ISL_912455	2021-01-05	Europe / Belgium / Bekkevoort	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2003/2021	EPI_ISL_913792	2021-01-09	Europe / Belgium / Bierbeek	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/England/ALDP-10100BF/2021	EPI_ISL_917127	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-10F9FDD/2021	EPI_ISL_917260	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/Ireland/WX-NVRL-AIIDV1510/2021	EPI_ISL_918435	2021-01-02	Europe / Ireland / Wexford	Human	Original	Oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 protocol			B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-AIIDB0161/2020	EPI_ISL_918450	2020-12-31	Europe / Ireland / Dublin	Human	Original	Oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 protocol			B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-AIIDB0162/2020	EPI_ISL_918451	2020-12-31	Europe / Ireland / Dublin	Human	Original	Oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 protocol			B.1.177.56	GV
hCoV-19/England/BIRM-698A3/2020	EPI_ISL_918590	2020-11-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.55	GV
hCoV-19/England/SHEF-10C699F/2021	EPI_ISL_924104	2021-01-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10CE3F3/2021	EPI_ISL_924230	2021-01-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10D8C19/2021	EPI_ISL_924414	2021-01-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-CE47B/2020	EPI_ISL_924426	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Denmark/DCGC-35612/2021	EPI_ISL_926753	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-35632/2020	EPI_ISL_926773	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-35755/2021	EPI_ISL_926896	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-38000/2020	EPI_ISL_929141	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-38016/2020	EPI_ISL_929157	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-38040/2021	EPI_ISL_929181	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-38082/2021	EPI_ISL_929223	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-38113/2021	EPI_ISL_929254	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-38978/2021	EPI_ISL_930120	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-39134/2021	EPI_ISL_930276	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-39155/2021	EPI_ISL_930297	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Netherlands/NH-RIVM-11244/2021	EPI_ISL_943443	2021-01-23	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/England/NORT-1B8D03A/2021	EPI_ISL_950530	2021-01-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Insertion of 2 nucleotide(s) found at refpos 28251 (Frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/England/NOTT-24D366/2020	EPI_ISL_950704	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-24D384/2020	EPI_ISL_950705	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-24D427/2021	EPI_ISL_950715	2021-01-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/ALDP-11A9ACB/2021	EPI_ISL_956757	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-11D0D77/2021	EPI_ISL_956797	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Spain/VC-IBV-99016691/2021	EPI_ISL_961258	2021-01-25	Europe / Spain / Comunitat Valenciana / Alicante	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/VC-IBV-99016700/2021	EPI_ISL_961265	2021-01-26	Europe / Spain / Comunitat Valenciana / Alicante	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/England/ALDP-11B277D/2021	EPI_ISL_963701	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/Denmark/DCGC-39522/2021	EPI_ISL_970918	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-41772/2021	EPI_ISL_973449	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-41774/2021	EPI_ISL_973451	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-41803/2021	EPI_ISL_973484	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/QEUH-10F0501/2021	EPI_ISL_992264	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-10F05A7/2021	EPI_ISL_992313	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10ED570/2021	EPI_ISL_992451	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Ireland/G-NVRL-84IRL95499/2021	EPI_ISL_1001261	2021-02-01	Europe / Ireland / Galway	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-21IRL30982/2021	EPI_ISL_1001264	2021-02-03	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Switzerland/ZH-ETHZ-450637/2021	EPI_ISL_1002559	2021-01-08	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Switzerland/ZH-ETHZ-450551/2021	EPI_ISL_1002568	2021-01-08	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/England/CAMC-1235805/2021	EPI_ISL_1006189	2021-02-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-44756/2021	EPI_ISL_1025134	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/England/MILK-12601D9/2021	EPI_ISL_1033731	2021-02-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ARCH-REACT0000325/2020	EPI_ISL_1046895	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/NOTT-24E848/2021	EPI_ISL_1051560	2021-02-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-24F4DA/2021	EPI_ISL_1051582	2021-02-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Denmark/DCGC-47509/2020	EPI_ISL_1067044	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/England/MILK-12B4F27/2021	EPI_ISL_1069526	2021-02-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-12C7B0F/2021	EPI_ISL_1070638	2021-02-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 8 nucleotide(s) found at refpos 27571 (frameshift confirmed by the submitter). NS7a without BLAST coverage.	info	B.1.177.4	GV
hCoV-19/England/CAMC-12C75F2/2021	EPI_ISL_1070659	2021-02-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 8 nucleotide(s) found at refpos 27571 (frameshift confirmed by the submitter). NS7a without BLAST coverage.	info	B.1.177.4	GV
hCoV-19/Netherlands/OV-RIVM-13421/2021	EPI_ISL_1089829	2021-01-24	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/OV-RIVM-13450/2021	EPI_ISL_1089837	2021-01-26	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/OV-RIVM-13592/2021	EPI_ISL_1089842	2021-01-27	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/England/QEUH-997E92/2020	EPI_ISL_537157	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-98F97E/2020	EPI_ISL_539898	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/NOTT-1131CA/2020	EPI_ISL_540708	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-C955F/2020	EPI_ISL_540743	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Scotland/CVR4165/2020	EPI_ISL_540846	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Scotland/CVR4196/2020	EPI_ISL_540866	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/MILK-992028/2020	EPI_ISL_540895	2020-08-27	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.177.3	GV
hCoV-19/England/MILK-99CC1B/2020	EPI_ISL_549815	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99CFE5/2020	EPI_ISL_549850	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-99D2FA/2020	EPI_ISL_549852	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A8432/2020	EPI_ISL_550133	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A864B/2020	EPI_ISL_550197	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A8CC1/2020	EPI_ISL_550208	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A8CEF/2020	EPI_ISL_550214	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-9A8C49/2020	EPI_ISL_550216	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9A566C/2020	EPI_ISL_550222	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A8317/2020	EPI_ISL_550236	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9A8C3A/2020	EPI_ISL_550258	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-999E90/2020	EPI_ISL_550268	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99A4BB/2020	EPI_ISL_550278	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9AA5F1/2020	EPI_ISL_550801	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9AA46D/2020	EPI_ISL_550807	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9AA904/2020	EPI_ISL_550815	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9AA3AC/2020	EPI_ISL_550819	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9AA0F0/2020	EPI_ISL_550847	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9CCF55/2020	EPI_ISL_566397	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9CD6F5/2020	EPI_ISL_566398	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9C8C34/2020	EPI_ISL_567087	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9BE2C6/2020	EPI_ISL_568217	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-9B82EA/2020	EPI_ISL_568223	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Scotland/QEUH-9B84F3/2020	EPI_ISL_568273	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/PHWC-16C3DB/2020	EPI_ISL_574051	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16C502/2020	EPI_ISL_574063	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16C5D5/2020	EPI_ISL_574072	2020-09-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16C65A/2020	EPI_ISL_574079	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16C7C0/2020	EPI_ISL_574094	2020-09-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16C809/2020	EPI_ISL_574098	2020-09-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16C8BE/2020	EPI_ISL_574106	2020-09-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16C9BB/2020	EPI_ISL_574116	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16CC76/2020	EPI_ISL_574153	2020-09-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16CCB2/2020	EPI_ISL_574156	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16CD37/2020	EPI_ISL_574161	2020-09-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16CDA0/2020	EPI_ISL_574166	2020-09-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16D10D/2020	EPI_ISL_574203	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16D3DA/2020	EPI_ISL_574232	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16D3E9/2020	EPI_ISL_574233	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16D45F/2020	EPI_ISL_574238	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16D4C8/2020	EPI_ISL_574244	2020-09-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9CB34B/2020	EPI_ISL_575444	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9CADE4/2020	EPI_ISL_575478	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9CBDF2/2020	EPI_ISL_575485	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9CB9FE/2020	EPI_ISL_575497	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB4FD/2020	EPI_ISL_575509	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9CB800/2020	EPI_ISL_575522	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9CB19C/2020	EPI_ISL_575564	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9CB8D3/2020	EPI_ISL_575565	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9CAAB0/2020	EPI_ISL_575566	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9CB3C3/2020	EPI_ISL_575589	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9CBD6B/2020	EPI_ISL_575594	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9D91D7/2020	EPI_ISL_576707	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9D930E/2020	EPI_ISL_576717	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9D931D/2020	EPI_ISL_576718	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9D932C/2020	EPI_ISL_576719	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9D933B/2020	EPI_ISL_576720	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9D94CF/2020	EPI_ISL_576732	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9D95F9/2020	EPI_ISL_576746	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-9D9605/2020	EPI_ISL_576747	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9D96F6/2020	EPI_ISL_576755	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-9D98D2/2020	EPI_ISL_576768	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9D9A09/2020	EPI_ISL_576785	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9D9A72/2020	EPI_ISL_576788	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9D9A90/2020	EPI_ISL_576790	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9D9B51/2020	EPI_ISL_576795	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9D9D1F/2020	EPI_ISL_576812	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9D9F82/2020	EPI_ISL_576830	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9DA024/2020	EPI_ISL_576837	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9DA25B/2020	EPI_ISL_576859	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9DA349/2020	EPI_ISL_576864	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.2	GV
hCoV-19/England/MILK-9E15B2/2020	EPI_ISL_577074	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-9E1673/2020	EPI_ISL_577081	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-9EAA8D/2020	EPI_ISL_580064	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9EA20D/2020	EPI_ISL_580067	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9EAA05/2020	EPI_ISL_580070	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9EA72C/2020	EPI_ISL_580078	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9EA5AA/2020	EPI_ISL_580094	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EA021/2020	EPI_ISL_580095	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9EE430/2020	EPI_ISL_580687	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9DE837/2020	EPI_ISL_581230	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-9E2C52/2020	EPI_ISL_581231	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/MILK-9E2B64/2020	EPI_ISL_581234	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/MILK-9E2FD1/2020	EPI_ISL_581236	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9D4A3B/2020	EPI_ISL_581374	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/PHWC-16F8F7/2020	EPI_ISL_586037	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-47CDC8/2020	EPI_ISL_586049	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-47D073/2020	EPI_ISL_586092	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-47DAA2/2020	EPI_ISL_586234	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-A2DF42/2020	EPI_ISL_586801	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2D70E/2020	EPI_ISL_586806	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2E4BB/2020	EPI_ISL_586809	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A2D4E9/2020	EPI_ISL_586810	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A2D48F/2020	EPI_ISL_586818	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-A1E287/2020	EPI_ISL_587367	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A1DACC/2020	EPI_ISL_587409	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A1DB6F/2020	EPI_ISL_587454	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A1DFAF/2020	EPI_ISL_587509	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A1E4DC/2020	EPI_ISL_587518	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A1DDC3/2020	EPI_ISL_587520	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-A1E25A/2020	EPI_ISL_587557	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A20307/2020	EPI_ISL_587586	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9F31B9/2020	EPI_ISL_588694	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9F43A3/2020	EPI_ISL_588706	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F3948/2020	EPI_ISL_588707	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F87FE/2020	EPI_ISL_588726	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F6259/2020	EPI_ISL_588744	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F6417/2020	EPI_ISL_588751	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9F5EFC/2020	EPI_ISL_588767	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F6356/2020	EPI_ISL_588797	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9F6383/2020	EPI_ISL_588803	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-9F85E5/2020	EPI_ISL_588840	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F57E2/2020	EPI_ISL_588842	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9F64EA/2020	EPI_ISL_588890	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9F96D2/2020	EPI_ISL_589045	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9CF972/2020	EPI_ISL_590021	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9CF5AB/2020	EPI_ISL_590023	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9CF57E/2020	EPI_ISL_590073	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9CF17A/2020	EPI_ISL_590077	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/BIRM-65740/2020	EPI_ISL_594579	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/QEUH-A01454/2020	EPI_ISL_595814	2020-09-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-A01ACB/2020	EPI_ISL_595824	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/QEUH-A30F4C/2020	EPI_ISL_595848	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A3100C/2020	EPI_ISL_595852	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A3102A/2020	EPI_ISL_595854	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-A31109/2020	EPI_ISL_595866	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A3128E/2020	EPI_ISL_595876	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-A3129D/2020	EPI_ISL_595877	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A3145B/2020	EPI_ISL_595889	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/QEUH-A31479/2020	EPI_ISL_595891	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-A52849/2020	EPI_ISL_598012	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A5259D/2020	EPI_ISL_598013	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A51613/2020	EPI_ISL_598025	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A51D1E/2020	EPI_ISL_598028	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A51710/2020	EPI_ISL_598032	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A527D3/2020	EPI_ISL_598035	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A512C4/2020	EPI_ISL_598044	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A528EF/2020	EPI_ISL_598048	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A51CA8/2020	EPI_ISL_598053	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A52515/2020	EPI_ISL_598057	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A515CB/2020	EPI_ISL_598066	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A51EFD/2020	EPI_ISL_598069	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A5126A/2020	EPI_ISL_598084	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A51F54/2020	EPI_ISL_598085	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A52621/2020	EPI_ISL_598087	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A52014/2020	EPI_ISL_598091	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A51EC0/2020	EPI_ISL_598093	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A5222D/2020	EPI_ISL_598095	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A5176B/2020	EPI_ISL_598099	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A51552/2020	EPI_ISL_598110	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A52366/2020	EPI_ISL_598112	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A5107F/2020	EPI_ISL_598113	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A51E75/2020	EPI_ISL_598124	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A51B7E/2020	EPI_ISL_598208	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A52937/2020	EPI_ISL_598211	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A51CC6/2020	EPI_ISL_598216	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A52894/2020	EPI_ISL_598222	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A52357/2020	EPI_ISL_598245	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A5124C/2020	EPI_ISL_598246	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A0B9B5/2020	EPI_ISL_599337	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0B1BD/2020	EPI_ISL_599338	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0BEB6/2020	EPI_ISL_599373	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-A0AB47/2020	EPI_ISL_599375	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0BAC1/2020	EPI_ISL_599380	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0B636/2020	EPI_ISL_599381	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A0C0A0/2020	EPI_ISL_599382	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0B1AE/2020	EPI_ISL_599387	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A0B33F/2020	EPI_ISL_599389	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A0B997/2020	EPI_ISL_599405	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0C046/2020	EPI_ISL_599421	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0BAEF/2020	EPI_ISL_599428	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A0AAC2/2020	EPI_ISL_599432	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A0AFA5/2020	EPI_ISL_599433	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9DDCD2/2020	EPI_ISL_599500	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9DDB20/2020	EPI_ISL_599501	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/QEUH-9F2BF8/2020	EPI_ISL_600828	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-9F9502/2020	EPI_ISL_600920	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9E4A29/2020	EPI_ISL_600979	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Scotland/MILK-9E3116/2020	EPI_ISL_601224	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9DB041/2020	EPI_ISL_601257	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-9E086F/2020	EPI_ISL_601267	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6FF08/2020	EPI_ISL_608015	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6CCAA/2020	EPI_ISL_608021	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A7002F/2020	EPI_ISL_608022	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6FEED/2020	EPI_ISL_608025	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6D210/2020	EPI_ISL_608039	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6CCC8/2020	EPI_ISL_608045	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6D1C8/2020	EPI_ISL_608053	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6C6D9/2020	EPI_ISL_608056	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A6C6F7/2020	EPI_ISL_608059	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6C8F1/2020	EPI_ISL_608077	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-A51130/2020	EPI_ISL_609208	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-A51AF9/2020	EPI_ISL_609215	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/MILK-A46417/2020	EPI_ISL_609296	2020-10-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/CAMC-A40EE2/2020	EPI_ISL_609311	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A41EA5/2020	EPI_ISL_609316	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A41995/2020	EPI_ISL_609326	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A418B6/2020	EPI_ISL_609333	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A41BDB/2020	EPI_ISL_609336	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A41555/2020	EPI_ISL_609340	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A4125E/2020	EPI_ISL_609345	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A40E79/2020	EPI_ISL_609361	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A418A7/2020	EPI_ISL_609364	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A41E4B/2020	EPI_ISL_609365	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A42044/2020	EPI_ISL_609380	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A41F2A/2020	EPI_ISL_609390	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A4193B/2020	EPI_ISL_609396	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A411AC/2020	EPI_ISL_609397	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A41142/2020	EPI_ISL_609399	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A8582F/2020	EPI_ISL_610297	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A85C6F/2020	EPI_ISL_610304	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A85FFD/2020	EPI_ISL_610320	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A8586B/2020	EPI_ISL_610343	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A85B35/2020	EPI_ISL_610349	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A860DB/2020	EPI_ISL_610353	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A84ADF/2020	EPI_ISL_610358	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A85AED/2020	EPI_ISL_610367	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A85ED2/2020	EPI_ISL_610374	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A85458/2020	EPI_ISL_610384	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A84C24/2020	EPI_ISL_610386	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-47FD10/2020	EPI_ISL_612801	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-47FD7A/2020	EPI_ISL_612806	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-47FEB3/2020	EPI_ISL_612824	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-47FF92/2020	EPI_ISL_612836	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-47FFED/2020	EPI_ISL_612840	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-4800E6/2020	EPI_ISL_612851	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-4803B0/2020	EPI_ISL_612881	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-48074B/2020	EPI_ISL_612925	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-480787/2020	EPI_ISL_612929	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-4807A5/2020	EPI_ISL_612931	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-4807C3/2020	EPI_ISL_612932	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.2	GV
hCoV-19/Wales/PHWC-480ABB/2020	EPI_ISL_612967	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-480BE5/2020	EPI_ISL_612983	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-480C2E/2020	EPI_ISL_612985	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-ABB5DE/2020	EPI_ISL_623504	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-ABB583/2020	EPI_ISL_623512	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ABB653/2020	EPI_ISL_623519	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AB83C8/2020	EPI_ISL_623540	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AB211F/2020	EPI_ISL_623548	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-AB7EE6/2020	EPI_ISL_623566	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AB1338/2020	EPI_ISL_623574	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/CAMC-AB2100/2020	EPI_ISL_623595	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-AB1DD0/2020	EPI_ISL_623617	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AB7912/2020	EPI_ISL_623623	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/MILK-AB7C19/2020	EPI_ISL_623629	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AB8DCA/2020	EPI_ISL_623646	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AB221C/2020	EPI_ISL_623652	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AB87AE/2020	EPI_ISL_623656	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AB78CA/2020	EPI_ISL_623659	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AB861A/2020	EPI_ISL_623660	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AB1954/2020	EPI_ISL_623663	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AB1D2B/2020	EPI_ISL_623667	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AB8D24/2020	EPI_ISL_623693	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-AB9B74/2020	EPI_ISL_623697	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A95640/2020	EPI_ISL_624801	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A962A5/2020	EPI_ISL_624803	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A95288/2020	EPI_ISL_624813	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A95A44/2020	EPI_ISL_624814	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A96278/2020	EPI_ISL_624816	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A95CD5/2020	EPI_ISL_624828	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A95C4E/2020	EPI_ISL_624834	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A94C8B/2020	EPI_ISL_624840	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-A9572F/2020	EPI_ISL_624848	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A9469C/2020	EPI_ISL_624849	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A9582C/2020	EPI_ISL_624898	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A9475D/2020	EPI_ISL_624901	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA3603/2020	EPI_ISL_624936	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA55AA/2020	EPI_ISL_624938	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA322D/2020	EPI_ISL_624945	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA33B1/2020	EPI_ISL_624959	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA5434/2020	EPI_ISL_624965	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA0CE6/2020	EPI_ISL_624980	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA33C0/2020	EPI_ISL_624983	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_K85stop results in 30.6% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/Wales/ALDP-AA38A3/2020	EPI_ISL_624984	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA222E/2020	EPI_ISL_624985	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2CF3/2020	EPI_ISL_625209	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-AA5452/2020	EPI_ISL_625212	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA216D/2020	EPI_ISL_625219	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA180F/2020	EPI_ISL_625231	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA3F62/2020	EPI_ISL_625244	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Northern Ireland/NIRE-108B60/2020	EPI_ISL_627070	2020-10-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS8_W45stop results in 63.6% truncation of the protein sequence.	info	B.1.177.56	GV
hCoV-19/Wales/PHWC-48364B/2020	EPI_ISL_627840	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-4838FA/2020	EPI_ISL_627871	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/England/QEUH-A328D6/2020	EPI_ISL_628364	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A332B9/2020	EPI_ISL_628370	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-A332C8/2020	EPI_ISL_628371	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/QEUH-A333A7/2020	EPI_ISL_628374	2020-09-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/QEUH-A3340E/2020	EPI_ISL_628377	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-A33468/2020	EPI_ISL_628381	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/QEUH-A33477/2020	EPI_ISL_628382	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/QEUH-A334A4/2020	EPI_ISL_628383	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-A33538/2020	EPI_ISL_628391	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-A336BD/2020	EPI_ISL_628402	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A33899/2020	EPI_ISL_628412	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A338C6/2020	EPI_ISL_628414	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/QEUH-A3392D/2020	EPI_ISL_628415	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-A33969/2020	EPI_ISL_628417	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina		NSP11 without BLAST coverage.	warn	B.1.177.57	GV
hCoV-19/England/QEUH-A33996/2020	EPI_ISL_628419	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A497C0/2020	EPI_ISL_628430	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A49906/2020	EPI_ISL_628437	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-A49B1F/2020	EPI_ISL_628454	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-ACF267/2020	EPI_ISL_629740	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-ACEDEF/2020	EPI_ISL_629750	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD3DAB/2020	EPI_ISL_629756	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD0430/2020	EPI_ISL_629774	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A66FB6/2020	EPI_ISL_630676	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A66C0A/2020	EPI_ISL_630681	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67850/2020	EPI_ISL_630682	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67753/2020	EPI_ISL_630691	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67B2A/2020	EPI_ISL_630697	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A670B2/2020	EPI_ISL_630700	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AAF300/2020	EPI_ISL_630705	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA4ECE/2020	EPI_ISL_630707	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2561/2020	EPI_ISL_630715	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA1C5E/2020	EPI_ISL_630740	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA3928/2020	EPI_ISL_630744	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA1B60/2020	EPI_ISL_630751	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA4CA6/2020	EPI_ISL_630755	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA514C/2020	EPI_ISL_630759	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA09B2/2020	EPI_ISL_630769	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA2938/2020	EPI_ISL_630777	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-AA4E0A/2020	EPI_ISL_630798	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA272F/2020	EPI_ISL_630799	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD40ED/2020	EPI_ISL_634208	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD3D14/2020	EPI_ISL_634220	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD2CCD/2020	EPI_ISL_634232	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD2B93/2020	EPI_ISL_634233	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177.4	GV
hCoV-19/England/QEUH-AD485E/2020	EPI_ISL_634235	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-ACC6F5/2020	EPI_ISL_634258	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC75EE/2020	EPI_ISL_634307	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACCABD/2020	EPI_ISL_634316	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACD4BE/2020	EPI_ISL_634358	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr450/2020	EPI_ISL_636889	2020-09-07	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr458/2020	EPI_ISL_636893	2020-09-12	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr460/2020	EPI_ISL_636895	2020-09-12	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr468/2020	EPI_ISL_636898	2020-09-12	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/England/MILK-A912D7/2020	EPI_ISL_638520	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-A91310/2020	EPI_ISL_638522	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-A9135C/2020	EPI_ISL_638525	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-A915FC/2020	EPI_ISL_638530	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B0512B/2020	EPI_ISL_638541	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.2	GV
hCoV-19/Wales/PHWC-486499/2020	EPI_ISL_639049	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-486639/2020	EPI_ISL_639061	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-486824/2020	EPI_ISL_639083	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-4871DD/2020	EPI_ISL_639172	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Ireland/SO-NVRL-73IRL06905/2020	EPI_ISL_639826	2020-09-02	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177	GV
hCoV-19/Ireland/SO-NVRL-73IRL81508/2020	EPI_ISL_639851	2020-09-15	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.57	GV
hCoV-19/Ireland/LH-NVRL-73IRL40251/2020	EPI_ISL_639859	2020-09-09	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/SO-NVRL-73IRL81470/2020	EPI_ISL_639863	2020-09-15	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.57	GV
hCoV-19/Ireland/MN-NVRL-20IRL82789/2020	EPI_ISL_639868	2020-10-05	Europe / Ireland / Monaghan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CN-NVRL-20IRL82783/2020	EPI_ISL_639869	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CN-NVRL-20IRL82775/2020	EPI_ISL_639870	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CN-NVRL-20IRL82733/2020	EPI_ISL_639871	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CN-NVRL-20IRL82714/2020	EPI_ISL_639872	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CN-NVRL-20IRL82702/2020	EPI_ISL_639873	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CN-NVRL-20IRL82698/2020	EPI_ISL_639874	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-20IRL82457/2020	EPI_ISL_639878	2020-10-05	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-20IRL82456/2020	EPI_ISL_639879	2020-10-05	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/LH-NVRL-20IRL82344/2020	EPI_ISL_639880	2020-10-05	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/CN-NVRL-20IRL82841/2020	EPI_ISL_639882	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CN-NVRL-20IRL82826/2020	EPI_ISL_639884	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/WW-NVRL-20IRL60901/2020	EPI_ISL_639885	2020-10-13	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CN-NVRL-20IRL82685/2020	EPI_ISL_639886	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CN-NVRL-20IRL82679/2020	EPI_ISL_639887	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CN-NVRL-20IRL82677/2020	EPI_ISL_639888	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CN-NVRL-20IRL82669/2020	EPI_ISL_639889	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/England/QEUH-B0F130/2020	EPI_ISL_642669	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B14587/2020	EPI_ISL_642685	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B1263B/2020	EPI_ISL_642700	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0F16D/2020	EPI_ISL_642706	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B10A31/2020	EPI_ISL_642746	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B1452D/2020	EPI_ISL_642755	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B02355/2020	EPI_ISL_642769	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B02328/2020	EPI_ISL_642790	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACD81C/2020	EPI_ISL_643991	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B31171/2020	EPI_ISL_646201	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B320A0/2020	EPI_ISL_646206	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B23B29/2020	EPI_ISL_646207	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B31E10/2020	EPI_ISL_646213	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2F747/2020	EPI_ISL_646214	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B2401A/2020	EPI_ISL_646224	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2E0B6/2020	EPI_ISL_646237	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B23C08/2020	EPI_ISL_646268	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B31126/2020	EPI_ISL_646272	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B23C62/2020	EPI_ISL_646277	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B23CDB/2020	EPI_ISL_646291	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B31B19/2020	EPI_ISL_646311	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B23B47/2020	EPI_ISL_646318	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B32161/2020	EPI_ISL_646324	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B31180/2020	EPI_ISL_646329	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2E432/2020	EPI_ISL_646330	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-B1A9EF/2020	EPI_ISL_647528	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B20E9C/2020	EPI_ISL_647533	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/CAMC-B1FBA8/2020	EPI_ISL_647564	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1A4EE/2020	EPI_ISL_647579	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B1AA55/2020	EPI_ISL_647594	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B20227/2020	EPI_ISL_647599	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B21314/2020	EPI_ISL_647609	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B20E05/2020	EPI_ISL_647611	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B20290/2020	EPI_ISL_647625	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B1AACE/2020	EPI_ISL_647635	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B209AA/2020	EPI_ISL_647639	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B20F5D/2020	EPI_ISL_647642	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B1FEBE/2020	EPI_ISL_647644	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1AA28/2020	EPI_ISL_647650	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B1FECD/2020	EPI_ISL_647654	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1A7C7/2020	EPI_ISL_647659	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B20913/2020	EPI_ISL_647664	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B48F7D/2020	EPI_ISL_649200	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B493BC/2020	EPI_ISL_649206	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B48E43/2020	EPI_ISL_649207	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/LIVE-DB38E9/2020	EPI_ISL_652073	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/LIVE-DB3C74/2020	EPI_ISL_652075	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DB3DAE/2020	EPI_ISL_652077	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DB4B49/2020	EPI_ISL_652087	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/MILK-ACFD2A/2020	EPI_ISL_652135	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-AD004B/2020	EPI_ISL_652148	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/MILK-B02E63/2020	EPI_ISL_652153	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/MILK-B05370/2020	EPI_ISL_652180	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/MILK-B05738/2020	EPI_ISL_652193	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-AAB744/2020	EPI_ISL_652809	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AAB771/2020	EPI_ISL_652811	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-AAB780/2020	EPI_ISL_652812	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-AAB823/2020	EPI_ISL_652816	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AABCBE/2020	EPI_ISL_652820	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-AABCDC/2020	EPI_ISL_652822	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AABCEB/2020	EPI_ISL_652823	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AABD51/2020	EPI_ISL_652828	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AABD60/2020	EPI_ISL_652829	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/QEUH-AABD9D/2020	EPI_ISL_652831	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AAC1FA/2020	EPI_ISL_652848	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/QEUH-B68557/2020	EPI_ISL_655070	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B6C395/2020	EPI_ISL_655081	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B66A3C/2020	EPI_ISL_655094	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B6C6D8/2020	EPI_ISL_655971	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B46BD5/2020	EPI_ISL_655979	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B46D66/2020	EPI_ISL_655989	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B45BA9/2020	EPI_ISL_655990	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B46531/2020	EPI_ISL_655998	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B5A2CA/2020	EPI_ISL_658210	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B55BC4/2020	EPI_ISL_658219	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B51B31/2020	EPI_ISL_658220	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B5605B/2020	EPI_ISL_658230	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B5A5EF/2020	EPI_ISL_658298	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B5175B/2020	EPI_ISL_658299	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B5A497/2020	EPI_ISL_658302	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B5463D/2020	EPI_ISL_658316	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B34026/2020	EPI_ISL_659504	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B344FD/2020	EPI_ISL_659516	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B3285D/2020	EPI_ISL_659518	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B35474/2020	EPI_ISL_659524	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B3492B/2020	EPI_ISL_659528	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B347D6/2020	EPI_ISL_659533	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B3491C/2020	EPI_ISL_659547	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B329C3/2020	EPI_ISL_659561	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B34545/2020	EPI_ISL_659568	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B342B7/2020	EPI_ISL_659579	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B3433C/2020	EPI_ISL_659596	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B35368/2020	EPI_ISL_659605	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B34B34/2020	EPI_ISL_659608	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B344DF/2020	EPI_ISL_659634	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B3493A/2020	EPI_ISL_659641	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B7F001/2020	EPI_ISL_661802	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B779E0/2020	EPI_ISL_661805	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B7EB3E/2020	EPI_ISL_661819	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B804F2/2020	EPI_ISL_661823	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B827D9/2020	EPI_ISL_661846	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B827AC/2020	EPI_ISL_661860	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B8233F/2020	EPI_ISL_661880	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B7EFE7/2020	EPI_ISL_661890	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B8279D/2020	EPI_ISL_661891	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B7EC86/2020	EPI_ISL_661905	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B8237B/2020	EPI_ISL_661907	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B7ECD1/2020	EPI_ISL_661916	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B779D1/2020	EPI_ISL_661926	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B7ED29/2020	EPI_ISL_661931	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.54	GV
hCoV-19/England/QEUH-B7FE34/2020	EPI_ISL_661935	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B7EF8D/2020	EPI_ISL_661937	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B80B0C/2020	EPI_ISL_661938	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B82548/2020	EPI_ISL_661940	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/C200044586/2020	EPI_ISL_664043	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/C200045757/2020	EPI_ISL_664070	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.56	GV
hCoV-19/England/C200045797/2020	EPI_ISL_664080	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.56	GV
hCoV-19/England/C200045839/2020	EPI_ISL_664084	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.56	GV
hCoV-19/Germany/NW-HHU-325/2020	EPI_ISL_666626	2020-10-12	Europe / Germany / North Rhine-Westphalia / Dsseldorf	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177.77	GV
hCoV-19/England/C200042646/2020	EPI_ISL_666741	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/C200044425/2020	EPI_ISL_666754	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204490718/2020	EPI_ISL_666770	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/CAMC-B7AA08/2020	EPI_ISL_667954	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B7F1FF/2020	EPI_ISL_667960	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B81B47/2020	EPI_ISL_667962	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-B7967E/2020	EPI_ISL_667968	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B98A04/2020	EPI_ISL_673826	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B98D56/2020	EPI_ISL_673847	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B99F9B/2020	EPI_ISL_673855	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B95120/2020	EPI_ISL_673865	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8D10D/2020	EPI_ISL_673875	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-B8618C/2020	EPI_ISL_673881	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B8D4D7/2020	EPI_ISL_673884	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B8E6FE/2020	EPI_ISL_673896	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B8D194/2020	EPI_ISL_673898	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B85EB3/2020	EPI_ISL_673899	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8D39E/2020	EPI_ISL_673920	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B8690C/2020	EPI_ISL_673935	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B960C8/2020	EPI_ISL_676013	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B96453/2020	EPI_ISL_676017	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B942C4/2020	EPI_ISL_676023	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B96A15/2020	EPI_ISL_676035	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B94D0F/2020	EPI_ISL_676038	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B96B12/2020	EPI_ISL_676047	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B968C0/2020	EPI_ISL_676052	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B95F62/2020	EPI_ISL_676057	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B95DD1/2020	EPI_ISL_676060	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-B94D5A/2020	EPI_ISL_676061	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B942F1/2020	EPI_ISL_676063	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B966E4/2020	EPI_ISL_676070	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B94B23/2020	EPI_ISL_676076	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B94A9F/2020	EPI_ISL_676082	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B95D0E/2020	EPI_ISL_676085	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B96945/2020	EPI_ISL_676097	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B93BE8/2020	EPI_ISL_676106	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B94F09/2020	EPI_ISL_676110	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B96884/2020	EPI_ISL_676116	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B9663F/2020	EPI_ISL_676158	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B93C12/2020	EPI_ISL_676163	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B94EDF/2020	EPI_ISL_676167	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B965AB/2020	EPI_ISL_676171	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B944DD/2020	EPI_ISL_676182	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B94112/2020	EPI_ISL_676192	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B94A80/2020	EPI_ISL_676196	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/204521765/2020	EPI_ISL_678646	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204522829/2020	EPI_ISL_678647	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204540592/2020	EPI_ISL_678653	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204540593/2020	EPI_ISL_678654	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204540974/2020	EPI_ISL_678660	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/204560319/2020	EPI_ISL_678678	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204561474/2020	EPI_ISL_678687	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.50	GV
hCoV-19/England/204700596/2020	EPI_ISL_678709	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/BIRM-6A3B0/2020	EPI_ISL_679050	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-6A462/2020	EPI_ISL_679059	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11707E/2020	EPI_ISL_679924	2020-10-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11CC57/2020	EPI_ISL_679933	2020-11-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11DB2C/2020	EPI_ISL_679935	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11DBA4/2020	EPI_ISL_679936	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11DC65/2020	EPI_ISL_679937	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11DD71/2020	EPI_ISL_679938	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11DE6F/2020	EPI_ISL_679939	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11DE7E/2020	EPI_ISL_679940	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11DE8D/2020	EPI_ISL_679941	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11DE9C/2020	EPI_ISL_679942	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11E94F/2020	EPI_ISL_679944	2020-11-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11EC64/2020	EPI_ISL_679945	2020-11-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11F252/2020	EPI_ISL_679953	2020-11-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11F2F8/2020	EPI_ISL_679960	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-A0165E/2020	EPI_ISL_679993	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-48E7D4/2020	EPI_ISL_680913	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-48E9A1/2020	EPI_ISL_680941	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-48EAF9/2020	EPI_ISL_680962	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-BACDD7/2020	EPI_ISL_681359	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BA9E5F/2020	EPI_ISL_681360	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAA216/2020	EPI_ISL_681366	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAB4C4/2020	EPI_ISL_681371	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BAB558/2020	EPI_ISL_681396	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Spain/MD-ISCIII-2014585/2020	EPI_ISL_691700	2020-08-19	Europe / Spain / Madrid	Human	Original	Nasopharyngeal aspirate		Illumina Miseq				B.1.177	O
hCoV-19/Spain/MD-ISCIII-2014592/2020	EPI_ISL_691701	2020-08-19	Europe / Spain / Madrid	Human	Original	Nasopharyngeal aspirate		Illumina Miseq				B.1.177	O
hCoV-19/Spain/MD-ISCIII-2014601/2020	EPI_ISL_691703	2020-08-19	Europe / Spain / Madrid	Human	Original	Nasopharyngeal aspirate		Illumina Miseq				B.1.177	O
hCoV-19/Spain/MD-ISCIII-2014625/2020	EPI_ISL_691710	2020-08-18	Europe / Spain / Madrid	Human	Original	Nasopharyngeal aspirate		Illumina Miseq				B.1.177	O
hCoV-19/Spain/MD-ISCIII-2014664/2020	EPI_ISL_691719	2020-08-18	Europe / Spain / Madrid	Human	Original	Nasopharyngeal swab		Illumina Miseq				B.1.177	O
hCoV-19/Spain/MD-ISCIII-2014670/2020	EPI_ISL_691721	2020-08-18	Europe / Spain / Madrid	Human	Original	Nasopharyngeal swab		Illumina Miseq				B.1.177	GV
hCoV-19/Spain/MD-ISCIII-2014822/2020	EPI_ISL_691723	2020-08-26	Europe / Spain / Madrid	Human	Original	Nasopharyngeal swab		Illumina Miseq				B.1.177	O
hCoV-19/Spain/MD-ISCIII-2014833/2020	EPI_ISL_691729	2020-09-01	Europe / Spain / Madrid	Human	Original	Nasopharyngeal swab		Illumina Miseq				B.1.177	GV
hCoV-19/England/ALDP-BB9C43/2020	EPI_ISL_702606	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BB5782/2020	EPI_ISL_702617	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-BB9469/2020	EPI_ISL_702641	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB5755/2020	EPI_ISL_702657	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB32FC/2020	EPI_ISL_702701	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB5DF9/2020	EPI_ISL_702702	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB5913/2020	EPI_ISL_702709	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB9997/2020	EPI_ISL_702730	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB992E/2020	EPI_ISL_702777	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCA939/2020	EPI_ISL_703266	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BCA571/2020	EPI_ISL_703268	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-BCA6C9/2020	EPI_ISL_703271	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCA0AD/2020	EPI_ISL_703274	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BCA3C2/2020	EPI_ISL_703277	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BC3EB9/2020	EPI_ISL_703280	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-BC45D1/2020	EPI_ISL_703285	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCB81D/2020	EPI_ISL_703991	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCC278/2020	EPI_ISL_703993	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B3CEAC/2020	EPI_ISL_706201	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3CED9/2020	EPI_ISL_706203	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-B3D069/2020	EPI_ISL_706216	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3D0D2/2020	EPI_ISL_706220	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3D658/2020	EPI_ISL_706232	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3D7CE/2020	EPI_ISL_706236	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3D8E9/2020	EPI_ISL_706240	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/MILK-B3DC29/2020	EPI_ISL_706250	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3E37E/2020	EPI_ISL_706272	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NORT-1B70665/2020	EPI_ISL_706286	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/NORT-1B70EC7/2020	EPI_ISL_706297	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/Thailand/Chonburi-SQ-LN0002/2020	EPI_ISL_708804	2020-10-20	Asia / Thailand / Chonburi	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious 10.2.12			B.1.177.77	GV
hCoV-19/Thailand/Chonburi-SQ-SM0001/2020	EPI_ISL_708807	2020-10-16	Asia / Thailand / Chonburi	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious 10.2.12			B.1.177.77	GV
hCoV-19/England/ALDP-BE955E/2020	EPI_ISL_708846	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BE8E45/2020	EPI_ISL_708852	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BE9819/2020	EPI_ISL_708861	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BE963D/2020	EPI_ISL_708882	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BE9503/2020	EPI_ISL_708887	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BEE4E3/2020	EPI_ISL_708897	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BE8FAC/2020	EPI_ISL_708899	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BE959A/2020	EPI_ISL_708902	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BE93AF/2020	EPI_ISL_708914	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BE9512/2020	EPI_ISL_708929	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BE9372/2020	EPI_ISL_708935	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BE980A/2020	EPI_ISL_708940	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Denmark/DCGC-16302/2020	EPI_ISL_714691	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-16474/2020	EPI_ISL_714790	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-16483/2020	EPI_ISL_714794	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/CAMC-C3F3A9/2020	EPI_ISL_719548	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-C42473/2020	EPI_ISL_719583	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BABA2C/2020	EPI_ISL_720518	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB21C3/2020	EPI_ISL_720535	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB1A50/2020	EPI_ISL_720536	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB03DE/2020	EPI_ISL_720537	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB21E1/2020	EPI_ISL_720542	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BB06E4/2020	EPI_ISL_720548	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB1B5D/2020	EPI_ISL_720552	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BB0004/2020	EPI_ISL_720553	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB0EEC/2020	EPI_ISL_720561	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB0B5E/2020	EPI_ISL_720567	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BABA68/2020	EPI_ISL_720569	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAFACE/2020	EPI_ISL_720577	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B7B64F/2020	EPI_ISL_724019	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-B7B797/2020	EPI_ISL_724032	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-B7BD1D/2020	EPI_ISL_724053	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-B7BE74/2020	EPI_ISL_724059	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/CAMC-BBB986/2020	EPI_ISL_724074	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/CAMC-BBBA65/2020	EPI_ISL_724083	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMC-BBBB35/2020	EPI_ISL_724091	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMC-BBC493/2020	EPI_ISL_724142	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-BBC4FD/2020	EPI_ISL_724148	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-BBC518/2020	EPI_ISL_724149	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F6E6D/2020	EPI_ISL_725306	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F6E7C/2020	EPI_ISL_725307	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F6E9A/2020	EPI_ISL_725309	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F6EB8/2020	EPI_ISL_725311	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F7084/2020	EPI_ISL_725323	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F7093/2020	EPI_ISL_725324	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F7497/2020	EPI_ISL_725332	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F75EF/2020	EPI_ISL_725336	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F76DD/2020	EPI_ISL_725339	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F887C/2020	EPI_ISL_725368	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F8DAA/2020	EPI_ISL_725376	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/NORW-F8DB9/2020	EPI_ISL_725377	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F8FD1/2020	EPI_ISL_725381	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F96BD/2020	EPI_ISL_725391	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/NORW-F976F/2020	EPI_ISL_725393	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F9969/2020	EPI_ISL_725413	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F9D8B/2020	EPI_ISL_725441	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F9DE5/2020	EPI_ISL_725443	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F9EA6/2020	EPI_ISL_725449	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F9EE2/2020	EPI_ISL_725450	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F9F67/2020	EPI_ISL_725455	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-FA106/2020	EPI_ISL_725471	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-FA124/2020	EPI_ISL_725472	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-FA17F/2020	EPI_ISL_725477	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-FA2C7/2020	EPI_ISL_725490	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-FA36A/2020	EPI_ISL_725498	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-4966CD/2020	EPI_ISL_726621	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4966EB/2020	EPI_ISL_726623	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-496812/2020	EPI_ISL_726641	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-496830/2020	EPI_ISL_726643	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-496988/2020	EPI_ISL_726663	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-497019/2020	EPI_ISL_726765	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-499008/2020	EPI_ISL_727244	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-499062/2020	EPI_ISL_727250	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-499080/2020	EPI_ISL_727252	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-499114/2020	EPI_ISL_727258	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/SHEF-10CB639/2020	EPI_ISL_727903	2020-11-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10D5696/2020	EPI_ISL_727972	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-C39D74/2020	EPI_ISL_730884	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3B57A/2020	EPI_ISL_730895	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3A380/2020	EPI_ISL_731160	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3A247/2020	EPI_ISL_731161	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3BD90/2020	EPI_ISL_731165	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-C3D9B8/2020	EPI_ISL_731176	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3C816/2020	EPI_ISL_731177	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3CC83/2020	EPI_ISL_731178	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-C39C4A/2020	EPI_ISL_731183	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3C922/2020	EPI_ISL_731237	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-C39CB3/2020	EPI_ISL_731240	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3CC38/2020	EPI_ISL_731246	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C3125F/2020	EPI_ISL_731264	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C3177E/2020	EPI_ISL_731280	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C3169F/2020	EPI_ISL_731286	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3ACD0/2020	EPI_ISL_731288	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Ireland/D-NVRL-76IRL28438/2020	EPI_ISL_732490	2020-10-16	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KK-NVRL-76IRL28885/2020	EPI_ISL_732492	2020-10-18	Europe / Ireland / Kilkenny	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/MO-NVRL-76IRL31264/2020	EPI_ISL_732496	2020-10-18	Europe / Ireland / Mayo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-20ILR11475/2020	EPI_ISL_732502	2020-11-05	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-20ILR11476/2020	EPI_ISL_732503	2020-11-16	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-20ILR11478/2020	EPI_ISL_732505	2020-11-17	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-20ILR11479/2020	EPI_ISL_732506	2020-11-17	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-20ILR11480/2020	EPI_ISL_732507	2020-11-18	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-20ILR11483/2020	EPI_ISL_732508	2020-11-19	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-20ILR11484/2020	EPI_ISL_732509	2020-11-19	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-20ILR11485/2020	EPI_ISL_732510	2020-11-20	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-20ILR11488/2020	EPI_ISL_732512	2020-11-22	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-20ILR11489/2020	EPI_ISL_732513	2020-11-22	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-20ILR11491/2020	EPI_ISL_732515	2020-11-26	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/LH-NVRL-20ILR11492/2020	EPI_ISL_732516	2020-12-03	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CO-NVRL-76IRL32511/2020	EPI_ISL_732519	2020-10-18	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KE-NVRL-76IRL26610/2020	EPI_ISL_732521	2020-10-18	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KE-NVRL-79IRL02689/2020	EPI_ISL_732522	2020-11-28	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/England/MILK-C2F931/2020	EPI_ISL_733801	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C23029/2020	EPI_ISL_733806	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C2C8EC/2020	EPI_ISL_733812	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C2FBB3/2020	EPI_ISL_733813	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C240EC/2020	EPI_ISL_733818	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-C2FB95/2020	EPI_ISL_733828	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-C2FA6B/2020	EPI_ISL_733832	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C24495/2020	EPI_ISL_733837	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-C2CFAB/2020	EPI_ISL_733854	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C2FBA4/2020	EPI_ISL_733855	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C23092/2020	EPI_ISL_733877	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C58629/2020	EPI_ISL_736034	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C58638/2020	EPI_ISL_736051	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C585E0/2020	EPI_ISL_736065	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C5B76F/2020	EPI_ISL_736066	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-C581DD/2020	EPI_ISL_736071	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C580C1/2020	EPI_ISL_736122	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C5803A/2020	EPI_ISL_736152	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Belgium/ULG-11097/2020	EPI_ISL_737346	2020-12-16	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/Luxembourg/LNS1483758/2020	EPI_ISL_739943	2020-12-16	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS1639067/2020	EPI_ISL_739966	2020-11-20	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2846662/2020	EPI_ISL_740203	2020-12-15	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2904387/2020	EPI_ISL_740215	2020-11-04	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS3145817/2020	EPI_ISL_740257	2020-11-27	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/England/ALDP-B75223/2020	EPI_ISL_740901	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B75690/2020	EPI_ISL_740915	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B756BE/2020	EPI_ISL_740917	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B756DC/2020	EPI_ISL_740918	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B759B5/2020	EPI_ISL_740932	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina		NSP11 without BLAST coverage.	warn	B.1.177.4	GV
hCoV-19/England/ALDP-B759C4/2020	EPI_ISL_740933	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-B75AFE/2020	EPI_ISL_740935	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-B75E98/2020	EPI_ISL_740945	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B75EF2/2020	EPI_ISL_740950	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NORW-222D1E/2020	EPI_ISL_741518	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/NORW-222D2D/2020	EPI_ISL_741519	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/NORW-2232B4/2020	EPI_ISL_741581	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F6577/2020	EPI_ISL_741586	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-49D9FA/2020	EPI_ISL_742861	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49DA33/2020	EPI_ISL_742864	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49F49D/2020	EPI_ISL_743221	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Luxembourg/LNS6858142/2020	EPI_ISL_744475	2020-10-20	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS7088375/2020	EPI_ISL_744510	2020-11-13	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS7194612/2020	EPI_ISL_744530	2020-11-15	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS7205423/2020	EPI_ISL_744536	2020-11-02	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS7243430/2020	EPI_ISL_744542	2020-11-22	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Denmark/DCGC-20196/2020	EPI_ISL_748043	2020-11-30	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-20249/2020	EPI_ISL_748072	2020-11-30	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-20351/2020	EPI_ISL_748131	2020-10-05	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.4	GV
hCoV-19/England/ALDP-C8B739/2020	EPI_ISL_756524	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C8609D/2020	EPI_ISL_756554	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C8ABF2/2020	EPI_ISL_756583	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C88F9E/2020	EPI_ISL_756587	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-C85FEC/2020	EPI_ISL_756594	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-CB42CD/2020	EPI_ISL_761022	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CADA0B/2020	EPI_ISL_761026	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB4236/2020	EPI_ISL_761049	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-CB3826/2020	EPI_ISL_761104	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB3510/2020	EPI_ISL_761109	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-CA4B2F/2020	EPI_ISL_762324	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-CA41A5/2020	EPI_ISL_762326	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A5C32/2020	EPI_ISL_764962	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A5F66/2020	EPI_ISL_764985	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/ALDP-CB55D2/2020	EPI_ISL_767105	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/Wales/ALDP-C58049/2020	EPI_ISL_767131	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/ALDP-C3B343/2020	EPI_ISL_767167	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/ALDP-C3A4E7/2020	EPI_ISL_767173	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/ALDP-C3B46E/2020	EPI_ISL_767187	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-C709D7/2020	EPI_ISL_769080	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-C6FE54/2020	EPI_ISL_769091	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C71B2B/2020	EPI_ISL_769094	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-C73804/2020	EPI_ISL_769097	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C515D8/2020	EPI_ISL_769763	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C53442/2020	EPI_ISL_769766	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C539CB/2020	EPI_ISL_769814	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C539DA/2020	EPI_ISL_769827	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Luxembourg/LNS6178589/2020	EPI_ISL_770882	2020-12-21	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar	NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177.77	GV
hCoV-19/England/QEUH-C93EEE/2020	EPI_ISL_777504	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-C8C53E/2020	EPI_ISL_777509	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-CEB4C7/2020	EPI_ISL_781437	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-CECD25/2020	EPI_ISL_781508	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-CFC2C9/2020	EPI_ISL_781588	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CF1394/2020	EPI_ISL_782099	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C332B7/2020	EPI_ISL_782723	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C260AE/2020	EPI_ISL_782747	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-C3087C/2020	EPI_ISL_782749	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C2F45E/2020	EPI_ISL_782752	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C25F57/2020	EPI_ISL_782827	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C2F676/2020	EPI_ISL_782837	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-C30029/2020	EPI_ISL_782848	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C25F48/2020	EPI_ISL_782856	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C308D6/2020	EPI_ISL_782871	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C3089A/2020	EPI_ISL_782884	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B78CF5/2020	EPI_ISL_783380	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B7779B/2020	EPI_ISL_783389	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B7778C/2020	EPI_ISL_783392	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-23029/2020	EPI_ISL_793483	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-23038/2020	EPI_ISL_793489	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-23075/2020	EPI_ISL_793517	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-23078/2020	EPI_ISL_793519	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.4	GV
hCoV-19/Denmark/DCGC-23091/2020	EPI_ISL_793526	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-23103/2020	EPI_ISL_793534	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-23149/2020	EPI_ISL_793567	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.4	GV
hCoV-19/Denmark/DCGC-23150/2020	EPI_ISL_793568	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NSP11 without BLAST coverage.	warn	B.1.177.77	GV
hCoV-19/England/ALDP-DA7736/2020	EPI_ISL_797019	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-DA03DF/2020	EPI_ISL_797048	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-D4422B/2020	EPI_ISL_798329	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-D7ABB8/2020	EPI_ISL_798394	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-D18D89/2020	EPI_ISL_799699	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-E07232/2020	EPI_ISL_811873	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Spain/MD-IBV-99012915/2020	EPI_ISL_814056	2020-12-30	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/England/SHEF-10D506B/2020	EPI_ISL_816579	2020-12-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/SHEF-10D57A2/2021	EPI_ISL_816591	2021-01-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-E3075F/2021	EPI_ISL_821214	2021-01-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-E2BBB5/2021	EPI_ISL_821250	2021-01-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/PHWC-4AEECA/2020	EPI_ISL_822575	2020-12-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Italy/ABR-IZSGC-367277/2020	EPI_ISL_833256	2020-12-28	Europe / Italy / Abruzzo	Human	Original			ARTIC protocol+Illumina NestSeq500				B.1.177.77	GV
hCoV-19/Italy/ABR-IZSGC-368125/2020	EPI_ISL_833280	2020-12-28	Europe / Italy / Abruzzo	Human	Original			ARTIC protocol+Illumina NestSeq500				B.1.177.77	GV
hCoV-19/England/ALDP-EF032A/2021	EPI_ISL_834533	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/LOND-12F526D/2021	EPI_ISL_839287	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/LOND-DCBFD/2020	EPI_ISL_839305	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/LOND-DD048/2020	EPI_ISL_839347	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/MILK-B59C90/2020	EPI_ISL_839364	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B59F2E/2020	EPI_ISL_839389	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/OXON-F3F7C8/2020	EPI_ISL_840210	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/OXON-F4501F/2020	EPI_ISL_840317	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/OXON-F456B3/2020	EPI_ISL_840326	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/OXON-F45844/2020	EPI_ISL_840329	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/OXON-F45D36/2020	EPI_ISL_840335	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/LOND-128729D/2020	EPI_ISL_842870	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LOND-1287B92/2020	EPI_ISL_842992	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/205290559/2020	EPI_ISL_846593	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Insertion of 2 nucleotide(s) found at refpos 28251 (frameshift confirmed by the submitter). NSP11 without BLAST coverage.	info	B.1.177.54	GV
hCoV-19/United Arab Emirates/3835/2020	EPI_ISL_859862	2020-11-21	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-FB64C2/2021	EPI_ISL_863036	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/MILK-FAA300/2021	EPI_ISL_864250	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/LOND-1288B28/2020	EPI_ISL_865515	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/LOND-1288C70/2020	EPI_ISL_865534	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LOND-DEFD1/2021	EPI_ISL_866239	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.77	GV
hCoV-19/England/NOTT-122045/2020	EPI_ISL_866902	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-122184/2021	EPI_ISL_866906	2021-01-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-247575/2021	EPI_ISL_866913	2021-01-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-2493D3/2021	EPI_ISL_866965	2021-01-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-24941C/2021	EPI_ISL_866966	2021-01-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-2498C5/2021	EPI_ISL_866975	2021-01-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-249ADE/2021	EPI_ISL_866986	2021-01-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-249BCC/2020	EPI_ISL_866990	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-249BDB/2020	EPI_ISL_866991	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-24A369/2020	EPI_ISL_866992	2020-12-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/TFCI-26FEFFD/2020	EPI_ISL_868871	2020-12-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Denmark/DCGC-33013/2021	EPI_ISL_870017	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33027/2021	EPI_ISL_870031	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-33055/2021	EPI_ISL_870059	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33065/2021	EPI_ISL_870070	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-34456/2020	EPI_ISL_871467	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-34531/2020	EPI_ISL_871542	2020-12-28	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/ALDP-1065033/2021	EPI_ISL_878225	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-10370C1/2021	EPI_ISL_878875	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1035E6F/2021	EPI_ISL_879582	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-1030FE9/2021	EPI_ISL_880569	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-FB4B65/2021	EPI_ISL_882087	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-FAF893/2021	EPI_ISL_882143	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-FB4B38/2021	EPI_ISL_882151	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-FB589A/2021	EPI_ISL_882160	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-FB4A0E/2021	EPI_ISL_882169	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-FB4B0B/2021	EPI_ISL_882175	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-FB49B6/2021	EPI_ISL_882188	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-FB4A59/2021	EPI_ISL_882207	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-FB4CAE/2021	EPI_ISL_882221	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-10B4FA1/2021	EPI_ISL_885999	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-10BA363/2021	EPI_ISL_891851	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-1091775/2021	EPI_ISL_891913	2021-01-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Belgium/rega-1780/2021	EPI_ISL_894211	2021-01-07	Europe / Belgium / Bekkevoort	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1786/2021	EPI_ISL_894213	2021-01-07	Europe / Belgium / Deurne	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Netherlands/NH-RIVM-10434/2021	EPI_ISL_905302	2021-01-11	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/UT-RIVM-10399/2021	EPI_ISL_905317	2021-01-11	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/NB-RIVM-21375/2020	EPI_ISL_905370	2020-12-28	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/ZH-RIVM-10047/2021	EPI_ISL_905386	2021-01-04	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/England/ALDP-10E19F8/2021	EPI_ISL_907818	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-10E1A31/2021	EPI_ISL_907954	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Luxembourg/LNS0799882/2020	EPI_ISL_911057	2020-12-15	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177	GV
hCoV-19/Luxembourg/LNS0296910/2020	EPI_ISL_911092	2020-12-16	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0802349/2020	EPI_ISL_911094	2020-12-16	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS8613075/2021	EPI_ISL_911140	2021-01-12	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2491986/2021	EPI_ISL_911164	2021-01-14	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2286695/2021	EPI_ISL_911165	2021-01-14	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2710992/2021	EPI_ISL_911166	2021-01-14	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Belgium/AZDelta2103-23339/2021	EPI_ISL_911254	2021-01	Europe / Belgium / Ruiselede	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZDelta2103-23962/2021	EPI_ISL_911255	2021-01	Europe / Belgium / Torhout	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/rega-2017/2021	EPI_ISL_913810	2021-01-12	Europe / Belgium / Leopoldsburg	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2021/2021	EPI_ISL_913816	2021-01-12	Europe / Belgium / Berlaar	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2023/2021	EPI_ISL_913819	2021-01-12	Europe / Belgium / Heist-op-den-Berg	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2065/2021	EPI_ISL_913872	2021-01-13	Europe / Belgium / Heist-op-den-Berg	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/England/ALDP-BC90DB/2020	EPI_ISL_915709	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC991C/2020	EPI_ISL_915711	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC9026/2020	EPI_ISL_915712	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC993A/2020	EPI_ISL_915719	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC99EF/2020	EPI_ISL_915721	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BC70FB/2020	EPI_ISL_916020	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC7DD6/2020	EPI_ISL_916025	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BC7E6A/2020	EPI_ISL_916040	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC6DE6/2020	EPI_ISL_916047	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BC843A/2020	EPI_ISL_916053	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC7E3D/2020	EPI_ISL_916059	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10F9F28/2021	EPI_ISL_917393	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-9E9787/2020	EPI_ISL_918563	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-6858F/2020	EPI_ISL_918567	2020-11-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-6C8DD/2020	EPI_ISL_918601	2020-12-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.55	GV
hCoV-19/England/BIRM-6C907/2020	EPI_ISL_918603	2020-12-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-6CA8C/2020	EPI_ISL_918606	2020-12-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6CC4A/2020	EPI_ISL_918618	2020-12-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-6CCC2/2020	EPI_ISL_918620	2020-12-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-6CCD1/2020	EPI_ISL_918621	2020-12-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-6CFF6/2020	EPI_ISL_918650	2020-12-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Northern Ireland/NIRE-236272/2021	EPI_ISL_920986	2021-01-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.2	GV
hCoV-19/England/SHEF-10D511D/2021	EPI_ISL_924354	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/Denmark/DCGC-36880/2021	EPI_ISL_928021	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 5 nucleotide(s) found at refpos 28028 (frameshift confirmed by the submitter). NS8 without BLAST coverage.	info	B.1.177.77	GV
hCoV-19/Denmark/DCGC-36913/2021	EPI_ISL_928054	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-38182/2021	EPI_ISL_929323	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-38240/2021	EPI_ISL_929381	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-39226/2021	EPI_ISL_930368	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.56	GV
hCoV-19/England/ALDP-11857BF/2021	EPI_ISL_931661	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1186AA6/2021	EPI_ISL_931690	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1185DCC/2021	EPI_ISL_931699	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Belgium/rega-2113/2020	EPI_ISL_935209	2020-12-27	Europe / Belgium / Oostende	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/England/ALDP-115D46E/2021	EPI_ISL_937806	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-119D59C/2021	EPI_ISL_945590	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-116EC08/2021	EPI_ISL_948389	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-116EC53/2021	EPI_ISL_948398	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1145B73/2021	EPI_ISL_948525	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/NOTT-246E4E/2020	EPI_ISL_950607	2020-06-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-246EF3/2020	EPI_ISL_950610	2020-06-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-246F3C/2020	EPI_ISL_950611	2020-06-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/NOTT-246F5A/2020	EPI_ISL_950613	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-247083/2020	EPI_ISL_950617	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-247223/2020	EPI_ISL_950631	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-24735D/2020	EPI_ISL_950637	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-24CCB7/2021	EPI_ISL_950666	2021-01-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-24D0F6/2021	EPI_ISL_950684	2021-02-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-24D102/2021	EPI_ISL_950685	2021-02-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-24D2E1/2020	EPI_ISL_950699	2020-12-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-24D6A9/2021	EPI_ISL_950727	2021-02-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/OXON-F44A03/2020	EPI_ISL_950788	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/OXON-F4520A/2020	EPI_ISL_950828	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-1196EC5/2021	EPI_ISL_959160	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-40363/2021	EPI_ISL_972040	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/MILK-11EFC5A/2021	EPI_ISL_980661	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-11EFBA8/2021	EPI_ISL_980690	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/Switzerland/GE-33170677/2021	EPI_ISL_981814	2021-02-04	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B.1.177.77	GV
hCoV-19/Spain/AN-HUSC_144260265517/2020	EPI_ISL_981925	2020-12-17	Europe / Spain / Andalusia / Granada	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.177	GV
hCoV-19/Wales/ALDP-BCB1A9/2020	EPI_ISL_991331	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/ALDP-BC718F/2020	EPI_ISL_991346	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10EDEFD/2021	EPI_ISL_992467	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-10ECF64/2021	EPI_ISL_992516	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10EDF81/2021	EPI_ISL_992605	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-10ED24C/2021	EPI_ISL_992616	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10ED2F1/2021	EPI_ISL_992669	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10EE032/2021	EPI_ISL_992678	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-108A0ED/2021	EPI_ISL_993216	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/MILK-1089CEA/2021	EPI_ISL_993222	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-108A135/2021	EPI_ISL_993231	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/CAMC-1062C32/2021	EPI_ISL_993873	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/EXET-144D17/2020	EPI_ISL_997307	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/EXET-144DAE/2020	EPI_ISL_997315	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/EXET-144E41/2020	EPI_ISL_997320	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Sweden/21-50483/2021	EPI_ISL_1008397	2021-01-25	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.177.77	GV
hCoV-19/Sweden/21-50618/2021	EPI_ISL_1008478	2021-01-21	Europe / Sweden / Vasterbotten	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.177.60	GV
hCoV-19/England/ALDP-1198E0F/2021	EPI_ISL_1044024	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1198CAB/2021	EPI_ISL_1044091	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-1280EFA/2021	EPI_ISL_1045513	2021-02-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Spain/CT-IrsiCaixaR004QZ1C1/2021	EPI_ISL_1046817	2021-01-29	Europe / Spain / Catalunya / Santa Coloma de Gramenet	Human	Original	Oropharyngeal swab		Illumina/MiSeq	Viralrecon/iVar			B.1.177	GV
hCoV-19/England/NORT-1B86F9E/2021	EPI_ISL_1051210	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina		Insertion of 2 nucleotide(s) found at refpos 28251 (frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/Scotland/QEUH-1268E25/2021	EPI_ISL_1063200	2021-02-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Northern Ireland/RAND-1267916/2021	EPI_ISL_1063259	2021-02-03	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				V.1	GV
hCoV-19/Northern Ireland/RAND-1287B0B/2021	EPI_ISL_1063313	2021-02-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				V.1	GV
hCoV-19/Sweden/21-20616/2021	EPI_ISL_1064693	2021-02-12	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.177.79	GV
hCoV-19/Sweden/21-51229/2021	EPI_ISL_1064696	2021-02-10	Europe / Sweden / Dalarna	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.177.79	GV
hCoV-19/Denmark/DCGC-46301/2021	EPI_ISL_1065811	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-46304/2020	EPI_ISL_1065814	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/England/QEUH-1292754/2021	EPI_ISL_1070380	2021-02-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-96F1B8/2020	EPI_ISL_530422	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Northern Ireland/QEUH-96E887/2020	EPI_ISL_530428	2020-08-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-962D0C/2020	EPI_ISL_531623	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9B8C28/2020	EPI_ISL_549723	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B838D/2020	EPI_ISL_549735	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B89D6/2020	EPI_ISL_549758	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B8569/2020	EPI_ISL_549759	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B9128/2020	EPI_ISL_549776	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99CF8B/2020	EPI_ISL_549893	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-99E138/2020	EPI_ISL_550725	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99C4F5/2020	EPI_ISL_550757	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9AAA3E/2020	EPI_ISL_550863	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9AA02D/2020	EPI_ISL_550871	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9AAB86/2020	EPI_ISL_550884	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9AA63A/2020	EPI_ISL_550897	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9711C2/2020	EPI_ISL_553052	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/PHWC-16AFF7/2020	EPI_ISL_560230	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16B04E/2020	EPI_ISL_560235	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16B10F/2020	EPI_ISL_560245	2020-09-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16B13C/2020	EPI_ISL_560248	2020-09-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16B1C3/2020	EPI_ISL_560257	2020-09-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16B21B/2020	EPI_ISL_560260	2020-09-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16B345/2020	EPI_ISL_560276	2020-09-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9CD015/2020	EPI_ISL_566214	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9CDE1B/2020	EPI_ISL_566220	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9CD473/2020	EPI_ISL_566223	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-9CE18A/2020	EPI_ISL_566224	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9CD701/2020	EPI_ISL_566236	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9CD349/2020	EPI_ISL_566237	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9CD9A1/2020	EPI_ISL_566251	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9CCDF1/2020	EPI_ISL_566253	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9CD3B2/2020	EPI_ISL_566279	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9CD8E0/2020	EPI_ISL_566284	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9CCE3A/2020	EPI_ISL_566285	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9CE032/2020	EPI_ISL_566286	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-9CDE39/2020	EPI_ISL_566291	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9CE0AB/2020	EPI_ISL_566304	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9CD7F2/2020	EPI_ISL_566310	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9CCFA0/2020	EPI_ISL_566335	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9CCE49/2020	EPI_ISL_566348	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9CDEEE/2020	EPI_ISL_566351	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9CDB9C/2020	EPI_ISL_566368	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CE09C/2020	EPI_ISL_566386	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9CE1A8/2020	EPI_ISL_566387	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9CDF63/2020	EPI_ISL_566409	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-9CE17B/2020	EPI_ISL_566417	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-9B25AB/2020	EPI_ISL_566423	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9C93F2/2020	EPI_ISL_567524	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9C57FA/2020	EPI_ISL_567535	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-9C597C/2020	EPI_ISL_567537	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9C60FE/2020	EPI_ISL_567544	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9C5E40/2020	EPI_ISL_567641	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9C5A1F/2020	EPI_ISL_567681	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9C5B85/2020	EPI_ISL_567700	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9C5208/2020	EPI_ISL_567724	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9C5E7D/2020	EPI_ISL_567742	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9C5A2E/2020	EPI_ISL_567744	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/NOTT-113D11/2020	EPI_ISL_573476	2020-09-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-9B3D84/2020	EPI_ISL_573549	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-9BA1EB/2020	EPI_ISL_573585	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/MILK-991A76/2020	EPI_ISL_577017	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Ireland/D-NVRL-72IRL36222/2020	EPI_ISL_578257	2020-08-17	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-73IRL14028/2020	EPI_ISL_578259	2020-09-16	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL22431/2020	EPI_ISL_578261	2020-09-16	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-73IRL25093/2020	EPI_ISL_578263	2020-09-16	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-73IRL25386/2020	EPI_ISL_578264	2020-09-05	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-73IRL26673/2020	EPI_ISL_578266	2020-09-16	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-73IRL27308/2020	EPI_ISL_578267	2020-09-16	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-73IRL34820/2020	EPI_ISL_578272	2020-09-08	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-73IRL38296/2020	EPI_ISL_578274	2020-09-16	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/G-NVRL-73IRL24800/2020	EPI_ISL_578279	2020-09-05	Europe / Ireland / Galway	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/G-NVRL-73IRL28287/2020	EPI_ISL_578281	2020-09-16	Europe / Ireland / Galway	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/KE-NVRL-73IRL13506/2020	EPI_ISL_578285	2020-09-16	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KE-NVRL-73IRL13510/2020	EPI_ISL_578286	2020-09-16	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KE-NVRL-73IRL13512/2020	EPI_ISL_578287	2020-09-16	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KE-NVRL-73IRL13514/2020	EPI_ISL_578288	2020-09-16	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KE-NVRL-73IRL13515/2020	EPI_ISL_578289	2020-09-16	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KE-NVRL-73IRL25898/2020	EPI_ISL_578292	2020-09-16	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KE-NVRL-73IRL25939/2020	EPI_ISL_578293	2020-09-16	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KE-NVRL-73IRL25948/2020	EPI_ISL_578294	2020-09-16	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KE-NVRL-73IRL25972/2020	EPI_ISL_578295	2020-09-05	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KE-NVRL-73IRL28838/2020	EPI_ISL_578296	2020-09-16	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KE-NVRL-73IRL29421/2020	EPI_ISL_578297	2020-09-07	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/KE-NVRL-73IRL40359/2020	EPI_ISL_578301	2020-09-16	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LK-NVRL-73IRL26070/2020	EPI_ISL_578313	2020-09-06	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/MH-NVRL-73IRL26442/2020	EPI_ISL_578316	2020-09-06	Europe / Ireland / Meath	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/SO-NVRL-73IRL13569/2020	EPI_ISL_578320	2020-09-16	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177	GV
hCoV-19/Ireland/WW-NVRL-73IRL23909/2020	EPI_ISL_578328	2020-09-05	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.57	GV
hCoV-19/Ireland/WW-NVRL-73IRL23922/2020	EPI_ISL_578329	2020-09-05	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/WW-NVRL-73IRL29878/2020	EPI_ISL_578331	2020-09-07	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/WW-NVRL-73IRL29985/2020	EPI_ISL_578332	2020-09-07	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/England/ALDP-9E62F2/2020	EPI_ISL_580525	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-9EC3BD/2020	EPI_ISL_580533	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E714F/2020	EPI_ISL_580538	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E69EE/2020	EPI_ISL_580542	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E6BBB/2020	EPI_ISL_580544	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9E6632/2020	EPI_ISL_580545	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9E6061/2020	EPI_ISL_580551	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E6993/2020	EPI_ISL_580553	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E6F37/2020	EPI_ISL_580555	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-9EC10E/2020	EPI_ISL_580582	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-9E70BB/2020	EPI_ISL_580585	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E6395/2020	EPI_ISL_580592	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-9E6368/2020	EPI_ISL_580598	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E6526/2020	EPI_ISL_580602	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E72A6/2020	EPI_ISL_580605	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E7051/2020	EPI_ISL_580614	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E63A4/2020	EPI_ISL_580620	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E60DA/2020	EPI_ISL_580629	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-9EE403/2020	EPI_ISL_580716	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E98B1/2020	EPI_ISL_584260	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/ALDP-9E9963/2020	EPI_ISL_584269	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/ALDP-9E9990/2020	EPI_ISL_584271	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/CAMB-1B6606/2020	EPI_ISL_584293	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-A2E59A/2020	EPI_ISL_586791	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A2D2D0/2020	EPI_ISL_586821	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2E2B1/2020	EPI_ISL_586825	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2D05E/2020	EPI_ISL_586828	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2E3EB/2020	EPI_ISL_586832	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2E512/2020	EPI_ISL_586846	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A2DDFD/2020	EPI_ISL_586858	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A2E54F/2020	EPI_ISL_586860	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2DD1B/2020	EPI_ISL_586871	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2DCE1/2020	EPI_ISL_586879	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2D249/2020	EPI_ISL_586880	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-A2E178/2020	EPI_ISL_586889	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2D258/2020	EPI_ISL_586890	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-A2E10F/2020	EPI_ISL_586896	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F606E/2020	EPI_ISL_589005	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9F26AC/2020	EPI_ISL_589017	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9CEFDB/2020	EPI_ISL_590062	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A4CFA7/2020	EPI_ISL_596074	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A4D00D/2020	EPI_ISL_596080	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A4D0B2/2020	EPI_ISL_596088	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A4D0C1/2020	EPI_ISL_596089	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-A4D10A/2020	EPI_ISL_596091	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A4D128/2020	EPI_ISL_596093	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A4D155/2020	EPI_ISL_596096	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-A633AE/2020	EPI_ISL_596118	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A635E4/2020	EPI_ISL_596122	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-A6361E/2020	EPI_ISL_596124	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A63696/2020	EPI_ISL_596131	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Scotland/QEUH-A63881/2020	EPI_ISL_596156	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Scotland/QEUH-A639E8/2020	EPI_ISL_596177	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/SHEF-C1FC2/2020	EPI_ISL_596191	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.2	GV
hCoV-19/England/SHEF-C7551/2020	EPI_ISL_596202	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-C8CA6/2020	EPI_ISL_596205	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-CFD33/2020	EPI_ISL_596220	2020-09-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-D0E0F/2020	EPI_ISL_596223	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-D18A6/2020	EPI_ISL_596224	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-D2016/2020	EPI_ISL_596225	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A5E591/2020	EPI_ISL_597448	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A5E78C/2020	EPI_ISL_597456	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A57228/2020	EPI_ISL_597468	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A571D0/2020	EPI_ISL_597470	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A571C1/2020	EPI_ISL_597487	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-A5E151/2020	EPI_ISL_597501	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A5E397/2020	EPI_ISL_597506	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A5E27C/2020	EPI_ISL_597516	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/CAMC-A570C4/2020	EPI_ISL_597519	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A572FB/2020	EPI_ISL_597520	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50E2B/2020	EPI_ISL_597526	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A51051/2020	EPI_ISL_597529	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50DF1/2020	EPI_ISL_597530	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A509A2/2020	EPI_ISL_597537	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A5068D/2020	EPI_ISL_597539	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A507A8/2020	EPI_ISL_597540	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A50429/2020	EPI_ISL_597551	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A509DF/2020	EPI_ISL_597554	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A4FE3E/2020	EPI_ISL_597555	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A5009E/2020	EPI_ISL_597560	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A50BCA/2020	EPI_ISL_597561	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A4FBEC/2020	EPI_ISL_597573	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50122/2020	EPI_ISL_597578	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A4FA0D/2020	EPI_ISL_597579	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A4FD8C/2020	EPI_ISL_597583	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A50456/2020	EPI_ISL_597584	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A4FFD1/2020	EPI_ISL_597586	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A4FC07/2020	EPI_ISL_597591	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A4FB91/2020	EPI_ISL_597592	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-A44E84/2020	EPI_ISL_598781	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A45EED/2020	EPI_ISL_598794	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A44BAB/2020	EPI_ISL_598801	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A45F08/2020	EPI_ISL_598803	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A459BF/2020	EPI_ISL_598807	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A45BC8/2020	EPI_ISL_598822	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2F098/2020	EPI_ISL_598828	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-9DAF18/2020	EPI_ISL_601104	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-9DE8BF/2020	EPI_ISL_601195	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9DE8A0/2020	EPI_ISL_601232	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9E0CDC/2020	EPI_ISL_601242	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9DC110/2020	EPI_ISL_601296	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9E039B/2020	EPI_ISL_601299	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A86DA7/2020	EPI_ISL_606005	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A876F6/2020	EPI_ISL_606011	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A873C2/2020	EPI_ISL_606013	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A87CB8/2020	EPI_ISL_606022	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A87C21/2020	EPI_ISL_606024	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A87B06/2020	EPI_ISL_606027	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A87D88/2020	EPI_ISL_606033	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A86457/2020	EPI_ISL_606034	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A8667F/2020	EPI_ISL_606035	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A86150/2020	EPI_ISL_606042	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A864FD/2020	EPI_ISL_606047	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A87368/2020	EPI_ISL_606049	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A87D4C/2020	EPI_ISL_606051	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A87BBB/2020	EPI_ISL_606087	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A86387/2020	EPI_ISL_606096	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6E4FB/2020	EPI_ISL_607240	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6D641/2020	EPI_ISL_607241	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-A6CA82/2020	EPI_ISL_607245	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6F8C1/2020	EPI_ISL_607251	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A6F2E1/2020	EPI_ISL_607256	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F964/2020	EPI_ISL_607261	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7C69A/2020	EPI_ISL_607315	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7BA71/2020	EPI_ISL_607356	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7C18A/2020	EPI_ISL_607366	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7BD96/2020	EPI_ISL_607367	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A7CC98/2020	EPI_ISL_607382	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7BAEA/2020	EPI_ISL_607388	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7C560/2020	EPI_ISL_607390	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7B7C5/2020	EPI_ISL_607398	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7BA9F/2020	EPI_ISL_607405	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7B4DD/2020	EPI_ISL_607422	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7C7D3/2020	EPI_ISL_607425	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A6500F/2020	EPI_ISL_608522	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-A6501E/2020	EPI_ISL_608527	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A6878F/2020	EPI_ISL_608534	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A67E21/2020	EPI_ISL_608564	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A65139/2020	EPI_ISL_608565	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A68FB4/2020	EPI_ISL_608581	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A651FD/2020	EPI_ISL_608588	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A68F3C/2020	EPI_ISL_608599	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A68B83/2020	EPI_ISL_608601	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A64F30/2020	EPI_ISL_608618	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A64B4B/2020	EPI_ISL_608619	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A67BFD/2020	EPI_ISL_608621	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A64EE8/2020	EPI_ISL_608628	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A651EE/2020	EPI_ISL_608631	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A65A6B/2020	EPI_ISL_608653	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A6596E/2020	EPI_ISL_608656	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6837C/2020	EPI_ISL_608665	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A68C08/2020	EPI_ISL_608667	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A681AF/2020	EPI_ISL_608672	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A68F87/2020	EPI_ISL_608680	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6886E/2020	EPI_ISL_608685	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A64F03/2020	EPI_ISL_608688	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-A6836D/2020	EPI_ISL_608690	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/England/CAMC-A64F21/2020	EPI_ISL_608695	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A6B740/2020	EPI_ISL_608698	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.16	GV
hCoV-19/England/MILK-A6B31F/2020	EPI_ISL_608700	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A6B388/2020	EPI_ISL_608710	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A6BC32/2020	EPI_ISL_608721	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A69C70/2020	EPI_ISL_608742	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6BACF/2020	EPI_ISL_608743	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A6B2E5/2020	EPI_ISL_608744	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-A69EC5/2020	EPI_ISL_608751	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A6BA74/2020	EPI_ISL_608755	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6B4A3/2020	EPI_ISL_608757	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/204161206/2020	EPI_ISL_609853	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.56	GV
hCoV-19/England/204190389/2020	EPI_ISL_609858	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/CAMC-A81146/2020	EPI_ISL_610881	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A8295C/2020	EPI_ISL_610916	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A9287A/2020	EPI_ISL_610926	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A92C14/2020	EPI_ISL_610934	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A928E3/2020	EPI_ISL_610938	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A92DD5/2020	EPI_ISL_610946	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A93B07/2020	EPI_ISL_610951	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A93994/2020	EPI_ISL_610963	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A96E65/2020	EPI_ISL_610966	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A92DF3/2020	EPI_ISL_610967	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A92397/2020	EPI_ISL_610979	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A93EC2/2020	EPI_ISL_610981	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A92D02/2020	EPI_ISL_610986	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A9294A/2020	EPI_ISL_610987	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A92607/2020	EPI_ISL_610994	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/PHWC-4817D1/2020	EPI_ISL_613111	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.2	GV
hCoV-19/Wales/PHWC-4817FF/2020	EPI_ISL_613113	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-4818FC/2020	EPI_ISL_613123	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4819BD/2020	EPI_ISL_613131	2020-10-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4819DB/2020	EPI_ISL_613133	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-481AE7/2020	EPI_ISL_613144	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-481CF0/2020	EPI_ISL_613164	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-481E27/2020	EPI_ISL_613176	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-481F9D/2020	EPI_ISL_613190	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-481FD9/2020	EPI_ISL_613191	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-48203F/2020	EPI_ISL_613194	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-482354/2020	EPI_ISL_613214	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-482433/2020	EPI_ISL_613219	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-482CE0/2020	EPI_ISL_613280	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/PORT-2D465C/2020	EPI_ISL_613288	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Denmark/DCGC-7428/2020	EPI_ISL_619335	2020-10-12	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.177.4	GV
hCoV-19/New Zealand/20CV0487/2020	EPI_ISL_622819	2020-10-22	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.177.4	GV
hCoV-19/New Zealand/20CV0511/2020	EPI_ISL_622832	2020-10-29	Oceania / New Zealand / Counties Manukau	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.177.4	GV
hCoV-19/England/ALDP-AA571D/2020	EPI_ISL_625093	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA5513/2020	EPI_ISL_625094	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA2C11/2020	EPI_ISL_625096	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA564D/2020	EPI_ISL_625097	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA0E59/2020	EPI_ISL_625099	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA119B/2020	EPI_ISL_625110	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA52FE/2020	EPI_ISL_625116	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA53DD/2020	EPI_ISL_625124	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA5531/2020	EPI_ISL_625125	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA0BDA/2020	EPI_ISL_625134	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-AA5328/2020	EPI_ISL_625157	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA3F44/2020	EPI_ISL_625164	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA0D5C/2020	EPI_ISL_625169	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA57C2/2020	EPI_ISL_625177	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA55E6/2020	EPI_ISL_625189	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA0AA0/2020	EPI_ISL_625194	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA4AE8/2020	EPI_ISL_625201	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-AA530A/2020	EPI_ISL_625255	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2CC6/2020	EPI_ISL_625261	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-A85160/2020	EPI_ISL_625268	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-A8517F/2020	EPI_ISL_625269	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-A85810/2020	EPI_ISL_625271	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/ALDP-A85115/2020	EPI_ISL_625272	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-A851D9/2020	EPI_ISL_625273	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-A85151/2020	EPI_ISL_625279	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/CAMC-A82ED5/2020	EPI_ISL_625294	2020-10-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/CAMC-A81D24/2020	EPI_ISL_625296	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/NOTT-1196A7/2020	EPI_ISL_627710	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-1196F2/2020	EPI_ISL_627713	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11973B/2020	EPI_ISL_627715	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1197B3/2020	EPI_ISL_627716	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1199F9/2020	EPI_ISL_627718	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-119BD5/2020	EPI_ISL_627727	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-4837EE/2020	EPI_ISL_627859	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-AAF582/2020	EPI_ISL_631001	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AAF75F/2020	EPI_ISL_631003	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AAF652/2020	EPI_ISL_631005	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-ABC018/2020	EPI_ISL_631006	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AC5D24/2020	EPI_ISL_631018	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ABBBFA/2020	EPI_ISL_631020	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ABBC33/2020	EPI_ISL_631022	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ABC2E5/2020	EPI_ISL_631024	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AAF6E9/2020	EPI_ISL_631025	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ABC28B/2020	EPI_ISL_631029	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ABC34C/2020	EPI_ISL_631034	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-AAF801/2020	EPI_ISL_631039	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ABB574/2020	EPI_ISL_631040	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AC5E5E/2020	EPI_ISL_631046	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-AC12ED/2020	EPI_ISL_631050	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AAF643/2020	EPI_ISL_631062	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AC12CF/2020	EPI_ISL_631074	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ABC32E/2020	EPI_ISL_631076	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ABC41C/2020	EPI_ISL_631082	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/ALDP-ABD2B7/2020	EPI_ISL_631089	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE287B/2020	EPI_ISL_633501	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE1CAD/2020	EPI_ISL_633502	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AE29F0/2020	EPI_ISL_633509	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AE3160/2020	EPI_ISL_633510	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AE1F1D/2020	EPI_ISL_633533	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE2FC1/2020	EPI_ISL_633542	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE1A85/2020	EPI_ISL_633546	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE2B27/2020	EPI_ISL_633600	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE324F/2020	EPI_ISL_633602	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE2CD9/2020	EPI_ISL_633606	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AE1EF2/2020	EPI_ISL_633607	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE28D5/2020	EPI_ISL_633608	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE2C9D/2020	EPI_ISL_633614	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE2820/2020	EPI_ISL_633617	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE27D8/2020	EPI_ISL_633629	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE1B55/2020	EPI_ISL_633630	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AE2398/2020	EPI_ISL_633635	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE27E7/2020	EPI_ISL_633639	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE200A/2020	EPI_ISL_633641	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE3054/2020	EPI_ISL_633661	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE2DE5/2020	EPI_ISL_633669	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AE2969/2020	EPI_ISL_633672	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE2987/2020	EPI_ISL_633679	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AE291E/2020	EPI_ISL_633680	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AE226E/2020	EPI_ISL_633683	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/204241546/2020	EPI_ISL_637115	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/204241547/2020	EPI_ISL_637116	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/204361198/2020	EPI_ISL_637120	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/204390077/2020	EPI_ISL_637129	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204393675/2020	EPI_ISL_637149	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/204481931/2020	EPI_ISL_637161	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204481933/2020	EPI_ISL_637162	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204481935/2020	EPI_ISL_637163	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204481936/2020	EPI_ISL_637164	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204481937/2020	EPI_ISL_637165	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204481938/2020	EPI_ISL_637166	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204481940/2020	EPI_ISL_637167	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204520186/2020	EPI_ISL_637181	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/CAMC-9DF3DB/2020	EPI_ISL_638404	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/CAMC-9DF3EA/2020	EPI_ISL_638405	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/CAMC-9DF4E7/2020	EPI_ISL_638408	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/CAMC-9DF502/2020	EPI_ISL_638409	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/CAMC-9DF520/2020	EPI_ISL_638410	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/CAMC-9DF836/2020	EPI_ISL_638426	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/MILK-A7DE55/2020	EPI_ISL_638480	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-A7E461/2020	EPI_ISL_638487	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-A7E4DA/2020	EPI_ISL_638490	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-A7E4E9/2020	EPI_ISL_638491	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-A7E4F8/2020	EPI_ISL_638492	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-A91073/2020	EPI_ISL_638502	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-A910EC/2020	EPI_ISL_638503	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/MILK-A91134/2020	EPI_ISL_638505	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-A9126E/2020	EPI_ISL_638516	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-A9129B/2020	EPI_ISL_638518	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-F3932/2020	EPI_ISL_638583	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/NOTT-114D5C/2020	EPI_ISL_638584	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1163D0/2020	EPI_ISL_638585	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-119513/2020	EPI_ISL_638586	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11A08A/2020	EPI_ISL_638587	2020-11-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11A1A5/2020	EPI_ISL_638591	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11A433/2020	EPI_ISL_638592	2020-11-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11A503/2020	EPI_ISL_638593	2020-11-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11A5C7/2020	EPI_ISL_638594	2020-11-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11A6C4/2020	EPI_ISL_638595	2020-11-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11A6F1/2020	EPI_ISL_638596	2020-11-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11A934/2020	EPI_ISL_638597	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11A961/2020	EPI_ISL_638599	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/Ireland/SO-NVRL-73IRL20048/2020	EPI_ISL_639833	2020-09-04	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177	GV
hCoV-19/Ireland/SO-NVRL-73IRL20020/2020	EPI_ISL_639836	2020-09-04	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177	GV
hCoV-19/Ireland/SO-NVRL-73IRL20015/2020	EPI_ISL_639838	2020-09-04	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177	GV
hCoV-19/Ireland/SO-NVRL-73IRL69650/2020	EPI_ISL_639846	2020-09-13	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.57	GV
hCoV-19/Ireland/CN-NVRL-20IRL82667/2020	EPI_ISL_639890	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/CN-NVRL-20IRL82773/2020	EPI_ISL_639891	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-20IRL51127/2020	EPI_ISL_639894	2020-09-30	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/England/MILK-B026D4/2020	EPI_ISL_643003	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-B023A0/2020	EPI_ISL_643014	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B061DF/2020	EPI_ISL_643024	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-B02D0C/2020	EPI_ISL_643030	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8C15A/2020	EPI_ISL_643053	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A8BA6F/2020	EPI_ISL_643054	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A8BFD9/2020	EPI_ISL_643059	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8B892/2020	EPI_ISL_643065	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8B4F8/2020	EPI_ISL_643069	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A8B4E9/2020	EPI_ISL_643071	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A8BC78/2020	EPI_ISL_643079	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8BB8A/2020	EPI_ISL_643089	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B3E51E/2020	EPI_ISL_645508	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B3D227/2020	EPI_ISL_645513	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B3608E/2020	EPI_ISL_645514	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1D0F6/2020	EPI_ISL_645609	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1BC21/2020	EPI_ISL_645613	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B1C3FE/2020	EPI_ISL_645627	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1C552/2020	EPI_ISL_645636	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B1A554/2020	EPI_ISL_645637	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1B9DF/2020	EPI_ISL_645646	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B1B0BC/2020	EPI_ISL_645647	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B1C5AD/2020	EPI_ISL_645662	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B1C5BC/2020	EPI_ISL_645674	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B1CCE4/2020	EPI_ISL_645676	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1B605/2020	EPI_ISL_645679	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1B061/2020	EPI_ISL_645680	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1A0CC/2020	EPI_ISL_645692	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B1BA90/2020	EPI_ISL_645694	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B23910/2020	EPI_ISL_646812	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B241DB/2020	EPI_ISL_646817	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B24223/2020	EPI_ISL_646830	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B2496A/2020	EPI_ISL_646836	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B24690/2020	EPI_ISL_646844	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B237E9/2020	EPI_ISL_646856	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2DD56/2020	EPI_ISL_646902	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B2392F/2020	EPI_ISL_646904	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B23B1A/2020	EPI_ISL_646910	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B23A1D/2020	EPI_ISL_646913	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B2D7D0/2020	EPI_ISL_646915	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2D7EF/2020	EPI_ISL_646921	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B24302/2020	EPI_ISL_646926	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B24830/2020	EPI_ISL_646927	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2D80A/2020	EPI_ISL_646929	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B249E2/2020	EPI_ISL_646932	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B242C9/2020	EPI_ISL_646933	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2DBF2/2020	EPI_ISL_646936	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B246AF/2020	EPI_ISL_646940	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B245A2/2020	EPI_ISL_646952	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B23752/2020	EPI_ISL_646954	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B2491F/2020	EPI_ISL_646980	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B24311/2020	EPI_ISL_646982	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B24821/2020	EPI_ISL_646994	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B2ECC1/2020	EPI_ISL_646996	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B236A0/2020	EPI_ISL_646997	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B48353/2020	EPI_ISL_649221	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B48FAA/2020	EPI_ISL_649223	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B49404/2020	EPI_ISL_649227	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B50A17/2020	EPI_ISL_649234	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B48784/2020	EPI_ISL_649241	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B48FB9/2020	EPI_ISL_649247	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B485D5/2020	EPI_ISL_649250	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B50CE4/2020	EPI_ISL_649252	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B47DFC/2020	EPI_ISL_649260	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A9FFC3/2020	EPI_ISL_652698	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-AA0026/2020	EPI_ISL_652701	2020-10-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-AA0053/2020	EPI_ISL_652703	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-AA04EE/2020	EPI_ISL_652709	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-AAA89D/2020	EPI_ISL_652715	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-AAA9A9/2020	EPI_ISL_652724	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AAA9C7/2020	EPI_ISL_652726	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-AAABFE/2020	EPI_ISL_652733	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-AAADAD/2020	EPI_ISL_652742	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-AAADE9/2020	EPI_ISL_652744	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-AAAE04/2020	EPI_ISL_652745	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-AAAE6E/2020	EPI_ISL_652750	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-AAAEF5/2020	EPI_ISL_652754	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAAF10/2020	EPI_ISL_652755	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AAB1EC/2020	EPI_ISL_652777	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-AAB4D4/2020	EPI_ISL_652795	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-AAC628/2020	EPI_ISL_652861	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Scotland/QEUH-AACB1A/2020	EPI_ISL_652896	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B69C33/2020	EPI_ISL_655012	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B68548/2020	EPI_ISL_655031	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B69F1C/2020	EPI_ISL_655035	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6BEA4/2020	EPI_ISL_655049	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B67D9C/2020	EPI_ISL_655066	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B4703F/2020	EPI_ISL_656260	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B47011/2020	EPI_ISL_656263	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B46601/2020	EPI_ISL_656277	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B465AA/2020	EPI_ISL_656278	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B45FE9/2020	EPI_ISL_656295	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B45CE2/2020	EPI_ISL_656306	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B45F34/2020	EPI_ISL_656307	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B45B21/2020	EPI_ISL_656322	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B46AE7/2020	EPI_ISL_656343	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B637ED/2020	EPI_ISL_656346	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B628AF/2020	EPI_ISL_656348	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B634E6/2020	EPI_ISL_656366	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B63A99/2020	EPI_ISL_656379	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B626C3/2020	EPI_ISL_656391	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B56228/2020	EPI_ISL_657503	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-B52C88/2020	EPI_ISL_657597	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B565E3/2020	EPI_ISL_657602	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B56237/2020	EPI_ISL_657605	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-B5646E/2020	EPI_ISL_657631	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B556C3/2020	EPI_ISL_657644	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B53258/2020	EPI_ISL_657664	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B52A33/2020	EPI_ISL_657690	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B52F9E/2020	EPI_ISL_657691	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B52A15/2020	EPI_ISL_657698	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B394DA/2020	EPI_ISL_658827	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B3820E/2020	EPI_ISL_658914	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B38356/2020	EPI_ISL_658915	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B387B4/2020	EPI_ISL_658950	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B38417/2020	EPI_ISL_658962	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B38B8B/2020	EPI_ISL_658965	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B3870F/2020	EPI_ISL_658983	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B3A5C7/2020	EPI_ISL_658985	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B38C97/2020	EPI_ISL_658997	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B6925F/2020	EPI_ISL_662040	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-B73FD3/2020	EPI_ISL_662047	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B7496B/2020	EPI_ISL_662057	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B68DB9/2020	EPI_ISL_662059	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B744F1/2020	EPI_ISL_662060	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B74C80/2020	EPI_ISL_662067	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B673A9/2020	EPI_ISL_662083	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B66EB8/2020	EPI_ISL_662088	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B752C9/2020	EPI_ISL_662093	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B74707/2020	EPI_ISL_662108	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B74D6F/2020	EPI_ISL_662116	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B742AC/2020	EPI_ISL_662120	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B74C71/2020	EPI_ISL_662123	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B74DD8/2020	EPI_ISL_662124	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B74682/2020	EPI_ISL_662140	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B751BD/2020	EPI_ISL_662143	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B73FA6/2020	EPI_ISL_662146	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6891F/2020	EPI_ISL_662153	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-B685FD/2020	EPI_ISL_662155	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B74752/2020	EPI_ISL_662156	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B752F6/2020	EPI_ISL_662167	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B68F68/2020	EPI_ISL_662172	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-B691CB/2020	EPI_ISL_662180	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B74CEA/2020	EPI_ISL_662181	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B74761/2020	EPI_ISL_662191	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B74DE7/2020	EPI_ISL_662214	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B75557/2020	EPI_ISL_662215	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B7445B/2020	EPI_ISL_662218	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B75180/2020	EPI_ISL_662219	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B74691/2020	EPI_ISL_662227	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B74C53/2020	EPI_ISL_662228	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1CA71/2020	EPI_ISL_664843	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-B1CC4E/2020	EPI_ISL_664849	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-B1D0C9/2020	EPI_ISL_664854	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-B73CCD/2020	EPI_ISL_664881	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B73D06/2020	EPI_ISL_664882	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B73F88/2020	EPI_ISL_664898	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B74039/2020	EPI_ISL_664899	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B7E8DD/2020	EPI_ISL_668253	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B77D4E/2020	EPI_ISL_668254	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B80692/2020	EPI_ISL_668256	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B7776E/2020	EPI_ISL_668319	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B7F65A/2020	EPI_ISL_668350	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B77FDF/2020	EPI_ISL_668353	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B80638/2020	EPI_ISL_668367	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B78123/2020	EPI_ISL_668373	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Ireland/D-NVRL-75IRL26026/2020	EPI_ISL_671884	2020-10-07	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-75IRL68622/2020	EPI_ISL_671889	2020-10-12	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/D-NVRL-75IRL75521/2020	EPI_ISL_671890	2020-10-13	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/D-NVRL-75IRL77394/2020	EPI_ISL_671894	2020-10-13	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/G-NVRL-75IRL71302/2020	EPI_ISL_671902	2020-10-12	Europe / Ireland / Galway	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KY-NVRL-75IRL32742/2020	EPI_ISL_671909	2020-10-07	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KY-NVRL-75IRL93222/2020	EPI_ISL_671910	2020-10-14	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/LH-NVRL-75IRL19162/2020	EPI_ISL_671911	2020-10-06	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/LK-NVRL-75IRL23376/2020	EPI_ISL_671915	2020-10-06	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/LK-NVRL-75IRL23491/2020	EPI_ISL_671916	2020-10-06	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/LK-NVRL-75IRL32487/2020	EPI_ISL_671919	2020-10-07	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/LK-NVRL-75IRL32488/2020	EPI_ISL_671920	2020-10-07	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/LS-NVRL-75IRL79312/2020	EPI_ISL_671922	2020-10-13	Europe / Ireland / Laois	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LS-NVRL-75IRL79332/2020	EPI_ISL_671923	2020-10-13	Europe / Ireland / Laois	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/MO-NVRL-75IRL73163/2020	EPI_ISL_671924	2020-10-12	Europe / Ireland / Mayo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/OY-NVRL-75IRL90286/2020	EPI_ISL_671927	2020-10-14	Europe / Ireland / Offaly	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/RN-NVRL-75IRL84062/2020	EPI_ISL_671929	2020-10-13	Europe / Ireland / Roscommon	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/SO-NVRL-75IRL23335/2020	EPI_ISL_671930	2020-10-06	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/TA-NVRL-75IRL33036/2020	EPI_ISL_671931	2020-10-07	Europe / Ireland / Tipperary	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/WH-NVRL-75IRL28485/2020	EPI_ISL_671934	2020-10-07	Europe / Ireland / Westmeath	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/WX-NVRL-75IRL33947/2020	EPI_ISL_671938	2020-10-07	Europe / Ireland / Wexford	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/England/MILK-B8D5B6/2020	EPI_ISL_674014	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B85F29/2020	EPI_ISL_674048	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B8E6A3/2020	EPI_ISL_674049	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B860BC/2020	EPI_ISL_674059	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B85DC5/2020	EPI_ISL_674063	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8E667/2020	EPI_ISL_674075	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B85EE0/2020	EPI_ISL_674101	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8E755/2020	EPI_ISL_674120	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B8E843/2020	EPI_ISL_674132	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8E7CE/2020	EPI_ISL_674135	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8E728/2020	EPI_ISL_674151	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B8440D/2020	EPI_ISL_674161	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-B8C326/2020	EPI_ISL_674167	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B83DB8/2020	EPI_ISL_674168	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B853F0/2020	EPI_ISL_674170	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B8527B/2020	EPI_ISL_674176	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B851D8/2020	EPI_ISL_674177	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B85211/2020	EPI_ISL_674179	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8C308/2020	EPI_ISL_674187	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B84BF9/2020	EPI_ISL_674188	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B88506/2020	EPI_ISL_674200	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B83FA3/2020	EPI_ISL_674206	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B85457/2020	EPI_ISL_674222	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B83E00/2020	EPI_ISL_675356	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B841CA/2020	EPI_ISL_675360	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B8429A/2020	EPI_ISL_675387	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B83705/2020	EPI_ISL_675405	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B857E5/2020	EPI_ISL_675414	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8F208/2020	EPI_ISL_675417	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B836AE/2020	EPI_ISL_675426	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B84528/2020	EPI_ISL_675427	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8F095/2020	EPI_ISL_675432	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B857B8/2020	EPI_ISL_675437	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B83662/2020	EPI_ISL_675445	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B84106/2020	EPI_ISL_675457	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B835CF/2020	EPI_ISL_675460	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B89FBC/2020	EPI_ISL_675504	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B89D85/2020	EPI_ISL_675518	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B83213/2020	EPI_ISL_675529	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B92493/2020	EPI_ISL_675546	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B74EA8/2020	EPI_ISL_679001	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/BIRM-69F9F/2020	EPI_ISL_679009	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/BIRM-6A07D/2020	EPI_ISL_679017	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/BIRM-6A1E3/2020	EPI_ISL_679028	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A01B04/2020	EPI_ISL_680006	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/QEUH-B2D06C/2020	EPI_ISL_680098	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-48FDE0/2020	EPI_ISL_681231	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-48FE65/2020	EPI_ISL_681239	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-48FF9F/2020	EPI_ISL_681257	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-BAA9C6/2020	EPI_ISL_681327	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BA9E40/2020	EPI_ISL_681331	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAB97A/2020	EPI_ISL_681336	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB50F0/2020	EPI_ISL_702007	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB5403/2020	EPI_ISL_702008	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BD13AA/2020	EPI_ISL_702028	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BD2A0E/2020	EPI_ISL_702032	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BD2B56/2020	EPI_ISL_702067	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BD1E5E/2020	EPI_ISL_702080	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BD2172/2020	EPI_ISL_702087	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BD23A9/2020	EPI_ISL_702089	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BC3F3E/2020	EPI_ISL_703309	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BCA140/2020	EPI_ISL_703328	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-BCA5AE/2020	EPI_ISL_703333	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-BCA386/2020	EPI_ISL_703365	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCA517/2020	EPI_ISL_703368	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BC4270/2020	EPI_ISL_703371	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-BC44F2/2020	EPI_ISL_703382	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCA210/2020	EPI_ISL_703388	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BCA447/2020	EPI_ISL_703394	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCA614/2020	EPI_ISL_703404	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-BCB798/2020	EPI_ISL_704667	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/LIVE-DC4690/2020	EPI_ISL_705901	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DC46DC/2020	EPI_ISL_705904	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DC677D/2020	EPI_ISL_705922	2020-11-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/LIVE-DC6A1A/2020	EPI_ISL_705923	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/LOND-1251B82/2020	EPI_ISL_705951	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/LOND-12646C7/2020	EPI_ISL_705970	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-A91644/2020	EPI_ISL_705972	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-A91705/2020	EPI_ISL_705977	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-A917F6/2020	EPI_ISL_705988	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Norway/5796/2020	EPI_ISL_708177	2020-11-09	Europe / Norway / Vestland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/England/ALDP-C069D6/2020	EPI_ISL_709448	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C15FF0/2020	EPI_ISL_709456	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-C17F0D/2020	EPI_ISL_709469	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C06587/2020	EPI_ISL_709477	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C14E8B/2020	EPI_ISL_709502	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C06402/2020	EPI_ISL_709519	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C05FF3/2020	EPI_ISL_709563	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BDC309/2020	EPI_ISL_709577	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-14411/2020	EPI_ISL_711752	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-14434/2020	EPI_ISL_711764	2020-11-30	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-14612/2020	EPI_ISL_711871	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-14637/2020	EPI_ISL_711885	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-15771/2020	EPI_ISL_714012	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-15842/2020	EPI_ISL_714055	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/QEUH-B9FD9B/2020	EPI_ISL_721126	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B9FBBF/2020	EPI_ISL_721128	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B9FAEF/2020	EPI_ISL_721138	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B9F91F/2020	EPI_ISL_721165	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B9F33F/2020	EPI_ISL_721177	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC6584/2020	EPI_ISL_721203	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BC8519/2020	EPI_ISL_721221	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BC6575/2020	EPI_ISL_721225	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC7AC0/2020	EPI_ISL_721229	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BC645A/2020	EPI_ISL_721271	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC61AE/2020	EPI_ISL_721275	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC65C0/2020	EPI_ISL_721276	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Netherlands/ZH-EMC-985/2020	EPI_ISL_722555	2020-10-26	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/England/ALDP-B75D6E/2020	EPI_ISL_723701	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B75DAA/2020	EPI_ISL_723703	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-B75DB9/2020	EPI_ISL_723704	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B75DE6/2020	EPI_ISL_723705	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B75E01/2020	EPI_ISL_723707	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B75EE3/2020	EPI_ISL_723715	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B75FB3/2020	EPI_ISL_723719	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/ALDP-B75FD1/2020	EPI_ISL_723721	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B75FE0/2020	EPI_ISL_723722	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-B76028/2020	EPI_ISL_723725	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B760EC/2020	EPI_ISL_723732	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-B76107/2020	EPI_ISL_723734	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B7618F/2020	EPI_ISL_723741	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B761BC/2020	EPI_ISL_723743	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B7625F/2020	EPI_ISL_723748	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/ALDP-B76301/2020	EPI_ISL_723754	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-B7633E/2020	EPI_ISL_723757	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/ALDP-B76741/2020	EPI_ISL_723777	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B7691E/2020	EPI_ISL_723785	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B7694B/2020	EPI_ISL_723786	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/ALDP-B76A0C/2020	EPI_ISL_723797	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B76A66/2020	EPI_ISL_723800	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-B76CE8/2020	EPI_ISL_723804	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-B76D7C/2020	EPI_ISL_723810	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B76DE5/2020	EPI_ISL_723814	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-B76E00/2020	EPI_ISL_723816	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B76EC4/2020	EPI_ISL_723824	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B76EF1/2020	EPI_ISL_723826	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/ALDP-B76F76/2020	EPI_ISL_723832	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B76FA3/2020	EPI_ISL_723833	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B77009/2020	EPI_ISL_723838	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-493F2F/2020	EPI_ISL_726041	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-499457/2020	EPI_ISL_727306	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-499651/2020	EPI_ISL_727336	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4999A3/2020	EPI_ISL_727383	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-499A28/2020	EPI_ISL_727390	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-499A73/2020	EPI_ISL_727395	2020-12-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Netherlands/FR-RIVM-20386/2020	EPI_ISL_728606	2020-12-07	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/UT-RIVM-20409/2020	EPI_ISL_728629	2020-12-07	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/England/ALDP-C3B7CF/2020	EPI_ISL_730927	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3D077/2020	EPI_ISL_730933	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3C8F8/2020	EPI_ISL_730943	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3C4E5/2020	EPI_ISL_730946	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3D94F/2020	EPI_ISL_730953	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3BDBE/2020	EPI_ISL_730963	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3CD35/2020	EPI_ISL_730965	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-C3C7A0/2020	EPI_ISL_730979	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3D4F3/2020	EPI_ISL_730981	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3C8CB/2020	EPI_ISL_730982	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3CAE3/2020	EPI_ISL_730997	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Belgium/rega-10191281/2020	EPI_ISL_734499	2020-10-19	Europe / Belgium / Berg	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.77	GV
hCoV-19/England/MILK-C63AB6/2020	EPI_ISL_735745	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/MILK-C61CD0/2020	EPI_ISL_735758	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C61F04/2020	EPI_ISL_735807	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C63B0E/2020	EPI_ISL_735814	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C615C6/2020	EPI_ISL_735844	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C585B3/2020	EPI_ISL_735888	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Luxembourg/LNS3219758/2020	EPI_ISL_740276	2020-11-12	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS3274577/2020	EPI_ISL_740281	2020-11-05	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS3355829/2020	EPI_ISL_740296	2020-10-23	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS3488904/2020	EPI_ISL_740316	2020-10-20	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS3533793/2020	EPI_ISL_740329	2020-10-27	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS3591441/2020	EPI_ISL_740340	2020-10-23	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS3712604/2020	EPI_ISL_740364	2020-11-02	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/England/NORW-22307E/2020	EPI_ISL_741558	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-22322D/2020	EPI_ISL_741574	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-22323C/2020	EPI_ISL_741575	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-22324B/2020	EPI_ISL_741576	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NOTT-11EA2E/2020	EPI_ISL_741611	2020-11-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11EE04/2020	EPI_ISL_741612	2020-12-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1209A4/2020	EPI_ISL_741614	2020-12-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-120F93/2020	EPI_ISL_741621	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-120FC0/2020	EPI_ISL_741622	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-121017/2020	EPI_ISL_741623	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121123/2020	EPI_ISL_741626	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1212C6/2020	EPI_ISL_741630	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-12141B/2020	EPI_ISL_741632	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121439/2020	EPI_ISL_741634	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121475/2020	EPI_ISL_741638	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121518/2020	EPI_ISL_741639	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1215FA/2020	EPI_ISL_741644	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121606/2020	EPI_ISL_741645	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-121707/2020	EPI_ISL_741647	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121716/2020	EPI_ISL_741649	2020-12-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121729/2020	EPI_ISL_741651	2020-12-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121792/2020	EPI_ISL_741656	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-49E285/2020	EPI_ISL_742977	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Denmark/DCGC-17465/2020	EPI_ISL_751000	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-17480/2020	EPI_ISL_751012	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-17527/2020	EPI_ISL_751044	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-17534/2020	EPI_ISL_751050	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-17559/2020	EPI_ISL_751069	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-21882/2020	EPI_ISL_758429	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-22144/2020	EPI_ISL_758582	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/ALDP-CB4773/2020	EPI_ISL_760868	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-CB470A/2020	EPI_ISL_760887	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-CB3D09/2020	EPI_ISL_760890	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234AC7/2020	EPI_ISL_764387	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234B2E/2020	EPI_ISL_764389	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234B5B/2020	EPI_ISL_764390	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234B6A/2020	EPI_ISL_764391	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234B79/2020	EPI_ISL_764392	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234CC1/2020	EPI_ISL_764393	2020-10-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234D91/2020	EPI_ISL_764395	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234DFB/2020	EPI_ISL_764396	2020-10-23	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-234E16/2020	EPI_ISL_764397	2020-10-23	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234E34/2020	EPI_ISL_764398	2020-10-23	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/CAMC-C709E6/2020	EPI_ISL_769110	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-C75495/2020	EPI_ISL_769120	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C71C28/2020	EPI_ISL_769168	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-C72234/2020	EPI_ISL_769192	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C71DCB/2020	EPI_ISL_769199	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-C71C73/2020	EPI_ISL_769211	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C70CED/2020	EPI_ISL_769213	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.60	GV
hCoV-19/England/ALDP-C8C501/2020	EPI_ISL_777573	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-C9847E/2020	EPI_ISL_777578	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C8E709/2020	EPI_ISL_777634	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-CB7840/2020	EPI_ISL_777689	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	G
hCoV-19/England/QEUH-CC98E1/2020	EPI_ISL_782074	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-CF2973/2020	EPI_ISL_782139	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CCDDB1/2020	EPI_ISL_782156	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q76stop results in 38.0% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-CDEA89/2020	EPI_ISL_782182	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B7868E/2020	EPI_ISL_783409	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B787B8/2020	EPI_ISL_783419	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B78B52/2020	EPI_ISL_783421	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B788A6/2020	EPI_ISL_783451	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B77DE4/2020	EPI_ISL_783456	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B77AB0/2020	EPI_ISL_783495	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B78642/2020	EPI_ISL_783496	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B786BB/2020	EPI_ISL_783499	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B77E4B/2020	EPI_ISL_783507	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B777B9/2020	EPI_ISL_783510	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B77F75/2020	EPI_ISL_783523	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Netherlands/FR-RIVM-20559/2020	EPI_ISL_790644	2020-12-15	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Denmark/DCGC-24271/2020	EPI_ISL_795448	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-24281/2020	EPI_ISL_795454	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Norway/7118/2020	EPI_ISL_796705	2020-12-21	Europe / Norway / Vestfold og Telemark	Human	Original	Nasopharyngeal swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.177.57	GV
hCoV-19/England/ALDP-D9E1AD/2020	EPI_ISL_796809	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CE23A5/2020	EPI_ISL_800474	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-25633/2021	EPI_ISL_818573	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-25645/2021	EPI_ISL_818578	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/NOTT-121751/2020	EPI_ISL_819800	2020-12-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121752/2020	EPI_ISL_819801	2020-12-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121754/2020	EPI_ISL_819802	2020-12-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/OXON-F416F3/2020	EPI_ISL_819803	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/OXON-F43DDE/2020	EPI_ISL_819813	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/NOTT-121764/2020	EPI_ISL_819830	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121767/2020	EPI_ISL_819832	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121768/2020	EPI_ISL_819833	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121769/2020	EPI_ISL_819834	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/OXON-F41936/2020	EPI_ISL_819837	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/OXON-F42C1E/2020	EPI_ISL_819844	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-EB8AA1/2021	EPI_ISL_820869	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/Wales/PHWC-4A9F44/2020	EPI_ISL_823198	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A9F53/2020	EPI_ISL_823199	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/ALDP-EE90C3/2021	EPI_ISL_835089	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ECE04C/2021	EPI_ISL_836390	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMB-A9A12C/2021	EPI_ISL_837844	2021-01-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-10C66B6/2021	EPI_ISL_842208	2021-01-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Denmark/DCGC-29472/2021	EPI_ISL_843519	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-29503/2021	EPI_ISL_843550	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-29518/2021	EPI_ISL_843565	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Wales/ALDP-C8BA7C/2020	EPI_ISL_859023	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/QEUH-CC394E/2020	EPI_ISL_859152	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-CBE445/2020	EPI_ISL_859204	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Germany/NW-HHU-581/2020	EPI_ISL_861519	2020-12-16	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177.77	GV
hCoV-19/Germany/NW-HHU-583/2020	EPI_ISL_861521	2020-12-16	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177.77	GV
hCoV-19/Germany/NW-HHU-584/2020	EPI_ISL_861522	2020-12-16	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177.77	GV
hCoV-19/England/ALDP-1003C33/2021	EPI_ISL_863984	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/Scotland/CVR6547/2021	EPI_ISL_865043	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.77	GV
hCoV-19/Scotland/EDB12845/2021	EPI_ISL_865099	2021-01-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Northern Ireland/NIRE-2360F0/2021	EPI_ISL_866392	2021-01-04	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2361B1/2021	EPI_ISL_866398	2021-01-06	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS8_R52stop results in 57.9% truncation of the protein sequence.	info	V.2	GV
hCoV-19/Wales/PHWC-4B8CB4/2021	EPI_ISL_867515	2021-01-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4B97FE/2021	EPI_ISL_867679	2021-01-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/TFCI-26FEB44/2020	EPI_ISL_868810	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/TFCI-26FED6C/2020	EPI_ISL_868832	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Belgium/ULG-11317/2020	EPI_ISL_872060	2020-12-24	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/England/ALDP-100922C/2021	EPI_ISL_874813	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-100714F/2021	EPI_ISL_874816	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-106590B/2021	EPI_ISL_878236	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-1065947/2021	EPI_ISL_878315	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-1064EFE/2021	EPI_ISL_878328	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1035CDE/2021	EPI_ISL_879550	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-103106D/2021	EPI_ISL_880530	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-103059C/2021	EPI_ISL_880577	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-102F90D/2021	EPI_ISL_880620	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-102F1C9/2021	EPI_ISL_880697	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-FA27EE/2021	EPI_ISL_881941	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-FB54E1/2021	EPI_ISL_881972	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-10F89A3/2021	EPI_ISL_907205	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Ireland/D-NVRL-83IRL57276/2021	EPI_ISL_909940	2021-01-14	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/RN-NVRL-21IRL19491/2021	EPI_ISL_909945	2021-01-20	Europe / Ireland / Roscommon	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Belgium/AZDelta-2103154042021/2021	EPI_ISL_909963	2021-01-20	Europe / Belgium / Kortemark	Human	Original			Illumina MiSeq		Insertion of 8 nucleotides when compared to the reference sequence.	info	B.1.177.77	GV
hCoV-19/Luxembourg/LNS2555001/2020	EPI_ISL_910802	2020-12-11	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS6573689/2020	EPI_ISL_910808	2020-12-11	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177	GV
hCoV-19/Luxembourg/LNS8289725/2020	EPI_ISL_910854	2020-12-12	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS7357845/2020	EPI_ISL_910989	2020-12-13	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Spain/CE-ISCIII-210078/2021	EPI_ISL_913055	2021-01-05	Europe / Spain / Ceuta	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.177	GV
hCoV-19/England/ALDP-BC974F/2020	EPI_ISL_915626	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BC9B9E/2020	EPI_ISL_915629	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BC918D/2020	EPI_ISL_915632	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BC9712/2020	EPI_ISL_915639	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BC919C/2020	EPI_ISL_915643	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC99C1/2020	EPI_ISL_915647	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BC9F29/2020	EPI_ISL_915648	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC9581/2020	EPI_ISL_915649	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BC9D3E/2020	EPI_ISL_915665	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC90CC/2020	EPI_ISL_915670	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BC9C04/2020	EPI_ISL_915674	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCB31C/2020	EPI_ISL_915682	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC981F/2020	EPI_ISL_915684	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC9202/2020	EPI_ISL_915695	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC6CF8/2020	EPI_ISL_915801	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BC70A0/2020	EPI_ISL_915804	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC832E/2020	EPI_ISL_915829	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-BC7019/2020	EPI_ISL_915856	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-100E588/2021	EPI_ISL_916978	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-10BAB01/2021	EPI_ISL_918050	2021-01-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.77	GV
hCoV-19/England/LOND-1324871/2020	EPI_ISL_920355	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/NORT-28E396/2020	EPI_ISL_921693	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Insertion of 2 nucleotide(s) found at refpos 28251 (Frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/Wales/PHWC-4BCB68/2021	EPI_ISL_922831	2021-01-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Denmark/DCGC-35251/2021	EPI_ISL_926391	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-36547/2021	EPI_ISL_927688	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-37814/2021	EPI_ISL_928955	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-37850/2021	EPI_ISL_928991	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/ALDP-11700F8/2021	EPI_ISL_932220	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-1182336/2021	EPI_ISL_932233	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-1143B2A/2021	EPI_ISL_932393	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-119C612/2021	EPI_ISL_945614	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-1195E20/2021	EPI_ISL_946846	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-1195AA4/2021	EPI_ISL_946944	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Belgium/Jessa_55-2103-000111/2021	EPI_ISL_949000	2021-01-18	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/Jessa_55-2103-000112/2021	EPI_ISL_949003	2021-01-18	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/Jessa_55-2103-000114/2021	EPI_ISL_949005	2021-01-18	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/Jessa_55-2103-000115/2021	EPI_ISL_949008	2021-01-18	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/Jessa_11-2103-003372/2021	EPI_ISL_949070	2021-01-19	Europe / Belgium / Genk	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/Jessa_11-2103-003992/2021	EPI_ISL_949071	2021-01-20	Europe / Belgium / Genk	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/Jessa_11-2103-006728/2021	EPI_ISL_949083	2021-01-21	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/Jessa_21-2103-006243/2021	EPI_ISL_949092	2021-01-21	Europe / Belgium / Heusden-Zolder	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/Jessa_55-2103-000103-2/2021	EPI_ISL_949095	2021-01-18	Europe / Belgium / Diepenbeek	Human	Original			Illumina MiSeq				B.1.177.50	GV
hCoV-19/Belgium/Jessa_55-2103-000533/2021	EPI_ISL_949117	2021-01-21	Europe / Belgium / Diepenbeek	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/Jessa_11-2104-000769/2021	EPI_ISL_949139	2021-01-25	Europe / Belgium / Heusden-Zolder	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/Jessa_55-2103-000968-RunCov7/2021	EPI_ISL_949150	2021-01-23	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/Jessa_55-2103-001107/2021	EPI_ISL_949153	2021-01-24	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/Jessa_55-2104-000116/2021	EPI_ISL_949170	2021-01-25	Europe / Belgium / Zonhoven	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/England/OXON-F50E9F/2021	EPI_ISL_951305	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina				U.1	GV
hCoV-19/England/OXON-F52A8A/2021	EPI_ISL_951337	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/OXON-F569B6/2021	EPI_ISL_951450	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina				U.1	GV
hCoV-19/England/ALDP-1197116/2021	EPI_ISL_958922	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-1199B43/2021	EPI_ISL_963434	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-11D5A99/2021	EPI_ISL_964793	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Denmark/DCGC-40279/2021	EPI_ISL_971956	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Spain/CT-HUVH-51136/2021	EPI_ISL_981330	2021-01-25	Europe / Spain / Catalunya	Human	Original			Illumina MiSeq				B.1.177	GV
hCoV-19/England/ALDP-1203132/2021	EPI_ISL_988791	2021-02-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/MILK-1089CAE/2021	EPI_ISL_993122	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-1089D23/2021	EPI_ISL_993174	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1068C0F/2021	EPI_ISL_994418	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-1066A70/2021	EPI_ISL_994487	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-1090A13/2021	EPI_ISL_994615	2021-01-15	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-1090AD7/2021	EPI_ISL_994626	2021-01-15	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Finland/HEL-12-92/2021	EPI_ISL_995934	2021-01-15	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.177	GV
hCoV-19/Finland/HEL-12-100/2021	EPI_ISL_995944	2021-01-15	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.177	GV
hCoV-19/Finland/HEL-12-59/2021	EPI_ISL_995947	2021-01-14	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.177	GV
hCoV-19/Finland/HEL-12-61/2021	EPI_ISL_995949	2021-01-14	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.177	GV
hCoV-19/Finland/HEL-12-77/2021	EPI_ISL_995962	2021-01-16	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.177	GV
hCoV-19/England/MILK-11C9B59/2021	EPI_ISL_998100	2021-01-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/OXON-F60676/2021	EPI_ISL_999459	2021-01-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-125509E/2021	EPI_ISL_1005925	2021-02-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-125C316/2021	EPI_ISL_1011870	2021-02-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/Netherlands/UT-RIVM-11921/2021	EPI_ISL_1014058	2021-02-02	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/UT-RIVM-11955/2021	EPI_ISL_1014082	2021-02-02	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/ZH-RIVM-11719/2021	EPI_ISL_1014356	2021-01-19	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/ZE-RIVM-11663/2021	EPI_ISL_1014366	2021-01-25	Europe / Netherlands / Zeeland	Human	Original			Nanopore MinION				B.1.177	G
hCoV-19/Netherlands/ZE-RIVM-11638/2021	EPI_ISL_1014368	2021-01-22	Europe / Netherlands / Zeeland	Human	Original			Nanopore MinION				B.1.177.54	GV
hCoV-19/Denmark/DCGC-42189/2021	EPI_ISL_1022467	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-42197/2021	EPI_ISL_1022475	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-42230/2021	EPI_ISL_1022508	2021-02-08	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-42259/2021	EPI_ISL_1022537	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-42264/2021	EPI_ISL_1022542	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-42273/2021	EPI_ISL_1022551	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/ALDP-129A710/2021	EPI_ISL_1042932	2021-02-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 13 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/Switzerland/ZH-ETHZ-461509/2021	EPI_ISL_1059799	2021-01-20	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Switzerland/ZH-ETHZ-471294/2021	EPI_ISL_1059825	2021-01-23	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Denmark/DCGC-46116/2020	EPI_ISL_1065626	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-46273/2020	EPI_ISL_1065783	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-46431/2020	EPI_ISL_1065941	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Belgium/ULG-12362/2021	EPI_ISL_1076429	2021-02-09	Europe / Belgium / Hainaut	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Finland/HEL-15-238/2021	EPI_ISL_1082179	2021-01-18	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.177	GV
hCoV-19/Netherlands/NB-RIVM-14063/2021	EPI_ISL_1089610	2021-02-10	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION		NS8_G50stop results in 59.5% truncation of the protein sequence.	info	B.1.177.77	GV
hCoV-19/Northern Ireland/QEUH-9639DA/2020	EPI_ISL_531568	2020-08-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Northern Ireland/QEUH-963257/2020	EPI_ISL_531608	2020-08-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/NOTT-1133C4/2020	EPI_ISL_549502	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11341C/2020	EPI_ISL_549503	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113449/2020	EPI_ISL_549505	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1134FE/2020	EPI_ISL_549509	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113555/2020	EPI_ISL_549512	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113582/2020	EPI_ISL_549515	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-9B862A/2020	EPI_ISL_549602	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B8C55/2020	EPI_ISL_549624	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B902B/2020	EPI_ISL_549642	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9B8851/2020	EPI_ISL_549661	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B9E03/2020	EPI_ISL_549798	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99D236/2020	EPI_ISL_550608	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99D9F5/2020	EPI_ISL_550621	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99DE50/2020	EPI_ISL_550630	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99DDDB/2020	EPI_ISL_550670	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-99C6C2/2020	EPI_ISL_550788	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9AACDE/2020	EPI_ISL_550798	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-991232/2020	EPI_ISL_551909	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.77	GV
hCoV-19/England/MILK-992714/2020	EPI_ISL_551929	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99292D/2020	EPI_ISL_551931	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99327C/2020	EPI_ISL_551968	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/MILK-993054/2020	EPI_ISL_551975	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99286C/2020	EPI_ISL_551976	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9AF0CE/2020	EPI_ISL_560025	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Scotland/QEUH-9B3F51/2020	EPI_ISL_560067	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-16A6B6/2020	EPI_ISL_560088	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16A953/2020	EPI_ISL_560129	2020-09-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16A980/2020	EPI_ISL_560132	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16A9F9/2020	EPI_ISL_560138	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16AA05/2020	EPI_ISL_560139	2020-09-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-9CD90B/2020	EPI_ISL_566115	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9CD947/2020	EPI_ISL_566123	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9CDF09/2020	EPI_ISL_566126	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9CCF82/2020	EPI_ISL_566137	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CE005/2020	EPI_ISL_566138	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9CD992/2020	EPI_ISL_566143	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9CDFDC/2020	EPI_ISL_566144	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9CCDE2/2020	EPI_ISL_566169	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9C9D5E/2020	EPI_ISL_567374	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9C9714/2020	EPI_ISL_567376	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9C9CBB/2020	EPI_ISL_567379	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9C9D8B/2020	EPI_ISL_567400	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9C99C3/2020	EPI_ISL_567408	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9CA731/2020	EPI_ISL_567471	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9CA8F2/2020	EPI_ISL_567474	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9CA40D/2020	EPI_ISL_567482	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9CA591/2020	EPI_ISL_567501	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/NOTT-1134B2/2020	EPI_ISL_573420	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113731/2020	EPI_ISL_573424	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11378C/2020	EPI_ISL_573427	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-1137AA/2020	EPI_ISL_573429	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1137D7/2020	EPI_ISL_573431	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1137E6/2020	EPI_ISL_573432	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113810/2020	EPI_ISL_573434	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11382F/2020	EPI_ISL_573435	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113A56/2020	EPI_ISL_573451	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113A83/2020	EPI_ISL_573453	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113AA1/2020	EPI_ISL_573455	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113ADE/2020	EPI_ISL_573456	2020-09-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113AED/2020	EPI_ISL_573457	2020-09-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/NOTT-113B26/2020	EPI_ISL_573459	2020-09-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113B35/2020	EPI_ISL_573460	2020-09-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113B71/2020	EPI_ISL_573462	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113BBD/2020	EPI_ISL_573465	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113C7E/2020	EPI_ISL_573470	2020-09-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113CAB/2020	EPI_ISL_573471	2020-09-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113CBA/2020	EPI_ISL_573472	2020-09-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113CF6/2020	EPI_ISL_573475	2020-09-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/MILK-97495E/2020	EPI_ISL_575961	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E715E/2020	EPI_ISL_580324	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-9EC696/2020	EPI_ISL_580327	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9E60AD/2020	EPI_ISL_580342	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E6ED0/2020	EPI_ISL_580347	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-9E6D79/2020	EPI_ISL_580350	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9E6FBF/2020	EPI_ISL_580357	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9E60F8/2020	EPI_ISL_580408	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E723D/2020	EPI_ISL_580426	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E631D/2020	EPI_ISL_580431	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E6B24/2020	EPI_ISL_580454	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/CAMC-9EC61E/2020	EPI_ISL_580459	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E71F4/2020	EPI_ISL_580473	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E6386/2020	EPI_ISL_580482	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E6070/2020	EPI_ISL_580489	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/20422146704/2020	EPI_ISL_584055	2020-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/ALDP-A2E011/2020	EPI_ISL_586602	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2DD57/2020	EPI_ISL_586603	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2D5F5/2020	EPI_ISL_586605	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2E0A8/2020	EPI_ISL_586606	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2DFBB/2020	EPI_ISL_586608	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2E7C1/2020	EPI_ISL_586614	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A2E7D0/2020	EPI_ISL_586616	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2D72C/2020	EPI_ISL_586619	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2E0C6/2020	EPI_ISL_586626	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2DABA/2020	EPI_ISL_586630	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A2DE27/2020	EPI_ISL_586634	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A2DEFA/2020	EPI_ISL_586635	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2D847/2020	EPI_ISL_586637	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2DEDC/2020	EPI_ISL_586657	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A2E5D6/2020	EPI_ISL_586663	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2E4CA/2020	EPI_ISL_586675	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A2DDA2/2020	EPI_ISL_586683	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2E3DC/2020	EPI_ISL_586711	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A2D07C/2020	EPI_ISL_586714	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2DDDF/2020	EPI_ISL_586721	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2DBA8/2020	EPI_ISL_586722	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2DC5A/2020	EPI_ISL_586730	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2DEBE/2020	EPI_ISL_586735	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A2E776/2020	EPI_ISL_586742	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2DC3C/2020	EPI_ISL_586749	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2D2A3/2020	EPI_ISL_586762	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2D56E/2020	EPI_ISL_586765	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2DD39/2020	EPI_ISL_586770	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD823/2020	EPI_ISL_587914	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FC903/2020	EPI_ISL_587935	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD665/2020	EPI_ISL_587938	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9FDC45/2020	EPI_ISL_587945	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD03A/2020	EPI_ISL_587963	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD5E0/2020	EPI_ISL_587965	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD42F/2020	EPI_ISL_587968	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD726/2020	EPI_ISL_587976	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9FCCFB/2020	EPI_ISL_587994	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Australia/NSW1106/2020	EPI_ISL_593721	2020-08-20	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.177	GV
hCoV-19/Wales/MILK-9EF9E5/2020	EPI_ISL_594966	2020-09-23	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.177.3	GV
hCoV-19/Scotland/QEUH-A4C7EB/2020	EPI_ISL_596001	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A4CB49/2020	EPI_ISL_596023	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A4CE04/2020	EPI_ISL_596058	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-A4CEE6/2020	EPI_ISL_596065	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-A57CA2/2020	EPI_ISL_597285	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A5DE00/2020	EPI_ISL_597290	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A5E1F7/2020	EPI_ISL_597291	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A5E94A/2020	EPI_ISL_597292	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A57C48/2020	EPI_ISL_597297	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A57C84/2020	EPI_ISL_597300	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A5E7AA/2020	EPI_ISL_597302	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A5E6BC/2020	EPI_ISL_597303	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A56F9B/2020	EPI_ISL_597304	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A5E081/2020	EPI_ISL_597315	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A5E6DA/2020	EPI_ISL_597328	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-A5E68F/2020	EPI_ISL_597329	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-A5E801/2020	EPI_ISL_597332	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A5E8F2/2020	EPI_ISL_597334	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A572BF/2020	EPI_ISL_597354	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-A5E106/2020	EPI_ISL_597357	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A5DD03/2020	EPI_ISL_597364	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A5E0DC/2020	EPI_ISL_597369	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A5DE4C/2020	EPI_ISL_597379	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A575F2/2020	EPI_ISL_597392	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A5E4FE/2020	EPI_ISL_597395	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A56FE6/2020	EPI_ISL_597398	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A57A3F/2020	EPI_ISL_597399	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A5E573/2020	EPI_ISL_597400	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A578EA/2020	EPI_ISL_597412	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-A5E1AC/2020	EPI_ISL_597417	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A57932/2020	EPI_ISL_597478	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A57158/2020	EPI_ISL_597489	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A45EDE/2020	EPI_ISL_598617	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A44C02/2020	EPI_ISL_598663	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A4607D/2020	EPI_ISL_598688	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A45F53/2020	EPI_ISL_598699	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A45C10/2020	EPI_ISL_598702	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-A46365/2020	EPI_ISL_598704	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A45B8C/2020	EPI_ISL_598707	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A44E1B/2020	EPI_ISL_598711	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A45F44/2020	EPI_ISL_598719	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A44E48/2020	EPI_ISL_598722	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A4668A/2020	EPI_ISL_598723	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A45F35/2020	EPI_ISL_598724	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A44F63/2020	EPI_ISL_598728	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A46110/2020	EPI_ISL_598743	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A06431/2020	EPI_ISL_599927	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A05A30/2020	EPI_ISL_599937	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A05BE2/2020	EPI_ISL_599962	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-A061EF/2020	EPI_ISL_599980	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A057EE/2020	EPI_ISL_599989	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9E4D11/2020	EPI_ISL_601004	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9E51D8/2020	EPI_ISL_601029	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Scotland/QEUH-9E4D4E/2020	EPI_ISL_601043	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9E44B2/2020	EPI_ISL_601049	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9E51F6/2020	EPI_ISL_601077	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A6FBE6/2020	EPI_ISL_607100	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6C7A9/2020	EPI_ISL_607118	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A6E6F5/2020	EPI_ISL_607120	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A6EB7E/2020	EPI_ISL_607123	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A6EEC0/2020	EPI_ISL_607126	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A6F82B/2020	EPI_ISL_607137	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A6E5CB/2020	EPI_ISL_607142	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F6F4/2020	EPI_ISL_607151	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A6FD3B/2020	EPI_ISL_607154	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F2C3/2020	EPI_ISL_607155	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/England/ALDP-A6E2A6/2020	EPI_ISL_607167	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F928/2020	EPI_ISL_607170	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6FB8C/2020	EPI_ISL_607188	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6D67E/2020	EPI_ISL_607211	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A6EEB1/2020	EPI_ISL_607220	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6F946/2020	EPI_ISL_607221	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6E14F/2020	EPI_ISL_607226	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-A6CD2F/2020	EPI_ISL_607281	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6F8FE/2020	EPI_ISL_607282	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F24B/2020	EPI_ISL_607284	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6DCB8/2020	EPI_ISL_607290	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7BA53/2020	EPI_ISL_607293	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A65175/2020	EPI_ISL_608400	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A68C26/2020	EPI_ISL_608406	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A64B5A/2020	EPI_ISL_608416	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A68BB0/2020	EPI_ISL_608420	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67DD9/2020	EPI_ISL_608425	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A64C48/2020	EPI_ISL_608427	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A68910/2020	EPI_ISL_608440	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67BDF/2020	EPI_ISL_608444	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A68901/2020	EPI_ISL_608461	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A65421/2020	EPI_ISL_608466	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A683B8/2020	EPI_ISL_608470	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A68F78/2020	EPI_ISL_608487	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A68224/2020	EPI_ISL_608502	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A6537F/2020	EPI_ISL_608506	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A688F5/2020	EPI_ISL_608518	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A68EC6/2020	EPI_ISL_608541	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A65193/2020	EPI_ISL_608559	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F60C/2020	EPI_ISL_609731	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F47B/2020	EPI_ISL_609742	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A3EC1A/2020	EPI_ISL_609750	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F3E7/2020	EPI_ISL_609761	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/CAMC-A3F61B/2020	EPI_ISL_609762	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F54B/2020	EPI_ISL_609764	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A3E7A0/2020	EPI_ISL_609765	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3E45E/2020	EPI_ISL_609782	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F341/2020	EPI_ISL_609794	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3E5B5/2020	EPI_ISL_609795	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A3F3D8/2020	EPI_ISL_609796	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/204200491/2020	EPI_ISL_609882	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/CAMC-A82AE0/2020	EPI_ISL_610711	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A80D52/2020	EPI_ISL_610712	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A82F96/2020	EPI_ISL_610719	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A81137/2020	EPI_ISL_610732	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A82FB4/2020	EPI_ISL_610741	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A8292F/2020	EPI_ISL_610751	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A8200C/2020	EPI_ISL_610757	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A83083/2020	EPI_ISL_610768	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A8153B/2020	EPI_ISL_610769	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-A8251C/2020	EPI_ISL_610774	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A81F97/2020	EPI_ISL_610805	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-A82DAB/2020	EPI_ISL_610824	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-A81E9A/2020	EPI_ISL_610828	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-A82224/2020	EPI_ISL_610830	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A82F5A/2020	EPI_ISL_610854	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-A8293E/2020	EPI_ISL_610857	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A819D5/2020	EPI_ISL_610874	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-480DA3/2020	EPI_ISL_613000	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-480E73/2020	EPI_ISL_613010	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-480F52/2020	EPI_ISL_613017	2020-10-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-48130A/2020	EPI_ISL_613054	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4813BF/2020	EPI_ISL_613063	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-481443/2020	EPI_ISL_613070	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-48149E/2020	EPI_ISL_613074	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-481522/2020	EPI_ISL_613081	2020-10-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-48158C/2020	EPI_ISL_613087	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-48163E/2020	EPI_ISL_613095	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Denmark/DCGC-3088/2020	EPI_ISL_616868	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/England/204190425/2020	EPI_ISL_622843	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204240978/2020	EPI_ISL_622850	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/ALDP-AA218B/2020	EPI_ISL_625001	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA0BAD/2020	EPI_ISL_625016	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA1E1C/2020	EPI_ISL_625022	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-AA54F8/2020	EPI_ISL_625025	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA0A46/2020	EPI_ISL_625028	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA44F9/2020	EPI_ISL_625031	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA3EFC/2020	EPI_ISL_625032	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA1131/2020	EPI_ISL_625034	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA4514/2020	EPI_ISL_625038	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA3F08/2020	EPI_ISL_625041	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA2C8A/2020	EPI_ISL_625047	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA33EE/2020	EPI_ISL_625048	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_K85stop results in 30.6% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-AA52B2/2020	EPI_ISL_625057	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/Wales/ALDP-AA37D3/2020	EPI_ISL_625064	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA55C8/2020	EPI_ISL_625068	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA5610/2020	EPI_ISL_625077	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA4523/2020	EPI_ISL_625083	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-AA566B/2020	EPI_ISL_625086	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/New Zealand/20CV0513/2020	EPI_ISL_626352	2020-10-31	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.177.57	GV
hCoV-19/England/MILK-A6A5A1/2020	EPI_ISL_627512	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Northern Ireland/NIRE-1089DF/2020	EPI_ISL_627521	2020-10-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-1089FD/2020	EPI_ISL_627523	2020-10-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108A27/2020	EPI_ISL_627526	2020-10-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-108A45/2020	EPI_ISL_627527	2020-10-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108A54/2020	EPI_ISL_627528	2020-10-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108A72/2020	EPI_ISL_627530	2020-10-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108A90/2020	EPI_ISL_627531	2020-10-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108ADC/2020	EPI_ISL_627533	2020-10-08	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108AFA/2020	EPI_ISL_627535	2020-10-08	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-108B33/2020	EPI_ISL_627538	2020-10-08	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108B42/2020	EPI_ISL_627539	2020-10-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108B51/2020	EPI_ISL_627540	2020-10-08	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-108BD9/2020	EPI_ISL_627543	2020-10-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-108BE8/2020	EPI_ISL_627544	2020-10-07	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108BF7/2020	EPI_ISL_627545	2020-10-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-108C12/2020	EPI_ISL_627547	2020-10-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-108C6D/2020	EPI_ISL_627549	2020-10-06	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/NORW-F23CC/2020	EPI_ISL_627663	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NORW-F3CB1/2020	EPI_ISL_627664	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NOTT-116A80/2020	EPI_ISL_627666	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-116DA5/2020	EPI_ISL_627668	2020-10-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1175F7/2020	EPI_ISL_627670	2020-10-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1184DB/2020	EPI_ISL_627675	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11857E/2020	EPI_ISL_627676	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11865D/2020	EPI_ISL_627679	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-118778/2020	EPI_ISL_627683	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-118945/2020	EPI_ISL_627685	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-118990/2020	EPI_ISL_627686	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-118A7F/2020	EPI_ISL_627687	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-118A9D/2020	EPI_ISL_627689	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-118C79/2020	EPI_ISL_627692	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-118E28/2020	EPI_ISL_627696	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-118E55/2020	EPI_ISL_627697	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-118FF8/2020	EPI_ISL_627701	2020-10-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11908B/2020	EPI_ISL_627704	2020-10-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-AE5395/2020	EPI_ISL_633396	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AEA72B/2020	EPI_ISL_633403	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AE237A/2020	EPI_ISL_633409	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AE2723/2020	EPI_ISL_633410	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE30FA/2020	EPI_ISL_633411	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE2705/2020	EPI_ISL_633415	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE2D9A/2020	EPI_ISL_633418	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE318E/2020	EPI_ISL_633422	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AE27AB/2020	EPI_ISL_633426	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE2D30/2020	EPI_ISL_633431	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AE1B73/2020	EPI_ISL_633436	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE28A8/2020	EPI_ISL_633441	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE283F/2020	EPI_ISL_633449	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE1C70/2020	EPI_ISL_633450	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE2BAF/2020	EPI_ISL_633452	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-AE2A75/2020	EPI_ISL_633455	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE21DA/2020	EPI_ISL_633464	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE26EA/2020	EPI_ISL_633467	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE3081/2020	EPI_ISL_633469	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE2583/2020	EPI_ISL_633484	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE3063/2020	EPI_ISL_633496	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE1A49/2020	EPI_ISL_633562	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE2FA3/2020	EPI_ISL_633570	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE2899/2020	EPI_ISL_633571	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE3036/2020	EPI_ISL_633576	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE2A93/2020	EPI_ISL_633583	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE2064/2020	EPI_ISL_633592	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE2B90/2020	EPI_ISL_633594	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE2459/2020	EPI_ISL_633597	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD583F/2020	EPI_ISL_634717	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD3F96/2020	EPI_ISL_634721	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/QEUH-AD3E5D/2020	EPI_ISL_634746	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/QEUH-AD1781/2020	EPI_ISL_634752	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Wales/ALDP-AA504F/2020	EPI_ISL_634786	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/CAMC-AAF83E/2020	EPI_ISL_634790	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/CAMC-AAF82F/2020	EPI_ISL_634797	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Belgium/UGent-167/2020	EPI_ISL_634883	2020-10-19	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/England/ALDP-9E8AF8/2020	EPI_ISL_638281	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-9E8BD7/2020	EPI_ISL_638284	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/ALDP-9E8BF5/2020	EPI_ISL_638285	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMB-1B7061/2020	EPI_ISL_638298	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMB-1B731D/2020	EPI_ISL_638316	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMB-1B767E/2020	EPI_ISL_638326	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMB-1B7C4F/2020	EPI_ISL_638369	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-488F78/2020	EPI_ISL_639521	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/QEUH-A36A81/2020	EPI_ISL_639626	2020-10-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Latvia/182/2020	EPI_ISL_639679	2020-09-27	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.79	GV
hCoV-19/Latvia/189/2020	EPI_ISL_639686	2020-10-13	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.60	GV
hCoV-19/England/QEUH-B10794/2020	EPI_ISL_641803	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B133D9/2020	EPI_ISL_641808	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B12F30/2020	EPI_ISL_641812	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B145E1/2020	EPI_ISL_641825	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B137A0/2020	EPI_ISL_641908	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B137EC/2020	EPI_ISL_641911	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0F367/2020	EPI_ISL_641915	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B0DCAA/2020	EPI_ISL_641924	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B0E632/2020	EPI_ISL_641928	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B0E614/2020	EPI_ISL_641949	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B0DD10/2020	EPI_ISL_641965	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0E5BD/2020	EPI_ISL_641989	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0F3FE/2020	EPI_ISL_641990	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0DE1D/2020	EPI_ISL_641998	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/MILK-ACC31C/2020	EPI_ISL_644077	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACE550/2020	EPI_ISL_644079	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA2956/2020	EPI_ISL_644097	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AC1283/2020	EPI_ISL_644118	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B3D4A9/2020	EPI_ISL_645395	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B35E3A/2020	EPI_ISL_645397	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B366AA/2020	EPI_ISL_645414	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B370F6/2020	EPI_ISL_645416	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B36929/2020	EPI_ISL_645417	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B361E5/2020	EPI_ISL_645430	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B362F1/2020	EPI_ISL_645432	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B3D51F/2020	EPI_ISL_645453	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B36419/2020	EPI_ISL_645469	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B3E657/2020	EPI_ISL_645473	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B3680E/2020	EPI_ISL_645474	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B36437/2020	EPI_ISL_645487	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B36103/2020	EPI_ISL_645488	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B3706F/2020	EPI_ISL_645498	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B3E55A/2020	EPI_ISL_645499	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1B40B/2020	EPI_ISL_645533	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B1B3A4/2020	EPI_ISL_645534	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1C561/2020	EPI_ISL_645549	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B1BAAF/2020	EPI_ISL_645563	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B1B508/2020	EPI_ISL_645580	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B1A79A/2020	EPI_ISL_645582	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1B9EE/2020	EPI_ISL_645598	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B2635B/2020	EPI_ISL_646706	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2B480/2020	EPI_ISL_646717	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B2B374/2020	EPI_ISL_646720	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2BA51/2020	EPI_ISL_646745	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2C8DE/2020	EPI_ISL_646754	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B25FFE/2020	EPI_ISL_646758	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2C874/2020	EPI_ISL_646764	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B2BACA/2020	EPI_ISL_646772	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2C962/2020	EPI_ISL_646775	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2B2D1/2020	EPI_ISL_646786	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2DA8C/2020	EPI_ISL_646798	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B23AB3/2020	EPI_ISL_646799	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-B2DC3B/2020	EPI_ISL_646874	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2DB01/2020	EPI_ISL_646885	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2EC85/2020	EPI_ISL_646891	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B2378F/2020	EPI_ISL_646895	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B24B73/2020	EPI_ISL_646896	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-48A9C3/2020	EPI_ISL_652619	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/England/QEUH-A9CF02/2020	EPI_ISL_652646	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A9D9E5/2020	EPI_ISL_652668	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-A9F1BE/2020	EPI_ISL_652675	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/QEUH-A9F260/2020	EPI_ISL_652680	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-A9F8AA/2020	EPI_ISL_652683	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-A9FD23/2020	EPI_ISL_652694	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/204420852/2020	EPI_ISL_653964	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204440720/2020	EPI_ISL_653969	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204441467/2020	EPI_ISL_653970	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/204481627/2020	EPI_ISL_653989	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204481791/2020	EPI_ISL_653994	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/ALDP-B4614C/2020	EPI_ISL_656042	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B46FD9/2020	EPI_ISL_656050	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B46E27/2020	EPI_ISL_656055	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B46980/2020	EPI_ISL_656063	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B45EA0/2020	EPI_ISL_656064	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B46461/2020	EPI_ISL_656070	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B46F8E/2020	EPI_ISL_656074	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B46188/2020	EPI_ISL_656091	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B46DC0/2020	EPI_ISL_656101	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B462FE/2020	EPI_ISL_656104	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B46364/2020	EPI_ISL_656105	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B45A9D/2020	EPI_ISL_656116	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B46D57/2020	EPI_ISL_656121	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B45A7F/2020	EPI_ISL_656145	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B45945/2020	EPI_ISL_656147	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B45FBC/2020	EPI_ISL_656148	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B45B8B/2020	EPI_ISL_656168	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B467FF/2020	EPI_ISL_656172	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B467D1/2020	EPI_ISL_656176	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B45C6A/2020	EPI_ISL_656181	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B46A8D/2020	EPI_ISL_656183	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B45A42/2020	EPI_ISL_656184	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B45E82/2020	EPI_ISL_656186	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B45CF1/2020	EPI_ISL_656207	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B461C4/2020	EPI_ISL_656223	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B45DA3/2020	EPI_ISL_656234	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B464E9/2020	EPI_ISL_656235	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B46DDF/2020	EPI_ISL_656238	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B53267/2020	EPI_ISL_657394	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B527D2/2020	EPI_ISL_657415	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B563E9/2020	EPI_ISL_657425	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B55757/2020	EPI_ISL_657438	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B555E4/2020	EPI_ISL_657457	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B530A9/2020	EPI_ISL_657471	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B5565A/2020	EPI_ISL_657472	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B561C1/2020	EPI_ISL_657473	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B52C97/2020	EPI_ISL_657477	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B567DE/2020	EPI_ISL_657479	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-B52CD3/2020	EPI_ISL_657507	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B53285/2020	EPI_ISL_657523	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B53179/2020	EPI_ISL_657534	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B5670B/2020	EPI_ISL_657536	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B5561E/2020	EPI_ISL_657568	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B56729/2020	EPI_ISL_657575	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B529EB/2020	EPI_ISL_657576	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B3F45C/2020	EPI_ISL_658720	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B41475/2020	EPI_ISL_658734	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B38945/2020	EPI_ISL_658761	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B3880C/2020	EPI_ISL_658773	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B38A9D/2020	EPI_ISL_658774	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B3949E/2020	EPI_ISL_658793	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B38DD0/2020	EPI_ISL_658860	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B38C2E/2020	EPI_ISL_658861	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B38990/2020	EPI_ISL_658869	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B39382/2020	EPI_ISL_658872	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-B393BF/2020	EPI_ISL_658898	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B6918F/2020	EPI_ISL_662012	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B691E9/2020	EPI_ISL_662021	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B7527E/2020	EPI_ISL_662032	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/NORW-F745B/2020	EPI_ISL_665897	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NOTT-11A3AF/2020	EPI_ISL_665898	2020-11-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11B0E3/2020	EPI_ISL_665899	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11BD91/2020	EPI_ISL_665900	2020-11-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C48C/2020	EPI_ISL_665902	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C60E/2020	EPI_ISL_665903	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11C941/2020	EPI_ISL_665905	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11CC66/2020	EPI_ISL_665906	2020-11-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11CD09/2020	EPI_ISL_665907	2020-11-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11CF7C/2020	EPI_ISL_665909	2020-11-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11CFB8/2020	EPI_ISL_665910	2020-11-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11CFC7/2020	EPI_ISL_665911	2020-11-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11CFF4/2020	EPI_ISL_665913	2020-11-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D00F/2020	EPI_ISL_665914	2020-11-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D03C/2020	EPI_ISL_665915	2020-11-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D0C3/2020	EPI_ISL_665917	2020-11-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D157/2020	EPI_ISL_665918	2020-11-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D1EE/2020	EPI_ISL_665919	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11D236/2020	EPI_ISL_665920	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D245/2020	EPI_ISL_665921	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D272/2020	EPI_ISL_665923	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D333/2020	EPI_ISL_665926	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11D3CA/2020	EPI_ISL_665928	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-11D3D9/2020	EPI_ISL_665929	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D48B/2020	EPI_ISL_665930	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D49A/2020	EPI_ISL_665931	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D4B8/2020	EPI_ISL_665933	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D56A/2020	EPI_ISL_665936	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D5A6/2020	EPI_ISL_665937	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D685/2020	EPI_ISL_665938	2020-11-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11D7FB/2020	EPI_ISL_665940	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11D807/2020	EPI_ISL_665941	2020-11-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11D88F/2020	EPI_ISL_665943	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11D8DA/2020	EPI_ISL_665945	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/PORT-2EA3D4/2020	EPI_ISL_665953	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/PORT-2EA495/2020	EPI_ISL_665954	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-A313F4/2020	EPI_ISL_665957	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A605E7/2020	EPI_ISL_665965	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A60CC4/2020	EPI_ISL_665968	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A60D2B/2020	EPI_ISL_665970	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A76C8F/2020	EPI_ISL_665976	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A9FA3B/2020	EPI_ISL_665988	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A9FA86/2020	EPI_ISL_665990	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/QEUH-B80E9A/2020	EPI_ISL_668022	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B7E49D/2020	EPI_ISL_668034	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B78D98/2020	EPI_ISL_668037	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B7E503/2020	EPI_ISL_668053	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B79D4C/2020	EPI_ISL_668065	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B78A37/2020	EPI_ISL_668077	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B81B0B/2020	EPI_ISL_668078	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B7EA5F/2020	EPI_ISL_668105	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B7E5C7/2020	EPI_ISL_668106	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B78BF8/2020	EPI_ISL_668115	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B81A68/2020	EPI_ISL_668118	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B7E916/2020	EPI_ISL_668119	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B7FD91/2020	EPI_ISL_668132	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B776BC/2020	EPI_ISL_668137	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B7BFBD/2020	EPI_ISL_668181	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B7C16B/2020	EPI_ISL_668183	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B823F3/2020	EPI_ISL_668216	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B7C2FF/2020	EPI_ISL_668218	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Denmark/DCGC-11181/2020	EPI_ISL_670439	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.4	GV
hCoV-19/Ireland/CN-NVRL-75IRL94334/2020	EPI_ISL_671865	2020-10-14	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CO-NVRL-75IRL33101/2020	EPI_ISL_671873	2020-10-07	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CO-NVRL-75IRL75321/2020	EPI_ISL_671880	2020-10-12	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.54	GV
hCoV-19/England/MILK-B85E95/2020	EPI_ISL_674000	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/MILK-B8E61C/2020	EPI_ISL_674085	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B85EFF/2020	EPI_ISL_674089	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B8F04A/2020	EPI_ISL_675217	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B83C24/2020	EPI_ISL_675237	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B82D9B/2020	EPI_ISL_675239	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B83BEB/2020	EPI_ISL_675257	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B84564/2020	EPI_ISL_675261	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B829E2/2020	EPI_ISL_675263	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B83653/2020	EPI_ISL_675270	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B836BD/2020	EPI_ISL_675271	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B837BA/2020	EPI_ISL_675279	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B844B2/2020	EPI_ISL_675281	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B82CDA/2020	EPI_ISL_675296	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B82DB9/2020	EPI_ISL_675297	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B8431F/2020	EPI_ISL_675302	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B82F3B/2020	EPI_ISL_675314	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8F235/2020	EPI_ISL_675332	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-48EDD2/2020	EPI_ISL_681007	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-48EE66/2020	EPI_ISL_681014	2020-11-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-48F5D9/2020	EPI_ISL_681114	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-48F5E8/2020	EPI_ISL_681115	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GH
hCoV-19/Wales/PHWC-48F7F1/2020	EPI_ISL_681142	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-48FA43/2020	EPI_ISL_681177	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Denmark/DCGC-12265/2020	EPI_ISL_682446	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/England/CAMC-BD2127/2020	EPI_ISL_702108	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BD48D5/2020	EPI_ISL_702113	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BD469F/2020	EPI_ISL_702118	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BD2057/2020	EPI_ISL_702120	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BD22F7/2020	EPI_ISL_702124	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-BD1E7C/2020	EPI_ISL_702144	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BD1322/2020	EPI_ISL_702148	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BD15A4/2020	EPI_ISL_702166	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BD18AB/2020	EPI_ISL_702172	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-BD2B65/2020	EPI_ISL_702198	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BD137D/2020	EPI_ISL_702202	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BD1E8B/2020	EPI_ISL_702217	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BD1C72/2020	EPI_ISL_702223	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BD1E4F/2020	EPI_ISL_702234	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BD17CC/2020	EPI_ISL_702261	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BCA887/2020	EPI_ISL_703420	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BC453B/2020	EPI_ISL_703431	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BCA0F8/2020	EPI_ISL_703433	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-BCA3FF/2020	EPI_ISL_703448	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BCA84B/2020	EPI_ISL_703461	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BC42F8/2020	EPI_ISL_703472	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BCA2A7/2020	EPI_ISL_703477	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BC43E6/2020	EPI_ISL_703482	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-BC3FC5/2020	EPI_ISL_703496	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BC41A0/2020	EPI_ISL_703501	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BCA9A2/2020	EPI_ISL_703504	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BC4410/2020	EPI_ISL_703510	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-BC428F/2020	EPI_ISL_703514	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCA4ED/2020	EPI_ISL_703520	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-BC011D/2020	EPI_ISL_704718	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/MILK-B3C738/2020	EPI_ISL_704817	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/CAMC-BBFF17/2020	EPI_ISL_704830	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BC0274/2020	EPI_ISL_704844	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BC05A8/2020	EPI_ISL_704846	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BBFF44/2020	EPI_ISL_704860	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BC22FA/2020	EPI_ISL_704883	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BC07C0/2020	EPI_ISL_704893	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/SHEF-CDA5C/2020	EPI_ISL_707002	2020-11-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/MILK-BDC318/2020	EPI_ISL_709608	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BDC7B2/2020	EPI_ISL_709658	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BDBFBB/2020	EPI_ISL_709684	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BDBDB1/2020	EPI_ISL_709742	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BDC71C/2020	EPI_ISL_709747	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BDBA05/2020	EPI_ISL_709754	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BDB7B3/2020	EPI_ISL_709757	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Denmark/DCGC-14700/2020	EPI_ISL_711917	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-14730/2020	EPI_ISL_711938	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-14771/2020	EPI_ISL_711968	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/England/CAMC-C44EEC/2020	EPI_ISL_719044	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C43AAD/2020	EPI_ISL_719086	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-C41C5E/2020	EPI_ISL_719096	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BB1373/2020	EPI_ISL_720008	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB20E4/2020	EPI_ISL_720013	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB13CE/2020	EPI_ISL_720025	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB0277/2020	EPI_ISL_720060	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB155F/2020	EPI_ISL_720072	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB1285/2020	EPI_ISL_720078	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB0514/2020	EPI_ISL_720089	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB01E3/2020	EPI_ISL_720090	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-BB0550/2020	EPI_ISL_720093	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB020E/2020	EPI_ISL_720094	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-BB0981/2020	EPI_ISL_720098	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BC742C/2020	EPI_ISL_721291	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC87C8/2020	EPI_ISL_721292	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC8713/2020	EPI_ISL_721302	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC85FB/2020	EPI_ISL_721305	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC878C/2020	EPI_ISL_721317	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC885C/2020	EPI_ISL_721319	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BC86AD/2020	EPI_ISL_721329	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BC633F/2020	EPI_ISL_721332	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-BC78B7/2020	EPI_ISL_721359	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC7C60/2020	EPI_ISL_721368	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC8801/2020	EPI_ISL_721379	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC7B45/2020	EPI_ISL_721384	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC7BFA/2020	EPI_ISL_721385	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC869E/2020	EPI_ISL_721393	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMB-1BCEF9/2020	EPI_ISL_723908	2020-12-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/CAMB-1BD001/2020	EPI_ISL_723921	2020-12-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/CAMC-B7AC7B/2020	EPI_ISL_723954	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/CAMC-B7AD5A/2020	EPI_ISL_723960	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-B7B014/2020	EPI_ISL_723977	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-B7B050/2020	EPI_ISL_723981	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-B7B16C/2020	EPI_ISL_723987	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-49439B/2020	EPI_ISL_726107	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-49454A/2020	EPI_ISL_726131	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-494559/2020	EPI_ISL_726132	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-494568/2020	EPI_ISL_726133	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-494577/2020	EPI_ISL_726134	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-4946CF/2020	EPI_ISL_726155	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-494726/2020	EPI_ISL_726161	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-494D42/2020	EPI_ISL_726247	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-494D8E/2020	EPI_ISL_726251	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-494DE8/2020	EPI_ISL_726256	2020-11-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-494EC7/2020	EPI_ISL_726268	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-499B9E/2020	EPI_ISL_727410	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-499F38/2020	EPI_ISL_727468	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-49A25C/2020	EPI_ISL_727516	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-49A377/2020	EPI_ISL_727534	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49A386/2020	EPI_ISL_727535	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49A447/2020	EPI_ISL_727546	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-C57FB6/2020	EPI_ISL_735943	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C5802B/2020	EPI_ISL_735980	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C580FE/2020	EPI_ISL_735988	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C58CFA/2020	EPI_ISL_735989	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C57FA7/2020	EPI_ISL_735998	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Luxembourg/LNS4041175/2020	EPI_ISL_740406	2020-10-20	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS4302819/2020	EPI_ISL_740445	2020-10-31	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS4658560/2020	EPI_ISL_740517	2020-11-17	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS4788360/2020	EPI_ISL_740546	2020-12-18	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/England/PORT-2F60B0/2020	EPI_ISL_741736	2020-12-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A4BEAB/2020	EPI_ISL_741764	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AAF2F4/2020	EPI_ISL_741776	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B7C4CC/2020	EPI_ISL_741781	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-B7C4EA/2020	EPI_ISL_741782	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B7C4F9/2020	EPI_ISL_741783	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-B7C8C0/2020	EPI_ISL_741798	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-B7C8DF/2020	EPI_ISL_741799	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/QEUH-B7CBB8/2020	EPI_ISL_741809	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.2	GV
hCoV-19/England/QEUH-B7CBC7/2020	EPI_ISL_741810	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B7CC4C/2020	EPI_ISL_741817	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B7CCD3/2020	EPI_ISL_741821	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-B7CD2B/2020	EPI_ISL_741823	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/QEUH-B7D021/2020	EPI_ISL_741840	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B7D04F/2020	EPI_ISL_741842	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B7D425/2020	EPI_ISL_741860	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-B7D540/2020	EPI_ISL_741872	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B7D5AA/2020	EPI_ISL_741874	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-B7D5D7/2020	EPI_ISL_741875	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-B7D81A/2020	EPI_ISL_741882	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-B7D865/2020	EPI_ISL_741886	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-4A2CEA/2020	EPI_ISL_744006	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A2EC6/2020	EPI_ISL_744031	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A3074/2020	EPI_ISL_744046	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Denmark/DCGC-20021/2020	EPI_ISL_747935	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Ireland/LD-NVRL-77IRL69816/2020	EPI_ISL_752518	2020-11-05	Europe / Ireland / Longford	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/MH-NVRL-77IRL71270/2020	EPI_ISL_752520	2020-11-05	Europe / Ireland / Meath	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/MN-NVRL-77IRL72276/2020	EPI_ISL_752521	2020-11-05	Europe / Ireland / Monaghan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/MH-NVRL-77IRL72666/2020	EPI_ISL_752522	2020-11-05	Europe / Ireland / Meath	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/MN-NVRL-77IRL73367/2020	EPI_ISL_752526	2020-11-05	Europe / Ireland / Monaghan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CO-NVRL-77IRL74089/2020	EPI_ISL_752528	2020-11-05	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.54	GV
hCoV-19/Ireland/WD-NVRL-77IRL74386/2020	EPI_ISL_752529	2020-11-05	Europe / Ireland / Waterford	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CO-NVRL-77IRL76087/2020	EPI_ISL_752530	2020-11-05	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KK-NVRL-78IRL61331/2020	EPI_ISL_752531	2020-11-22	Europe / Ireland / Kilkenny	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/TA-NVRL-78IRL62510/2020	EPI_ISL_752532	2020-11-22	Europe / Ireland / Tipperary	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LH-NVRL-78IRL62518/2020	EPI_ISL_752533	2020-11-22	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/WW-NVRL-78IRL69294/2020	EPI_ISL_752539	2020-11-22	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LK-NVRL-78IRL69435/2020	EPI_ISL_752540	2020-11-22	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/TA-NVRL-78IRL73009/2020	EPI_ISL_752547	2020-11-22	Europe / Ireland / Tipperary	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KE-NVRL-78IRL61834/2020	EPI_ISL_752549	2020-11-23	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/LS-NVRL-78IRL80633/2020	EPI_ISL_752597	2020-11-24	Europe / Ireland / Laois	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Scotland/QEUH-C01B6C/2020	EPI_ISL_757266	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.77	GV
hCoV-19/Denmark/DCGC-22236/2020	EPI_ISL_758629	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-22311/2020	EPI_ISL_758670	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/QEUH-CAD519/2020	EPI_ISL_760856	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CADAB0/2020	EPI_ISL_760914	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB4DEA/2020	EPI_ISL_760941	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB34B9/2020	EPI_ISL_760982	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C5F464/2020	EPI_ISL_760984	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.77	GV
hCoV-19/England/ALDP-CAE6E8/2020	EPI_ISL_760989	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Netherlands/ZH-EMC-1143/2020	EPI_ISL_763220	2020-12-19	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/Northern Ireland/NIRE-234EBC/2020	EPI_ISL_764401	2020-10-23	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234FD7/2020	EPI_ISL_764403	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-235097/2020	EPI_ISL_764407	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2350A6/2020	EPI_ISL_764408	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/Northern Ireland/NIRE-2350B5/2020	EPI_ISL_764409	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2350D3/2020	EPI_ISL_764410	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2350E2/2020	EPI_ISL_764411	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2350F1/2020	EPI_ISL_764412	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23510D/2020	EPI_ISL_764413	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23512B/2020	EPI_ISL_764414	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235149/2020	EPI_ISL_764415	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2351C1/2020	EPI_ISL_764416	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23520A/2020	EPI_ISL_764418	2020-10-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235228/2020	EPI_ISL_764420	2020-10-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235237/2020	EPI_ISL_764421	2020-10-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235246/2020	EPI_ISL_764422	2020-10-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235273/2020	EPI_ISL_764423	2020-10-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-235282/2020	EPI_ISL_764424	2020-10-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/Northern Ireland/NIRE-235307/2020	EPI_ISL_764426	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-235352/2020	EPI_ISL_764429	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23555C/2020	EPI_ISL_764441	2020-10-26	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23556B/2020	EPI_ISL_764442	2020-10-26	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23557A/2020	EPI_ISL_764443	2020-10-26	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/NORW-2219DF/2020	EPI_ISL_764459	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-22233A/2020	EPI_ISL_764487	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-222543/2020	EPI_ISL_764491	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-222895/2020	EPI_ISL_764492	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NOTT-121786/2020	EPI_ISL_764493	2020-12-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121787/2020	EPI_ISL_764494	2020-12-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121801/2020	EPI_ISL_764495	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121805/2020	EPI_ISL_764497	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121813/2020	EPI_ISL_764498	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-121817/2020	EPI_ISL_764499	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121833/2020	EPI_ISL_764504	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121835/2020	EPI_ISL_764505	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121836/2020	EPI_ISL_764506	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-121837/2020	EPI_ISL_764507	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-121840/2020	EPI_ISL_764508	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121842/2020	EPI_ISL_764509	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121856/2020	EPI_ISL_764513	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-121857/2020	EPI_ISL_764514	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121859/2020	EPI_ISL_764515	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121861/2020	EPI_ISL_764516	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121862/2020	EPI_ISL_764517	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121865/2020	EPI_ISL_764518	2020-12-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121868/2020	EPI_ISL_764520	2020-12-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121869/2020	EPI_ISL_764521	2020-12-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121936/2020	EPI_ISL_764522	2020-12-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/OXON-F40DC2/2020	EPI_ISL_764552	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/OXON-F411D4/2020	EPI_ISL_764560	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/OXON-F4149F/2020	EPI_ISL_764567	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/OXON-F414DB/2020	EPI_ISL_764569	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/OXON-F414EA/2020	EPI_ISL_764570	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-C5D606/2020	EPI_ISL_769290	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C63290/2020	EPI_ISL_769305	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C5FF45/2020	EPI_ISL_769318	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C5B978/2020	EPI_ISL_769319	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C60F6F/2020	EPI_ISL_769324	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C5BF58/2020	EPI_ISL_769330	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C60F50/2020	EPI_ISL_769332	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C5BD9A/2020	EPI_ISL_769352	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C60C95/2020	EPI_ISL_769357	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C5BFEF/2020	EPI_ISL_769365	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C5C036/2020	EPI_ISL_769374	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/QEUH-C5C018/2020	EPI_ISL_769385	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-C5BE79/2020	EPI_ISL_769388	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C5BF76/2020	EPI_ISL_769389	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/CAMC-CB78E6/2020	EPI_ISL_777700	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-CB87F7/2020	EPI_ISL_777781	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-CB786E/2020	EPI_ISL_777829	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-CBA036/2020	EPI_ISL_777857	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-CB7831/2020	EPI_ISL_777860	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-CDF4C6/2020	EPI_ISL_782206	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CEC253/2020	EPI_ISL_782207	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CDF3C9/2020	EPI_ISL_782213	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CCDCA5/2020	EPI_ISL_782236	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CCC9FA/2020	EPI_ISL_782272	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CEBA98/2020	EPI_ISL_782292	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CCDCF0/2020	EPI_ISL_782301	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CCDD84/2020	EPI_ISL_782308	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CECA6A/2020	EPI_ISL_782335	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Netherlands/NH-RIVM-20629/2020	EPI_ISL_790706	2020-12-16	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/OV-RIVM-20679/2020	EPI_ISL_790748	2020-12-19	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/GE-RIVM-20732/2020	EPI_ISL_790798	2020-12-16	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Denmark/DCGC-24406/2020	EPI_ISL_795521	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-24659/2020	EPI_ISL_795665	2020-12-28	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/ALDP-DA0384/2020	EPI_ISL_796868	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-DA0287/2020	EPI_ISL_796939	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-DA77DC/2020	EPI_ISL_796949	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-DA76EE/2020	EPI_ISL_796951	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-D45C2C/2020	EPI_ISL_799143	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-D5081B/2020	EPI_ISL_799193	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C21BDF/2020	EPI_ISL_800583	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C22CBD/2020	EPI_ISL_800613	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-C18B35/2020	EPI_ISL_800628	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C1836A/2020	EPI_ISL_800654	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C22D7E/2020	EPI_ISL_800677	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C185FB/2020	EPI_ISL_800691	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C18670/2020	EPI_ISL_800692	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C1B9B0/2020	EPI_ISL_800707	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C22D23/2020	EPI_ISL_800711	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-C185CE/2020	EPI_ISL_800715	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-C18986/2020	EPI_ISL_800731	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-DD3009/2021	EPI_ISL_822033	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-4AA893/2020	EPI_ISL_823290	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4AA9CD/2020	EPI_ISL_823300	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4AA9FA/2020	EPI_ISL_823302	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4AAB4F/2020	EPI_ISL_823317	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4AAB5E/2020	EPI_ISL_823318	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4AAC3D/2020	EPI_ISL_823326	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Iceland/5643/2021	EPI_ISL_829325	2021-01-02	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.177.60	GV
hCoV-19/Iceland/5734/2020	EPI_ISL_829416	2020-12-26	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.177.60	GV
hCoV-19/England/QEUH-EFAF4A/2021	EPI_ISL_835287	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-EFB037/2021	EPI_ISL_835308	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-29591/2020	EPI_ISL_843638	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-29604/2020	EPI_ISL_843651	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-29628/2020	EPI_ISL_843675	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-29633/2020	EPI_ISL_843680	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-29637/2020	EPI_ISL_843684	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-29670/2020	EPI_ISL_843717	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-29688/2020	EPI_ISL_843735	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-29138/2021	EPI_ISL_844997	2021-01-04	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-31366/2021	EPI_ISL_855746	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-31371/2021	EPI_ISL_855751	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Scotland/QEUH-CC44D3/2020	EPI_ISL_859173	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-CBF990/2020	EPI_ISL_859247	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/ALDP-CC0422/2020	EPI_ISL_859273	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/ALDP-CBF936/2020	EPI_ISL_859274	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/ALDP-CB3A3F/2020	EPI_ISL_859331	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Norway/0499/2021	EPI_ISL_860283	2021-01-11	Europe / Norway / Nordland	Human	original	nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.177.60	GV
hCoV-19/England/ALDP-FB5BBF/2021	EPI_ISL_862980	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/LIVE-DB3157/2020	EPI_ISL_865169	2020-11-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.55	GV
hCoV-19/England/NORT-1B730EC/2020	EPI_ISL_866417	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/NORT-28D9C2/2020	EPI_ISL_866477	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/NORW-220897/2021	EPI_ISL_866576	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/TFCI-26FF24E/2020	EPI_ISL_868900	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.55	GV
hCoV-19/England/TFCI-26FF32D/2020	EPI_ISL_868911	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/TFCI-26FF33C/2020	EPI_ISL_868912	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/TFCI-26FF396/2020	EPI_ISL_868918	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/TFCI-26FF4A2/2020	EPI_ISL_868935	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/TFCI-26FF712/2020	EPI_ISL_868959	2020-12-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/TFCI-26FF7C7/2020	EPI_ISL_868970	2020-12-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/MILK-102E045/2021	EPI_ISL_873590	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-1008B5F/2021	EPI_ISL_874895	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-10092D1/2021	EPI_ISL_874897	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-106478A/2021	EPI_ISL_878444	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-101AE42/2021	EPI_ISL_879728	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-102F2F3/2021	EPI_ISL_880858	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-102F132/2021	EPI_ISL_880883	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-FA272A/2021	EPI_ISL_881916	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-10B5F46/2021	EPI_ISL_885496	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-10B6886/2021	EPI_ISL_885509	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Belgium/rega-1569/2020	EPI_ISL_890247	2020-12-23	Europe / Belgium / Lokeren	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1574/2020	EPI_ISL_890251	2020-12-23	Europe / Belgium / Langdorp	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/England/ALDP-10B9364/2021	EPI_ISL_891403	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-10BA57C/2021	EPI_ISL_891508	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-10EB1C9/2021	EPI_ISL_907464	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10EB09F/2021	EPI_ISL_907480	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/Ireland/OY-NVRL-83IRL28778/2021	EPI_ISL_909921	2021-01-12	Europe / Ireland / Offaly	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/SO-NVRL-21IRL17303/2021	EPI_ISL_909922	2021-01-18	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/SO-NVRL-83IRL56731/2021	EPI_ISL_909923	2021-01-14	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/MH-NVRL-21IRL17830/2021	EPI_ISL_909925	2021-01-20	Europe / Ireland / Meath	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-21IRL17665/2021	EPI_ISL_909926	2021-01-18	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KE-NVRL-83IRL59763/2021	EPI_ISL_909932	2021-01-15	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/MO-NVRL-83IRL56540/2021	EPI_ISL_909936	2021-01-14	Europe / Ireland / Mayo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CO-NVRL-83IRL55842/2021	EPI_ISL_909938	2021-01-13	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Luxembourg/LNS8923377/2021	EPI_ISL_910904	2021-01-05	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS5017349/2021	EPI_ISL_910907	2021-01-06	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/England/ALDP-BC693D/2020	EPI_ISL_915747	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-BC841C/2020	EPI_ISL_915750	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BC7FB2/2020	EPI_ISL_915763	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-BC8A74/2020	EPI_ISL_915765	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC6BEC/2020	EPI_ISL_915773	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BCAD6A/2020	EPI_ISL_915774	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC72C8/2020	EPI_ISL_915777	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BC7F3A/2020	EPI_ISL_915786	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-BC7116/2020	EPI_ISL_915791	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC8124/2020	EPI_ISL_915865	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCB09D/2020	EPI_ISL_915872	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCAD88/2020	EPI_ISL_915873	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BC81E8/2020	EPI_ISL_915878	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCB033/2020	EPI_ISL_915889	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BCAC12/2020	EPI_ISL_915899	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BC7301/2020	EPI_ISL_915924	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-BC7310/2020	EPI_ISL_915930	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-BC70EC/2020	EPI_ISL_915967	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCAF82/2020	EPI_ISL_915975	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BCAC6D/2020	EPI_ISL_915977	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/LOND-1325500/2020	EPI_ISL_920482	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORT-28E4DF/2020	EPI_ISL_921706	2020-12-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Insertion of 2 nucleotide(s) found at refpos 28251 (Frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/England/NORT-28E615/2020	EPI_ISL_921719	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Insertion of 2 nucleotide(s) found at refpos 28251 (Frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/England/NORT-28E78B/2020	EPI_ISL_921730	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NORT-28E976/2020	EPI_ISL_921751	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Insertion of 2 nucleotide(s) found at refpos 28251 (Frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/England/NORT-28EA0A/2020	EPI_ISL_921755	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Insertion of 2 nucleotide(s) found at refpos 28251 (Frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/England/NORT-28EB16/2020	EPI_ISL_921763	2020-12-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Insertion of 2 nucleotide(s) found at refpos 28251 (Frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/England/NORT-28EBAD/2020	EPI_ISL_921770	2020-12-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Insertion of 2 nucleotide(s) found at refpos 28251 (Frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/England/NORT-28EBE9/2020	EPI_ISL_921771	2020-12-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NORT-28EC22/2020	EPI_ISL_921772	2020-12-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Insertion of 2 nucleotide(s) found at refpos 28251 (Frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/England/NORT-28ECAA/2020	EPI_ISL_921776	2020-12-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Insertion of 2 nucleotide(s) found at refpos 28251 (Frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/Denmark/DCGC-35283/2021	EPI_ISL_926423	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-35483/2021	EPI_ISL_926624	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-36617/2021	EPI_ISL_927758	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-36635/2021	EPI_ISL_927776	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-36757/2021	EPI_ISL_927898	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/MILK-112E93A/2021	EPI_ISL_932468	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Belgium/UZA-UA-7372/2021	EPI_ISL_940772	2021-01-15	Europe / Belgium / Herentals	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.177.77	GV
hCoV-19/Netherlands/ZE-RIVM-10880/2021	EPI_ISL_943114	2021-01-15	Europe / Netherlands / Zeeland	Human	Original			Nanopore MinION				B.1.177.54	GV
hCoV-19/Netherlands/ZE-RIVM-10881/2021	EPI_ISL_943115	2021-01-15	Europe / Netherlands / Zeeland	Human	Original			Nanopore MinION				B.1.177.54	GV
hCoV-19/Netherlands/ZE-RIVM-10882/2021	EPI_ISL_943116	2021-01-15	Europe / Netherlands / Zeeland	Human	Original			Nanopore MinION				B.1.177.54	GV
hCoV-19/Netherlands/ZE-RIVM-10883/2021	EPI_ISL_943117	2021-01-13	Europe / Netherlands / Zeeland	Human	Original			Nanopore MinION				B.1.177.54	GV
hCoV-19/Netherlands/ZE-RIVM-10899/2021	EPI_ISL_943124	2021-01-15	Europe / Netherlands / Zeeland	Human	Original			Nanopore MinION				B.1.177.54	GV
hCoV-19/Netherlands/ZE-RIVM-10900/2021	EPI_ISL_943125	2021-01-15	Europe / Netherlands / Zeeland	Human	Original			Nanopore MinION				B.1.177.54	GV
hCoV-19/Netherlands/UT-RIVM-10923/2021	EPI_ISL_943138	2021-01-17	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/UT-RIVM-10950/2021	EPI_ISL_943165	2021-01-17	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/LI-RIVM-10980/2021	EPI_ISL_943180	2021-01-18	Europe / Netherlands / Limburg	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/England/ALDP-1036208/2021	EPI_ISL_949281	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				U.1	GV
hCoV-19/England/ALDP-11AFC74/2021	EPI_ISL_956468	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-11AF97D/2021	EPI_ISL_956582	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-1199ABF/2021	EPI_ISL_963511	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-11D5F03/2021	EPI_ISL_964813	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Norway/1722/2021	EPI_ISL_964973	2021-01-18	Europe / Norway / Viken	Human	original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			U.3	GV
hCoV-19/England/ALDP-11BD60C/2021	EPI_ISL_969551	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-11BD54B/2021	EPI_ISL_969849	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/Denmark/DCGC-39445/2021	EPI_ISL_970833	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-39451/2021	EPI_ISL_970839	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-40218/2021	EPI_ISL_971895	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-41348/2021	EPI_ISL_973025	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-41407/2021	EPI_ISL_973084	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Spain/CT-HUVH-51920/2021	EPI_ISL_981340	2021-01-26	Europe / Spain / Catalunya	Human	Original			Illumina MiSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/Spain/CT-HUVH-94730/2021	EPI_ISL_981367	2021-01-27	Europe / Spain / Catalunya	Human	Original			Illumina MiSeq				B.1.177.4	O
hCoV-19/England/QEUH-120C4C7/2021	EPI_ISL_986388	2021-02-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/Finland/HUS-41-81/2021	EPI_ISL_995994	2021-01-19	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.177	GV
hCoV-19/Finland/HUS-41-87/2021	EPI_ISL_995998	2021-01-19	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.177	GV
hCoV-19/Finland/HUS-41-92/2021	EPI_ISL_995999	2021-01-11	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.177	GV
hCoV-19/England/NORT-1B7D880/2021	EPI_ISL_998339	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina		Insertion of 2 nucleotide(s) found at refpos 28251 (frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/Switzerland/ZH-ETHZ-460368/2021	EPI_ISL_1003433	2021-01-21	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Netherlands/UT-RIVM-12028/2021	EPI_ISL_1014108	2021-02-02	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/UT-RIVM-12029/2021	EPI_ISL_1014109	2021-02-02	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/UT-RIVM-12041/2021	EPI_ISL_1014117	2021-02-02	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/UT-RIVM-12295/2021	EPI_ISL_1014131	2021-01-30	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/France/IDF-B108-25/2020	EPI_ISL_1015413	2020-10-21	Europe / France / Ile-de-France	Human	Original	Oropharyngeal swab		Nanopore MinION				B.1.177.77	GV
hCoV-19/Denmark/DCGC-42315/2021	EPI_ISL_1022593	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-42386/2021	EPI_ISL_1022664	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-43252/2021	EPI_ISL_1023544	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44483/2021	EPI_ISL_1024861	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44499/2021	EPI_ISL_1024877	2021-02-01	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44564/2021	EPI_ISL_1024942	2021-02-01	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-44572/2021	EPI_ISL_1024950	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44599/2021	EPI_ISL_1024977	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/CAMC-127117B/2021	EPI_ISL_1033285	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Netherlands/UT-RIVM-12453/2021	EPI_ISL_1035549	2021-01-28	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/OV-RIVM-21735/2020	EPI_ISL_1035560	2020-12-24	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/NB-RIVM-12933/2021	EPI_ISL_1035614	2021-02-05	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/England/LCST-24DC65C/2020	EPI_ISL_1047918	2020-12-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/LCST-24DC7A4/2020	EPI_ISL_1047931	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/LCST-24DC7FF/2020	EPI_ISL_1047936	2020-12-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/LCST-24DC865/2020	EPI_ISL_1047941	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/LCST-24DC9F9/2020	EPI_ISL_1047953	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NORT-1B86AE8/2021	EPI_ISL_1051187	2021-01-07	Europe / United Kingdom / England	Human	Original			Illumina		Insertion of 2 nucleotide(s) found at refpos 28251 (frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/Switzerland/ZH-ETHZ-461441/2021	EPI_ISL_1059844	2021-01-19	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Switzerland/ZH-ETHZ-490832/2021	EPI_ISL_1059850	2021-02-09	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Switzerland/ZH-ETHZ-490833/2021	EPI_ISL_1059886	2021-02-09	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/England/ALDP-12AA73B/2021	EPI_ISL_1061822	2021-02-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-1268DFB/2021	EPI_ISL_1063197	2021-02-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.77	GV
hCoV-19/Belgium/rega-3137/2021	EPI_ISL_1064474	2021-02-08	Europe / Belgium / Neerpelt	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/England/QEUH-12C0B06/2021	EPI_ISL_1070203	2021-02-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 2 nucleotide(s) found at refpos 28251 (frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/Finland/HEL-14-266/2021	EPI_ISL_1082204	2021-01-23	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.177	GV
hCoV-19/Finland/HEL-18-V121/2021	EPI_ISL_1082236	2021-01-20	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.177.60	GV
hCoV-19/Finland/HEL-19-541/2021	EPI_ISL_1082246	2021-01-24	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.177	GV
hCoV-19/Northern Ireland/QEUH-96C5DD/2020	EPI_ISL_530888	2020-08-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Northern Ireland/QEUH-96AF95/2020	EPI_ISL_531409	2020-08-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-96AFA4/2020	EPI_ISL_531410	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-964335/2020	EPI_ISL_534365	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-96449C/2020	EPI_ISL_536960	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9A475B/2020	EPI_ISL_540180	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9A4409/2020	EPI_ISL_540194	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9A40F6/2020	EPI_ISL_540201	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-96F868/2020	EPI_ISL_540259	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9B9216/2020	EPI_ISL_549548	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B9CEB/2020	EPI_ISL_549560	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B9A0F/2020	EPI_ISL_549569	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B9AD2/2020	EPI_ISL_549570	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-99D913/2020	EPI_ISL_550518	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/CAMC-991223/2020	EPI_ISL_551841	2020-08-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-990FA5/2020	EPI_ISL_551852	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-9912E7/2020	EPI_ISL_551857	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-990A4A/2020	EPI_ISL_551860	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-992C42/2020	EPI_ISL_552165	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-992F76/2020	EPI_ISL_552171	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-995429/2020	EPI_ISL_552189	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-991DC8/2020	EPI_ISL_552194	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-995052/2020	EPI_ISL_552196	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99517D/2020	EPI_ISL_552237	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C33AD/2020	EPI_ISL_566840	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C3D09/2020	EPI_ISL_566843	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C45D3/2020	EPI_ISL_566854	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9C9FB2/2020	EPI_ISL_567320	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9C9C33/2020	EPI_ISL_567345	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-9C19CB/2020	EPI_ISL_573212	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/CAMC-9C1A22/2020	EPI_ISL_573215	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-9C1A5F/2020	EPI_ISL_573217	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-9C1B4D/2020	EPI_ISL_573222	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-9C1D92/2020	EPI_ISL_573234	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/MILK-9A7F41/2020	EPI_ISL_573247	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/MILK-9C4931/2020	EPI_ISL_573260	2020-09-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/MILK-9C7154/2020	EPI_ISL_573283	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-16B8EC/2020	EPI_ISL_573915	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16B952/2020	EPI_ISL_573921	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16BA5F/2020	EPI_ISL_573933	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16BAF5/2020	EPI_ISL_573942	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16BB2F/2020	EPI_ISL_573943	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16BE44/2020	EPI_ISL_573980	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16BE53/2020	EPI_ISL_573981	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16BE71/2020	EPI_ISL_573983	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16D9E7/2020	EPI_ISL_577477	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16DE24/2020	EPI_ISL_577541	2020-09-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/CAMC-9EC511/2020	EPI_ISL_580301	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9E6D1F/2020	EPI_ISL_580303	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E72D3/2020	EPI_ISL_580317	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E7112/2020	EPI_ISL_580372	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E60BC/2020	EPI_ISL_580375	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E6377/2020	EPI_ISL_580377	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E632C/2020	EPI_ISL_580379	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E633B/2020	EPI_ISL_580383	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	G
hCoV-19/Spain/PV-IBV-98007679/2020	EPI_ISL_582078	2020-09-13	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Northern Ireland/NIRE-1088A5/2020	EPI_ISL_585212	2020-09-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Scotland/CVR4414/2020	EPI_ISL_585288	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-16F0E0/2020	EPI_ISL_585913	2020-10-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-16F1ED/2020	EPI_ISL_585928	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16F36F/2020	EPI_ISL_585952	2020-10-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-16F3BA/2020	EPI_ISL_585957	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16F411/2020	EPI_ISL_585963	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/England/ALDP-A2E56D/2020	EPI_ISL_586578	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2E62E/2020	EPI_ISL_586579	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A2D3DD/2020	EPI_ISL_586584	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A2D66B/2020	EPI_ISL_586585	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2D416/2020	EPI_ISL_586588	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2D452/2020	EPI_ISL_586590	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A2D777/2020	EPI_ISL_586593	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-9FD656/2020	EPI_ISL_587801	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FCD34/2020	EPI_ISL_587804	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD674/2020	EPI_ISL_587833	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9FDBFD/2020	EPI_ISL_587848	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FDF5B/2020	EPI_ISL_587849	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD595/2020	EPI_ISL_587860	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FDB2A/2020	EPI_ISL_587864	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FCB3A/2020	EPI_ISL_587870	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FDC18/2020	EPI_ISL_587871	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD920/2020	EPI_ISL_587879	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD410/2020	EPI_ISL_587882	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FCF89/2020	EPI_ISL_587884	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FCDF8/2020	EPI_ISL_587887	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FDEE5/2020	EPI_ISL_587891	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-9FD304/2020	EPI_ISL_587894	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FDCEB/2020	EPI_ISL_587895	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9FCB67/2020	EPI_ISL_587898	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9FA695/2020	EPI_ISL_588106	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9FA3DA/2020	EPI_ISL_588115	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9FAD09/2020	EPI_ISL_588120	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9FA3F8/2020	EPI_ISL_588130	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9FB0F0/2020	EPI_ISL_588132	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9FA8F9/2020	EPI_ISL_588147	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9FABF0/2020	EPI_ISL_588154	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9FA5E3/2020	EPI_ISL_588156	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-9FB56A/2020	EPI_ISL_588166	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9FA7DE/2020	EPI_ISL_588182	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9FADAF/2020	EPI_ISL_588190	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FA361/2020	EPI_ISL_588191	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9FAC0C/2020	EPI_ISL_588200	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9E5C22/2020	EPI_ISL_589426	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E5BCB/2020	EPI_ISL_589436	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E5C31/2020	EPI_ISL_589448	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E5BAD/2020	EPI_ISL_589456	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E5BDA/2020	EPI_ISL_589458	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E5A0A/2020	EPI_ISL_589459	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E5A19/2020	EPI_ISL_589473	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E5BBC/2020	EPI_ISL_589479	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E585B/2020	EPI_ISL_589484	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9E5CD7/2020	EPI_ISL_589505	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9E57B8/2020	EPI_ISL_589532	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E57E5/2020	EPI_ISL_589533	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9B561E/2020	EPI_ISL_590411	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B52A1/2020	EPI_ISL_590435	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Northern Ireland/QEUH-9B459A/2020	EPI_ISL_590457	2020-09-04	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B7579/2020	EPI_ISL_590508	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9EF7FA/2020	EPI_ISL_594944	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-47E063/2020	EPI_ISL_595398	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-A58834/2020	EPI_ISL_597166	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A59675/2020	EPI_ISL_597179	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A58E6F/2020	EPI_ISL_597181	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A58CDE/2020	EPI_ISL_597182	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-A593F6/2020	EPI_ISL_597184	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A5854C/2020	EPI_ISL_597193	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/CAMC-A58DAE/2020	EPI_ISL_597199	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A57E60/2020	EPI_ISL_597202	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A57E42/2020	EPI_ISL_597206	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A58B1D/2020	EPI_ISL_597218	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A5E91D/2020	EPI_ISL_597235	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A57282/2020	EPI_ISL_597238	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A5E124/2020	EPI_ISL_597240	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A5703D/2020	EPI_ISL_597253	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A5E69E/2020	EPI_ISL_597260	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-A5E31F/2020	EPI_ISL_597278	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A51E39/2020	EPI_ISL_597907	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A511B8/2020	EPI_ISL_597915	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A5116D/2020	EPI_ISL_597916	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A51701/2020	EPI_ISL_597923	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A516F5/2020	EPI_ISL_597926	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A5177A/2020	EPI_ISL_597939	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A5223C/2020	EPI_ISL_597980	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A511D6/2020	EPI_ISL_597990	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A510BB/2020	EPI_ISL_597991	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A46D94/2020	EPI_ISL_598498	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A47CB4/2020	EPI_ISL_598503	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A46CD3/2020	EPI_ISL_598507	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A47DEE/2020	EPI_ISL_598508	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 5 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/MILK-A47522/2020	EPI_ISL_598512	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A46E82/2020	EPI_ISL_598515	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-A478FC/2020	EPI_ISL_598522	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A45BF5/2020	EPI_ISL_598537	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-A466F3/2020	EPI_ISL_598539	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A4575B/2020	EPI_ISL_598542	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/MILK-A44D0F/2020	EPI_ISL_598547	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A44C7B/2020	EPI_ISL_598557	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A44FEB/2020	EPI_ISL_598590	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A45858/2020	EPI_ISL_598595	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A45032/2020	EPI_ISL_598596	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9DE406/2020	EPI_ISL_599805	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9DD1E2/2020	EPI_ISL_599813	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A06871/2020	EPI_ISL_599846	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-A05F40/2020	EPI_ISL_599866	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A05AF4/2020	EPI_ISL_599872	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/MILK-A05DDD/2020	EPI_ISL_599895	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-9D3C72/2020	EPI_ISL_601649	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-9D22EA/2020	EPI_ISL_601657	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-A7DF43/2020	EPI_ISL_606468	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7AA09/2020	EPI_ISL_606471	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7D1B6/2020	EPI_ISL_606478	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7D699/2020	EPI_ISL_606483	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7D839/2020	EPI_ISL_606494	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7A6E7/2020	EPI_ISL_606503	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7D3CF/2020	EPI_ISL_606513	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7CA43/2020	EPI_ISL_606515	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7AABE/2020	EPI_ISL_606529	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A7CB40/2020	EPI_ISL_606537	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7D57E/2020	EPI_ISL_606538	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7DDD0/2020	EPI_ISL_606539	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7DE0A/2020	EPI_ISL_606542	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7D884/2020	EPI_ISL_606546	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7D2FF/2020	EPI_ISL_606556	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7CDB3/2020	EPI_ISL_606564	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7C71F/2020	EPI_ISL_606568	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-A7C436/2020	EPI_ISL_606572	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-A7D787/2020	EPI_ISL_606576	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6EE2A/2020	EPI_ISL_607012	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6F014/2020	EPI_ISL_607015	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6C967/2020	EPI_ISL_607016	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6EE0C/2020	EPI_ISL_607018	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6FC98/2020	EPI_ISL_607021	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6DD97/2020	EPI_ISL_607032	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6CC5F/2020	EPI_ISL_607035	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6E31C/2020	EPI_ISL_607043	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6EE84/2020	EPI_ISL_607047	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6EE75/2020	EPI_ISL_607058	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6E112/2020	EPI_ISL_607066	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6DA09/2020	EPI_ISL_607068	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6C9B2/2020	EPI_ISL_607073	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6FB6E/2020	EPI_ISL_607075	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6F8B2/2020	EPI_ISL_607078	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6FC89/2020	EPI_ISL_607090	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6E83B/2020	EPI_ISL_607793	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A7061E/2020	EPI_ISL_607796	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F64F/2020	EPI_ISL_607797	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6DF91/2020	EPI_ISL_607800	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6E09D/2020	EPI_ISL_607805	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6EA80/2020	EPI_ISL_607825	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6E76B/2020	EPI_ISL_607831	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A706D2/2020	EPI_ISL_607848	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F0AB/2020	EPI_ISL_607870	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6D4A1/2020	EPI_ISL_608303	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6D17D/2020	EPI_ISL_608315	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/CAMC-A64F8B/2020	EPI_ISL_608348	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-A64F4F/2020	EPI_ISL_608357	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A68CBD/2020	EPI_ISL_608369	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A64F7C/2020	EPI_ISL_608382	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A68400/2020	EPI_ISL_608387	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A64F5E/2020	EPI_ISL_608389	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A64E51/2020	EPI_ISL_608392	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A68C35/2020	EPI_ISL_608399	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3E4D6/2020	EPI_ISL_609612	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F156/2020	EPI_ISL_609618	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A3EB77/2020	EPI_ISL_609632	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3E4B8/2020	EPI_ISL_609651	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A3E5F1/2020	EPI_ISL_609654	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3ECDE/2020	EPI_ISL_609655	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A3E500/2020	EPI_ISL_609660	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A3F97C/2020	EPI_ISL_609667	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A3EF8A/2020	EPI_ISL_609676	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-A3F96D/2020	EPI_ISL_609682	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3E4A9/2020	EPI_ISL_609685	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F208/2020	EPI_ISL_609688	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F745/2020	EPI_ISL_609690	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A3E44F/2020	EPI_ISL_609696	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3F709/2020	EPI_ISL_609698	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A3F37E/2020	EPI_ISL_609708	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3ECED/2020	EPI_ISL_609709	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A3F2DB/2020	EPI_ISL_609712	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A3F7DC/2020	EPI_ISL_609714	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A3E685/2020	EPI_ISL_609717	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A3FA00/2020	EPI_ISL_609720	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A860CC/2020	EPI_ISL_610601	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A84D6D/2020	EPI_ISL_610626	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/CAMC-A80FB6/2020	EPI_ISL_610629	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A8101C/2020	EPI_ISL_610636	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A81155/2020	EPI_ISL_610637	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A80DCB/2020	EPI_ISL_610642	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A81A3C/2020	EPI_ISL_610649	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A824F1/2020	EPI_ISL_610650	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A82E5D/2020	EPI_ISL_610658	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/CAMC-A81FF1/2020	EPI_ISL_610662	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A80C91/2020	EPI_ISL_610671	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A8227F/2020	EPI_ISL_610701	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A822BB/2020	EPI_ISL_610704	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A96E74/2020	EPI_ISL_611012	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A9482D/2020	EPI_ISL_611024	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A93ADD/2020	EPI_ISL_611039	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A92564/2020	EPI_ISL_611058	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A92E2D/2020	EPI_ISL_611059	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A94438/2020	EPI_ISL_611061	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A93DD4/2020	EPI_ISL_611075	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A923C4/2020	EPI_ISL_611086	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A19538/2020	EPI_ISL_611968	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/EXET-138235/2020	EPI_ISL_612392	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/EXET-13836F/2020	EPI_ISL_612395	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/EXET-13838D/2020	EPI_ISL_612396	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/EXET-13839C/2020	EPI_ISL_612397	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/EXET-1383AB/2020	EPI_ISL_612398	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/ALDP-AA126B/2020	EPI_ISL_623909	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA32E1/2020	EPI_ISL_623913	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AAE4D1/2020	EPI_ISL_623934	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA11D7/2020	EPI_ISL_623936	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA318A/2020	EPI_ISL_623941	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA5188/2020	EPI_ISL_623970	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA19B1/2020	EPI_ISL_623981	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA10F8/2020	EPI_ISL_624321	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA47C3/2020	EPI_ISL_624331	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA3B6E/2020	EPI_ISL_624343	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA1544/2020	EPI_ISL_624345	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA2798/2020	EPI_ISL_624361	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2886/2020	EPI_ISL_624371	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA471E/2020	EPI_ISL_624377	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA3D77/2020	EPI_ISL_624381	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2024/2020	EPI_ISL_624390	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA1D88/2020	EPI_ISL_624393	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA424A/2020	EPI_ISL_624394	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2367/2020	EPI_ISL_624398	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Belgium/ULG-10597/2020	EPI_ISL_626261	2020-10-23	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Northern Ireland/NIRE-108CB8/2020	EPI_ISL_627550	2020-10-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108CC7/2020	EPI_ISL_627551	2020-10-06	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-108CD6/2020	EPI_ISL_627552	2020-10-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108CF4/2020	EPI_ISL_627553	2020-10-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108D3D/2020	EPI_ISL_627555	2020-10-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-108D5B/2020	EPI_ISL_627556	2020-10-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-108DA6/2020	EPI_ISL_627559	2020-10-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108DB5/2020	EPI_ISL_627560	2020-10-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Northern Ireland/NIRE-108DE2/2020	EPI_ISL_627563	2020-10-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108E0D/2020	EPI_ISL_627564	2020-10-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108E49/2020	EPI_ISL_627566	2020-10-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108E58/2020	EPI_ISL_627567	2020-10-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-108E85/2020	EPI_ISL_627569	2020-10-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/MILK-ACBD79/2020	EPI_ISL_629133	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC82E6/2020	EPI_ISL_629134	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACE909/2020	EPI_ISL_629135	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACBE0D/2020	EPI_ISL_629150	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC928B/2020	EPI_ISL_629155	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-AC8671/2020	EPI_ISL_629169	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC8635/2020	EPI_ISL_629204	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-AC9397/2020	EPI_ISL_630102	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACDEB0/2020	EPI_ISL_630105	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ACE12F/2020	EPI_ISL_630132	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ACD08D/2020	EPI_ISL_630133	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACCCB7/2020	EPI_ISL_630154	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC777F/2020	EPI_ISL_630158	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AE4DB6/2020	EPI_ISL_633303	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE5061/2020	EPI_ISL_633310	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-AEAE71/2020	EPI_ISL_633345	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE4C13/2020	EPI_ISL_633352	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AE4EA4/2020	EPI_ISL_633355	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/CAMC-AEB13B/2020	EPI_ISL_633359	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AEAC3B/2020	EPI_ISL_633374	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AE4E1D/2020	EPI_ISL_633377	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AE53D1/2020	EPI_ISL_633381	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD588A/2020	EPI_ISL_634615	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD5E88/2020	EPI_ISL_634617	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD41AE/2020	EPI_ISL_634622	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD4C9E/2020	EPI_ISL_634638	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD1F4D/2020	EPI_ISL_634643	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD4C16/2020	EPI_ISL_634648	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD1E7D/2020	EPI_ISL_634653	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AD41CC/2020	EPI_ISL_634657	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD35B2/2020	EPI_ISL_634668	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-AD1930/2020	EPI_ISL_634694	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Norway/4617/2020	EPI_ISL_635065	2020-09-30	Europe / Norway / Vestland	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.177.60	GV
hCoV-19/Norway/4695/2020	EPI_ISL_635068	2020-10-14	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.177.60	GV
hCoV-19/Norway/4697/2020	EPI_ISL_635069	2020-10-15	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.177.60	GV
hCoV-19/Norway/4698/2020	EPI_ISL_635070	2020-10-15	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.177.60	GV
hCoV-19/Norway/4745/2020	EPI_ISL_635073	2020-10-20	Europe / Norway / Troms og Finnmark	Human	Original	Respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.177.60	GV
hCoV-19/England/ALDP-9E76C8/2020	EPI_ISL_638211	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-9E77F2/2020	EPI_ISL_638223	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/ALDP-9E780E/2020	EPI_ISL_638224	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-9E7859/2020	EPI_ISL_638227	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-9E7DA5/2020	EPI_ISL_638229	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/ALDP-9E80E7/2020	EPI_ISL_638236	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/ALDP-9E8120/2020	EPI_ISL_638239	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-9E84AF/2020	EPI_ISL_638249	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-9E8797/2020	EPI_ISL_638255	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-9E87B5/2020	EPI_ISL_638257	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/ALDP-9E8894/2020	EPI_ISL_638262	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-9E8A61/2020	EPI_ISL_638276	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-B13F4E/2020	EPI_ISL_641845	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B14208/2020	EPI_ISL_641852	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B106C4/2020	EPI_ISL_641858	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B0F710/2020	EPI_ISL_641859	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B13719/2020	EPI_ISL_641861	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B13A5C/2020	EPI_ISL_641867	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B13764/2020	EPI_ISL_641877	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B10749/2020	EPI_ISL_641891	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B0EAEB/2020	EPI_ISL_642106	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B0DD4D/2020	EPI_ISL_642114	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0E1D7/2020	EPI_ISL_642120	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0F32B/2020	EPI_ISL_642132	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-B0AF2C/2020	EPI_ISL_643409	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B07E31/2020	EPI_ISL_643416	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0B750/2020	EPI_ISL_643419	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0CBBD/2020	EPI_ISL_643433	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-AD4AD0/2020	EPI_ISL_644011	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Scotland/QEUH-AD4B64/2020	EPI_ISL_644024	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-AC77E8/2020	EPI_ISL_644053	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B3D500/2020	EPI_ISL_645300	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B363EF/2020	EPI_ISL_645304	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B370E7/2020	EPI_ISL_645305	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B36938/2020	EPI_ISL_645309	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B35E2B/2020	EPI_ISL_645310	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B375D9/2020	EPI_ISL_645312	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B3672F/2020	EPI_ISL_645316	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B3D55B/2020	EPI_ISL_645319	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B3D4E5/2020	EPI_ISL_645327	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B3D48B/2020	EPI_ISL_645329	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B36868/2020	EPI_ISL_645351	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B36701/2020	EPI_ISL_645353	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B3D6D0/2020	EPI_ISL_645354	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B37393/2020	EPI_ISL_645355	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B37384/2020	EPI_ISL_645361	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B26063/2020	EPI_ISL_646610	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B24F4A/2020	EPI_ISL_646618	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B2B981/2020	EPI_ISL_646619	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B24F59/2020	EPI_ISL_646631	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2B57E/2020	EPI_ISL_646641	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B25EB5/2020	EPI_ISL_646652	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B2C908/2020	EPI_ISL_646657	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B2B839/2020	EPI_ISL_646663	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B24FA4/2020	EPI_ISL_646666	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2B7C3/2020	EPI_ISL_646667	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B26300/2020	EPI_ISL_646684	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B26160/2020	EPI_ISL_646691	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B252F5/2020	EPI_ISL_646692	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B2394D/2020	EPI_ISL_647000	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2D9BC/2020	EPI_ISL_647001	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2D7A3/2020	EPI_ISL_647003	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B23682/2020	EPI_ISL_647011	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B23619/2020	EPI_ISL_647019	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2DB10/2020	EPI_ISL_647035	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B241EA/2020	EPI_ISL_647056	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-B239A7/2020	EPI_ISL_647062	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B242E7/2020	EPI_ISL_647065	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B23761/2020	EPI_ISL_647084	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B2479D/2020	EPI_ISL_647085	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B2D98F/2020	EPI_ISL_647087	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B24557/2020	EPI_ISL_647093	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B24636/2020	EPI_ISL_647095	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/QEUH-AD4302/2020	EPI_ISL_647922	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/QEUH-AD42AB/2020	EPI_ISL_647926	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/QEUH-AD577E/2020	EPI_ISL_647940	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B0802B/2020	EPI_ISL_649625	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/CAMC-B0C485/2020	EPI_ISL_649628	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/Scotland/QEUH-AD1657/2020	EPI_ISL_649687	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Scotland/CVR5683/2020	EPI_ISL_651906	2020-11-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-489D8C/2020	EPI_ISL_652489	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-489E98/2020	EPI_ISL_652502	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-48A161/2020	EPI_ISL_652528	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B62D28/2020	EPI_ISL_655401	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5B1BD/2020	EPI_ISL_655409	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B62D0A/2020	EPI_ISL_655426	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B63C0C/2020	EPI_ISL_655434	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B5B1EA/2020	EPI_ISL_655435	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B62D91/2020	EPI_ISL_655438	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B4659B/2020	EPI_ISL_656014	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B4621C/2020	EPI_ISL_656018	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B46ECD/2020	EPI_ISL_656035	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B5224A/2020	EPI_ISL_656724	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B544D9/2020	EPI_ISL_656748	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B5258D/2020	EPI_ISL_656769	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B522E0/2020	EPI_ISL_656800	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B53759/2020	EPI_ISL_656803	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B54327/2020	EPI_ISL_656804	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B56BD2/2020	EPI_ISL_656810	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B433D0/2020	EPI_ISL_657301	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B43613/2020	EPI_ISL_657303	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B4369B/2020	EPI_ISL_657312	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B404A3/2020	EPI_ISL_657332	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-B529BE/2020	EPI_ISL_657366	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B3F850/2020	EPI_ISL_658600	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B3F999/2020	EPI_ISL_658602	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B3F6ED/2020	EPI_ISL_658610	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B41C7D/2020	EPI_ISL_658622	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B41457/2020	EPI_ISL_658633	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B41035/2020	EPI_ISL_658636	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B4177C/2020	EPI_ISL_658638	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B3FBFD/2020	EPI_ISL_658645	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B3F7F9/2020	EPI_ISL_658651	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B40F75/2020	EPI_ISL_658656	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B411E7/2020	EPI_ISL_658659	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B3FCDC/2020	EPI_ISL_658665	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B3F2DA/2020	EPI_ISL_658677	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B3FC18/2020	EPI_ISL_658679	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B3FB39/2020	EPI_ISL_658680	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B3F261/2020	EPI_ISL_658689	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B4124E/2020	EPI_ISL_658696	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B394F8/2020	EPI_ISL_659008	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B3857E/2020	EPI_ISL_659036	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B38A8E/2020	EPI_ISL_659049	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B37FEA/2020	EPI_ISL_659050	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B39373/2020	EPI_ISL_659065	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B38268/2020	EPI_ISL_659076	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B38866/2020	EPI_ISL_659081	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B38A51/2020	EPI_ISL_659089	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2D3CD/2020	EPI_ISL_659924	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B2FCFD/2020	EPI_ISL_659925	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B30BED/2020	EPI_ISL_659943	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2DEF9/2020	EPI_ISL_659944	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B30AB3/2020	EPI_ISL_659946	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2CEAF/2020	EPI_ISL_660006	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2D2EE/2020	EPI_ISL_660015	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B2DEAE/2020	EPI_ISL_660016	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B2E8AF/2020	EPI_ISL_660030	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2EF7D/2020	EPI_ISL_660035	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B2F6C2/2020	EPI_ISL_660036	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-B2E863/2020	EPI_ISL_660039	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B2D460/2020	EPI_ISL_660040	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B2D442/2020	EPI_ISL_660060	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/England/QEUH-B66EE5/2020	EPI_ISL_661315	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B66F79/2020	EPI_ISL_661316	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B6983F/2020	EPI_ISL_661361	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B664D4/2020	EPI_ISL_661380	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B66C18/2020	EPI_ISL_662615	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5C635/2020	EPI_ISL_662623	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B6C0E9/2020	EPI_ISL_662627	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF00FA/2020	EPI_ISL_662655	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AEFC81/2020	EPI_ISL_662681	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF0F75/2020	EPI_ISL_662689	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF04FE/2020	EPI_ISL_662690	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AEFBB1/2020	EPI_ISL_662698	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AF52C2/2020	EPI_ISL_663109	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AF517A/2020	EPI_ISL_663120	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF4946/2020	EPI_ISL_663121	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AF5ACA/2020	EPI_ISL_663136	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AF4B31/2020	EPI_ISL_663153	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF48C1/2020	EPI_ISL_663154	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF4E47/2020	EPI_ISL_663158	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF575A/2020	EPI_ISL_663163	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AF5EDD/2020	EPI_ISL_663170	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF563F/2020	EPI_ISL_663173	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF6962/2020	EPI_ISL_663198	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AF53B0/2020	EPI_ISL_663204	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/LOND-1250BDE/2020	EPI_ISL_665805	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/LOND-1250DE7/2020	EPI_ISL_665816	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.2	GV
hCoV-19/England/LOND-125140F/2020	EPI_ISL_665848	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B065F1/2020	EPI_ISL_665865	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NORW-F2CC1/2020	EPI_ISL_665876	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-B81A95/2020	EPI_ISL_668004	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B79D6A/2020	EPI_ISL_668019	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B09A95/2020	EPI_ISL_672914	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B09F1E/2020	EPI_ISL_672955	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0A5A2/2020	EPI_ISL_672978	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B09EE4/2020	EPI_ISL_672989	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B99D46/2020	EPI_ISL_673300	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B9AFE5/2020	EPI_ISL_673302	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B99DEC/2020	EPI_ISL_673309	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B997EE/2020	EPI_ISL_673311	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B99C2B/2020	EPI_ISL_673324	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B99D19/2020	EPI_ISL_673338	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B99C67/2020	EPI_ISL_673363	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B98D83/2020	EPI_ISL_673364	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B98FBA/2020	EPI_ISL_673372	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B9ABC3/2020	EPI_ISL_673374	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B98FD8/2020	EPI_ISL_673375	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B9A158/2020	EPI_ISL_673381	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B8E00F/2020	EPI_ISL_674602	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/MILK-B8F745/2020	EPI_ISL_674610	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8EDDB/2020	EPI_ISL_674638	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8ECA1/2020	EPI_ISL_674650	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B7F599/2020	EPI_ISL_674655	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8EC92/2020	EPI_ISL_674694	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B8096C/2020	EPI_ISL_674698	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8FA1F/2020	EPI_ISL_674699	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B95E29/2020	EPI_ISL_675100	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B96B9A/2020	EPI_ISL_675116	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				V.1	GV
hCoV-19/England/CAMC-B9804E/2020	EPI_ISL_675120	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B95973/2020	EPI_ISL_675122	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B96C79/2020	EPI_ISL_675125	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8F1A1/2020	EPI_ISL_675131	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B83C7F/2020	EPI_ISL_675175	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8EE6F/2020	EPI_ISL_675179	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B83A84/2020	EPI_ISL_675192	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B829F1/2020	EPI_ISL_675194	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B8CA12/2020	EPI_ISL_675933	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B896C6/2020	EPI_ISL_675938	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8C854/2020	EPI_ISL_675998	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-B2B972/2020	EPI_ISL_676430	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/LOND-126372F/2020	EPI_ISL_679471	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Scotland/EDB10180/2020	EPI_ISL_680493	2020-11-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Wales/PHWC-48F2D2/2020	EPI_ISL_681072	2020-11-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-48F348/2020	EPI_ISL_681078	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-48F463/2020	EPI_ISL_681095	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-48F4AF/2020	EPI_ISL_681099	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/204961122/2020	EPI_ISL_700687	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/ALDP-BB3CB2/2020	EPI_ISL_701908	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BB3942/2020	EPI_ISL_701917	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BBAF94/2020	EPI_ISL_701922	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BBB476/2020	EPI_ISL_701940	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB3C85/2020	EPI_ISL_701944	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-BBA1BC/2020	EPI_ISL_701946	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB547C/2020	EPI_ISL_701948	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BB5148/2020	EPI_ISL_701954	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BBB142/2020	EPI_ISL_701968	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB3C67/2020	EPI_ISL_701981	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BB9E98/2020	EPI_ISL_701982	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB505A/2020	EPI_ISL_701984	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BBB0DC/2020	EPI_ISL_701998	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BD235E/2020	EPI_ISL_702346	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BD1780/2020	EPI_ISL_702348	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BD1F3D/2020	EPI_ISL_702360	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BD2303/2020	EPI_ISL_702368	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-BBA468/2020	EPI_ISL_702371	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BB4E24/2020	EPI_ISL_702373	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BBA90F/2020	EPI_ISL_702377	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BB96AF/2020	EPI_ISL_702378	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB4A4E/2020	EPI_ISL_702383	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB9BDD/2020	EPI_ISL_702390	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BB92D8/2020	EPI_ISL_702397	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB4E8E/2020	EPI_ISL_702398	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BCA2B6/2020	EPI_ISL_703613	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCA7B7/2020	EPI_ISL_703615	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BCA289/2020	EPI_ISL_703628	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BC4489/2020	EPI_ISL_703677	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCA2C5/2020	EPI_ISL_703686	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BCA948/2020	EPI_ISL_703699	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BC4AA5/2020	EPI_ISL_704135	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	O
hCoV-19/England/QEUH-BC3684/2020	EPI_ISL_704143	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCB437/2020	EPI_ISL_704160	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCC72E/2020	EPI_ISL_704186	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCB464/2020	EPI_ISL_704188	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCC6E5/2020	EPI_ISL_704199	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BC0F7D/2020	EPI_ISL_704906	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-BC002F/2020	EPI_ISL_704907	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BC0414/2020	EPI_ISL_704975	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BC006B/2020	EPI_ISL_704988	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-491D27/2020	EPI_ISL_706771	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-492227/2020	EPI_ISL_706831	2020-11-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-492263/2020	EPI_ISL_706832	2020-11-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Belgium/ULG-11015/2020	EPI_ISL_708459	2020-11-17	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/England/CAMC-BFB638/2020	EPI_ISL_709001	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BF475A/2020	EPI_ISL_709039	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BDB698/2020	EPI_ISL_709738	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BDBF15/2020	EPI_ISL_709761	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BDB65C/2020	EPI_ISL_709764	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BDC239/2020	EPI_ISL_709792	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BDBFF7/2020	EPI_ISL_709794	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/ALDP-BB50A5/2020	EPI_ISL_710704	2020-11-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177.56	GV
hCoV-19/Wales/ALDP-BB4A02/2020	EPI_ISL_710722	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Denmark/DCGC-13199/2020	EPI_ISL_712646	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-15582/2020	EPI_ISL_713907	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-15722/2020	EPI_ISL_713982	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-15749/2020	EPI_ISL_713997	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/England/ALDP-C49C1A/2020	EPI_ISL_718759	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-C481EF/2020	EPI_ISL_718767	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C48149/2020	EPI_ISL_718777	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C47C76/2020	EPI_ISL_718779	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C4820A/2020	EPI_ISL_718791	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C49A5C/2020	EPI_ISL_718795	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C44EFB/2020	EPI_ISL_719160	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB049F/2020	EPI_ISL_720115	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB058D/2020	EPI_ISL_720124	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB0A9D/2020	EPI_ISL_720126	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB162F/2020	EPI_ISL_720137	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB24CA/2020	EPI_ISL_720157	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BB059C/2020	EPI_ISL_720161	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BB12C1/2020	EPI_ISL_720167	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BC84A3/2020	EPI_ISL_721410	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC86CB/2020	EPI_ISL_721413	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC7D9A/2020	EPI_ISL_721415	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC7899/2020	EPI_ISL_721419	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-BC8458/2020	EPI_ISL_721441	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC7D4F/2020	EPI_ISL_721458	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC7608/2020	EPI_ISL_721462	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BC7BEB/2020	EPI_ISL_721465	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC8494/2020	EPI_ISL_721479	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BC644B/2020	EPI_ISL_721488	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BC7A0C/2020	EPI_ISL_721491	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Netherlands/ZH-EMC-1062/2020	EPI_ISL_722797	2020-12-07	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/Netherlands/OV-RIVM-20145/2020	EPI_ISL_723315	2020-11-29	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/England/LOND-DAB3B/2020	EPI_ISL_724695	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/NORT-28846C/2020	EPI_ISL_725015	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/NORW-21F682/2020	EPI_ISL_725038	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-493657/2020	EPI_ISL_725919	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-493A2E/2020	EPI_ISL_725973	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-493A3D/2020	EPI_ISL_725974	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-493A4C/2020	EPI_ISL_725975	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4952AC/2020	EPI_ISL_726321	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4952E8/2020	EPI_ISL_726325	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-C3CBD1/2020	EPI_ISL_731712	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3CBC2/2020	EPI_ISL_731732	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3D6EE/2020	EPI_ISL_731733	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3D569/2020	EPI_ISL_731734	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3BB78/2020	EPI_ISL_731744	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3BF21/2020	EPI_ISL_731753	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3BC93/2020	EPI_ISL_731756	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3D192/2020	EPI_ISL_731765	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3BB3C/2020	EPI_ISL_731768	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3BF4F/2020	EPI_ISL_731774	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3DD16/2020	EPI_ISL_731793	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3D781/2020	EPI_ISL_731794	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-C33EFF/2020	EPI_ISL_734002	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C33E2C/2020	EPI_ISL_734012	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C342D4/2020	EPI_ISL_734019	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C487DE/2020	EPI_ISL_736607	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C4846E/2020	EPI_ISL_736634	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C48CA2/2020	EPI_ISL_736652	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C48CFD/2020	EPI_ISL_736667	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C4BBC0/2020	EPI_ISL_736678	2020-12-14	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B7A3B2/2020	EPI_ISL_741106	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-B7A525/2020	EPI_ISL_741121	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-B7A789/2020	EPI_ISL_741138	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-B7A7E3/2020	EPI_ISL_741143	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-B7A7F2/2020	EPI_ISL_741144	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-B7A80E/2020	EPI_ISL_741145	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-B7A868/2020	EPI_ISL_741149	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-B7AA26/2020	EPI_ISL_741154	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-B7AACC/2020	EPI_ISL_741159	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-B7B58E/2020	EPI_ISL_741181	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-B7DB99/2020	EPI_ISL_741902	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/QEUH-B7DBC6/2020	EPI_ISL_741904	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-B7DC87/2020	EPI_ISL_741912	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.2	GV
hCoV-19/England/QEUH-B7DCE1/2020	EPI_ISL_741915	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/QEUH-B7DD39/2020	EPI_ISL_741919	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/QEUH-B7DFCA/2020	EPI_ISL_741933	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-49B90B/2020	EPI_ISL_742403	2020-12-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-49BF54/2020	EPI_ISL_742485	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-49BF81/2020	EPI_ISL_742487	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4A17CC/2020	EPI_ISL_743726	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A17DB/2020	EPI_ISL_743727	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A187E/2020	EPI_ISL_743736	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A1920/2020	EPI_ISL_743747	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A34F0/2020	EPI_ISL_744104	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A3539/2020	EPI_ISL_744108	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-4A3575/2020	EPI_ISL_744112	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A36EB/2020	EPI_ISL_744127	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Luxembourg/LNS4835406/2020	EPI_ISL_744144	2020-11-11	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Denmark/DCGC-18946/2020	EPI_ISL_748657	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-18428/2020	EPI_ISL_749960	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-18450/2020	EPI_ISL_749975	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-17372/2020	EPI_ISL_750940	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-17385/2020	EPI_ISL_750947	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-17389/2020	EPI_ISL_750949	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-17398/2020	EPI_ISL_750956	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Ireland/MN-NVRL-78IRL71980/2020	EPI_ISL_752546	2020-11-22	Europe / Ireland / Monaghan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/LK-NVRL-78IRL69457/2020	EPI_ISL_752550	2020-11-23	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/WW-NVRL-78IRL70235/2020	EPI_ISL_752552	2020-11-23	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CO-NVRL-78IRL70434/2020	EPI_ISL_752553	2020-11-22	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/G-NVRL-78IRL71368/2020	EPI_ISL_752554	2020-11-23	Europe / Ireland / Galway	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/KE-NVRL-78IRL71660/2020	EPI_ISL_752555	2020-11-23	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/England/205141198/2020	EPI_ISL_756146	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/205141214/2020	EPI_ISL_756153	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205141222/2020	EPI_ISL_756157	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205141224/2020	EPI_ISL_756158	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.55	GV
hCoV-19/England/205141228/2020	EPI_ISL_756159	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/Denmark/DCGC-20786/2020	EPI_ISL_759362	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-20789/2020	EPI_ISL_759364	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/ALDP-CB59A9/2020	EPI_ISL_761676	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Netherlands/ZH-EMC-1125/2020	EPI_ISL_763204	2020-12-16	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/Netherlands/ZH-EMC-1229/2020	EPI_ISL_763298	2020-12-21	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/England/NOTT-121952/2020	EPI_ISL_764524	2020-12-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Northern Ireland/OXON-F40533/2020	EPI_ISL_764532	2020-12-08	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/OXON-F40885/2020	EPI_ISL_764539	2020-12-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/OXON-F40A07/2020	EPI_ISL_764543	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4A39B5/2020	EPI_ISL_764594	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/PORT-2D5B7A/2020	EPI_ISL_765137	2020-12-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/SHEF-10CF77E/2020	EPI_ISL_765173	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10D00F7/2020	EPI_ISL_765175	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10D02C4/2020	EPI_ISL_765176	2020-12-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10D4F9C/2020	EPI_ISL_765198	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/205140908/2020	EPI_ISL_766404	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/205160918/2020	EPI_ISL_766424	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/MILK-C609E9/2020	EPI_ISL_769409	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C60CE0/2020	EPI_ISL_769444	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C5BBFA/2020	EPI_ISL_769450	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C60C68/2020	EPI_ISL_769451	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C5BB81/2020	EPI_ISL_769482	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr237564/2020	EPI_ISL_770498	2020-12-22	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.60	GV
hCoV-19/Lithuania/MR-LUHS-Eilnr572/2020	EPI_ISL_770499	2020-11-12	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.177.60	GV
hCoV-19/Luxembourg/LNS9018804/2020	EPI_ISL_771003	2020-12-02	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/England/QEUH-C9383B/2020	EPI_ISL_777112	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C8C194/2020	EPI_ISL_777119	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C8C54D/2020	EPI_ISL_777126	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C8C49B/2020	EPI_ISL_777193	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-CB7C17/2020	EPI_ISL_777841	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-CB7EC6/2020	EPI_ISL_777914	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C6BA81/2020	EPI_ISL_778455	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C6BA36/2020	EPI_ISL_778471	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C6CA35/2020	EPI_ISL_778476	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C6A150/2020	EPI_ISL_778478	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C6BABE/2020	EPI_ISL_778488	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/France/ARA-122868/2020	EPI_ISL_779797	2020-12-21	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CDEA7A/2020	EPI_ISL_782406	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CECAB5/2020	EPI_ISL_782471	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C32B08/2020	EPI_ISL_782484	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C31DB8/2020	EPI_ISL_782493	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Netherlands/OV-RIVM-20751/2020	EPI_ISL_790815	2020-12-17	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/FR-RIVM-20809/2020	EPI_ISL_790866	2020-12-13	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/FR-RIVM-20810/2020	EPI_ISL_790867	2020-12-13	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/FR-RIVM-20811/2020	EPI_ISL_790868	2020-12-12	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/FR-RIVM-20817/2020	EPI_ISL_790873	2020-12-22	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Denmark/DCGC-22675/2020	EPI_ISL_794448	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-22687/2020	EPI_ISL_794458	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-22689/2020	EPI_ISL_794460	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-22690/2020	EPI_ISL_794461	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-22699/2020	EPI_ISL_794467	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-22747/2020	EPI_ISL_794491	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-24719/2020	EPI_ISL_795700	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-24745/2020	EPI_ISL_795709	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-24770/2020	EPI_ISL_795723	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-24782/2020	EPI_ISL_795731	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-24871/2020	EPI_ISL_795782	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/CAMC-D39E8F/2020	EPI_ISL_798971	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-D3A39E/2020	EPI_ISL_799223	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-D45C0E/2020	EPI_ISL_799228	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/MILK-C22B0B/2020	EPI_ISL_800740	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C22C35/2020	EPI_ISL_800757	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-C1876E/2020	EPI_ISL_800760	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B81FC3/2020	EPI_ISL_801279	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B81F96/2020	EPI_ISL_801286	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B82690/2020	EPI_ISL_801296	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B81FF0/2020	EPI_ISL_801297	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.177.54	GV
hCoV-19/England/QEUH-B7FC3A/2020	EPI_ISL_801307	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B8044D/2020	EPI_ISL_801316	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B81E20/2020	EPI_ISL_801318	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B8153A/2020	EPI_ISL_801325	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B80BEE/2020	EPI_ISL_801344	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B7FC49/2020	EPI_ISL_801347	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B8042F/2020	EPI_ISL_801362	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B800FE/2020	EPI_ISL_801367	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B7FC85/2020	EPI_ISL_801374	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/210100195/2020	EPI_ISL_804258	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/MILK-E72214/2021	EPI_ISL_811456	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/MILK-E026FF/2020	EPI_ISL_812033	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Turkey/HSGM-1197/2020	EPI_ISL_812780	2020-12-30	Europe / Turkey / Ankara	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.177.4	GV
hCoV-19/England/CAMB-A995F4/2020	EPI_ISL_813262	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/TFCI-26FC627/2020	EPI_ISL_814611	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/TFCI-26FC94C/2020	EPI_ISL_814617	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/Scotland/CVR6240/2020	EPI_ISL_814625	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Scotland/CVR6260/2020	EPI_ISL_814634	2020-12-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.77	GV
hCoV-19/Scotland/CVR6261/2020	EPI_ISL_814635	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Scotland/CVR6271/2020	EPI_ISL_814640	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Wales/OXON-F42AF6/2020	EPI_ISL_814691	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Denmark/DCGC-27823/2020	EPI_ISL_815917	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27873/2020	EPI_ISL_815949	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/SHEF-10C6D57/2021	EPI_ISL_816253	2021-01-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10C7433/2020	EPI_ISL_816262	2020-12-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-10C87C0/2020	EPI_ISL_816291	2020-12-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Denmark/DCGC-26471/2021	EPI_ISL_817580	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-26231/2021	EPI_ISL_818847	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-25478/2021	EPI_ISL_818862	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-25494/2021	EPI_ISL_818863	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-25529/2021	EPI_ISL_818866	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-25632/2021	EPI_ISL_818873	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-25723/2021	EPI_ISL_818883	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-25791/2021	EPI_ISL_818889	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-25885/2021	EPI_ISL_818895	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-25953/2021	EPI_ISL_818901	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-25961/2021	EPI_ISL_818902	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-25991/2021	EPI_ISL_818906	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-26017/2021	EPI_ISL_818908	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-26093/2021	EPI_ISL_818919	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-26110/2021	EPI_ISL_818921	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-26124/2021	EPI_ISL_818924	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-26229/2021	EPI_ISL_818933	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/LOND-E259C/2020	EPI_ISL_819491	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/CAMC-DEF8B7/2020	EPI_ISL_821798	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-DB1AE5/2021	EPI_ISL_822199	2021-01-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-4ABB8A/2020	EPI_ISL_823460	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4ABDC0/2020	EPI_ISL_823483	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Iceland/4204/2021	EPI_ISL_827898	2021-01-03	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.60	GV
hCoV-19/Iceland/5876/2020	EPI_ISL_829556	2020-11-14	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	MPileup			B.1.177.60	GV
hCoV-19/Spain/MD-IBV-99013284/2020	EPI_ISL_831167	2020-09-16	Europe / Spain / Madrid / Madrid	Human	Original			IonTorrent				B.1.177	GV
hCoV-19/Spain/MD-IBV-99013312/2020	EPI_ISL_831194	2020-10-03	Europe / Spain / Madrid / Madrid	Human	Original			IonTorrent				B.1.177	GV
hCoV-19/Spain/MD-IBV-99013313/2020	EPI_ISL_831195	2020-10-03	Europe / Spain / Madrid / Madrid	Human	Original			IonTorrent				B.1.177	GV
hCoV-19/England/MILK-F739D1/2021	EPI_ISL_833789	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-E94908/2021	EPI_ISL_836768	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-E93541/2021	EPI_ISL_836789	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-E94926/2021	EPI_ISL_836790	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/205300058/2020	EPI_ISL_837218	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/205341052/2020	EPI_ISL_837225	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.55	GV
hCoV-19/England/LIVE-DCF38F/2020	EPI_ISL_838550	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina	unknown			B.1.177.57	GV
hCoV-19/England/LIVE-DD39C2/2020	EPI_ISL_838634	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina	unknown			B.1.177.57	GV
hCoV-19/England/NORW-224F8F/2021	EPI_ISL_839925	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NOTT-120072/2020	EPI_ISL_839988	2020-12-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-4B4FA0/2021	EPI_ISL_841263	2021-01-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/Denmark/DCGC-29753/2020	EPI_ISL_843800	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-29765/2020	EPI_ISL_843812	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-31039/2021	EPI_ISL_847376	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 21575 (frameshift confirmed by the submitter). NSP11 without BLAST coverage.	info	U.2	GV
hCoV-19/Denmark/DCGC-30602/2021	EPI_ISL_847401	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-30827/2021	EPI_ISL_847440	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-30863/2021	EPI_ISL_847447	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-30935/2021	EPI_ISL_847462	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-31076/2021	EPI_ISL_847486	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-31464/2021	EPI_ISL_855844	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-32006/2021	EPI_ISL_856422	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-32047/2021	EPI_ISL_856463	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/England/CAMC-FB1F99/2021	EPI_ISL_857739	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-F4B0A0/2021	EPI_ISL_858089	2021-01-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/ALDP-CB53AB/2020	EPI_ISL_859352	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/ALDP-CB67F9/2020	EPI_ISL_859362	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-1004528/2021	EPI_ISL_863506	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-1005C22/2021	EPI_ISL_863529	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/NORW-2205CD/2021	EPI_ISL_866542	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/NORW-220615/2021	EPI_ISL_866545	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/NORW-2206CA/2021	EPI_ISL_866553	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.60	GV
hCoV-19/England/OXON-F4A95B/2021	EPI_ISL_867120	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/OXON-F4A96A/2021	EPI_ISL_867121	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/SHEF-10C856C/2021	EPI_ISL_868410	2021-01-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10C93DA/2021	EPI_ISL_868428	2021-01-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/SHEF-10CB077/2021	EPI_ISL_868458	2021-01-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-10CB217/2021	EPI_ISL_868461	2021-01-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/SHEF-10CD39A/2021	EPI_ISL_868493	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Denmark/DCGC-32719/2021	EPI_ISL_869723	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-32729/2021	EPI_ISL_869733	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-33690/2021	EPI_ISL_870700	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33712/2021	EPI_ISL_870722	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33726/2021	EPI_ISL_870736	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33740/2021	EPI_ISL_870750	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-33742/2021	EPI_ISL_870752	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-33744/2021	EPI_ISL_870754	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33753/2021	EPI_ISL_870763	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33999/2021	EPI_ISL_871009	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-34011/2021	EPI_ISL_871021	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-34026/2021	EPI_ISL_871036	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-34027/2021	EPI_ISL_871037	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-34033/2021	EPI_ISL_871043	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-34051/2021	EPI_ISL_871061	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/England/MILK-10282AF/2021	EPI_ISL_873724	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1006BCA/2021	EPI_ISL_874984	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-1068C4B/2021	EPI_ISL_879100	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-10681E2/2021	EPI_ISL_879124	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-101B193/2021	EPI_ISL_880086	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-1027B87/2021	EPI_ISL_880800	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1014789/2021	EPI_ISL_881401	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-100E087/2021	EPI_ISL_881423	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-10B675C/2021	EPI_ISL_885631	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Belgium/rega-1580/2020	EPI_ISL_890256	2020-12-23	Europe / Belgium / Sint-Gillis	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1586/2020	EPI_ISL_890262	2020-12-23	Europe / Belgium / Tessenderlo	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1592/2020	EPI_ISL_890267	2020-12-23	Europe / Belgium / Holsbeek	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1598/2020	EPI_ISL_890273	2020-12-24	Europe / Belgium / Erps-Kwerps	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1639/2020	EPI_ISL_890295	2020-12-30	Europe / Belgium / Meerhout	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-1645/2021	EPI_ISL_890299	2021-01-02	Europe / Belgium / Leuven	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Switzerland/NE-ETHZ-451695/2021	EPI_ISL_899596	2021-01-13	Europe / Switzerland / Neuchatel	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/England/ALDP-10B8BE5/2021	EPI_ISL_909478	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Luxembourg/LNS6341050/2020	EPI_ISL_910416	2020-12-03	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0770745/2020	EPI_ISL_910460	2020-11-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS6128126/2020	EPI_ISL_910476	2020-12-06	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS9716777/2020	EPI_ISL_910482	2020-12-06	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS7362134/2020	EPI_ISL_910484	2020-12-06	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS5706867/2020	EPI_ISL_910485	2020-12-06	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS7205718/2020	EPI_ISL_910487	2020-12-06	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Sweden/21-00376/2021	EPI_ISL_913360	2021-01-08	Europe / Sweden / Kronoberg	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins			B.1.177.4	GV
hCoV-19/England/ALDP-BC7FC1/2020	EPI_ISL_915987	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC6C61/2020	EPI_ISL_915990	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-BC80CD/2020	EPI_ISL_915992	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Northern Ireland/NIRE-2461CD/2021	EPI_ISL_921103	2021-01-04	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS8_R52stop results in 57.9% truncation of the protein sequence.	info	V.2	GV
hCoV-19/Northern Ireland/NIRE-24628E/2021	EPI_ISL_921113	2021-01-03	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.2	GV
hCoV-19/Northern Ireland/NIRE-2465C1/2020	EPI_ISL_921135	2020-12-31	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.2	GV
hCoV-19/Northern Ireland/NIRE-2465D0/2020	EPI_ISL_921136	2020-12-31	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS8_R52stop results in 57.9% truncation of the protein sequence.	info	V.2	GV
hCoV-19/England/NORT-1B73477/2020	EPI_ISL_921139	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina		Insertion of 2 nucleotide(s) found at refpos 28251 (Frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/England/NORW-2213FF/2020	EPI_ISL_921804	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-221429/2020	EPI_ISL_921807	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-226776/2021	EPI_ISL_921882	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-4BADEC/2021	EPI_ISL_922411	2021-01-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-1033A5E/2021	EPI_ISL_924013	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				U.1	GV
hCoV-19/England/SHEF-10C5796/2021	EPI_ISL_924082	2021-01-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Belgium/ULG-10509/2020	EPI_ISL_925362	2020-10-23	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/ULG-10805/2020	EPI_ISL_925377	2020-11-17	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/ULG-11098/2020	EPI_ISL_925390	2020-12-16	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Denmark/DCGC-35524/2021	EPI_ISL_926665	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-35548/2021	EPI_ISL_926689	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-36109/2021	EPI_ISL_927250	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-36143/2021	EPI_ISL_927284	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-36145/2021	EPI_ISL_927286	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-37375/2021	EPI_ISL_928516	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/CAMC-1102389/2021	EPI_ISL_933158	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.60	GV
hCoV-19/England/MILK-116C666/2021	EPI_ISL_938693	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Netherlands/ZE-RIVM-11047/2021	EPI_ISL_943230	2021-01-20	Europe / Netherlands / Zeeland	Human	Original			Nanopore MinION				B.1.177.54	GV
hCoV-19/England/MILK-F7283F/2021	EPI_ISL_945080	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-114F8EB/2021	EPI_ISL_947775	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-114F775/2021	EPI_ISL_948045	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/BIRM-6B540/2020	EPI_ISL_949352	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/BIRM-6B57D/2020	EPI_ISL_949354	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-1032FF6/2021	EPI_ISL_952913	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/Spain/CN-ISCIII-210140/2020	EPI_ISL_954809	2020-12-20	Europe / Spain / Islas Canarias	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.177.57	GV
hCoV-19/Spain/CM-ISCIII-210239/2020	EPI_ISL_954810	2020-08-20	Europe / Spain / Castilla la Mancha	Human	Original			Illumina MiSeq				B.1.177	GV
hCoV-19/Belgium/AZdelta2104-06121/2021	EPI_ISL_954814	2021-01-26	Europe / Belgium / Sint-Eloois-Vijve	Human	Original	Nasopharyngeal swab	unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZdelta2104-10928/2021	EPI_ISL_954816	2021-01-26	Europe / Belgium / Wingene	Human	Original	Nasopharyngeal swab	unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZdelta2104-12960/2021	EPI_ISL_954817	2021-01-26	Europe / Belgium / Oostrozebeke	Human	Original	Nasopharyngeal swab	unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/Ireland/DL-NVRL-84IRL19190/2021	EPI_ISL_959765	2021-01-21	Europe / Ireland / Donegal	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/DL-NVRL-84IRL06561/2021	EPI_ISL_959771	2021-01-20	Europe / Ireland / Donegal	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			V.1	GV
hCoV-19/Portugal/IGC_g136/2020	EPI_ISL_960751	2020-12-23	Europe / Portugal / Lisboa	Human	Original			Illumina NextSeq				B.1.177.4	GV
hCoV-19/England/ALDP-11C6451/2021	EPI_ISL_970188	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-39765/2021	EPI_ISL_971439	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-39784/2021	EPI_ISL_971461	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/ALDP-1202CF6/2021	EPI_ISL_988895	2021-02-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-10E9F3A/2021	EPI_ISL_992062	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Belgium/Jessa_11-2105-006910/2021	EPI_ISL_995496	2021-02-04	Europe / Belgium / Genk	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Northern Ireland/NIRE-23B7BA/2021	EPI_ISL_998216	2021-01-17	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23C054/2021	EPI_ISL_998270	2021-01-21	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23C063/2021	EPI_ISL_998271	2021-01-21	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		Insertion of 6 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23C0CD/2021	EPI_ISL_998273	2021-01-22	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.2	GV
hCoV-19/Northern Ireland/NIRE-23C3B5/2021	EPI_ISL_998298	2021-01-26	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/England/SHEF-10CEE89/2021	EPI_ISL_1000718	2021-02-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Switzerland/ZH-ETHZ-460928/2021	EPI_ISL_1003114	2021-01-17	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Switzerland/BS-ETHZ-440562/2021	EPI_ISL_1004598	2021-01-02	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/England/CAMC-125530E/2021	EPI_ISL_1005827	2021-02-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Norway/0949/2021	EPI_ISL_1034336	2021-01-11	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.79	GV
hCoV-19/Norway/0303/2021	EPI_ISL_1034345	2021-01-06	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Netherlands/NH-RIVM-21757/2020	EPI_ISL_1035590	2020-12-14	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/LI-RIVM-13235/2021	EPI_ISL_1035665	2021-01-11	Europe / Netherlands / Limburg	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/GE-RIVM-12675/2021	EPI_ISL_1035712	2021-01-27	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/GE-RIVM-12622/2021	EPI_ISL_1035713	2021-02-03	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/GE-RIVM-12434/2021	EPI_ISL_1035726	2021-02-03	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Belgium/UZA-UA-00162919/2021	EPI_ISL_1039211	2021-02-05	Europe / Belgium / Boechout	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Italy/ABR-IZSGC-TE361890/2020	EPI_ISL_1055816	2020-12-22	Europe / Italy / Abruzzo	Human	Original			ARTIC protocol + Illumina NestSeq500				B.1.177.77	GV
hCoV-19/Belgium/rega-2981/2021	EPI_ISL_1057024	2021-02-05	Europe / Belgium / Turnhout	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2952/2021	EPI_ISL_1057033	2021-01-27	Europe / Belgium / Arendonk	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-3049/2021	EPI_ISL_1057089	2021-02-06	Europe / Belgium / Genk	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-3012/2021	EPI_ISL_1057090	2021-02-05	Europe / Belgium / Evere	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177	GV
hCoV-19/Switzerland/BE-ETHZ-481508/2021	EPI_ISL_1059577	2021-01-04	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Denmark/DCGC-46068/2021	EPI_ISL_1065578	2021-02-08	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-47051/2020	EPI_ISL_1066562	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/England/MILK-1286656/2021	EPI_ISL_1071098	2021-02-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-1286AB4/2021	EPI_ISL_1071345	2021-02-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Belgium/UGent-1287/2021	EPI_ISL_1073890	2021-01-19	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/UGent-1289/2021	EPI_ISL_1073891	2021-01-20	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Belgium/UGent-1570/2021	EPI_ISL_1073914	2021-01-23	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Norway/3393/2021	EPI_ISL_1073941	2021-01-31	Europe / Norway / Trondelag	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.177.79	GV
hCoV-19/Norway/3403/2021	EPI_ISL_1073942	2021-02-03	Europe / Norway / Trondelag	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.177.79	GV
hCoV-19/Ireland/MH-NVRL-72IRL21078/2020	EPI_ISL_528482	2020-08-13	Europe / Ireland / Meath	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177	GV
hCoV-19/England/QEUH-990206/2020	EPI_ISL_540115	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-99342B/2020	EPI_ISL_552031	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/CAMC-99141E/2020	EPI_ISL_552051	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9930AF/2020	EPI_ISL_552054	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-992F85/2020	EPI_ISL_552070	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9931D9/2020	EPI_ISL_552075	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-991ED4/2020	EPI_ISL_552085	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-991E3E/2020	EPI_ISL_552097	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-991EB6/2020	EPI_ISL_552101	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-99288A/2020	EPI_ISL_552122	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-992E6A/2020	EPI_ISL_552141	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-970D74/2020	EPI_ISL_553256	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9C1EF9/2020	EPI_ISL_566558	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/MILK-9C2423/2020	EPI_ISL_566560	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9C22DE/2020	EPI_ISL_566570	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9C1E80/2020	EPI_ISL_566671	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C2371/2020	EPI_ISL_566673	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C401E/2020	EPI_ISL_566721	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C4728/2020	EPI_ISL_566726	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C3826/2020	EPI_ISL_566753	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C4209/2020	EPI_ISL_566757	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C4403/2020	EPI_ISL_566801	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C356B/2020	EPI_ISL_566810	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9BE91C/2020	EPI_ISL_567886	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9BDDE4/2020	EPI_ISL_567888	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9BDE0F/2020	EPI_ISL_567892	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/SHEF-C6D5A/2020	EPI_ISL_573708	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-C8A24/2020	EPI_ISL_573716	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/SHEF-C95E6/2020	EPI_ISL_573720	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/SHEF-CB274/2020	EPI_ISL_573726	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-CBC85/2020	EPI_ISL_573729	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/SHEF-CC835/2020	EPI_ISL_573732	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-CD2EB/2020	EPI_ISL_573734	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/SHEF-CDAB6/2020	EPI_ISL_573736	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-CF4C5/2020	EPI_ISL_573746	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-D12E4/2020	EPI_ISL_573750	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9D1C1A/2020	EPI_ISL_573865	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/ALDP-9BCED3/2020	EPI_ISL_573866	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16B58B/2020	EPI_ISL_573873	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16BF6F/2020	EPI_ISL_573993	2020-09-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Scotland/QEUH-9C7D14/2020	EPI_ISL_576012	2020-09-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9D14B8/2020	EPI_ISL_577287	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9AE751/2020	EPI_ISL_577370	2020-09-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/Wales/ALDP-9D9492/2020	EPI_ISL_577384	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-16D659/2020	EPI_ISL_577425	2020-09-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/England/QEUH-9E4BBD/2020	EPI_ISL_579873	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9E4BCC/2020	EPI_ISL_579885	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EAE36/2020	EPI_ISL_579977	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EA7E0/2020	EPI_ISL_579989	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9EAB8A/2020	EPI_ISL_579994	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9EA6C5/2020	EPI_ISL_579995	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-9EADA2/2020	EPI_ISL_579997	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-9EE6D0/2020	EPI_ISL_580854	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9DB0E7/2020	EPI_ISL_580865	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9DB0AB/2020	EPI_ISL_580879	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9DC7E1/2020	EPI_ISL_580962	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9DB09C/2020	EPI_ISL_580965	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9DAB05/2020	EPI_ISL_580967	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9E0EE5/2020	EPI_ISL_580976	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9DAC3F/2020	EPI_ISL_580989	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-16E3BB/2020	EPI_ISL_585709	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-16E48B/2020	EPI_ISL_585721	2020-09-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-16E49A/2020	EPI_ISL_585722	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16EA4D/2020	EPI_ISL_585809	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16EB68/2020	EPI_ISL_585827	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16EC47/2020	EPI_ISL_585841	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16F4B7/2020	EPI_ISL_585973	2020-10-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-16F4D5/2020	EPI_ISL_585975	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/England/ALDP-9FDAD2/2020	EPI_ISL_588012	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD3E6/2020	EPI_ISL_588030	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FD683/2020	EPI_ISL_588049	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9FD586/2020	EPI_ISL_588051	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-9FD1DD/2020	EPI_ISL_588052	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9FCF98/2020	EPI_ISL_588054	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9FAD45/2020	EPI_ISL_588070	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9FAA4E/2020	EPI_ISL_588092	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9FA47D/2020	EPI_ISL_588093	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F955D/2020	EPI_ISL_589201	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-9F2B07/2020	EPI_ISL_589242	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9E582E/2020	EPI_ISL_589278	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E5CAA/2020	EPI_ISL_589298	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E5BF8/2020	EPI_ISL_589300	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E59D0/2020	EPI_ISL_589372	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9E578B/2020	EPI_ISL_589373	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E57F4/2020	EPI_ISL_589378	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9B49E9/2020	EPI_ISL_590221	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B4BC5/2020	EPI_ISL_590273	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-9B4C86/2020	EPI_ISL_590301	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B56B4/2020	EPI_ISL_590305	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B4B98/2020	EPI_ISL_590311	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B4DCF/2020	EPI_ISL_590316	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B5283/2020	EPI_ISL_590333	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B4D29/2020	EPI_ISL_590334	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9B5B2E/2020	EPI_ISL_590335	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9B5A21/2020	EPI_ISL_590388	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/NOTT-114BF8/2020	EPI_ISL_595233	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114C40/2020	EPI_ISL_595235	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-115043/2020	EPI_ISL_595237	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1153A4/2020	EPI_ISL_595239	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-1153C2/2020	EPI_ISL_595240	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1153D1/2020	EPI_ISL_595241	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-1153E0/2020	EPI_ISL_595242	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-115492/2020	EPI_ISL_595244	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-115580/2020	EPI_ISL_595247	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1155AE/2020	EPI_ISL_595249	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-115632/2020	EPI_ISL_595252	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-115641/2020	EPI_ISL_595253	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11567E/2020	EPI_ISL_595255	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11575D/2020	EPI_ISL_595258	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/NOTT-11576C/2020	EPI_ISL_595259	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11577B/2020	EPI_ISL_595260	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-11578A/2020	EPI_ISL_595261	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-115799/2020	EPI_ISL_595262	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/NOTT-1157A8/2020	EPI_ISL_595263	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-115984/2020	EPI_ISL_595275	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-115A27/2020	EPI_ISL_595280	2020-10-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-115A36/2020	EPI_ISL_595281	2020-10-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-115CC7/2020	EPI_ISL_595290	2020-10-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-116112/2020	EPI_ISL_595303	2020-10-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-116121/2020	EPI_ISL_595304	2020-10-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11614F/2020	EPI_ISL_595305	2020-10-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1161B8/2020	EPI_ISL_595307	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-1161E5/2020	EPI_ISL_595309	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-116B6F/2020	EPI_ISL_595322	2020-10-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-47DB18/2020	EPI_ISL_595329	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-47DB45/2020	EPI_ISL_595331	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-47DB63/2020	EPI_ISL_595333	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-47DBCD/2020	EPI_ISL_595337	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-47DC15/2020	EPI_ISL_595342	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-47DC8E/2020	EPI_ISL_595347	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-47DD6D/2020	EPI_ISL_595359	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-47DDF4/2020	EPI_ISL_595366	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-47DE6A/2020	EPI_ISL_595371	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-47DE97/2020	EPI_ISL_595374	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-A509C0/2020	EPI_ISL_597703	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A50C5E/2020	EPI_ISL_597706	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A508B4/2020	EPI_ISL_597708	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A5090C/2020	EPI_ISL_597800	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A5075D/2020	EPI_ISL_597801	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A50EB2/2020	EPI_ISL_597817	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50B7F/2020	EPI_ISL_597822	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50C7C/2020	EPI_ISL_597825	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A5017D/2020	EPI_ISL_597846	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A5092A/2020	EPI_ISL_597854	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A5015F/2020	EPI_ISL_597855	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A4FC70/2020	EPI_ISL_597875	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A503B3/2020	EPI_ISL_597876	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A4FFE0/2020	EPI_ISL_597881	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A501AA/2020	EPI_ISL_597882	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50939/2020	EPI_ISL_597883	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A5172F/2020	EPI_ISL_597888	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A5130D/2020	EPI_ISL_597966	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A525AC/2020	EPI_ISL_597967	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A51859/2020	EPI_ISL_597995	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A51CD5/2020	EPI_ISL_597999	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A05CD0/2020	EPI_ISL_600122	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9FF9E2/2020	EPI_ISL_600153	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9FF4B4/2020	EPI_ISL_600160	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9FFAFE/2020	EPI_ISL_600182	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9FF609/2020	EPI_ISL_600183	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9FF5C0/2020	EPI_ISL_600187	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9FF830/2020	EPI_ISL_600188	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-9FF78E/2020	EPI_ISL_600207	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177	G
hCoV-19/England/QEUH-A0023D/2020	EPI_ISL_600311	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9FFDC8/2020	EPI_ISL_600313	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A0073E/2020	EPI_ISL_600315	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9FFC52/2020	EPI_ISL_600334	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9FF77F/2020	EPI_ISL_600351	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9DBDA4/2020	EPI_ISL_601467	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9E04A7/2020	EPI_ISL_601470	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9DA710/2020	EPI_ISL_601489	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-9D3CCD/2020	EPI_ISL_601490	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-9D203B/2020	EPI_ISL_601495	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/MILK-9D495C/2020	EPI_ISL_601497	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/Wales/MILK-9D3C36/2020	EPI_ISL_601510	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/MILK-9D4682/2020	EPI_ISL_601513	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9D4F2D/2020	EPI_ISL_601531	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-9D40FD/2020	EPI_ISL_601572	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-9D21A1/2020	EPI_ISL_601619	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/MILK-9D3A2D/2020	EPI_ISL_601621	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/MILK-9D4BDE/2020	EPI_ISL_601659	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/MILK-9D450D/2020	EPI_ISL_601665	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A7C287/2020	EPI_ISL_606325	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7CFDB/2020	EPI_ISL_606329	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7CA16/2020	EPI_ISL_606330	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7C2A5/2020	EPI_ISL_606342	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7CADA/2020	EPI_ISL_606352	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7C418/2020	EPI_ISL_606371	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7D602/2020	EPI_ISL_606388	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A7DAE8/2020	EPI_ISL_606398	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7D022/2020	EPI_ISL_606433	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7AADC/2020	EPI_ISL_606445	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7D24A/2020	EPI_ISL_606446	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A7D2A4/2020	EPI_ISL_606448	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7C1F3/2020	EPI_ISL_606454	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A70371/2020	EPI_ISL_607642	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F490/2020	EPI_ISL_607645	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A6E18B/2020	EPI_ISL_607652	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6EF72/2020	EPI_ISL_607661	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6F67C/2020	EPI_ISL_607666	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A70308/2020	EPI_ISL_607667	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A6E3FE/2020	EPI_ISL_607669	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A6F5F7/2020	EPI_ISL_607673	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A6EFEB/2020	EPI_ISL_607679	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A702B0/2020	EPI_ISL_607685	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F06F/2020	EPI_ISL_607692	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6EFCD/2020	EPI_ISL_607701	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F3DF/2020	EPI_ISL_607704	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6E72F/2020	EPI_ISL_607714	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6F120/2020	EPI_ISL_607719	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F041/2020	EPI_ISL_607730	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A6F66D/2020	EPI_ISL_607733	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6E74D/2020	EPI_ISL_607734	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A6E446/2020	EPI_ISL_607735	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F4EB/2020	EPI_ISL_607737	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A705F3/2020	EPI_ISL_607756	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6E75C/2020	EPI_ISL_607759	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A6E956/2020	EPI_ISL_607764	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A6F621/2020	EPI_ISL_607769	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A6F4AF/2020	EPI_ISL_607774	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A7049C/2020	EPI_ISL_607779	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6F630/2020	EPI_ISL_607787	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6900B/2020	EPI_ISL_608900	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6BFDF/2020	EPI_ISL_608901	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A6462C/2020	EPI_ISL_608910	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A68BDE/2020	EPI_ISL_608917	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A67D33/2020	EPI_ISL_608973	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A693B7/2020	EPI_ISL_608983	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A68251/2020	EPI_ISL_608991	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A68BCF/2020	EPI_ISL_608992	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A69083/2020	EPI_ISL_608999	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A93E1D/2020	EPI_ISL_611003	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/BIRM-65DB7/2020	EPI_ISL_612228	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMB-1B6624/2020	EPI_ISL_612261	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMB-1B6660/2020	EPI_ISL_612263	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-AA51A6/2020	EPI_ISL_624100	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA3111/2020	EPI_ISL_624115	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA331B/2020	EPI_ISL_624124	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA409B/2020	EPI_ISL_624125	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2E93/2020	EPI_ISL_624139	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-AA41D4/2020	EPI_ISL_624143	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2EA2/2020	EPI_ISL_624144	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA3393/2020	EPI_ISL_624150	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/ALDP-AA314E/2020	EPI_ISL_624155	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA567A/2020	EPI_ISL_624157	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-AA373D/2020	EPI_ISL_624170	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-AA4909/2020	EPI_ISL_624206	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA1C7C/2020	EPI_ISL_624209	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA1D2E/2020	EPI_ISL_624211	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA1EC1/2020	EPI_ISL_624213	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA3A61/2020	EPI_ISL_624214	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA23A3/2020	EPI_ISL_624240	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2859/2020	EPI_ISL_624253	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA3B04/2020	EPI_ISL_624257	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-AA4480/2020	EPI_ISL_624272	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA2DC3/2020	EPI_ISL_624274	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA3CD4/2020	EPI_ISL_624278	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA48FD/2020	EPI_ISL_624280	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA48C0/2020	EPI_ISL_624293	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA42A4/2020	EPI_ISL_624294	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2060/2020	EPI_ISL_624300	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA1F91/2020	EPI_ISL_624304	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/CAMC-A410EB/2020	EPI_ISL_625440	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/Wales/CAMC-A4176E/2020	EPI_ISL_625442	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-AC92D6/2020	EPI_ISL_629191	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACC72F/2020	EPI_ISL_629196	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD25D1/2020	EPI_ISL_630002	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD2FD3/2020	EPI_ISL_630004	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACDF44/2020	EPI_ISL_630012	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACD937/2020	EPI_ISL_630031	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACCD0F/2020	EPI_ISL_630059	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ACDB9B/2020	EPI_ISL_630072	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC73D5/2020	EPI_ISL_630075	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-AC7654/2020	EPI_ISL_630084	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-ACD621/2020	EPI_ISL_630085	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ACE013/2020	EPI_ISL_630089	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACDD3B/2020	EPI_ISL_630098	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-AC7706/2020	EPI_ISL_630174	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACDFAE/2020	EPI_ISL_630177	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ACDCF2/2020	EPI_ISL_630190	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ACCE1B/2020	EPI_ISL_630194	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD0E32/2020	EPI_ISL_633901	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD0BC2/2020	EPI_ISL_633953	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AD0E05/2020	EPI_ISL_633962	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AD592D/2020	EPI_ISL_633970	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD5DC7/2020	EPI_ISL_633977	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD4F2C/2020	EPI_ISL_633995	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A778A8/2020	EPI_ISL_638736	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-A77E4C/2020	EPI_ISL_638741	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-A782B8/2020	EPI_ISL_638748	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A7834C/2020	EPI_ISL_638749	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A78485/2020	EPI_ISL_638756	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A786BC/2020	EPI_ISL_638760	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A7875F/2020	EPI_ISL_638764	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-A78D02/2020	EPI_ISL_638777	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A78D11/2020	EPI_ISL_638778	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A7925D/2020	EPI_ISL_638792	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A7926C/2020	EPI_ISL_638793	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-A7928A/2020	EPI_ISL_638795	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A792C6/2020	EPI_ISL_638798	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A79484/2020	EPI_ISL_638803	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-A794EE/2020	EPI_ISL_638807	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A89AF8/2020	EPI_ISL_638810	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/QEUH-A89B04/2020	EPI_ISL_638811	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A89E92/2020	EPI_ISL_638827	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A8A189/2020	EPI_ISL_638836	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A8A7B4/2020	EPI_ISL_638845	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A8A893/2020	EPI_ISL_638855	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A8A8FD/2020	EPI_ISL_638859	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-A8AAF7/2020	EPI_ISL_638873	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/SHEF-C0D32/2020	EPI_ISL_638877	2020-10-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Scotland/QEUH-9AE3B7/2020	EPI_ISL_638902	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A77C24/2020	EPI_ISL_638949	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-B1107A/2020	EPI_ISL_642004	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0F358/2020	EPI_ISL_642012	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B0E4ED/2020	EPI_ISL_642017	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0DB43/2020	EPI_ISL_642024	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/England/QEUH-B0E66F/2020	EPI_ISL_642028	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B10F7E/2020	EPI_ISL_642040	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B0DC31/2020	EPI_ISL_642057	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/QEUH-B0FBBA/2020	EPI_ISL_642068	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0F8A4/2020	EPI_ISL_642085	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B0E975/2020	EPI_ISL_642159	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.54	GV
hCoV-19/England/QEUH-B0F8D1/2020	EPI_ISL_642161	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B0E553/2020	EPI_ISL_642171	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0E9FD/2020	EPI_ISL_642184	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B0E641/2020	EPI_ISL_642192	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B0C467/2020	EPI_ISL_643315	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B0C449/2020	EPI_ISL_643327	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B0AA76/2020	EPI_ISL_643352	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0C85C/2020	EPI_ISL_643361	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0B25F/2020	EPI_ISL_643480	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0B459/2020	EPI_ISL_643495	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B0AAD0/2020	EPI_ISL_643498	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B1B7B7/2020	EPI_ISL_645903	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B1BD00/2020	EPI_ISL_645906	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B1A2C6/2020	EPI_ISL_645907	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B1A299/2020	EPI_ISL_645913	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1DB6E/2020	EPI_ISL_645919	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1C042/2020	EPI_ISL_645931	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q76stop results in 38.0% truncation of the protein sequence.	info	B.1.177.56	GV
hCoV-19/England/ALDP-B1F829/2020	EPI_ISL_645947	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1D515/2020	EPI_ISL_645965	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B1AE86/2020	EPI_ISL_645969	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/ALDP-B1FA6F/2020	EPI_ISL_645991	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1DB8C/2020	EPI_ISL_645999	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B488BE/2020	EPI_ISL_649422	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-B50525/2020	EPI_ISL_649424	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B485A8/2020	EPI_ISL_649433	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B47D29/2020	EPI_ISL_649437	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B47CB3/2020	EPI_ISL_649440	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Scotland/QEUH-B0EFFB/2020	EPI_ISL_649502	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Scotland/QEUH-B1303C/2020	EPI_ISL_649508	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B1352E/2020	EPI_ISL_649512	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177.4	GV
hCoV-19/Scotland/QEUH-B0DD5C/2020	EPI_ISL_649527	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B132FA/2020	EPI_ISL_649589	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMB-1B9375/2020	EPI_ISL_651702	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMB-1B9DA4/2020	EPI_ISL_651710	2020-11-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMC-B23145/2020	EPI_ISL_651720	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMC-B2328E/2020	EPI_ISL_651726	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Scotland/CVR4984/2020	EPI_ISL_651739	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/Scotland/CVR5295/2020	EPI_ISL_651742	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/Scotland/CVR5659/2020	EPI_ISL_651890	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/204481927/2020	EPI_ISL_654001	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204481947/2020	EPI_ISL_654004	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204481951/2020	EPI_ISL_654006	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204490706/2020	EPI_ISL_654010	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204490902/2020	EPI_ISL_654011	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204490997/2020	EPI_ISL_654012	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/204491013/2020	EPI_ISL_654014	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/Spain/MD-IBV-99008476/2020	EPI_ISL_654059	2020-08-09	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/MD-IBV-99008494/2020	EPI_ISL_654065	2020-09-10	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/MD-IBV-99008550/2020	EPI_ISL_654092	2020-09-10	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/MD-IBV-99008554/2020	EPI_ISL_654095	2020-09-17	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/MD-IBV-99008795/2020	EPI_ISL_654146	2020-09-21	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/MD-IBV-99008800/2020	EPI_ISL_654151	2020-09-21	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/MD-IBV-99008802/2020	EPI_ISL_654153	2020-09-21	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/England/ALDP-B62CD0/2020	EPI_ISL_655300	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B62BD3/2020	EPI_ISL_655307	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B62C85/2020	EPI_ISL_655326	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5AEB7/2020	EPI_ISL_655328	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5B79D/2020	EPI_ISL_655329	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5B575/2020	EPI_ISL_655342	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B5E6AC/2020	EPI_ISL_655343	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B5B681/2020	EPI_ISL_655363	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B62C0D/2020	EPI_ISL_655365	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B5B6EB/2020	EPI_ISL_655374	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B5B830/2020	EPI_ISL_655380	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5BDB9/2020	EPI_ISL_655386	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5B2F6/2020	EPI_ISL_655388	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B62C58/2020	EPI_ISL_655459	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B6303D/2020	EPI_ISL_655472	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B5E79A/2020	EPI_ISL_655477	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B62F31/2020	EPI_ISL_655478	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B62B97/2020	EPI_ISL_655485	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5B320/2020	EPI_ISL_655489	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B5B223/2020	EPI_ISL_655491	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B5B3F3/2020	EPI_ISL_655497	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B62669/2020	EPI_ISL_656600	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B6353E/2020	EPI_ISL_656610	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B639D8/2020	EPI_ISL_656615	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B63950/2020	EPI_ISL_656619	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B6364A/2020	EPI_ISL_656649	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B629E8/2020	EPI_ISL_656660	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B6271B/2020	EPI_ISL_656661	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B63BC3/2020	EPI_ISL_656673	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B5456D/2020	EPI_ISL_656793	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B5109C/2020	EPI_ISL_657909	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B54CC2/2020	EPI_ISL_657932	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B51E74/2020	EPI_ISL_657945	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B54AF5/2020	EPI_ISL_657950	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B51CC5/2020	EPI_ISL_657964	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B54C2C/2020	EPI_ISL_657970	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B54D83/2020	EPI_ISL_657972	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51F35/2020	EPI_ISL_657992	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B73683/2020	EPI_ISL_662405	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B6B74F/2020	EPI_ISL_662409	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B6A546/2020	EPI_ISL_662467	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6A713/2020	EPI_ISL_662471	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B66B0C/2020	EPI_ISL_662476	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B672CA/2020	EPI_ISL_662484	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B6A5A0/2020	EPI_ISL_662498	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B73577/2020	EPI_ISL_662499	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177.54	GV
hCoV-19/England/QEUH-B663C8/2020	EPI_ISL_662504	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B6B79A/2020	EPI_ISL_662512	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B73A3C/2020	EPI_ISL_662514	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6A75F/2020	EPI_ISL_662527	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6AE5A/2020	EPI_ISL_662530	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6B75E/2020	EPI_ISL_662544	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B73665/2020	EPI_ISL_662558	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B735D1/2020	EPI_ISL_662578	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B6A6DA/2020	EPI_ISL_662596	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AA0493/2020	EPI_ISL_666000	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-AF119C/2020	EPI_ISL_666007	2020-10-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-AF11E7/2020	EPI_ISL_666009	2020-10-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-AF18C4/2020	EPI_ISL_666018	2020-10-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Scotland/EDB9291/2020	EPI_ISL_666071	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Wales/PHWC-48A9D2/2020	EPI_ISL_666110	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-48AB18/2020	EPI_ISL_666123	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/England/CAMC-B09321/2020	EPI_ISL_673106	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B0988C/2020	EPI_ISL_673117	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B0946A/2020	EPI_ISL_673118	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B08F4C/2020	EPI_ISL_673122	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B0952B/2020	EPI_ISL_673128	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B09F0F/2020	EPI_ISL_673143	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B09664/2020	EPI_ISL_673150	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B098D7/2020	EPI_ISL_673151	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B0A557/2020	EPI_ISL_673153	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B0A539/2020	EPI_ISL_673163	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B09E7B/2020	EPI_ISL_673165	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0A584/2020	EPI_ISL_673166	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B09734/2020	EPI_ISL_673170	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B09B92/2020	EPI_ISL_673188	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B09AD1/2020	EPI_ISL_673206	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B08F2E/2020	EPI_ISL_673214	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B08E21/2020	EPI_ISL_673216	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B09066/2020	EPI_ISL_673233	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B9AC0C/2020	EPI_ISL_673244	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B99C3A/2020	EPI_ISL_673249	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B9C4F3/2020	EPI_ISL_673252	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B99DDD/2020	EPI_ISL_673256	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B83D6D/2020	EPI_ISL_674465	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B882C3/2020	EPI_ISL_674473	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B84A29/2020	EPI_ISL_674486	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B84C41/2020	EPI_ISL_674490	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8F411/2020	EPI_ISL_674496	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8EED8/2020	EPI_ISL_674505	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B8F7FA/2020	EPI_ISL_674509	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B7F520/2020	EPI_ISL_674516	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-B7F53F/2020	EPI_ISL_674527	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B8F8CA/2020	EPI_ISL_674555	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8F61B/2020	EPI_ISL_674577	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8F587/2020	EPI_ISL_674581	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B830BF/2020	EPI_ISL_675703	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B8C7C0/2020	EPI_ISL_675754	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B84704/2020	EPI_ISL_675794	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8CA21/2020	EPI_ISL_675814	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B89787/2020	EPI_ISL_675821	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-B88CB6/2020	EPI_ISL_675854	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B859B2/2020	EPI_ISL_675855	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B89550/2020	EPI_ISL_675873	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B8C9D9/2020	EPI_ISL_675874	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B88B40/2020	EPI_ISL_675888	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B899FA/2020	EPI_ISL_675898	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BBC90D/2020	EPI_ISL_679255	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/CAMC-BBCA0A/2020	EPI_ISL_679265	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMC-BBCC40/2020	EPI_ISL_679270	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMC-BBCD2F/2020	EPI_ISL_679277	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMC-BBCE4A/2020	EPI_ISL_679289	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/EXET-139DD9/2020	EPI_ISL_679343	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/LIVE-DBD2E1/2020	EPI_ISL_679391	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LOND-1251672/2020	EPI_ISL_679421	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/LOND-125178E/2020	EPI_ISL_679434	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/LOND-12517CA/2020	EPI_ISL_679438	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/LOND-126359E/2020	EPI_ISL_679449	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Northern Ireland/NIRE-232E81/2020	EPI_ISL_680231	2020-09-25	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-232E90/2020	EPI_ISL_680232	2020-09-25	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-232EBE/2020	EPI_ISL_680233	2020-09-25	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-232EEB/2020	EPI_ISL_680235	2020-09-25	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-232F9D/2020	EPI_ISL_680239	2020-09-26	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-233002/2020	EPI_ISL_680245	2020-09-28	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-233020/2020	EPI_ISL_680247	2020-09-28	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-23307B/2020	EPI_ISL_680250	2020-09-28	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2332FD/2020	EPI_ISL_680279	2020-09-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-233327/2020	EPI_ISL_680280	2020-09-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2336E2/2020	EPI_ISL_680309	2020-09-29	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-233749/2020	EPI_ISL_680313	2020-09-29	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-233785/2020	EPI_ISL_680316	2020-10-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2337B2/2020	EPI_ISL_680317	2020-10-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-233FBA/2020	EPI_ISL_680329	2020-10-13	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Northern Ireland/NIRE-233FC9/2020	EPI_ISL_680330	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Northern Ireland/NIRE-233FF6/2020	EPI_ISL_680332	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234010/2020	EPI_ISL_680334	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23402F/2020	EPI_ISL_680335	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23403E/2020	EPI_ISL_680336	2020-10-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23404D/2020	EPI_ISL_680337	2020-10-17	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23405C/2020	EPI_ISL_680338	2020-10-18	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23406B/2020	EPI_ISL_680339	2020-10-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234089/2020	EPI_ISL_680340	2020-10-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234098/2020	EPI_ISL_680341	2020-10-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-234168/2020	EPI_ISL_680346	2020-10-13	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234229/2020	EPI_ISL_680355	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-234238/2020	EPI_ISL_680356	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Northern Ireland/NIRE-234274/2020	EPI_ISL_680360	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234292/2020	EPI_ISL_680362	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2342B0/2020	EPI_ISL_680364	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2342CF/2020	EPI_ISL_680365	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2342ED/2020	EPI_ISL_680367	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234335/2020	EPI_ISL_680371	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234344/2020	EPI_ISL_680372	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2343BD/2020	EPI_ISL_680379	2020-10-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-2343CC/2020	EPI_ISL_680380	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-2343DB/2020	EPI_ISL_680381	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-2343EA/2020	EPI_ISL_680382	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/Northern Ireland/NIRE-2343F9/2020	EPI_ISL_680383	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/Northern Ireland/NIRE-234405/2020	EPI_ISL_680384	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-234414/2020	EPI_ISL_680385	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/Northern Ireland/NIRE-234441/2020	EPI_ISL_680388	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-234450/2020	EPI_ISL_680389	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-23446F/2020	EPI_ISL_680390	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-23447E/2020	EPI_ISL_680391	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-23448D/2020	EPI_ISL_680392	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-23449C/2020	EPI_ISL_680393	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-2344AB/2020	EPI_ISL_680394	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-2344BA/2020	EPI_ISL_680395	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-2344C9/2020	EPI_ISL_680396	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-2344D8/2020	EPI_ISL_680397	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-2344E7/2020	EPI_ISL_680398	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-234520/2020	EPI_ISL_680402	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-23453F/2020	EPI_ISL_680403	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-23454E/2020	EPI_ISL_680404	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-23455D/2020	EPI_ISL_680405	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-23458A/2020	EPI_ISL_680408	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2345A8/2020	EPI_ISL_680409	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2345F3/2020	EPI_ISL_680414	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23462D/2020	EPI_ISL_680417	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/Northern Ireland/NIRE-2346A5/2020	EPI_ISL_680421	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-2346C3/2020	EPI_ISL_680423	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2346D2/2020	EPI_ISL_680424	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2346F0/2020	EPI_ISL_680426	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23471B/2020	EPI_ISL_680428	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-23472A/2020	EPI_ISL_680429	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234757/2020	EPI_ISL_680431	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234784/2020	EPI_ISL_680432	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-2347EE/2020	EPI_ISL_680435	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-234818/2020	EPI_ISL_680437	2020-10-06	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/Northern Ireland/NIRE-234827/2020	EPI_ISL_680438	2020-10-06	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/Scotland/CVR5715/2020	EPI_ISL_680445	2020-11-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/MILK-BABE3F/2020	EPI_ISL_681598	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BA9F2F/2020	EPI_ISL_681608	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAABFD/2020	EPI_ISL_681615	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAA771/2020	EPI_ISL_681623	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177.56	GV
hCoV-19/England/MILK-BA9F89/2020	EPI_ISL_681642	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAB27F/2020	EPI_ISL_681650	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B96D2B/2020	EPI_ISL_681668	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-12735/2020	EPI_ISL_682916	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-12800/2020	EPI_ISL_682981	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/204021372/2020	EPI_ISL_686538	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.56	GV
hCoV-19/England/ALDP-BB34C9/2020	EPI_ISL_703004	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB8F3C/2020	EPI_ISL_703022	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB32ED/2020	EPI_ISL_703058	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB8F5A/2020	EPI_ISL_703065	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BB996A/2020	EPI_ISL_703095	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB5940/2020	EPI_ISL_703097	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-BCBA08/2020	EPI_ISL_704200	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCB4FB/2020	EPI_ISL_704220	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCCDE0/2020	EPI_ISL_704227	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BCBD4B/2020	EPI_ISL_704242	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BCBAAE/2020	EPI_ISL_704268	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCE944/2020	EPI_ISL_704288	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCCDA4/2020	EPI_ISL_704293	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BCC16C/2020	EPI_ISL_704303	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCD383/2020	EPI_ISL_704314	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCBDE1/2020	EPI_ISL_704352	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5DACF/2020	EPI_ISL_705535	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/CAMB-1B7CB8/2020	EPI_ISL_705539	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/CAMB-1B91D5/2020	EPI_ISL_705544	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMB-1B921E/2020	EPI_ISL_705547	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMB-1BCA31/2020	EPI_ISL_705558	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMC-BBBD6C/2020	EPI_ISL_705568	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-BBBE0F/2020	EPI_ISL_705570	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-BBBE1E/2020	EPI_ISL_705571	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-BBBED2/2020	EPI_ISL_705574	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-BBBF1B/2020	EPI_ISL_705575	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-BBC30F/2020	EPI_ISL_705590	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-BBC35A/2020	EPI_ISL_705593	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/CAMC-BBC509/2020	EPI_ISL_705594	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-BBC82E/2020	EPI_ISL_705599	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/CAMC-BBCA46/2020	EPI_ISL_705602	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-BBCA55/2020	EPI_ISL_705603	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/CAMC-BBCE59/2020	EPI_ISL_705613	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMC-BBDB33/2020	EPI_ISL_705616	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMC-BC1835/2020	EPI_ISL_705630	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Scotland/CVR5881/2020	EPI_ISL_705643	2020-11-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Scotland/CVR5909/2020	EPI_ISL_705665	2020-11-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Wales/PHWC-492184/2020	EPI_ISL_706825	2020-11-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-49256A/2020	EPI_ISL_706857	2020-11-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-4925A6/2020	EPI_ISL_706861	2020-11-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-4925B5/2020	EPI_ISL_706862	2020-11-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/PORT-2E9BA0/2020	EPI_ISL_706873	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/PORT-2E9BBF/2020	EPI_ISL_706874	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/PORT-2F50EE/2020	EPI_ISL_706884	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/PORT-2F5118/2020	EPI_ISL_706885	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/PORT-2F5303/2020	EPI_ISL_706887	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/PORT-2F534F/2020	EPI_ISL_706888	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-A35DF2/2020	EPI_ISL_706895	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A35E1D/2020	EPI_ISL_706896	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/QEUH-A361B9/2020	EPI_ISL_706904	2020-10-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-A36465/2020	EPI_ISL_706905	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A368B4/2020	EPI_ISL_706923	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A61ECD/2020	EPI_ISL_706940	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A61EDC/2020	EPI_ISL_706941	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A61F51/2020	EPI_ISL_706947	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-A61F8E/2020	EPI_ISL_706950	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A6207B/2020	EPI_ISL_706954	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-A622C0/2020	EPI_ISL_706964	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A62600/2020	EPI_ISL_706973	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/SHEF-C48A6/2020	EPI_ISL_706994	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-BF0A73/2020	EPI_ISL_709082	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BFB717/2020	EPI_ISL_709088	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-BFB9B7/2020	EPI_ISL_709124	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BF0ABF/2020	EPI_ISL_709140	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-BFB665/2020	EPI_ISL_709143	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BF0B8F/2020	EPI_ISL_709190	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-13916/2020	EPI_ISL_711449	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-13283/2020	EPI_ISL_712703	2020-11-30	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/ALDP-C49B77/2020	EPI_ISL_718801	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C49913/2020	EPI_ISL_718833	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C49BA4/2020	EPI_ISL_718841	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C48185/2020	EPI_ISL_718849	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C49B4A/2020	EPI_ISL_718915	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C480E2/2020	EPI_ISL_718929	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C4226A/2020	EPI_ISL_718997	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Netherlands/NH-RIVM-20230/2020	EPI_ISL_723380	2020-12-06	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/England/MILK-B8759E/2020	EPI_ISL_724783	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B8766E/2020	EPI_ISL_724790	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B876F5/2020	EPI_ISL_724793	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B878FF/2020	EPI_ISL_724812	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B87A17/2020	EPI_ISL_724821	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B87A26/2020	EPI_ISL_724822	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177.57	GV
hCoV-19/Wales/PHWC-497F67/2020	EPI_ISL_727002	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-498203/2020	EPI_ISL_727040	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-49826D/2020	EPI_ISL_727045	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49843A/2020	EPI_ISL_727074	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-B9F065/2020	EPI_ISL_728300	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Germany/SH-ChVir20743/2020	EPI_ISL_729680	2020-11-19	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	bowtie2			B.1.177.60	GV
hCoV-19/Germany/ChVir20769/2020	EPI_ISL_729683	2020-11	Europe / Germany	Human	Original			NextSeq	bowtie2			B.1.177.4	GV
hCoV-19/Germany/SH-ChVir20786/2020	EPI_ISL_729696	2020-11-28	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	bowtie2			B.1.177.4	GV
hCoV-19/England/QEUH-C3227C/2020	EPI_ISL_730656	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C39DB0/2020	EPI_ISL_730670	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3D0FF/2020	EPI_ISL_731803	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-C3D7BE/2020	EPI_ISL_731812	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3D50F/2020	EPI_ISL_731823	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3B5D4/2020	EPI_ISL_731838	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3B02E/2020	EPI_ISL_731846	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3ABE2/2020	EPI_ISL_731858	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3D341/2020	EPI_ISL_731870	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3DCDD/2020	EPI_ISL_731882	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BA3945/2020	EPI_ISL_731894	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Portugal/PT1757/2020	EPI_ISL_731909	2020-11-13	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU	NS7a_Q94stop results in 23.1% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/Portugal/PT1790/2020	EPI_ISL_731936	2020-11-15	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.54	GV
hCoV-19/Portugal/PT1660/2020	EPI_ISL_731962	2020-11-11	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.177.56	GV
hCoV-19/Portugal/PT1664/2020	EPI_ISL_731965	2020-11-12	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.177.56	GV
hCoV-19/England/QEUH-C34043/2020	EPI_ISL_734032	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C345BD/2020	EPI_ISL_734047	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C33E59/2020	EPI_ISL_734074	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-C343E0/2020	EPI_ISL_734103	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C33C13/2020	EPI_ISL_734114	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C3419B/2020	EPI_ISL_734145	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C62AB7/2020	EPI_ISL_735516	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C4852F/2020	EPI_ISL_736705	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C4C224/2020	EPI_ISL_736721	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C48835/2020	EPI_ISL_736751	2020-12-13	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C4BD8E/2020	EPI_ISL_736752	2020-12-14	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-C3A9F7/2020	EPI_ISL_736758	2020-12-08	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.4	GV
hCoV-19/Luxembourg/LNS1916767/2020	EPI_ISL_740022	2020-10-17	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS1931761/2020	EPI_ISL_740025	2020-12-14	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/England/MILK-A90FD1/2020	EPI_ISL_741349	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-A91C60/2020	EPI_ISL_741355	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-ACFF51/2020	EPI_ISL_741356	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B39908/2020	EPI_ISL_741360	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/MILK-B3BAE5/2020	EPI_ISL_741362	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-B3D403/2020	EPI_ISL_741369	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3DA5C/2020	EPI_ISL_741381	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/MILK-B3DA89/2020	EPI_ISL_741382	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3DE14/2020	EPI_ISL_741399	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-49C0AB/2020	EPI_ISL_742504	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-49C4AF/2020	EPI_ISL_742561	2020-11-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-49C5D9/2020	EPI_ISL_742578	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49C603/2020	EPI_ISL_742581	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49C849/2020	EPI_ISL_742610	2020-11-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-49C9BF/2020	EPI_ISL_742626	2020-11-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-4A1DF7/2020	EPI_ISL_743818	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina		NSP11 without BLAST coverage.	warn	B.1.177	GV
hCoV-19/Wales/PHWC-4A1F5B/2020	EPI_ISL_743834	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A20EE/2020	EPI_ISL_743846	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A2576/2020	EPI_ISL_743907	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A25A3/2020	EPI_ISL_743910	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A25EF/2020	EPI_ISL_743914	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A260A/2020	EPI_ISL_743916	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A27DA/2020	EPI_ISL_743942	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4A289B/2020	EPI_ISL_743952	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Denmark/DCGC-19023/2020	EPI_ISL_748705	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-19148/2020	EPI_ISL_748781	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-19178/2020	EPI_ISL_748796	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-17456/2020	EPI_ISL_750995	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-21454/2020	EPI_ISL_758175	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-20772/2020	EPI_ISL_759354	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/QEUH-CC2305/2020	EPI_ISL_760316	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CC2B85/2020	EPI_ISL_760323	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CC5F86/2020	EPI_ISL_760375	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-CC2648/2020	EPI_ISL_760482	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-CA68AE/2020	EPI_ISL_761640	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB60B2/2020	EPI_ISL_761674	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB65B3/2020	EPI_ISL_761689	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB5323/2020	EPI_ISL_761692	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-CB6119/2020	EPI_ISL_761726	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB4816/2020	EPI_ISL_761742	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB5921/2020	EPI_ISL_761758	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-CB3CC0/2020	EPI_ISL_761792	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/205190473/2020	EPI_ISL_766500	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/Australia/NSW1284/2020	EPI_ISL_767850	2020-11-12	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.177.57	GV
hCoV-19/Luxembourg/LNS5945877/2020	EPI_ISL_771026	2020-12-03	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0588798/2020	EPI_ISL_771029	2020-12-03	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS4445166/2020	EPI_ISL_771032	2020-12-02	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS9600772/2020	EPI_ISL_771035	2020-12-02	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS5106192/2020	EPI_ISL_771044	2020-12-24	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS1649463/2020	EPI_ISL_771049	2020-12-26	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2560142/2020	EPI_ISL_771050	2020-12-26	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2104020/2020	EPI_ISL_771094	2020-12-22	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS5351629/2020	EPI_ISL_771099	2020-12-29	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0171483/2020	EPI_ISL_771141	2020-12-28	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS9562893/2020	EPI_ISL_771150	2020-12-29	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/England/ALDP-C8C64A/2020	EPI_ISL_777278	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C6CBD8/2020	EPI_ISL_778507	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C643D8/2020	EPI_ISL_778560	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-C654F2/2020	EPI_ISL_778594	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C6B8B4/2020	EPI_ISL_778615	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C51927/2020	EPI_ISL_778643	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/France/ARA-SC724/2020	EPI_ISL_779818	2020-11-15	Europe / France / Auvergne-Rhone-Alpes / Grenoble	Human	Original	Nasopharyngeal swab		Illumina NextSeq				B.1.177	GV
hCoV-19/France/ARA-SC725/2020	EPI_ISL_779819	2020-11-15	Europe / France / Auvergne-Rhone-Alpes / Grenoble	Human	Original	Nasopharyngeal swab		Illumina NextSeq				B.1.177	GV
hCoV-19/France/ARA-SC731/2020	EPI_ISL_779825	2020-11-16	Europe / France / Auvergne-Rhone-Alpes / Grenoble	Human	Original	Nasopharyngeal swab		Illumina NextSeq				B.1.177	GV
hCoV-19/France/ARA-SC734/2020	EPI_ISL_779828	2020-11-17	Europe / France / Auvergne-Rhone-Alpes / Grenoble	Human	Original	Nasopharyngeal swab		Illumina NextSeq				B.1.177	GV
hCoV-19/France/ARA-SC736/2020	EPI_ISL_779830	2020-11-17	Europe / France / Auvergne-Rhone-Alpes / Grenoble	Human	Original	Nasopharyngeal swab		Illumina NextSeq				B.1.177.77	GV
hCoV-19/France/ARA-SC738/2020	EPI_ISL_779832	2020-11-17	Europe / France / Auvergne-Rhone-Alpes / Grenoble	Human	Original	Nasopharyngeal swab		Illumina NextSeq				B.1.177.77	GV
hCoV-19/France/ARA-SC742/2020	EPI_ISL_779834	2020-11-17	Europe / France / Auvergne-Rhone-Alpes / Grenoble	Human	Original	Nasopharyngeal swab		Illumina NextSeq				B.1.177.77	GV
hCoV-19/England/ALDP-C25C7E/2020	EPI_ISL_783000	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C308C7/2020	EPI_ISL_783013	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C26BF8/2020	EPI_ISL_783019	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C2F6B2/2020	EPI_ISL_783027	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-C2674F/2020	EPI_ISL_783028	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C23627/2020	EPI_ISL_783046	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAAD8E/2020	EPI_ISL_783081	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAC153/2020	EPI_ISL_783098	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-BAADAC/2020	EPI_ISL_783118	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAC162/2020	EPI_ISL_783145	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAA313/2020	EPI_ISL_783149	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-BAA6B0/2020	EPI_ISL_783153	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAAF2E/2020	EPI_ISL_783166	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAC7BB/2020	EPI_ISL_783193	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BABEA8/2020	EPI_ISL_783196	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-24097/2020	EPI_ISL_792936	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-24099/2020	EPI_ISL_792938	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-24178/2020	EPI_ISL_792980	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Switzerland/AG-ETHZ-430747/2020	EPI_ISL_796356	2020-12-31	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			V.1	GV
hCoV-19/Switzerland/AG-ETHZ-430479/2020	EPI_ISL_796361	2020-12-28	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Switzerland/AG-ETHZ-430480/2020	EPI_ISL_796374	2020-12-28	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/England/CAMC-D11C38/2020	EPI_ISL_800089	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CE29C1/2020	EPI_ISL_800091	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-D0E375/2020	EPI_ISL_800177	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Netherlands/ZH-EMC-1276/2020	EPI_ISL_801499	2020-12-27	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/Spain/CT-ISCIII-2017683/2020	EPI_ISL_802726	2020-11-11	Europe / Spain / Catalonia	Human	Original	Nasopharyngeal swab		Illumina NextSeq				B.1.177	GV
hCoV-19/England/MILK-E06B92/2020	EPI_ISL_812060	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/EXET-13FABE/2020	EPI_ISL_813454	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/PHWC-4A724D/2020	EPI_ISL_814817	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A77B7/2020	EPI_ISL_814887	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Denmark/DCGC-27388/2020	EPI_ISL_818104	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27392/2020	EPI_ISL_818106	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27393/2020	EPI_ISL_818107	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27399/2020	EPI_ISL_818110	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-27415/2020	EPI_ISL_818120	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NSP11 without BLAST coverage.	warn	B.1.177.77	GV
hCoV-19/England/LOND-E2796/2020	EPI_ISL_819501	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NOTT-246A4A/2020	EPI_ISL_819504	2020-11-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/LOND-E272D/2020	EPI_ISL_819518	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/LOND-E264E/2020	EPI_ISL_819535	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/LOND-E24EA/2020	EPI_ISL_819544	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/LOND-E25E7/2020	EPI_ISL_819546	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/LOND-E2875/2020	EPI_ISL_819567	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NOTT-12109F/2020	EPI_ISL_819596	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-1210AE/2020	EPI_ISL_819597	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/ALDP-C6A9A3/2020	EPI_ISL_820411	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/NOTT-122067/2020	EPI_ISL_820433	2020-12-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/ALDP-C6A69D/2020	EPI_ISL_820443	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/NORW-2236C7/2020	EPI_ISL_820543	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-C6A9C1/2020	EPI_ISL_820545	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/NOTT-122187/2021	EPI_ISL_820583	2021-01-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-122190/2021	EPI_ISL_820586	2021-01-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-122216/2021	EPI_ISL_820591	2021-01-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-122236/2021	EPI_ISL_820593	2021-01-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Netherlands/NH-RIVM-21091/2020	EPI_ISL_824032	2020-12-21	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/OV-RIVM-21132/2020	EPI_ISL_824055	2020-12-10	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/NB-RIVM-21219/2020	EPI_ISL_824136	2020-12-21	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Spain/CT-HUVH-78438/2020	EPI_ISL_825360	2020-11-18	Europe / Spain / Catalunya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.177	GV
hCoV-19/Iceland/3186/2020	EPI_ISL_826879	2020-11-23	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.177.60	GV
hCoV-19/Iceland/5396/2021	EPI_ISL_829080	2021-01-02	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.177.60	GV
hCoV-19/Spain/MD-IBV-99013356/2020	EPI_ISL_831234	2020-11-05	Europe / Spain / Madrid / Madrid	Human	Original			IonTorrent				B.1.177	GV
hCoV-19/Spain/MD-IBV-99013425/2020	EPI_ISL_831268	2020-12-17	Europe / Spain / Madrid / Madrid	Human	Original			IonTorrent				B.1.177	GV
hCoV-19/Ireland/DL-NVRL-21IRL06768/2020	EPI_ISL_837402	2020-12-28	Europe / Ireland / Donegal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-81IRL12054/2020	EPI_ISL_837403	2020-12-27	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.60	GV
hCoV-19/Ireland/KE-NVRL-81IRL07744/2020	EPI_ISL_837407	2020-12-27	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CN-NVRL-81IRL42709/2020	EPI_ISL_837416	2020-12-29	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			V.1	GV
hCoV-19/Ireland/D-NVRL-81IRL09865/2020	EPI_ISL_837419	2020-12-27	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-81IRL10586/2020	EPI_ISL_837421	2020-12-27	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/D-NVRL-81IRL15357/2020	EPI_ISL_837422	2020-12-27	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/England/NOTT-121793/2020	EPI_ISL_839990	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121816/2020	EPI_ISL_839991	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121961/2020	EPI_ISL_839993	2020-12-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Denmark/DCGC-29159/2021	EPI_ISL_843206	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-29237/2021	EPI_ISL_843284	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-29299/2021	EPI_ISL_843346	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-29310/2021	EPI_ISL_843357	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-30494/2020	EPI_ISL_844542	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-32233/2020	EPI_ISL_856649	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/CAMC-FB3FB5/2021	EPI_ISL_857811	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-F91A61/2021	EPI_ISL_857884	2021-01-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Scotland/CVR6431/2020	EPI_ISL_864962	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/Scotland/CVR6432/2020	EPI_ISL_864963	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Scotland/CVR6433/2020	EPI_ISL_864964	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Scotland/CVR6434/2020	EPI_ISL_864965	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/Scotland/CVR6454/2020	EPI_ISL_864983	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/Scotland/CVR6463/2020	EPI_ISL_864992	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/LOND-1322DA1/2020	EPI_ISL_866053	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LOND-1322E26/2020	EPI_ISL_866057	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/SHEF-10D3531/2021	EPI_ISL_868595	2021-01-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/SHEF-10D6A4E/2021	EPI_ISL_868658	2021-01-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/SHEF-10D810B/2021	EPI_ISL_868698	2021-01-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Denmark/DCGC-32700/2021	EPI_ISL_869704	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-32805/2021	EPI_ISL_869809	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-32811/2021	EPI_ISL_869815	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-32849/2021	EPI_ISL_869853	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-32875/2021	EPI_ISL_869879	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-32954/2021	EPI_ISL_869958	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-32966/2021	EPI_ISL_869970	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33821/2021	EPI_ISL_870831	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33842/2021	EPI_ISL_870852	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33883/2021	EPI_ISL_870893	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-33922/2021	EPI_ISL_870932	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-33974/2021	EPI_ISL_870984	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-33981/2021	EPI_ISL_870991	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-33984/2021	EPI_ISL_870994	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/ALDP-FFFAE9/2021	EPI_ISL_874227	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-FC1084/2021	EPI_ISL_874249	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-FFFAAD/2021	EPI_ISL_874251	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-FC14B5/2021	EPI_ISL_874282	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10924F5/2021	EPI_ISL_878001	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-1092440/2021	EPI_ISL_878080	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-109171B/2021	EPI_ISL_878089	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10680E5/2021	EPI_ISL_879343	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1030110/2021	EPI_ISL_880318	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-1030426/2021	EPI_ISL_880333	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-10305AB/2021	EPI_ISL_880374	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-FA2256/2021	EPI_ISL_881665	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-FA2775/2021	EPI_ISL_881673	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-FA2A03/2021	EPI_ISL_881679	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/ALDP-1004DF3/2021	EPI_ISL_892166	2021-01-12	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/MILK-B975C8/2020	EPI_ISL_892217	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-9BE0AE/2020	EPI_ISL_892230	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Spain/NC-IBV-97011875/2020	EPI_ISL_892342	2020-12-08	Europe / Spain / Navarra / Pamplona	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Netherlands/ZH-EMC-1390/2021	EPI_ISL_904533	2021-01-02	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/Netherlands/NB-EMC-530/2021	EPI_ISL_904550	2021-01-05	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/Luxembourg/LNS1626039/2020	EPI_ISL_910520	2020-12-20	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS1251152/2020	EPI_ISL_910521	2020-12-05	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0277059/2020	EPI_ISL_910528	2020-12-20	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS4005910/2020	EPI_ISL_910558	2020-12-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS7107237/2020	EPI_ISL_910563	2020-12-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS5699192/2020	EPI_ISL_910568	2020-12-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS1798442/2021	EPI_ISL_910590	2021-01-01	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2784642/2021	EPI_ISL_910592	2021-01-01	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS3596487/2020	EPI_ISL_910651	2020-12-07	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS4753600/2020	EPI_ISL_910666	2020-12-07	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2561334/2020	EPI_ISL_910667	2020-12-07	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS9494299/2020	EPI_ISL_910685	2020-12-08	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177	GV
hCoV-19/Luxembourg/LNS0089028/2020	EPI_ISL_910687	2020-12-08	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177	GV
hCoV-19/Luxembourg/LNS1066194/2020	EPI_ISL_910697	2020-12-08	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS5237533/2020	EPI_ISL_910698	2020-12-08	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2818851/2020	EPI_ISL_910699	2020-12-08	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/England/ALDP-10132A7/2021	EPI_ISL_916636	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-100D04C/2021	EPI_ISL_916664	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1011E1E/2021	EPI_ISL_916680	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-110BC85/2021	EPI_ISL_917823	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/CAMB-A9E5FF/2021	EPI_ISL_919019	2021	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Northern Ireland/NIRE-245DD9/2021	EPI_ISL_921068	2021-01-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-245DF7/2021	EPI_ISL_921069	2021-01-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-245E12/2021	EPI_ISL_921071	2021-01-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-245E9A/2021	EPI_ISL_921077	2021-01-01	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-245F79/2020	EPI_ISL_921085	2020-12-29	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-245FC4/2020	EPI_ISL_921088	2020-12-29	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/NORT-1B7B05D/2020	EPI_ISL_921222	2020-12-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NORT-1B7B8CE/2021	EPI_ISL_921248	2021-01-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Insertion of 2 nucleotide(s) found at refpos 28251 (Frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/England/NORT-1B850F6/2020	EPI_ISL_921357	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina		Insertion of 2 nucleotide(s) found at refpos 28251 (Frameshift confirmed by the submitter).	info	B.1.177.54	GV
hCoV-19/Denmark/DCGC-34872/2021	EPI_ISL_926012	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-34911/2021	EPI_ISL_926051	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-36216/2021	EPI_ISL_927357	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-37480/2021	EPI_ISL_928621	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-38669/2020	EPI_ISL_929811	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-38761/2021	EPI_ISL_929903	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/England/CAMC-11023E3/2021	EPI_ISL_933348	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-1150E6D/2021	EPI_ISL_938062	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.77	GV
hCoV-19/England/MILK-1150D51/2021	EPI_ISL_938075	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-114CDB2/2021	EPI_ISL_939387	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Netherlands/GE-RIVM-10938/2021	EPI_ISL_942996	2021-01-05	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION		NS8_G50stop results in 59.5% truncation of the protein sequence.	info	B.1.177.77	GV
hCoV-19/England/QEUH-E4D300/2021	EPI_ISL_945144	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.60	GV
hCoV-19/England/CAMC-F0DB8B/2020	EPI_ISL_945226	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.60	GV
hCoV-19/England/MILK-F7329A/2021	EPI_ISL_945256	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-F6DD47/2021	EPI_ISL_945303	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.60	GV
hCoV-19/England/MILK-F6D98F/2021	EPI_ISL_945315	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-1150094/2021	EPI_ISL_947956	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/OXON-F4C3D3/2020	EPI_ISL_951170	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/OXON-F4D7C7/2021	EPI_ISL_951195	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina				U.1	GV
hCoV-19/England/MILK-118DD79/2021	EPI_ISL_958555	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-11A061B/2021	EPI_ISL_958600	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Ireland/D-NVRL-83IRL97287/2021	EPI_ISL_959798	2021-01-19	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/C-NVRL-84IRL03075/2021	EPI_ISL_959802	2021-01-19	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.56	GV
hCoV-19/Ireland/WH-NVRL-83IRL83526/2021	EPI_ISL_959835	2021-01-18	Europe / Ireland / Westmeath	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/G-NVRL-83IRL37330/2021	EPI_ISL_959848	2021-01-12	Europe / Ireland / Galway	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Portugal/IGC_g294/2020	EPI_ISL_960798	2020-12-26	Europe / Portugal / Peniche	Human	Original			Illumina NextSeq				B.1.177.77	GV
hCoV-19/Portugal/IGC_g235/2020	EPI_ISL_960815	2020-12-24	Europe / Portugal / Sintra	Human	Original			Illumina NextSeq				B.1.177.77	GV
hCoV-19/England/ALDP-11D5413/2021	EPI_ISL_963179	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-11B3439/2021	EPI_ISL_964225	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Norway/1292/2021	EPI_ISL_964262	2021-01-23	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			U.3	GV
hCoV-19/England/ALDP-11BED15/2021	EPI_ISL_970000	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-11C5D84/2021	EPI_ISL_970043	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/Denmark/DCGC-41064/2020	EPI_ISL_972741	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-41180/2021	EPI_ISL_972857	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-41315/2021	EPI_ISL_972992	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Belgium/AZDelta22435-2105R/2021	EPI_ISL_978802	2021-02-06	Europe / Belgium / Roeselare	Human	Original	Nasopharyngeal swab	unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZDelta11745-2105R/2021	EPI_ISL_978836	2021-02-06	Europe / Belgium / Staden	Human	Original	Nasopharyngeal swab	unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZDelta14038-2105R/2021	EPI_ISL_978844	2021-02-06	Europe / Belgium / Koekelare	Human	Original	Nasopharyngeal swab	unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZDelta19488-2105R/2021	EPI_ISL_978875	2021-02-06	Europe / Belgium / Koolskamp	Human	Original	Nasopharyngeal swab	unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/England/MILK-11EB27A/2021	EPI_ISL_985966	2021-02-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-118538E/2021	EPI_ISL_990564	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-10E9170/2021	EPI_ISL_993026	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-1062B80/2021	EPI_ISL_994050	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-1066B7D/2021	EPI_ISL_994398	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Belgium/rega-2769/2021	EPI_ISL_995626	2021-02-03	Europe / Belgium / Rijkevorsel	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2774/2021	EPI_ISL_995630	2021-02-03	Europe / Belgium / Antwerp	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2792/2021	EPI_ISL_995648	2021-02-03	Europe / Belgium / Genk	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2802/2021	EPI_ISL_995655	2021-01-29	Europe / Belgium / Genk	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2805/2021	EPI_ISL_995658	2021-01-29	Europe / Belgium / Genk	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2820/2021	EPI_ISL_995673	2021-01-28	Europe / Belgium / Lille (Antwerpen)	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2827/2021	EPI_ISL_995680	2021-01-28	Europe / Belgium / Turnhout	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2831/2021	EPI_ISL_995684	2021-01-29	Europe / Belgium / Herenthout	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2838/2021	EPI_ISL_995691	2021-01-29	Europe / Belgium / Gierle	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Northern Ireland/OXON-F54280/2021	EPI_ISL_999052	2021-01-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/England/SHEF-D19FE/2020	EPI_ISL_1000794	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/TFCI-27053D8/2021	EPI_ISL_1000898	2021-01-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/Italy/LAZ-INMI-215/2021	EPI_ISL_1009031	2021-01-28	Europe / Italy / Lazio	Human	Original			Ion Torrent	BWA 0.7.12 + Samtools 1.3.1 + IRMA + Geneious 2019.2.3			B.1.177.77	GV
hCoV-19/Spain/MD-IBV-98015559/2021	EPI_ISL_1009061	2021-01-20	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Wales/ALDP-118412B/2021	EPI_ISL_1012754	2021-01-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-126466D/2021	EPI_ISL_1018951	2021-02-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-43068/2021	EPI_ISL_1023346	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-43118/2021	EPI_ISL_1023396	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-43165/2021	EPI_ISL_1023443	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-43174/2021	EPI_ISL_1023458	2021-02-08	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44304/2021	EPI_ISL_1024682	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44430/2021	EPI_ISL_1024808	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44433/2021	EPI_ISL_1024811	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44437/2021	EPI_ISL_1024815	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-44458/2021	EPI_ISL_1024836	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Netherlands/UT-RIVM-12700/2021	EPI_ISL_1035475	2021-01-26	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Belgium/ULG-11954/2021	EPI_ISL_1036611	2021-01-29	Europe / Belgium / Hainaut	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/England/QEUH-126A01E/2021	EPI_ISL_1042584	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Italy/LOM-HSacco22/2020	EPI_ISL_1048810	2020-12-23	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.177.4	GV
hCoV-19/Belgium/AZDelta15835-2106R/2021	EPI_ISL_1058112	2021-02-13	Europe / Belgium / Roeselare	Human	Original	Nasopharyngeal swab	unbiased surveillance	Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/AZDelta19568-2106R/2021	EPI_ISL_1058145	2021-02-17	Europe / Belgium / Wervik	Human	Original	Nasopharyngeal swab	unbiased surveillance	Illumina MiSeq				B.1.177.8	GV
hCoV-19/England/CAMC-1299869/2021	EPI_ISL_1061694	2021-02-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/Denmark/DCGC-45864/2020	EPI_ISL_1065374	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-47047/2021	EPI_ISL_1066558	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-47118/2021	EPI_ISL_1066630	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/MILK-12848F8/2021	EPI_ISL_1071103	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-96F1A9/2020	EPI_ISL_530545	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Northern Ireland/QEUH-96EC6D/2020	EPI_ISL_530584	2020-08-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-99D61C/2020	EPI_ISL_549907	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A8C76/2020	EPI_ISL_549949	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9A8CD0/2020	EPI_ISL_549975	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9A6E72/2020	EPI_ISL_549999	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9AAA6B/2020	EPI_ISL_550908	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9AA03C/2020	EPI_ISL_550910	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9AA0B4/2020	EPI_ISL_550949	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9AAB3B/2020	EPI_ISL_550962	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9AA62B/2020	EPI_ISL_550972	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-991487/2020	EPI_ISL_552009	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-9916EB/2020	EPI_ISL_552017	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-992C33/2020	EPI_ISL_552024	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-970E08/2020	EPI_ISL_553198	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9707D0/2020	EPI_ISL_553210	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-16B512/2020	EPI_ISL_560300	2020-09-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16B55E/2020	EPI_ISL_560302	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/MILK-9C2C85/2020	EPI_ISL_566425	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9C1F9C/2020	EPI_ISL_566432	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C2D37/2020	EPI_ISL_566437	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C2881/2020	EPI_ISL_566443	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C2872/2020	EPI_ISL_566462	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C2863/2020	EPI_ISL_566491	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C2B97/2020	EPI_ISL_566498	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-9B1BF5/2020	EPI_ISL_566518	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9C1ECC/2020	EPI_ISL_566521	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C25E4/2020	EPI_ISL_566523	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9C1FBA/2020	EPI_ISL_566593	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9C26B4/2020	EPI_ISL_566604	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9C25C6/2020	EPI_ISL_566629	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9C2326/2020	EPI_ISL_566642	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-9C2739/2020	EPI_ISL_566652	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9C6270/2020	EPI_ISL_567756	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9C57EB/2020	EPI_ISL_567791	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9C4F6C/2020	EPI_ISL_567813	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9C4C0B/2020	EPI_ISL_567838	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9C5D43/2020	EPI_ISL_567870	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9C61FB/2020	EPI_ISL_567873	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9BE24E/2020	EPI_ISL_567918	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9BE18D/2020	EPI_ISL_567951	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9BEDA7/2020	EPI_ISL_567983	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9D17A0/2020	EPI_ISL_573659	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-C09B6/2020	EPI_ISL_573686	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-C276F/2020	EPI_ISL_573689	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/SHEF-C2C15/2020	EPI_ISL_573690	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-C30EB/2020	EPI_ISL_573693	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/SHEF-C3731/2020	EPI_ISL_573695	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Northern Ireland/CAMC-9BFDB5/2020	EPI_ISL_573759	2020-09-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Scotland/CVR4309/2020	EPI_ISL_573770	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4322/2020	EPI_ISL_573773	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Scotland/CVR4345/2020	EPI_ISL_573783	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-113DB7/2020	EPI_ISL_577110	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113E0F/2020	EPI_ISL_577113	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-113E2D/2020	EPI_ISL_577114	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113E69/2020	EPI_ISL_577118	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113E78/2020	EPI_ISL_577119	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113E96/2020	EPI_ISL_577120	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-113F1B/2020	EPI_ISL_577122	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113F39/2020	EPI_ISL_577123	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-113F84/2020	EPI_ISL_577124	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113F93/2020	EPI_ISL_577125	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-113FEE/2020	EPI_ISL_577128	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1140EA/2020	EPI_ISL_577139	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1140F9/2020	EPI_ISL_577140	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114123/2020	EPI_ISL_577141	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11416F/2020	EPI_ISL_577143	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11418D/2020	EPI_ISL_577145	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1141AB/2020	EPI_ISL_577146	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-1141F6/2020	EPI_ISL_577149	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-114202/2020	EPI_ISL_577150	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11427B/2020	EPI_ISL_577153	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-1142D5/2020	EPI_ISL_577156	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11432D/2020	EPI_ISL_577160	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114475/2020	EPI_ISL_577165	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-114484/2020	EPI_ISL_577166	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/NOTT-114536/2020	EPI_ISL_577172	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114554/2020	EPI_ISL_577173	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114615/2020	EPI_ISL_577180	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114624/2020	EPI_ISL_577181	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114633/2020	EPI_ISL_577182	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11468E/2020	EPI_ISL_577186	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-114730/2020	EPI_ISL_577192	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/QEUH-9AE7E8/2020	EPI_ISL_577242	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-9E4B9F/2020	EPI_ISL_579775	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9E4FB1/2020	EPI_ISL_579795	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9E4C23/2020	EPI_ISL_579799	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Northern Ireland/QEUH-9E5651/2020	EPI_ISL_579830	2020-09-22	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-9E4AED/2020	EPI_ISL_579846	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EA012/2020	EPI_ISL_579919	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-9E9BA9/2020	EPI_ISL_579921	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-9EA06D/2020	EPI_ISL_579923	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EA531/2020	EPI_ISL_579930	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EAFE8/2020	EPI_ISL_579944	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EA522/2020	EPI_ISL_579947	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EAB20/2020	EPI_ISL_579948	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-9EACE1/2020	EPI_ISL_579959	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EB05D/2020	EPI_ISL_579967	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EA874/2020	EPI_ISL_579969	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9E9C2E/2020	EPI_ISL_579970	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-9EB04E/2020	EPI_ISL_579974	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/MILK-9F05A1/2020	EPI_ISL_580732	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/Wales/MILK-9EECDE/2020	EPI_ISL_580752	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/MILK-9F035C/2020	EPI_ISL_580800	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9EE88F/2020	EPI_ISL_580809	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9EE421/2020	EPI_ISL_580814	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-9EE694/2020	EPI_ISL_580815	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9DC68A/2020	EPI_ISL_580899	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9DC8C0/2020	EPI_ISL_580919	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-9DCA7F/2020	EPI_ISL_580947	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMB-1B676D/2020	EPI_ISL_584303	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMB-1B677C/2020	EPI_ISL_584304	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMB-1B6897/2020	EPI_ISL_584310	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMB-1B68A6/2020	EPI_ISL_584311	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMB-1B68B5/2020	EPI_ISL_584312	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMB-1B68C4/2020	EPI_ISL_584313	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMC-9D71AC/2020	EPI_ISL_584351	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMC-9D73C4/2020	EPI_ISL_584366	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMC-9EBA22/2020	EPI_ISL_584388	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMC-9EBA31/2020	EPI_ISL_584389	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMC-9EBA40/2020	EPI_ISL_584390	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMC-9EBCC2/2020	EPI_ISL_584412	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMC-9EBECC/2020	EPI_ISL_584426	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/CAMC-9EBF05/2020	EPI_ISL_584430	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Wales/PHWC-16DE8E/2020	EPI_ISL_585633	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16DF03/2020	EPI_ISL_585640	2020-09-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16E6A3/2020	EPI_ISL_585753	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16E719/2020	EPI_ISL_585760	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-16E7BF/2020	EPI_ISL_585768	2020-10-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16E861/2020	EPI_ISL_585779	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16E8AD/2020	EPI_ISL_585783	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16E922/2020	EPI_ISL_585791	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16E940/2020	EPI_ISL_585793	2020-10-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/Wales/PHWC-16E99B/2020	EPI_ISL_585798	2020-09-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/England/ALDP-A2D8DE/2020	EPI_ISL_586904	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2D838/2020	EPI_ISL_586912	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A2E70D/2020	EPI_ISL_586913	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2DFAC/2020	EPI_ISL_586920	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A2DE09/2020	EPI_ISL_586933	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A2D601/2020	EPI_ISL_586935	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2FA7C/2020	EPI_ISL_586952	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2FB1F/2020	EPI_ISL_586955	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2F793/2020	EPI_ISL_586963	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2EF41/2020	EPI_ISL_586966	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2FE52/2020	EPI_ISL_586967	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A2FA4F/2020	EPI_ISL_586968	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2E9DA/2020	EPI_ISL_586969	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2FBE2/2020	EPI_ISL_586971	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A2F9CA/2020	EPI_ISL_586981	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2F1B3/2020	EPI_ISL_586986	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F99D/2020	EPI_ISL_586989	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2FE25/2020	EPI_ISL_586993	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A2FD37/2020	EPI_ISL_586998	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9F9784/2020	EPI_ISL_589126	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F962D/2020	EPI_ISL_589132	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-9F2475/2020	EPI_ISL_589169	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-9F2B25/2020	EPI_ISL_589251	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9CE58E/2020	EPI_ISL_590116	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9CF5E7/2020	EPI_ISL_590161	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-9B4E26/2020	EPI_ISL_590178	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-9B507A/2020	EPI_ISL_590197	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-9B4934/2020	EPI_ISL_590204	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A17FA5/2020	EPI_ISL_595005	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/MILK-A1829C/2020	EPI_ISL_595023	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/MILK-A1D3C1/2020	EPI_ISL_595055	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/MILK-A1D473/2020	EPI_ISL_595059	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/MILK-A1D482/2020	EPI_ISL_595060	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Wales/MILK-A1D4FB/2020	EPI_ISL_595065	2020-10-03	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/MILK-A1D798/2020	EPI_ISL_595084	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/MILK-A23C54/2020	EPI_ISL_595111	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/MILK-A56414/2020	EPI_ISL_595155	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-A56441/2020	EPI_ISL_595157	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-A503E0/2020	EPI_ISL_597608	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50C4F/2020	EPI_ISL_597612	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A506E7/2020	EPI_ISL_597614	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A50F55/2020	EPI_ISL_597615	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50052/2020	EPI_ISL_597626	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A4FBDD/2020	EPI_ISL_597630	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50D4C/2020	EPI_ISL_597636	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A4FB19/2020	EPI_ISL_597637	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50C30/2020	EPI_ISL_597642	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A50483/2020	EPI_ISL_597650	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A4FC43/2020	EPI_ISL_597651	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A503D1/2020	EPI_ISL_597652	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50CA9/2020	EPI_ISL_597657	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A4FB73/2020	EPI_ISL_597662	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A5083C/2020	EPI_ISL_597668	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A507F3/2020	EPI_ISL_597670	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A4FDC8/2020	EPI_ISL_597684	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A4FB82/2020	EPI_ISL_597691	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A50377/2020	EPI_ISL_597694	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A50E49/2020	EPI_ISL_597699	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A4FA2B/2020	EPI_ISL_597718	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50492/2020	EPI_ISL_597723	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50BBB/2020	EPI_ISL_597726	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A4FA1C/2020	EPI_ISL_597741	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50F46/2020	EPI_ISL_597742	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A4FF0E/2020	EPI_ISL_597752	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A50C6D/2020	EPI_ISL_597758	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A50F28/2020	EPI_ISL_597759	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A5069C/2020	EPI_ISL_597760	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A502B6/2020	EPI_ISL_597778	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A5073F/2020	EPI_ISL_597784	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A504DE/2020	EPI_ISL_597787	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A5023E/2020	EPI_ISL_597789	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A5114F/2020	EPI_ISL_597793	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-A4FF3B/2020	EPI_ISL_597794	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-A50A90/2020	EPI_ISL_597795	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Wales/MILK-A063F8/2020	EPI_ISL_600006	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.3	GV
hCoV-19/England/MILK-A053EA/2020	EPI_ISL_600011	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A05C1C/2020	EPI_ISL_600016	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A06862/2020	EPI_ISL_600029	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-A05BD3/2020	EPI_ISL_600039	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-A064B9/2020	EPI_ISL_600043	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A055C6/2020	EPI_ISL_600068	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A054F6/2020	EPI_ISL_600087	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-9E08AB/2020	EPI_ISL_601383	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A8627B/2020	EPI_ISL_606101	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A87508/2020	EPI_ISL_606119	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A86E0E/2020	EPI_ISL_606129	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A8617E/2020	EPI_ISL_606136	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A87A27/2020	EPI_ISL_606140	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A87DB5/2020	EPI_ISL_606168	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A873D1/2020	EPI_ISL_606176	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A865FA/2020	EPI_ISL_606177	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A874A1/2020	EPI_ISL_606192	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A87B42/2020	EPI_ISL_606199	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A86F74/2020	EPI_ISL_606203	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A8625D/2020	EPI_ISL_606217	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A86651/2020	EPI_ISL_606218	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A87359/2020	EPI_ISL_606219	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-A874B0/2020	EPI_ISL_606243	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A862C6/2020	EPI_ISL_606264	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A862E4/2020	EPI_ISL_606269	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A87A45/2020	EPI_ISL_606275	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A87C12/2020	EPI_ISL_606277	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A87AAF/2020	EPI_ISL_606292	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A87A63/2020	EPI_ISL_606294	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7B701/2020	EPI_ISL_607441	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A7BBE7/2020	EPI_ISL_607446	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A7BF45/2020	EPI_ISL_607462	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A7C4BE/2020	EPI_ISL_607467	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7BACC/2020	EPI_ISL_607470	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7B006/2020	EPI_ISL_607475	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7BA35/2020	EPI_ISL_607477	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7B07F/2020	EPI_ISL_607482	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A7AF64/2020	EPI_ISL_607501	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7AF91/2020	EPI_ISL_607502	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7B288/2020	EPI_ISL_607526	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7BFCD/2020	EPI_ISL_607527	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-A7B1B8/2020	EPI_ISL_607540	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A7BB8D/2020	EPI_ISL_607561	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A7B2F1/2020	EPI_ISL_607573	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177.57	GV
hCoV-19/England/MILK-A7CACB/2020	EPI_ISL_607602	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6E789/2020	EPI_ISL_607625	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/MILK-A6B42B/2020	EPI_ISL_608783	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6AFA3/2020	EPI_ISL_608790	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6B43A/2020	EPI_ISL_608792	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/MILK-A6B7E6/2020	EPI_ISL_608804	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A6BB17/2020	EPI_ISL_608807	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6B564/2020	EPI_ISL_608808	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A6B1E8/2020	EPI_ISL_608811	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-A6AF58/2020	EPI_ISL_608813	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A6B467/2020	EPI_ISL_608821	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6B300/2020	EPI_ISL_608823	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A69F3B/2020	EPI_ISL_608825	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6B18E/2020	EPI_ISL_608831	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6B40D/2020	EPI_ISL_608837	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-A69D5F/2020	EPI_ISL_608841	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A69D8C/2020	EPI_ISL_608842	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-A648EA/2020	EPI_ISL_608845	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6C17E/2020	EPI_ISL_608846	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6BC6F/2020	EPI_ISL_608848	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A68303/2020	EPI_ISL_608853	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-A6BFC0/2020	EPI_ISL_608857	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A647CF/2020	EPI_ISL_608868	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-A6942D/2020	EPI_ISL_608874	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A64783/2020	EPI_ISL_608875	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6828E/2020	EPI_ISL_608884	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A682BB/2020	EPI_ISL_608888	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A69399/2020	EPI_ISL_608899	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-A69135/2020	EPI_ISL_608931	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-A68A95/2020	EPI_ISL_608933	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-A6BF0C/2020	EPI_ISL_608951	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-A6829D/2020	EPI_ISL_608952	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-A692F6/2020	EPI_ISL_608956	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-A64A6C/2020	EPI_ISL_608959	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A76302/2020	EPI_ISL_613316	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A7642D/2020	EPI_ISL_613325	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-A7645A/2020	EPI_ISL_613326	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A767E8/2020	EPI_ISL_613331	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A76803/2020	EPI_ISL_613333	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-C3E3C/2020	EPI_ISL_613362	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-C418D/2020	EPI_ISL_613363	2020-10-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/SHEF-C4590/2020	EPI_ISL_613364	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/SHEF-CC2BF/2020	EPI_ISL_613385	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-CC677/2020	EPI_ISL_613386	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-D0485/2020	EPI_ISL_613396	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/SHEF-D092C/2020	EPI_ISL_613397	2020-10-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-D0D02/2020	EPI_ISL_613399	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-D192B/2020	EPI_ISL_613400	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-D1E1D/2020	EPI_ISL_613403	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-D3060/2020	EPI_ISL_613407	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-AA51B5/2020	EPI_ISL_624009	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA075E/2020	EPI_ISL_624014	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA134A/2020	EPI_ISL_624026	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2E39/2020	EPI_ISL_624031	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA1993/2020	EPI_ISL_624047	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA32F0/2020	EPI_ISL_624052	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA2F09/2020	EPI_ISL_624054	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AA371F/2020	EPI_ISL_624066	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA0DD4/2020	EPI_ISL_624090	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-AA520D/2020	EPI_ISL_624093	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-AA1386/2020	EPI_ISL_624096	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA1948/2020	EPI_ISL_624177	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AA2D78/2020	EPI_ISL_624191	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Wales/QEUH-A9FFE1/2020	EPI_ISL_625324	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Wales/ALDP-A700E3/2020	EPI_ISL_625403	2020-10-15	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-483FF5/2020	EPI_ISL_627954	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.3	GV
hCoV-19/England/ALDP-ABD30F/2020	EPI_ISL_631111	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-AAF79B/2020	EPI_ISL_631137	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-ABC133/2020	EPI_ISL_631139	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-ABBB90/2020	EPI_ISL_631156	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AC12B0/2020	EPI_ISL_631184	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/CAMC-AAF898/2020	EPI_ISL_631194	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ABBED3/2020	EPI_ISL_631197	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-AAF8F2/2020	EPI_ISL_631204	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-ABC19D/2020	EPI_ISL_631209	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ABBE3D/2020	EPI_ISL_631214	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-AC5D42/2020	EPI_ISL_631215	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ABC29A/2020	EPI_ISL_631218	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-ABD26C/2020	EPI_ISL_631222	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ABBB36/2020	EPI_ISL_631229	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-AC121A/2020	EPI_ISL_631231	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/MILK-ABBC8E/2020	EPI_ISL_631246	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-ABC3B5/2020	EPI_ISL_631253	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-AAF591/2020	EPI_ISL_631270	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD0A7A/2020	EPI_ISL_633714	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD3145/2020	EPI_ISL_633725	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-AD1129/2020	EPI_ISL_633727	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD32F7/2020	EPI_ISL_633732	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AD550B/2020	EPI_ISL_633734	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD0E6F/2020	EPI_ISL_633753	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.17	GV
hCoV-19/England/QEUH-AD0DBD/2020	EPI_ISL_633764	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD0825/2020	EPI_ISL_633767	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AD3567/2020	EPI_ISL_633775	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD1B3A/2020	EPI_ISL_633791	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-AD32BB/2020	EPI_ISL_633805	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD54A4/2020	EPI_ISL_633846	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD0C0B/2020	EPI_ISL_633848	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD38F5/2020	EPI_ISL_633852	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD4FFF/2020	EPI_ISL_633854	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD3558/2020	EPI_ISL_633857	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD5592/2020	EPI_ISL_633879	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-AD4FA4/2020	EPI_ISL_633880	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-AD0E41/2020	EPI_ISL_633888	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-AD279F/2020	EPI_ISL_633892	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-AD3910/2020	EPI_ISL_633898	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/NOTT-11AC0E/2020	EPI_ISL_638604	2020-11-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11ADCF/2020	EPI_ISL_638606	2020-11-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11AE26/2020	EPI_ISL_638607	2020-11-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11AE44/2020	EPI_ISL_638608	2020-11-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11AEDB/2020	EPI_ISL_638609	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11B353/2020	EPI_ISL_638610	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11B380/2020	EPI_ISL_638611	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-11B3BD/2020	EPI_ISL_638613	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-9F5366/2020	EPI_ISL_638666	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/QEUH-A36A63/2020	EPI_ISL_638690	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A36AEB/2020	EPI_ISL_638695	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Ireland/MN-NVRL-20IRL51554/2020	EPI_ISL_639902	2020-09-30	Europe / Ireland / Monaghan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.55	GV
hCoV-19/Ireland/CN-NVRL-20IRL82829/2020	EPI_ISL_639904	2020-10-05	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/Ireland/CN-NVRL-20IRL51356/2020	EPI_ISL_639907	2020-09-30	Europe / Ireland / Cavan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.54	GV
hCoV-19/England/QEUH-A8C415/2020	EPI_ISL_643112	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-A8C3DC/2020	EPI_ISL_643114	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-A8B856/2020	EPI_ISL_643119	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8BFCA/2020	EPI_ISL_643123	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8B57D/2020	EPI_ISL_643155	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A8C3BE/2020	EPI_ISL_643156	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8BA05/2020	EPI_ISL_643163	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8C7EF/2020	EPI_ISL_643165	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8B461/2020	EPI_ISL_643167	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A8B74A/2020	EPI_ISL_643168	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-A8C7C1/2020	EPI_ISL_643171	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-A8BA50/2020	EPI_ISL_643174	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A8B883/2020	EPI_ISL_643193	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8C49D/2020	EPI_ISL_643198	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-A8C794/2020	EPI_ISL_643201	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A8BD66/2020	EPI_ISL_643202	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A8B4CB/2020	EPI_ISL_643216	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A8B874/2020	EPI_ISL_643226	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A8B5AA/2020	EPI_ISL_643230	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8BA7E/2020	EPI_ISL_643232	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A8BCF0/2020	EPI_ISL_643233	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8B513/2020	EPI_ISL_643242	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A8BCC3/2020	EPI_ISL_643263	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8B8FC/2020	EPI_ISL_643276	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8B7D1/2020	EPI_ISL_643278	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-A8B4DA/2020	EPI_ISL_643279	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-A8B838/2020	EPI_ISL_643295	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-A8BAC9/2020	EPI_ISL_643296	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/France/PAC-MEPHI-2371/2020	EPI_ISL_644545	2020-10-10	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.177	GV
hCoV-19/England/ALDP-B1C570/2020	EPI_ISL_645718	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B1B948/2020	EPI_ISL_645723	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1BF73/2020	EPI_ISL_645732	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1BA81/2020	EPI_ISL_645737	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B1CEB1/2020	EPI_ISL_645740	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1B0CB/2020	EPI_ISL_645741	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1CE1B/2020	EPI_ISL_645743	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1AF74/2020	EPI_ISL_645754	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B1C59E/2020	EPI_ISL_645759	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B1BADC/2020	EPI_ISL_645761	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1A75E/2020	EPI_ISL_645768	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B1C3EF/2020	EPI_ISL_645773	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1BBF7/2020	EPI_ISL_645774	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B1BA72/2020	EPI_ISL_645792	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B1CD69/2020	EPI_ISL_645795	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1CE48/2020	EPI_ISL_645797	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1CCD5/2020	EPI_ISL_645799	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B1A712/2020	EPI_ISL_645804	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1B4DE/2020	EPI_ISL_645817	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1B33B/2020	EPI_ISL_645818	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1B8B4/2020	EPI_ISL_645827	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B22146/2020	EPI_ISL_645829	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1F73B/2020	EPI_ISL_645833	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B1D506/2020	EPI_ISL_645835	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B22128/2020	EPI_ISL_645852	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1AE59/2020	EPI_ISL_645860	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1D5AC/2020	EPI_ISL_645865	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B1A34B/2020	EPI_ISL_645878	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B1DB40/2020	EPI_ISL_645879	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B22207/2020	EPI_ISL_645885	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.60	GV
hCoV-19/England/ALDP-B1C14F/2020	EPI_ISL_645892	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B2260B/2020	EPI_ISL_645896	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B48362/2020	EPI_ISL_649294	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/ALDP-B484F6/2020	EPI_ISL_649296	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B48168/2020	EPI_ISL_649297	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B47E53/2020	EPI_ISL_649300	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B47FE7/2020	EPI_ISL_649308	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B490F1/2020	EPI_ISL_649322	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B47FAB/2020	EPI_ISL_649324	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B47E26/2020	EPI_ISL_649325	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B490A6/2020	EPI_ISL_649331	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B481C2/2020	EPI_ISL_649333	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B481E0/2020	EPI_ISL_649335	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B482ED/2020	EPI_ISL_649341	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B49440/2020	EPI_ISL_649350	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B481FF/2020	EPI_ISL_649351	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B4906A/2020	EPI_ISL_649357	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B47E17/2020	EPI_ISL_649367	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B505DA/2020	EPI_ISL_649370	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B47E35/2020	EPI_ISL_649383	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B48DFB/2020	EPI_ISL_649387	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B48195/2020	EPI_ISL_649394	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B48F5F/2020	EPI_ISL_649450	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B493CB/2020	EPI_ISL_649462	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B4938F/2020	EPI_ISL_649465	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B24EF2/2020	EPI_ISL_649487	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/BIRM-66F29/2020	EPI_ISL_651602	2020-10-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/BIRM-675AE/2020	EPI_ISL_651618	2020-10-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.55	GV
hCoV-19/England/BIRM-678C3/2020	EPI_ISL_651624	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/BIRM-6AAAC/2020	EPI_ISL_651643	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/BIRM-6AABB/2020	EPI_ISL_651644	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/CAMB-1B867D/2020	EPI_ISL_651655	2020-10-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/QEUH-AACCBD/2020	EPI_ISL_652911	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AACED5/2020	EPI_ISL_652922	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AACFB4/2020	EPI_ISL_652931	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AAD047/2020	EPI_ISL_652934	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AAD056/2020	EPI_ISL_652935	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-AAD162/2020	EPI_ISL_652946	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AADB55/2020	EPI_ISL_652948	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/QEUH-AAE1AD/2020	EPI_ISL_652961	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-AAE25F/2020	EPI_ISL_652965	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-AAEB09/2020	EPI_ISL_652984	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-AAEC51/2020	EPI_ISL_652992	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/QEUH-B67D23/2020	EPI_ISL_655116	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B65DCB/2020	EPI_ISL_655122	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6AC14/2020	EPI_ISL_655129	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B68A94/2020	EPI_ISL_655134	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6C070/2020	EPI_ISL_655135	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B684F0/2020	EPI_ISL_655137	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6C438/2020	EPI_ISL_655144	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B65CEC/2020	EPI_ISL_655145	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-B6C17D/2020	EPI_ISL_655165	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-B6C1AA/2020	EPI_ISL_655175	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B6ACBA/2020	EPI_ISL_655190	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/QEUH-B68CDA/2020	EPI_ISL_655194	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B68539/2020	EPI_ISL_655199	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B68593/2020	EPI_ISL_655204	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6AD3F/2020	EPI_ISL_655206	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B685EE/2020	EPI_ISL_655209	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-B67D8D/2020	EPI_ISL_655232	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6C474/2020	EPI_ISL_655241	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6BA19/2020	EPI_ISL_655250	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6C043/2020	EPI_ISL_655265	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B5BAA3/2020	EPI_ISL_655273	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B622FC/2020	EPI_ISL_656405	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B627C0/2020	EPI_ISL_656412	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B6272A/2020	EPI_ISL_656424	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B62335/2020	EPI_ISL_656432	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B626E1/2020	EPI_ISL_656436	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B635D4/2020	EPI_ISL_656446	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-B63A7B/2020	EPI_ISL_656463	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B6299D/2020	EPI_ISL_656491	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B61FBA/2020	EPI_ISL_656512	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B63765/2020	EPI_ISL_656520	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B63AD5/2020	EPI_ISL_656521	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B634AA/2020	EPI_ISL_656522	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B63413/2020	EPI_ISL_656524	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B63A5D/2020	EPI_ISL_656529	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B63835/2020	EPI_ISL_656554	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B633E9/2020	EPI_ISL_656562	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B61FE7/2020	EPI_ISL_656568	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B62371/2020	EPI_ISL_656569	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B631D0/2020	EPI_ISL_656579	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B63CB1/2020	EPI_ISL_656586	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B628FA/2020	EPI_ISL_656599	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B515F7/2020	EPI_ISL_657721	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B54B98/2020	EPI_ISL_657729	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B555A8/2020	EPI_ISL_657742	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B5115D/2020	EPI_ISL_657744	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B54DFC/2020	EPI_ISL_657755	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.4	GV
hCoV-19/England/CAMC-B51612/2020	EPI_ISL_657759	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B54E44/2020	EPI_ISL_657768	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B51515/2020	EPI_ISL_657801	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B5546F/2020	EPI_ISL_657808	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B51EA1/2020	EPI_ISL_657813	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B51348/2020	EPI_ISL_657824	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B54F14/2020	EPI_ISL_657830	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B51EFC/2020	EPI_ISL_657852	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B51463/2020	EPI_ISL_657866	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B54CD1/2020	EPI_ISL_657870	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B51F17/2020	EPI_ISL_657875	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B67FB4/2020	EPI_ISL_662262	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B74A1D/2020	EPI_ISL_662265	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-B74D9C/2020	EPI_ISL_662266	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B68E5C/2020	EPI_ISL_662271	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B7494D/2020	EPI_ISL_662273	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B74CDB/2020	EPI_ISL_662275	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6A1AC/2020	EPI_ISL_662294	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B66B57/2020	EPI_ISL_662323	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B736A1/2020	EPI_ISL_662334	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6687E/2020	EPI_ISL_662348	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B67321/2020	EPI_ISL_662349	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B6A607/2020	EPI_ISL_662362	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6A7B9/2020	EPI_ISL_662368	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B66832/2020	EPI_ISL_662370	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6A142/2020	EPI_ISL_662384	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B73726/2020	EPI_ISL_662385	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6A379/2020	EPI_ISL_662387	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-B6A625/2020	EPI_ISL_662430	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B672E8/2020	EPI_ISL_662435	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B74136/2020	EPI_ISL_664901	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B741BE/2020	EPI_ISL_664908	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B74215/2020	EPI_ISL_664911	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B74F2D/2020	EPI_ISL_664915	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B74FC3/2020	EPI_ISL_664921	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B7541E/2020	EPI_ISL_664926	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/ALDP-B75A3A/2020	EPI_ISL_664928	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B75A94/2020	EPI_ISL_664932	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-B772F4/2020	EPI_ISL_664935	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B7734C/2020	EPI_ISL_664940	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Norway/4795/2020	EPI_ISL_668408	2020-10-22	Europe / Norway / Rogaland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/4797/2020	EPI_ISL_668409	2020-10-23	Europe / Norway / Vestfold og Telemark	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/4880/2020	EPI_ISL_668417	2020-10-21	Europe / Norway / Trondelag	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/4889/2020	EPI_ISL_668421	2020-10-21	Europe / Norway / Trondelag	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Denmark/DCGC-11361/2020	EPI_ISL_670866	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/CAMC-B09F69/2020	EPI_ISL_673003	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B093E5/2020	EPI_ISL_673004	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B08D60/2020	EPI_ISL_673011	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/CAMC-B095C1/2020	EPI_ISL_673014	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B09576/2020	EPI_ISL_673019	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B099E3/2020	EPI_ISL_673035	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B09FB4/2020	EPI_ISL_673047	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B0A5B1/2020	EPI_ISL_673050	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0A19F/2020	EPI_ISL_673052	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B09558/2020	EPI_ISL_673054	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B09F4B/2020	EPI_ISL_673064	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-B093D6/2020	EPI_ISL_673065	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0A5C0/2020	EPI_ISL_673077	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B0A566/2020	EPI_ISL_673079	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMC-B09DD8/2020	EPI_ISL_673084	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B09075/2020	EPI_ISL_673090	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-B09E20/2020	EPI_ISL_673091	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-B8824B/2020	EPI_ISL_674236	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B8C0A7/2020	EPI_ISL_674246	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B840DC/2020	EPI_ISL_674276	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B83EF1/2020	EPI_ISL_674297	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B88339/2020	EPI_ISL_674306	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/MILK-B883A2/2020	EPI_ISL_674315	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B8C0E3/2020	EPI_ISL_674316	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B83D7C/2020	EPI_ISL_674317	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B83F1C/2020	EPI_ISL_674322	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B83F3A/2020	EPI_ISL_674323	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B8C335/2020	EPI_ISL_674356	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B8528A/2020	EPI_ISL_674361	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B83F49/2020	EPI_ISL_674366	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B88199/2020	EPI_ISL_674381	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.2	GV
hCoV-19/England/MILK-B883B1/2020	EPI_ISL_674388	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B83D5E/2020	EPI_ISL_674421	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B8C49C/2020	EPI_ISL_674422	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B83BDC/2020	EPI_ISL_675573	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B89D94/2020	EPI_ISL_675576	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B83B90/2020	EPI_ISL_675581	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B92448/2020	EPI_ISL_675589	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B831E9/2020	EPI_ISL_675590	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B83B36/2020	EPI_ISL_675614	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B83B27/2020	EPI_ISL_675615	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B832D7/2020	EPI_ISL_675618	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-B832F5/2020	EPI_ISL_675626	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B89F9E/2020	EPI_ISL_675631	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B83064/2020	EPI_ISL_675638	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B83231/2020	EPI_ISL_675647	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-B8530F/2020	EPI_ISL_675662	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-B89C88/2020	EPI_ISL_675682	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B85378/2020	EPI_ISL_675699	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/MILK-B8C687/2020	EPI_ISL_675725	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-B85985/2020	EPI_ISL_675740	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-B88A70/2020	EPI_ISL_675747	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/CAMB-1BB962/2020	EPI_ISL_679167	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMB-1BBAAB/2020	EPI_ISL_679187	2020-11-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/CAMB-1BBB5D/2020	EPI_ISL_679198	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/SHEF-C236B/2020	EPI_ISL_680121	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Northern Ireland/NIRE-1093C1/2020	EPI_ISL_680198	2020-10-22	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-1094A0/2020	EPI_ISL_680201	2020-10-22	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-109525/2020	EPI_ISL_680203	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Northern Ireland/NIRE-109604/2020	EPI_ISL_680205	2020-10-22	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-109613/2020	EPI_ISL_680206	2020-10-17	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/Northern Ireland/NIRE-10968C/2020	EPI_ISL_680213	2020-10-22	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-10969B/2020	EPI_ISL_680214	2020-10-17	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-1096AA/2020	EPI_ISL_680215	2020-10-22	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Northern Ireland/NIRE-1096E6/2020	EPI_ISL_680216	2020-10-22	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-109710/2020	EPI_ISL_680217	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/Northern Ireland/NIRE-10973E/2020	EPI_ISL_680219	2020-10-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-10974D/2020	EPI_ISL_680220	2020-10-17	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-109798/2020	EPI_ISL_680223	2020-10-23	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-1097B6/2020	EPI_ISL_680224	2020-10-23	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-1097F2/2020	EPI_ISL_680225	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Northern Ireland/NIRE-232E63/2020	EPI_ISL_680230	2020-09-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/MILK-BAB549/2020	EPI_ISL_681407	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAB93E/2020	EPI_ISL_681426	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BA9A79/2020	EPI_ISL_681440	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BABE5D/2020	EPI_ISL_681447	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BABE99/2020	EPI_ISL_681451	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAAF97/2020	EPI_ISL_681490	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAB9E3/2020	EPI_ISL_681538	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAB94D/2020	EPI_ISL_681541	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BA9B94/2020	EPI_ISL_681549	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BA9BD0/2020	EPI_ISL_681559	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/204661424/2020	EPI_ISL_693411	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/204661601/2020	EPI_ISL_693415	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204661604/2020	EPI_ISL_693416	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204682404/2020	EPI_ISL_693424	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204683182/2020	EPI_ISL_693428	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204691822/2020	EPI_ISL_693442	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204700011/2020	EPI_ISL_693455	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204722566/2020	EPI_ISL_693461	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204740527/2020	EPI_ISL_693467	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.56	GV
hCoV-19/England/ALDP-BB57BF/2020	EPI_ISL_703123	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB8DE7/2020	EPI_ISL_703131	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB2A22/2020	EPI_ISL_703145	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB2B98/2020	EPI_ISL_703161	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BB9D40/2020	EPI_ISL_703186	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BBACAC/2020	EPI_ISL_703188	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BBACF7/2020	EPI_ISL_703201	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB9900/2020	EPI_ISL_703220	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BB8EA8/2020	EPI_ISL_703231	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BB55B5/2020	EPI_ISL_703242	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCA896/2020	EPI_ISL_703247	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCE382/2020	EPI_ISL_704423	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-BCB6E6/2020	EPI_ISL_704474	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-BCCDB3/2020	EPI_ISL_704482	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-BCE8FC/2020	EPI_ISL_704539	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BCCDFF/2020	EPI_ISL_704560	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/LIVE-DC3998/2020	EPI_ISL_705865	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.55	GV
hCoV-19/England/LIVE-DC3B38/2020	EPI_ISL_705870	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/LIVE-DC3CBD/2020	EPI_ISL_705876	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/LIVE-DC40A1/2020	EPI_ISL_705884	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/LIVE-DC40ED/2020	EPI_ISL_705885	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/LIVE-DC41EA/2020	EPI_ISL_705889	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Norway/5165/2020	EPI_ISL_708042	2020-10-26	Europe / Norway / Trndelag	Human	Original			Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/5166/2020	EPI_ISL_708043	2020-10-19	Europe / Norway / Trndelag	Human	Original			Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/5366/2020	EPI_ISL_708065	2020-11-02	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/5367/2020	EPI_ISL_708066	2020-11-02	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/5369/2020	EPI_ISL_708067	2020-11-02	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/Norway/5371/2020	EPI_ISL_708068	2020-11-02	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.60	GV
hCoV-19/England/QEUH-BF117D/2020	EPI_ISL_709277	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C06208/2020	EPI_ISL_709296	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C068AC/2020	EPI_ISL_709298	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C17F1C/2020	EPI_ISL_709327	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C05F5D/2020	EPI_ISL_709337	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C062AE/2020	EPI_ISL_709339	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C14C18/2020	EPI_ISL_709345	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C064C6/2020	EPI_ISL_709350	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C149F3/2020	EPI_ISL_709364	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C14E4F/2020	EPI_ISL_709399	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-14083/2020	EPI_ISL_711555	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-14091/2020	EPI_ISL_711561	2020-11-30	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-13689/2020	EPI_ISL_712961	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-13750/2020	EPI_ISL_712999	2020-11-30	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/QEUH-BA35D8/2020	EPI_ISL_721016	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-BA4179/2020	EPI_ISL_721043	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-BA421C/2020	EPI_ISL_721079	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-B9F9B5/2020	EPI_ISL_721082	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Spain/AR-IBV-98010624/2020	EPI_ISL_722262	2020-11-10	Europe / Spain / Aragon / Zaragoza	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/England/ALDP-B1DF62/2020	EPI_ISL_723551	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/Wales/ALDP-B1DFBD/2020	EPI_ISL_723555	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.56	GV
hCoV-19/England/ALDP-B1DFDB/2020	EPI_ISL_723557	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-B5DB44/2020	EPI_ISL_723562	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-B5DBAE/2020	EPI_ISL_723567	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/ALDP-B5DCE7/2020	EPI_ISL_723582	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-B5DE1E/2020	EPI_ISL_723597	2020-11-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-B5DE96/2020	EPI_ISL_723604	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-B5DF93/2020	EPI_ISL_723618	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.2	GV
hCoV-19/England/ALDP-B5E19C/2020	EPI_ISL_723637	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B5E4FD/2020	EPI_ISL_723662	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B5E509/2020	EPI_ISL_723663	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B5E518/2020	EPI_ISL_723664	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/ALDP-B758C7/2020	EPI_ISL_723678	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-B7591F/2020	EPI_ISL_723681	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/ALDP-B75CCB/2020	EPI_ISL_723695	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-498AA1/2020	EPI_ISL_727168	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina		NSP11 without BLAST coverage.	warn	B.1.177.56	GV
hCoV-19/Wales/PHWC-498ADE/2020	EPI_ISL_727171	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-498DC6/2020	EPI_ISL_727211	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/ALDP-C39B5C/2020	EPI_ISL_730717	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C39D92/2020	EPI_ISL_730761	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-C3B6C2/2020	EPI_ISL_730775	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3AC58/2020	EPI_ISL_730798	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3D60C/2020	EPI_ISL_730818	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C3D89D/2020	EPI_ISL_730826	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3D824/2020	EPI_ISL_730829	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-C3ACB2/2020	EPI_ISL_730857	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-C61A4F/2020	EPI_ISL_735620	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/Japan/IC-0409/2020	EPI_ISL_736917	2020-12-14	Asia / Japan	Human	Original	Saliva		Illumina iSeq	SKESA v. 2.3.0			B.1.177	GV
hCoV-19/Luxembourg/LNS2186059/2020	EPI_ISL_740073	2020-11-10	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2264925/2020	EPI_ISL_740087	2020-11-09	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS2599024/2020	EPI_ISL_740154	2020-10-29	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/England/MILK-B3DE6F/2020	EPI_ISL_741403	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/England/MILK-B3DF6C/2020	EPI_ISL_741412	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/MILK-B3DF99/2020	EPI_ISL_741415	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21FAA4/2020	EPI_ISL_741460	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21FBED/2020	EPI_ISL_741467	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21FC53/2020	EPI_ISL_741470	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21FC80/2020	EPI_ISL_741472	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21FCBD/2020	EPI_ISL_741473	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21FD32/2020	EPI_ISL_741476	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21FD50/2020	EPI_ISL_741477	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21FD7E/2020	EPI_ISL_741478	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/NORW-21FD8D/2020	EPI_ISL_741479	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-49CF62/2020	EPI_ISL_742710	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49D383/2020	EPI_ISL_742771	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-49D5D8/2020	EPI_ISL_742805	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Luxembourg/LNS9897343/2020	EPI_ISL_745004	2020-10-20	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/England/205090548/2020	EPI_ISL_747509	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/Denmark/DCGC-19352/2020	EPI_ISL_748901	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/MILK-C78A54/2020	EPI_ISL_757010	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-C7B769/2020	EPI_ISL_757014	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/Denmark/DCGC-21514/2020	EPI_ISL_758205	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-21071/2020	EPI_ISL_759536	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-21172/2020	EPI_ISL_759590	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-21180/2020	EPI_ISL_759596	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-21244/2020	EPI_ISL_759632	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-21319/2020	EPI_ISL_759673	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-21339/2020	EPI_ISL_759689	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-21353/2020	EPI_ISL_759696	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/ALDP-CBE533/2020	EPI_ISL_760574	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CBE80D/2020	EPI_ISL_760625	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-CC046E/2020	EPI_ISL_760633	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/QEUH-CC2A00/2020	EPI_ISL_760675	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB4843/2020	EPI_ISL_761815	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-CB636E/2020	EPI_ISL_761838	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-CB53C9/2020	EPI_ISL_761843	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-CB52AE/2020	EPI_ISL_761860	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB560C/2020	EPI_ISL_761861	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-CB60FE/2020	EPI_ISL_761874	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CB5CA0/2020	EPI_ISL_761916	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-CB5411/2020	EPI_ISL_761917	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C93D69/2020	EPI_ISL_761980	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C98C67/2020	EPI_ISL_761981	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C754B3/2020	EPI_ISL_769012	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C737DA/2020	EPI_ISL_769042	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C7202B/2020	EPI_ISL_769046	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-C72146/2020	EPI_ISL_769050	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.60	GV
hCoV-19/England/CAMC-C71CDD/2020	EPI_ISL_769074	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Latvia/203/2020	EPI_ISL_770039	2020-09-10	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.177.60	GV
hCoV-19/England/QEUH-C940E7/2020	EPI_ISL_777436	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-C8D834/2020	EPI_ISL_777470	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/QEUH-C93F27/2020	EPI_ISL_777475	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/CAMC-C99361/2020	EPI_ISL_777488	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-C6A18D/2020	EPI_ISL_778635	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CED1A0/2020	EPI_ISL_782010	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAADD9/2020	EPI_ISL_783204	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAC0FC/2020	EPI_ISL_783210	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BAAEE5/2020	EPI_ISL_783218	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAAD51/2020	EPI_ISL_783227	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BA9DBC/2020	EPI_ISL_783235	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAA2DA/2020	EPI_ISL_783243	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BAF958/2020	EPI_ISL_783263	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAB761/2020	EPI_ISL_783266	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAAEF4/2020	EPI_ISL_783280	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-BAC0ED/2020	EPI_ISL_783292	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAC0DE/2020	EPI_ISL_783295	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAC135/2020	EPI_ISL_783325	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAAE7C/2020	EPI_ISL_783327	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAF90D/2020	EPI_ISL_783330	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-BAC232/2020	EPI_ISL_783343	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Switzerland/VD-ETHZ-430488/2020	EPI_ISL_796576	2020-12-28	Europe / Switzerland / Vaud	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177	G
hCoV-19/Switzerland/VS-ETHZ-430735/2020	EPI_ISL_796579	2020-12-31	Europe / Switzerland / Valais	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Switzerland/ZH-ETHZ-430199/2020	EPI_ISL_796597	2020-12-26	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.77	GV
hCoV-19/Norway/7123/2020	EPI_ISL_796679	2020-12-23	Europe / Norway / Vestfold og Telemark	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.177.57	GV
hCoV-19/Norway/7121/2020	EPI_ISL_796680	2020-12-23	Europe / Norway / Vestfold og Telemark	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.177.57	GV
hCoV-19/England/QEUH-D890F3/2020	EPI_ISL_797837	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/QEUH-D84DC4/2020	EPI_ISL_797974	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-CE1ADE/2020	EPI_ISL_800194	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/QEUH-D14D6F/2020	EPI_ISL_800210	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CE15FB/2020	EPI_ISL_800223	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-CE2C04/2020	EPI_ISL_800271	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-D0F57E/2020	EPI_ISL_800341	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/CAMC-D10871/2020	EPI_ISL_800391	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Netherlands/ZH-EMC-1302/2020	EPI_ISL_801508	2020-12-28	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.54	GV
hCoV-19/Netherlands/ZH-EMC-1303/2020	EPI_ISL_801509	2020-12-28	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/Netherlands/ZH-EMC-1306/2020	EPI_ISL_801511	2020-12-30	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.77	GV
hCoV-19/Netherlands/ZH-EMC-1317/2020	EPI_ISL_801514	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177.54	GV
hCoV-19/Lithuania/T-1670/2020	EPI_ISL_802855	2020-11-19	Europe / Lithuania / Vilnius	Human	Original	Oropharyngeal swab		Illumina Miniseq	CoVpipe assembly pipeline v2.0.4			B.1.177.60	GV
hCoV-19/Lithuania/T-2113/2020	EPI_ISL_802859	2020-11-28	Europe / Lithuania / Telsiai	Human	Original	Oropharyngeal swab		Illumina MiniSeq	CoVpipe assembly pipeline v2.0.4			B.1.177.79	GV
hCoV-19/England/EXET-13FE3A/2020	EPI_ISL_813495	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/LIVE-DCA551/2020	EPI_ISL_813686	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DCA5BB/2020	EPI_ISL_813689	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DCA73D/2020	EPI_ISL_813694	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/LIVE-DCA867/2020	EPI_ISL_813699	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Wales/PHWC-4A7B7F/2020	EPI_ISL_814928	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/Wales/PHWC-4A7D3D/2020	EPI_ISL_814948	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Wales/PHWC-4A7E3A/2020	EPI_ISL_814956	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4A7E94/2020	EPI_ISL_814958	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/Wales/PHWC-4A8288/2020	EPI_ISL_814992	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/TFCI-26FB7AD/2020	EPI_ISL_817003	2020-12-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/TFCI-26FBB29/2020	EPI_ISL_817033	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1211AB/2020	EPI_ISL_819601	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1211D8/2020	EPI_ISL_819602	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1211E7/2020	EPI_ISL_819603	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121202/2020	EPI_ISL_819604	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-12140C/2020	EPI_ISL_819649	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/NOTT-121545/2020	EPI_ISL_819652	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/OXON-F439AD/2020	EPI_ISL_819666	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/NOTT-1216BB/2020	EPI_ISL_819726	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1216CA/2020	EPI_ISL_819727	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1216D9/2020	EPI_ISL_819728	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-1216E8/2020	EPI_ISL_819729	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/England/NOTT-121703/2020	EPI_ISL_819730	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/OXON-F427E0/2020	EPI_ISL_819734	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.55	GV
hCoV-19/England/NOTT-122264/2021	EPI_ISL_820603	2021-01-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.4	GV
hCoV-19/England/ALDP-DB1BB5/2021	EPI_ISL_821996	2021-01-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/204000712/2020	EPI_ISL_825575	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/204100880/2020	EPI_ISL_825576	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/204340310/2020	EPI_ISL_825586	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.57	GV
hCoV-19/England/204490810/2020	EPI_ISL_825591	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204490811/2020	EPI_ISL_825592	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/204590602/2020	EPI_ISL_825595	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.4	GV
hCoV-19/England/205341103/2020	EPI_ISL_825614	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.54	GV
hCoV-19/England/ALDP-F4B77E/2021	EPI_ISL_833943	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-F51F5F/2021	EPI_ISL_833966	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-EE4A8E/2021	EPI_ISL_835009	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/MILK-EC92F0/2021	EPI_ISL_836241	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-ECBEAF/2021	EPI_ISL_836243	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-EC93DF/2021	EPI_ISL_836311	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/QEUH-A62433/2020	EPI_ISL_842134	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A62697/2020	EPI_ISL_842147	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A627A3/2020	EPI_ISL_842158	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/England/QEUH-A8C9BC/2020	EPI_ISL_842175	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.56	GV
hCoV-19/England/QEUH-A8CB5C/2020	EPI_ISL_842179	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
hCoV-19/Denmark/DCGC-29389/2021	EPI_ISL_843436	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-29417/2021	EPI_ISL_843464	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.79	GV
hCoV-19/Denmark/DCGC-29449/2021	EPI_ISL_843496	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-29450/2021	EPI_ISL_843497	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Denmark/DCGC-32197/2020	EPI_ISL_856613	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			U.2	GV
hCoV-19/Belgium/ULG-11309/2021	EPI_ISL_856753	2021-01-13	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.77	GV
hCoV-19/England/MILK-EC8C99/2021	EPI_ISL_863856	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.60	GV
hCoV-19/England/ALDP-10049B3/2021	EPI_ISL_863887	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1005B70/2021	EPI_ISL_863891	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Wales/PHWC-4B8ABA/2021	EPI_ISL_867486	2021	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.54	GV
hCoV-19/England/SHEF-10D8B2B/2021	EPI_ISL_868713	2021-01-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/TFCI-26FE5DD/2020	EPI_ISL_868742	2020-12-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/TFCI-26FE625/2020	EPI_ISL_868747	2020-12-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.54	GV
hCoV-19/England/TFCI-26FE6BC/2020	EPI_ISL_868756	2020-12-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.56	GV
hCoV-19/England/TFCI-26FE8D4/2020	EPI_ISL_868779	2020-11-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.57	GV
hCoV-19/Denmark/DCGC-33906/2021	EPI_ISL_870916	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/England/ALDP-100AC2D/2021	EPI_ISL_874439	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-10051D8/2021	EPI_ISL_874454	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-100724C/2021	EPI_ISL_874561	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1003CF7/2021	EPI_ISL_874580	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-106558F/2021	EPI_ISL_878131	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-1035BC2/2021	EPI_ISL_879392	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-1030D1C/2021	EPI_ISL_880417	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-1030909/2021	EPI_ISL_880421	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-1030CC4/2021	EPI_ISL_880486	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-FA2520/2021	EPI_ISL_881713	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-FA2845/2021	EPI_ISL_881726	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-FA2159/2021	EPI_ISL_881741	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-FA2836/2021	EPI_ISL_881748	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				U.1	GV
hCoV-19/England/ALDP-FA25B7/2021	EPI_ISL_881756	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Netherlands/ZE-RIVM-10610/2021	EPI_ISL_904912	2021-01-12	Europe / Netherlands / Zeeland	Human	Original			Nanopore MinION				B.1.177.77	GV
hCoV-19/Netherlands/ZH-RIVM-10588/2021	EPI_ISL_904916	2021-01-18	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.177.57	GV
hCoV-19/Lithuania/T_1740/2020	EPI_ISL_904949	2020-11-23	Europe / Lithuania / Molt r.	Human	Original	Oropharyngeal swab		Illumina Miniseq	CoVpipe assembly pipeline v2.0.4 combined with BLAST 2.10.17			B.1.177.60	GV
hCoV-19/Lithuania/T_1852/2020	EPI_ISL_904951	2020-11-24	Europe / Lithuania / Vilnius	Human	Original	Oropharyngeal swab		Illumina Miniseq	CoVpipe assembly pipeline v2.0.4 combined with BLAST 2.10.19			B.1.177.60	GV
hCoV-19/Lithuania/T_1657/2020	EPI_ISL_904954	2020-11-20	Europe / Lithuania / Vilnius	Human	Original	Oropharyngeal swab		Illumina Miniseq	CoVpipe assembly pipeline v2.0.4 combined with BLAST 2.10.21			B.1.177.60	GV
hCoV-19/England/ALDP-10DE76D/2021	EPI_ISL_908402	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/France/HDF-IPP01068/2021	EPI_ISL_909734	2021-01-14	Europe / France / Nord Pas de Calais / Henin-Beaumont	Human	Original	Nasopharyngeal		Illumina NextSeq 500	CLC Genomics Suite			B.1.177.54	GV
hCoV-19/Luxembourg/LNS2950420/2021	EPI_ISL_910611	2021-01-02	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS0483771/2021	EPI_ISL_910612	2021-01-02	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS3772864/2020	EPI_ISL_910647	2020-11-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS6441774/2020	EPI_ISL_910705	2020-11-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS8868889/2020	EPI_ISL_910727	2020-12-09	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS8061170/2020	EPI_ISL_910737	2020-12-09	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS9015402/2020	EPI_ISL_910740	2020-12-09	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS9486563/2020	EPI_ISL_910741	2020-12-09	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS5869615/2020	EPI_ISL_910748	2020-12-05	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS3707215/2020	EPI_ISL_910759	2020-12-10	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS8829303/2020	EPI_ISL_910760	2020-12-10	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS9765269/2020	EPI_ISL_910762	2020-12-10	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177	GV
hCoV-19/Luxembourg/LNS6553636/2020	EPI_ISL_910767	2020-12-03	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS7703976/2020	EPI_ISL_910775	2020-11-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/Luxembourg/LNS6101690/2020	EPI_ISL_910776	2020-11-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177.77	GV
hCoV-19/England/ALDP-BC9F47/2020	EPI_ISL_915442	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC909F/2020	EPI_ISL_915464	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/ALDP-BC95EB/2020	EPI_ISL_915470	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC9220/2020	EPI_ISL_915471	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCA09E/2020	EPI_ISL_915474	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BC9572/2020	EPI_ISL_915475	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.55	GV
hCoV-19/England/ALDP-BCB17C/2020	EPI_ISL_915500	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC9A37/2020	EPI_ISL_915516	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BC9703/2020	EPI_ISL_915538	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC91C9/2020	EPI_ISL_915544	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BCB2B5/2020	EPI_ISL_915554	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/ALDP-BC9FDE/2020	EPI_ISL_915563	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-BC9527/2020	EPI_ISL_915568	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-BC90BD/2020	EPI_ISL_915575	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.56	GV
hCoV-19/England/ALDP-BC9FFC/2020	EPI_ISL_915604	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-100D941/2021	EPI_ISL_916779	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1011E3C/2021	EPI_ISL_916785	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/ALDP-1014613/2021	EPI_ISL_916874	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Denmark/DCGC-35032/2021	EPI_ISL_926172	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-35103/2021	EPI_ISL_926243	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-35128/2021	EPI_ISL_926268	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-36305/2021	EPI_ISL_927446	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-36418/2021	EPI_ISL_927559	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-36442/2021	EPI_ISL_927583	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/England/ALDP-1182309/2021	EPI_ISL_932080	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-E0ABCB/2020	EPI_ISL_933464	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/England/MILK-E04A88/2020	EPI_ISL_933472	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/Northern Ireland/MILK-CA6A3F/2020	EPI_ISL_933481	2020-12-17	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.54	GV
hCoV-19/England/MILK-BB2239/2020	EPI_ISL_933495	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Belgium/Jessa_55-2103-000968/2021	EPI_ISL_940585	2021-01-23	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Portugal/PT2740/2021	EPI_ISL_941737	2021-01-12	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.177.4	GV
hCoV-19/Portugal/PT2913/2021	EPI_ISL_941895	2021-01-13	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.177.4	GV
hCoV-19/England/MILK-F6E2ED/2021	EPI_ISL_945274	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.57	GV
hCoV-19/England/ALDP-119D198/2021	EPI_ISL_945409	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/ALDP-119C490/2021	EPI_ISL_945437	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.4	GV
hCoV-19/England/OXON-F4ACE9/2021	EPI_ISL_951121	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.57	GV
hCoV-19/Northern Ireland/OXON-F4DD7A/2021	EPI_ISL_951215	2021-01-06	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				V.1	GV
hCoV-19/England/QEUH-11CC28E/2021	EPI_ISL_964440	2021-02-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.4	GV
hCoV-19/Denmark/DCGC-39914/2021	EPI_ISL_971591	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-39920/2021	EPI_ISL_971597	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.77	GV
hCoV-19/Denmark/DCGC-39970/2021	EPI_ISL_971647	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-40031/2021	EPI_ISL_971708	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Denmark/DCGC-40032/2021	EPI_ISL_971709	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.60	GV
hCoV-19/Belgium/UGent-1114/2021	EPI_ISL_982245	2021-01-14	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.60	GV
hCoV-19/Belgium/UGent-1225/2021	EPI_ISL_982277	2021-01-25	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.177.77	GV
hCoV-19/Wales/ALDP-11CF4D0/2021	EPI_ISL_989710	2021-01-30	Europe / United Kingdom / Wales	Human	Original			ILLUMINA NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-11BE01C/2021	EPI_ISL_989732	2021-01-30	Europe / United Kingdom / Wales	Human	Original			ILLUMINA NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-11BDBA3/2021	EPI_ISL_989734	2021-01-30	Europe / United Kingdom / Wales	Human	Original			ILLUMINA NovaSeq				B.1.177.57	GV
hCoV-19/Wales/ALDP-11BDEAA/2021	EPI_ISL_989744	2021-01-30	Europe / United Kingdom / Wales	Human	Original			ILLUMINA NovaSeq				B.1.177.57	GV
hCoV-19/Belgium/Jessa_55-2102-00356/2021	EPI_ISL_995547	2021-01-13	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.177.77	GV
hCoV-19/Belgium/rega-2719/2021	EPI_ISL_995576	2021-02-01	Europe / Belgium / Herentals	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/Belgium/rega-2727/2021	EPI_ISL_995584	2021-02-01	Europe / Belgium / Kasterlee	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.177.77	GV
hCoV-19/England/OXON-F56DF6/2021	EPI_ISL_999150	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.4	GV
